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Abstract 
The amber suppression technology is an intracellular methodology that allows 
position specific incorporation of a specific non-natural amino acid (NAA) into 
proteins using imported NAA-specific machinery during protein translation.  The 
method has been utilised to incorporate over 50 NAAs into proteins (e.g. those that 
confer unique reactivity (and allow subsequent conjugation of additional factors), 
installation of post-translational modification mimics, modulation of protein 
function and those that aid in structural determination).  Therefore, the aim of the 
work presented within this Thesis was to explore the use of this technology in novel 
applications; namely the installation and study of a reactive moiety within a defined 
environment and the creation of a ‘biological switch’ to control the production of 
the protein and subsequently a cellular phenotype. 
It was demonstrated that incorporation of the NAA, azidophenylalanine, within the 
hydrophobic pocket of T4 Lysozyme (T4LazF) could provide a protein scaffold to 
stabilise, shield and thereby allow exploration of the chemical reactivity of the 
photoreactive aryl azide moiety using various spectroscopic techniques. 
 Specifically, electron paramagnetic spectroscopy of irradiated T4LazF 
demonstrated that the singlet phenyl nitrene species had been captured.  To create 
a ‘biological switch’ to control the production of a protein and the subsequent 
cellular phenotype, the duality of the amber suppression method was the basis for 
the novel application rather than the chemical reactivity of the NAA.  E. coli and 
mammalian cell motility readout systems were successfully created using flagellin 
(non-flagellate) and Rac1 (GTPase protein involved in lamellipodia production) 
knockout cell lines respectively in conjunction with specially created plasmid 
constructs.  However, complexities regarding the implementation of amber 
suppression in order to control this motility via the presence/absence of NAA 
limited the functionality of these readout systems. 
The work presented has advanced the field of amber suppression and NAA 
technology by demonstrating that generating reactive intermediates derived from 
NAAs within a defined chemical environment of a protein provides a novel 
technique to generate and study highly reactive intermediates.  In addition, it has 
been shown that the amber suppression technology has potential to act as a 
biological switch to control cellular responses. 
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1 CHAPTER 1: INTRODUCTION 
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1.1 Introduction 
The aim of this Chapter is to introduce the reader to the topics that relate to the 
experimental study that is covered within this thesis.  Firstly, the process of 
translation will be described for both the prokaryotic system and eukaryotic 
system, as both systems are utilised within the experimental work reported in this 
thesis.  This includes the nature of the genetic code, the relationship to translation 
and processes which ensure the fidelity of the translation of the genetic code to 
protein.  Namely, the specific recognitions and aminoacylation reactions that occur 
between the aminoacyl tRNA synthetases and tRNA molecules.  This will focus on 
the tyrosine aminoacyl tRNA synthetases and tRNA from all the kingdoms of life.  
These particular points are outlined due to their importance in the methods used 
within this thesis.  This Chapter will then continue to introduce the variety of 
methods used to expand the chemical, biological and physical properties of 
proteins by the introduction of non-natural amino acids, focussing on the recently 
established method utilising genetic code expansion.  This method utilises the in 
vivo process of translation along with an orthogonal aminoacyl tRNA synthetases 
and tRNA pair and essentially recodes the amber stop codon to instead code for a 
non-natural amino acid.  The previous applications of this amber suppression 
method, in both prokaryotic and eukaryotic systems, will be outlined.  Explanation 
and rational for the work conveyed within this thesis will be considered, in 
particular in relation to the two novel applications addressed.  The first application 
involves the elucidation of reactive intermediates by creating a defined and 
stabilising environment, which was thought could be used to reduce the 
complications of bimolecular reactions which occur when studying highly reactive 
intermediates.  The environment considered is the hydrophobic pocket within the 
well-studied protein, T4 lysozyme and the photoreactive azide group providing an 
example of a highly reactive species.  The second application explores the use of the 
amber suppression method to control cellular phenotype by creating a switch 
controllable by the presence/absence of non-natural amino acid.  Both the 
prokaryotic and eukaryotic systems were used in the investigations.  In both cases 
the phenotype selected for control was motility.  The Chapter will then conclude 
3 
 
with the hypothesis for the investigations performed and reported within this 
Thesis. 
1.2 Translation 
Translation is the process by which genetic information in the form of messenger 
RNA (mRNA) is converted into a sequence of corresponding amino acids to form a 
peptide chain.  In the cell, this process is undertaken by the ribosome and involves a 
number of protein (e.g. aminoacyl tRNA synthetases) and RNA molecules (e.g. the 
amino acid - RNA adapter molecule, tRNA).  Translation can be divided into three 
steps, initiation of protein synthesis, elongation of the peptide chain and 
termination and release of the peptide.  During initiation the ribosome and required 
protein factors assemble on the mRNA, the start site of the gene is located and the 
initiator tRNA is bound.  Throughout elongation, amino acids are delivered to the 
ribosome by aminoacylated-tRNAs, codon : anticodon recognition occurs and the 
amino acids are joined on to the growing chain via a peptide bond.  At termination, 
a termination codon is read, which does not code for an amino acid because there 
is no tRNA with an anticodon that recognises it, causing the ribosome to dissociate 
and the peptide to be released from the complex.  A number of components are 
involved within translation and a selection function to ensure fidelity of protein 
synthesis.  The factors differ between prokaryotic and eukaryotic translation and 
will be considered below. 
1.3 Prokaryotic translation 
1.3.1 Ribosome 
The ribosome is a large complex made up of two subunits comprising of protein and 
RNA (for review see Ramakrishnan 2002).  The complex has three tRNA binding 
positions; the aminoacyl site (A-site), the peptidyl site (P-site) and the exit site (E-
site; Figure 1).  The small subunit (30S) comprises the 16S rRNA molecule and 21 
different ribosomal proteins (r-proteins, S1-S21).  The proteins are predominantly 
basic in order to stabilise the negatively charged RNA.  The rRNA plays an active role 
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in translation by intercalating with mRNA and facilitating its proper alignment 
within the ribosome complex.  The large subunit (50S) comprises the 23S, 5S rRNA 
and 34 proteins and confers peptidyltransferase and translocase activity. 
1.3.2 Initiation 
The process of initiation requires initiation factors, IF-1, IF-2 and IF-3 (for review see 
Laursen et al. 2005).  IF-1 and IF-3 bind to the free 30S subunit preventing re-
association with the 50S and blocks the A-site preventing tRNA from binding to the 
initiation complex.  During translation initiation the ribosome binding site (RBS; 
comprising the purine-rich Shine-Dalgarno sequence and start codon, typically AUG) 
of the mRNA is recognised by the 16S component of the small subunit of the 
ribosome (Figure 1A).  IF-2-GTP is responsible for transporting the first aminoacyl-
tRNA (fMet-tRNAf) to the P-site of the initiation complex.  If the base pairing 
between initiator tRNA and start codon is correct, IF-3 is released from the 
complex.  The 50S subunit then associates with the initiation complex concurrently 
with hydrolysis of IF-2-GTP and release of IF-1 and IF-2. 
1.3.3 Elongation 
During elongation aminoacyl-tRNA synthetases (aa-tRNAs) are transported to the A-
site by elongation factor, EF-Tu-GTP (Figure 1B).  If complementary base-pairing 
occurs within the A-site, GTP hydrolysis occurs and EF-Tu-GDP is released.  This GTP 
hydrolysis in response to correct aa-tRNA association acts as the rate-limiting step 
within translation elongation, providing a time interval during which an incorrect 
aminoacyl tRNA, which would bind less strongly to the mRNA codon, can dissociate 
from the ribosome rather than being incorporated incorrectly. 
The peptidyltransferase reaction, catalysed by the 23S rRNA (of the large subunit), 
occurs between the free carboxyl group of the amino acid connected to the tRNA 
present within the P-site (peptidyl-tRNA) and the free amino group of the amino 
acid connected to the tRNA within the A-site (aa-tRNA).  Translocation of the 
ribosome is promoted by elongation factor, EF-G-GTP.  GTP hydrolysis triggers a 
conformational change within the ribosome which promotes the translocation of 
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the ribosome.  The process results in the next 3’ codon to enter the A-site and the 
recently de-aminoacylated tRNA moves from the P-site to the E-site.  The ribosome 
is then left with a peptidyl tRNA bound at the P site, and an empty A site.  The 
process is repeated by the delivery of the next aa-tRNA to the A-site by EF-Tu and 
the de-aminoacylated tRNA is ejected from the E-site.   
6 
 
 
Figure 1.  Prokaryotic translation.  A) Initiation.  RBS of the mRNA is recognised by the 16S component of the small subunit of the ribosome (green) along with initiation factors IF-
1, IF-2 and IF-3.  IF-2-GTP transports the first aminoacyl-tRNA (fMet-tRNAf; yellow) to the P-site of the initiation complex, IF-3 is released from the complex.  The 50S subunit then 
associates to the initiation complex concurrently with hydrolysis of IF-2-GTP and release of IF-1 andIF-2-GDP. 
B)  Elongation.  aa-tRNAs are transported to the A-site by EF-Tu-GTP.  A peptidyltransferase reaction, catalysed by the 23S rRNA, occurs between the two amino acids.  
Translocation of the ribosome is promoted by hydrolysis of EF-G-GTP. 
C)  Termination.  Stop codons are recognised by release factors, which upon binding cause conformational changes that allow disassociation of the polypeptide, tRNA and 
ribosome subunits.  Subsequent binding of IF-3 to the 30S subunit results in disassociation of the release factors, mRNA and tRNA. 
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The cycle of elongation repeats throughout the reading frame of the target gene, 
decoding each codon to its corresponding amino acid, which is added to the 
growing peptide chain.  The recycling of EF-Tu-GDP to GTP requires the elongation 
factor EF-Ts, which facilitates the exchange of GDP to GTP.  
1.3.4 Termination 
Cycles of elongation are ended by the presence of a translational termination 
codon, namely UAA, UAG or UGA (ochre, amber, opal respectively), within the A-
site.  These codons are not recognised by any tRNA, but are recognised instead by 
release factors, RF (Figure 1C).  RF-1 terminates gene translation at UAA and UAG 
stop codons, RF-2 at UAA and UGA stop codons, and RF-3 facilitates the function of 
RF1 and RF2 (Nakamura et al., 2000).  The binding of RF-1 and RF-2 to the ribosomal 
complex causes conformational changes that allow hydrolysis of the ester bond 
between the polypeptide and tRNA.  After release of the peptide, the release 
factors catalyse the disassociation of the ribosome subunits.  Subsequent binding of 
IF-3 to the 30S subunit results in disassociation of the release factors, mRNA and 
tRNA. 
 
1.4 Eukaryotic translation 
1.4.1 Ribosome 
Translation of eukaryotic genes is much more complex than that of prokaryotes 
with the involvement of numerous factors.  As with the prokaryotic system, the 
eukaryotic ribosome is a large complex of comprising protein and RNA.  The small 
subunit (40S) is composed of the 18S rRNA and approximately 30 proteins; and the 
large subunit (60S) is composed of 28S, 5.8S, and 5S rRNAs and about 45 proteins. 
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1.4.2 Initiation 
At translation initiation, the eukaryotic initiation factors, eIF-1, eIF-1A and eIF-3 
bind the 40S ribosomal subunit and eIF-2 (in complex with GTP) associates with the 
initiator methionyl tRNA (Figure 2).  The eIF-4 group of factors recognise and bring 
eukaryotic mRNA to the ribosome.  Namely, eIF-4E mediates recognition of the 5’ 
terminal 7-methylguanosine cap, eIF-4G binds to both eIF-4E and to poly-A binding 
protein (PABP) that is associated with the poly-A tail at the 3’ end of the mRNA.  
The initiation factors eIF-4E and eIF-4G, in association with eIF-4A and eIF-4B, then 
bring the mRNA to the 40S ribosomal subunit, with eIF-4G interacting with eIF-3.  
The 40S ribosomal subunit, in association with the bound methionyl tRNA and eIFs, 
then scan the mRNA 5’ to 3’ to locate the AUG initiation codon.  Subsequent to the 
recognition of the initiation AUG codon, eIF-5 triggers the hydrolysis of GTP bound 
to eIF-2.  The eIFs are then released, and the ribosomal 60S subunit binds to the 40S 
subunit to form the 80S initiation complex of eukaryotic cells. 
1.4.3 Elongation 
The process of eukaryotic elongation is similar to that of prokaryotes utilising the 
three sites within the ribosomal complex, however aa-tRNAs are escorted to the 
complex via the GTP-complexed elongation factor, eEF-1α (in place of EF-Tu; Figure 
1B).  Here, as for prokaryotic translation, is a point of proofreading (before GTP 
hydrolysis) of the codon-anticodon pairing before the peptide bond forms.  
Translocation in eukaryotes requires eEF-2 and is again coupled to GTP hydrolysis.  
The GTP exchange factor for eukaryotic translation is eEF-1β.  The elongation cycle 
continues as for prokaryotic translation. 
1.4.4 Termination 
In eukaryotic cells a single release factor (eRF-1) recognises all three termination 
codons in conjunction with eRF-3 in a process much like prokaryotic termination 
(Figure 1C). 
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Figure 2.  Eukaryotic translation initiation.  eIF-1, eIF-1A and eIF-3 bind the 40S ribosomal subunit 
and eIF-2-GTP associates with the initiator methionyl tRNA.  The eIF-4 group of factors recognise and 
bring eukaryotic mRNA to the 40S ribosome subunit with eIF-4G interacting with eIF.  The 40S 
ribosomal subunit scans the mRNA to locate the AUG initiation codon.  eIF-5 triggers the hydrolysis 
of GTP bound to eIF-2.  The eIFs are then released, and the ribosomal 60S subunit binds to the 40S 
subunit to form the 80S initiation complex. 
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1.5 Genetic code 
Messenger RNA (mRNA) comprise a combination of the four nucleotides, U, T, G, 
and C.  These nucleotides are read by the ribosome by three-letter codons, which 
are interpreted to specify for one amino acid.  These codons have a corresponding 
anticodon present on tRNA that carries a specific amino acid.  This link between 
RNA and amino acid is known as the genetic code (Figure 3).  The code is 
degenerate in that a particular amino acid can be encoded by more than one 
codon.  Many organisms typically have less than 45 unique tRNAs, which is less than 
the total number of potential codons (64).  Therefore some codon : anticodon 
interactions may display non-canonical Watson-Crick base pairing, which is 
predominantly due to the “wobble” effect.  Namely, the third position in a tRNA 
codon is less crucial in decoding mRNA, because it can sometimes perform non-
standard basepairing (for example, G-U) or be replaced by a modified base pair 
(Inosine, I), allowing it to recognise more than one codon (I-A, I-C, I-U). 
Nature provides the genetic coding for the most common 20 amino acids, three 
codons that terminate translation (amber, ochre, and opal with codons UAG, UAA, 
and UGA respectively) plus the rarely incorporated amino acids, pyrrolysine (Hao et 
al. 2002) and selenocysteine (Boeck et al. 1991) for use in protein construction 
(Figure 3).  The incorporation of the natural 20 amino acids occurs using the 
cognate process of translation, as described within section 1.2.  The three stop 
codons are used with differing frequencies.  The amber codon is of particular 
interest, as this is the least frequently used stop codon in the E. coli genome (9 % 
bacterial proteins, very rarely used in essential genes; 23 % in Homo sapiens 
(Nakamura 2007)).  Interestingly, the incorporation of pyrrolysine and 
selenocysteine occurs at the UAG and UGA stop codons respectively.  The process 
to incorporate the 21st and 22nd amino acids is complex and requires extra 
information on the mRNA. 
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Figure 3.  Genetic code.  The 3-nucleotide codons and their corresponding amino acids.  Translation 
termination codons are indicated in red.  Amber codon, TAG, is indicated in bold. 
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1.5.1 Incorporation of pyrrolysine and selenocysteine 
The incorporation of the 21st and 22nd amino acids, selenocysteine (Sec) (Boeck et 
al. 1991) and pyrrolysine (Pyl) (Ibba and Söll 2002) are of particular interest because 
their incorporation is encoded by termination codons.  Selenocysteine is similar to 
cysteine, but carries selenium in place of sulphur.  The selenocysteine insertion 
element, SECIS, found on the mRNA of E. coli genes specifies the incorporation of 
selenocysteine at the UGA codon.  Firstly tRNA   , is aminoacylated with cysteine, 
which is then converted to selenocysteine by selenocysteine synthase (SelA).  Sec-
tRNA   , along with GTP and selenocysteine-specific elongation factor, SelB, binds 
to the SECIS element at the ribosome, which allows the incorporation of Sec into 
the protein.  Unlike with Sec, Pyrrolysine has a specific synthetase (PylRS) which 
charges the tRNA    with Pyl (Polycarpo et al. 2004).  The PYLIS element, within the 
mRNA, is thought to enhance the incorporation of Pyl at the specific UAG codon 
(Théobald-Dietrich et al. 2005). 
1.6 Aminoacylation 
A number of components function to ensure fidelity of protein synthesis.  Namely, 
the accuracy of codon : anticodon recognition and the aminoacylation of the tRNA 
(Figure 4).  The sequence of amino acids that are used to make up the peptide are 
determined by the three base-pair codons on the mRNA.  The mRNA codon is 
recognised, via complementary base-pairing, by the aminoacyl-tRNA anticodon 
region.  The tRNA is charged with its cognate amino acid in two steps.  Firstly, the α-
phosphate of ATP reacts with the amino acid to form a mixed anhydride 
intermediate, aminoacyl-adenylate, and inorganic pyrophosphate.  In the second 
step, an ester bond is formed between the 3'-terminal ribose of the cognate tRNA 
and the amino acid moiety of the aminoacyl-adenylate (Equation 1).  This yields an 
aminoacyl-tRNA and AMP.  These steps are catalysed by the specific aminoacyl 
tRNA synthetase (aaRS).  Once the tRNA is correctly charged, it is able to participate 
in codon : anticodon interaction and the amino acid can be incorporated into the 
growing peptide chain during translational elongation (see section 1.3.3 and 1.4.3). 
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Equation 1.  Two step aminoacylation of tRNA.  Firstly, the α-phosphate of ATP reacts with the 
amino acid (AA) to form a mixed anhydride intermediate, aminoacyl-adenylate (aaRS·aa-AMP), and 
inorganic pyrophosphate (PPi).  In the second step, an ester bond is formed between the 3'-terminal 
ribose of the cognate tRNA and the amino acid moiety of the aminoacyl-adenylate.  This yields an 
aminoacyl-tRNA (aa-tRNA) and AMP.  These steps are catalysed by the specific aminoacyl tRNA 
synthetase (aaRS). 
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Figure 4.  Role of aminoacyl-tRNA formation in the elongation phase of protein synthesis.  An 
uncharged tRNA is first aminoacylated with the appropriate amino acid to generate an aminoacyl 
tRNA.  The aminoacyl-tRNA is delivered to the ribosomal A site via a translation elongation factor.  
The aminoacyl-tRNA anticodon interacts with the corresponding codon in mRNA.  The example 
shown illustrates how this leads to the translation of the codon GGU as tryptophan. 
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1.7 The aminoacyl tRNA synthetase 
In most bacteria a family of 20 aminoacyl-tRNA synthetases (aaRS) are responsible 
for charging the correct tRNA with the correct amino acid.  Each synthetase enzyme 
is specific for one amino acid, but capable of aminoacylating one or more 
isoaccepting tRNA (Sprinzl et al. 1987).  In eukarya, multiple aaRSs for certain amino 
acids are present in the cytoplasm, while different aaRSs are present in the 
mitochondria.  Each synthetase catalyses a similar reaction, requiring ATP and Mg2+, 
and utilises similarly structured substrates, namely amino acid and tRNA.  
Therefore, the synthetases must share common features to enable them to catalyse 
the aminoacylation reaction, but enough variation in order to recognise slight 
differences in tRNA and amino acid.  Physical, chemical, and mutagenic studies (For 
review see Beuning and Musier-Forsyth 1999; Ibba and Söll 2000) demonstrate that 
the binding of tRNA into the tRNA-binding cleft of aaRSs occurs along the inside of 
the tertiary L-shaped tRNA structure in a general shape-related manner (see section 
1.8).  However, the specific interactions the aaRSs makes with the tRNA tend to be 
spatially diverse with specificity being achieved by the specific interactions of 
crucial position-specific amino acid residues.  There are two broad classes of 
synthetase.  The members of each class are broadly characterised by their sequence 
motifs, active site structure, mode of tRNA binding and the OH group of the 
cognate tRNA that is aminoacylated. 
Class I aaRSs, which includes the tyrosyl-aaRS, contain HIGH and KMSKS motifs with 
the active site containing a Rossmann fold (Rao and Rossmann 1973).  The peptide 
backbone of the Gly-His region of the HIGH motif associates with the adenine of 
ATP which is bound in an extended conformation, while the two His residues 
interact with the triphosphate both directly, and via water molecules.  The MSK, 
which is part of a loop, folds over the binding site, with the Lys interacting with the 
α- and ɣ-phosphates.  For class I enzymes, the acceptor stem of the tRNA interacts 
with the aaRS via the minor groove side with the variable loop facing the solvent 
and therefore, the amino acid is attached to the 2’-OH of the terminal adenosine of 
the tRNA.  However, for tyrosyl-tRNA synthetase the recognition of tRNA resembles 
16 
 
that of a class II synthetase, the tRNA associating by the major groove side of the 
acceptor stem (Yaremchuk et al. 2002).  Also to note is that class I aaRSs tend to be 
monomeric, with the exception of TyrRS and TrpRS, which are obligate dimers. 
Class II aaRSs contain conserved motifs, 1, 2 and 3.  The active site of these enzymes 
are composed of an anti-parallel β-fold, containing parts of motif 2 and 3.  Motif 1 
consists of a long α-helix linked to a β-strand, and participates in the dimer 
interface.  In Class II enzymes, the ATP binds in a bent conformation.  Class II aaRSs  
approach the major groove side of the tRNA acceptor stem with the variable loop 
facing the synthetase.  It is this binding which causes class II aaRS, with the 
exception of tRNAPhe (attaches Phe to 2’-OH), to attach amino acids to the 3'-OH of 
the terminal adenosine of the tRNA.  Class II enzymes tend to be obligate dimers. 
The class I and II aaRSs are then sub-divided into groups of RSs that have similar 
modules or type of amino acid they charge.  
1.8 tRNA 
Transfer RNA (tRNA) are small RNA molecules comprising 75 to 95 nucleotides.  
They contain standard RNA nucleotides, namely A, C, G, U, but also modified 
nucleotides, which are introduced post-transcriptionally (Figure 5A).  tRNAs have an 
important role in the fidelity of translating genetic information in to protein by 
acting as an adapter between the mRNA, amino acid and the protein synthesis 
machinery (Crick 1955, 1958).  All tRNAs have a similar primary (Sprinzl et al. 1987) 
secondary (Holley et al. 1965) and tertiary (Kim et al. 1973; Ladner et al. 1975) 
structure which allows them to be recognised by the translational machinery.  
Namely, the secondary cloverleaf and tertiary L-shaped structures respectively 
(Figure 5).  This structure is found in both prokaryotic and eukaryotic tRNAs; 
however, some differences in basic primary structures, such as kingdom-specific 
identity elements, are noted below. 
The cloverleaf structure is formed by a series of inverted repeats that allow the 
linear RNA molecule to form four double helical segments (Figure 5A).  The 5’ and 3’ 
terminals of the tRNA associate to form the accepter stem.  At this stem the -OH  
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Figure 5.  A) Secondary cloverleaf structure (adapted from Kim et al. 1973).  Stem and loop 
structures are labelled.  Modified residues are marked in blue and anticodon is marked in red.  
B)  Tertiary L-shape of prokaryotic tRNA (adapted from Kim et al. 1974).  Arms are labelled and 
certain residue numbers are indicated. 
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group of A76 of the 3’-CCA single stranded extension is coupled to the amino acid 
during aminoacylation of the tRNA.  The TψC arm, named because of the presence, 
in most tRNAs, of the modified uracil, pseudouridine, ψ, between a thymine and 
cytosine residue.  This sequence in eukaryotic initiator tRNAs is substituted with 
AUC or AψC.  The variable arm can be between four and twenty-one nucleotides in 
length.  The anticodon loop contains the three nucleotide anticodon (nucleotides 
34, 35, 36) which complementarily base-pairs with the corresponding mRNA codon 
during translation.  The first position of the anticodon, the “wobble” position, often 
contains modified bases that allow the formation of non-Watson-Crick base-pairing 
(see section 1.5).  The DHU arm or D-arm is named because of the presence of the 
modified nucleotide dihydrouridine, D.  The number of residues in the stem and 
loop regions is so well conserved, that all tRNAs are referred to using a standard 
numbering system (Schimmel and Soll 1979). The variations in size occur within the 
variable and D-arms. 
The tertiary, L-shape structure of tRNA is formed by the coaxial stacking of the 
double-stranded helices (Figure 5B).  The CCA region of the accepter stem and 
anticodon loop form the tips of the L shape, with the DHU and TψC arms folding in 
to form the corner of the L-shape.  A hydrogen-bond network creates associations 
throughout the molecule.  However, the nucleotides of the CCA extension and the 
anticodon are exposed and do not form part of this hydrogen bond network 
(Robertus et al. 1974).  This allows the anticodon loop to twist out, which enables 
interaction with the codon of the mRNA.  
1.9 Identity elements 
A major part in maintaining the fidelity of protein translation depends upon the 
strict recognition of the tRNA by its cognate aaRS and subsequent charging with the 
correct amino acid.  The tRNA is relied upon to make the association with the 
correct aaRS, but also to refrain from associating with other incorrect aaRSs.  As 
mentioned above, all tRNAs have similar primary, secondary and tertiary structures 
in order to function at the ribosome, but there are key differences in their 
structures that are important in discerning each tRNA’s cognate synthetase.  These 
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key differences are known as the identity elements of the tRNA (Giegé et al. 1998).  
The position and nature of these identity elements varies among different tRNAs.  
However, these identity elements are often found within the accepter stem 
(discriminator base), the anticodon and the variable arm. 
The use of naturally occurring amber suppressors, chemical modification and the 
design of synthetic RNAs with desired single or multiple mutations, in silico 
calculations, and crystal structures have been used to provide valuable evidence 
regarding the elucidation of identity elements in tRNA-aaRS recognition (for review 
see Giegé et al. 1998).  Originally the anticodon region was considered to confer 
tRNA identity and this is understandable as this is the obvious variable region of the 
tRNA and it is this region that provides the link between mRNA and protein.  
However, the first important observation was that many aaRSs aminoacylate more 
than one tRNA, i.e. tRNAs coding for the same AA, but with different anticodons.  
Therefore, it is more than just the anticodon region that determines the specificity 
of aminoacylation.  There was further evidence that the anticodon region may not 
be the major identity element in some tRNAs, as mutation of E. coli tRNAGln, tRNASer 
and most importantly tRNATyr (Goodman et al. 1968) anticodons to CUA, creating 
amber suppressor tRNAs, did not perturb correct aminoacylation of these tRNAs 
(Capecchi and Gussin 1965; Inokuchi et al. 1979; Kaplan et al. 1965; Weigert and 
Garen 1965).  Therefore, further investigation was required in order to elucidate 
the identity elements, and this research often concluded that the identity elements 
were predominantly specific to each tRNA-aaRS pair.  The identity elements specific 
to tRNATyr will subsequently be considered further.  The identity elements of 
tRNATyr between species is also important, therefore, these will also be considered. 
1.9.1 TyrRS-tRNATyr identity elements 
The discriminator base, A73 has been shown to be one of the major identity 
elements in tRNATyr from all kingdoms of life (Figure 6).  The A73 base is stacked on 
the C72 base in the prokaryotic TyrRS-tRNATyr complex to extend the RNA helix, 
whereas the A73 base in the Methanococcus jannaschii archaean (Mj)TyrRS-tRNATyr 
projects away from the helical axis.  The base pairs in region 1-72 are also important 
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in tRNATyr recognition, but displays a kingdom specific discrimination.  The crucial 
identity element that distinguishes a bacterial tRNATyr from an archaeal or 
eukaryotic tRNATyr is the C1-G72 (G1-C72 in prokaryotic tRNATyr) tRNA recognition 
element located at the top of the accepter stem (Fechter et al. 2001; Quinn et al. 
1995; Steer and Schimmel 1999).  Due to the similarities of the chemical groups 
presented to the minor groove, and differences presented in the major groove in 
tRNAs with either G-C or C-G pairs, it is thought that eukaryotic and archaeal TyrRS 
recognises its cognate tRNA via the major groove of the acceptor stem (Fechter et 
al. 2000; Fechter et al. 2001; Kobayashi et al. 2003). 
Comparing the crystal structure of MjTyrRS in complex with tRNATyr and tyrosine 
(Kobayashi et al. 2003; Zhang et al. 2005b), yeast (Fechter et al. 2000; Fechter et al. 
2001), human (Yang et al. 2002) and prokaryotic TyrRSs (Brick et al. 1989; 
Yaremchuk et al. 2002), showed that there were similarities between human and 
MjTyrRS, but significant differences between Mj and prokaryotic TyrRSs.  The 
bacterial TyrRS has an extra C-terminal domain which recognises the long variable 
domain of its cognate tRNATyr (Yaremchuk et al. 2002).  While the long variable arm 
is characteristic of prokaryotic tRNATyr-TyrRS recognition, the short variable arm of 
eukaryotic and archaeal tRNATyr is not (Marck and Grosjean 2002).   
The anticodon region has also been shown to be important in tRNATyr-TyrRS 
recognition, but varies between kingdoms (Kobayashi et al. 2003).  The portion that 
recognises the anticodon loop is similar between Mj and human, but varies for 
prokaryotes (Figure 7A).  Prokaryotic TyrRS differ distinctly from archaeal and 
eukaryotic TyrRS in tRNA anticodon recognition.  For prokaryotic systems, it has 
been shown that the central base of the anticodon, ψ35 (flipped out in comparison 
to G34 and A36, which are stacked), is the major element of recognition and is 
recognised by the extra C-terminal domain (Himeno et al. 1990; Hou and Schimmel 
1989; Sherman et al. 1992; Yaremchuk et al. 2002).  In contrast, in archaeal and 
eukaryotic tRNATyr all three anticodon bases are on the same side and G34 is 
stacked with hydrophobic residues of the TyrRS.  However, G34 is recognised by the 
carboxyl group of Asp in all TyrRSs. 
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Residues Tyr32 and Asp158 within MjTyrRS are responsible for tyrosine binding 
identity (Figure 7B).  Y32 and D158 coordinate the p-hydroxyl group of the phenyl 
ring of tyrosine.  Glu36, Tyr151, Gln155, Gln173 of MjTyrRS are responsible for 
coordinating the amino and carboxylic acid portion of tyrosine (Zhang et al. 2005b).  
Equivalent residues within prokaryotic TyrRS are responsible for recognition of Tyr.  
Bedouelle et al (1993) have shown that Glu 152 of the prokaryotic TyrRS acts as a 
negative discriminant towards non-cognate tRNAs by electrostatic and steric 
repulsion. 
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Figure 6.  Cloverleaf structures of tRNA
Tyr
 showing key identity elements (in red) relevant to the three kingdoms of life.  (Adapted from Kobayashi et al. 2003) 
23 
 
 
Figure 7.  A)  Comparison of overall structures of archaea (M. jannaschii; red; PDB 1J1U) and bacterial (T. thermophilus; black; PDB 1H3E) TyrRS-tRNA
Tyr
 (taken from Kobayashi 
et al. 2003).  Only one tRNA is shown. 
B)  Coordination of Tyr within AA binding site of bacterial TyrRS-tRNA
Tyr
 showing residues important in discriminating Tyr  (taken from Kobayashi et al. 2003). 
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1.10 Methods to incorporate NAAs  
While genetically encoded amino acids can also be modified post-translationally to 
aid in increasing the variety in protein structure and function, this limitation in 
building material for protein construction constricts the biological, chemical and 
physical properties a protein can possess.  Therefore, the incorporation of non-
natural amino acids containing moieties with distinct biological, chemical or 
physical properties into proteins can expand the chemical functionality of a protein 
(for review see Dougherty 2000).  
1.10.1 Chemical synthesis 
There have been a number of methods developed to increase the range of amino 
acids that can be incorporated into proteins (for review see Wang and Schultz 
2005).  Chemical modification, for example via conjugation to cysteine residues, can 
be used to add non-natural moieties to proteins.  For example, conjugation of a 
photoactivatable cross-linking agent to study protein-protein interactions (Chen et 
al. 1994).  This can be a site-specific method as site-directed mutagenesis can be 
used to introduce cysteine residues into proteins, which are then modified.  This 
technique has limited efficiency and uses a naturally occurring AA, which can create 
problems if the target protein contains multiple cysteines or requires cysteines to 
function. 
Chemical synthesis of peptides can be used to incorporate NAA into proteins.  The 
method of stepwise solid-phase peptide synthesis (SPPS) (Kent 1988; Merrifield 
1963), has been exploited to incorporate NAAs into proteins.  During this method, 
amino acids are chemically added to a growing chain immobilised on a bead.  This 
method is particularly useful if toxic AAs or AAs not compatible with translational 
machinery are required.  However, the method has a number of limitations, 
namely, the length of peptide is limited to <100 AAs, the peptide often has poor 
solubility and the method gives poor yields and is time-consuming. 
25 
 
1.10.2 Semisynthesis 
To try to increase the length of peptide produced, native chemical ligation (NCL) 
was used to attach peptide fragments to one another (Dawson et al. 1994), for 
example protein expressed using recombinant systems (Offord 1987; Wallace 
1995).  NCL has been utilised to incorporate a variety of NAAs into cytochrome c 
(Dyckes, Creighton and Sheppard 1974, Wallace and Clark-Lewis 1992, Wallace 
1993).  NAAs were incorporated into cytochrome c using autocatalytic re-ligation of 
peptide fragments generated by cyanogen bromide (CNBr) cleavage.  CNBr cleavage 
results in a C-terminal homoserine lactone, which reacts with a free N-terminus to 
reform the full-length protein. 
The technique termed expressed protein ligation (EPL) utilises C-terminal thioesters 
generated from thiol-cleavage of an intein-mediated protein-splicing reaction in 
which a mutation in the intein blocks the final splicing step (Muir et al. 1998; 
Severinov and Muir 1998).  The resulting α-thioester derivative can subsequently 
react with an N-terminal Cys, homocysteine (Roy et al. 1999) or selenocysteine 
peptide (Hondal et al. 2001). Numerous applications using EPL have been explored, 
for example, the incorporation of fluorescent moieties, spin-labels, FRET partners 
and ketone-containing constructs (Ayers et al. 1999); and incorporation of post-
translationally modified AAs, for example, phosphotyrosine to study the signalling 
of a protein tyrosine kinase C-terminal, Src kinase (Muir et al. 1998).  Semisynthetic 
techniques, however, do require cleavage and ligation sites and cannot be applied 
to in vivo study of protein.  
1.10.3 In vitro biosynthesis 
In vitro techniques utilising the existing protein biosynthetic machinery to 
incorporate NAAs in to protein have been established (Railey White et al. 2012).  
Chemical modification of enzymatically aminoacylated tRNAs were used to 
incorporate NAAs with synthetic reagents and probes.  Modification of this 
technique, using truncated tRNAs (with the 3’-terminal mono- or dinucleotide 
removed) allowed attachment of mono- and dinucleotides chemically 
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aminoacylated with a variety of NAAs (Baldini et al. 1988).  However, this technique 
gave poor yields, NAA incorporation was in competition with natural AA 
incorporation, and the NAA could be incorporated genome-wide.  To try to improve 
the site-specificity of NAA incorporation, the in vitro method was augmented to 
incorporate chemically aminoacylated tRNAs in response to stop codons (Noren et 
al. 1989).  An orthogonal amber suppressor tRNA derived from yeast phenylalanine-
tRNA was constructed.  Noren et al, (1989) used this technique to incorporate NAAs 
p-nitrophenylalanine, p-fluorophenylalanine and homophenylalanine in to Phe66 of 
β-lactamase.  The yield was small, but the specificity and fidelity of NAA 
incorporation was shown to be high.  Over 50 amino acids, with a variety of side 
chains for a variety of applications, have been incorporated site-specifically into 
proteins using this in vitro technique.  Extensions of this method have been used to 
explore the incorporation of more than one NAA (Ozawa et al. 2012), use of 
frameshift suppression of four-base codons (Hohsaka and Sisido 2002; Taki et al. 
2002); use of unnatural bases within the codon (Bain et al. 1992); microinjection of 
mutant RNA and chemically aminoacylated yeast tRNA   
   
 into Xenopus oocytes 
(Nowak et al. 1995).  However, all the in vitro methods to incorporate NAAs into 
proteins are technically demanding, give poor yields (as the supply of chemically 
aminoacylated tRNAs is non-renewable), and the stability of the aminoacyl-tRNA 
linkage limits the NAAs that can be used.  
1.10.4 In vivo biosynthesis 
The possibility of utilising in vivo expression to incorporate NAAs into protein has 
been explored.  Supplementing the growth media of an auxotrophic strain (cannot 
biosynthesise a specific amino acid) with an analogue of the amino acid allows 
incorporation of this analogue into proteins (Richmond 1962).  For example, 
supplementing a Phe auxotrophic strain of E. coli with p-fluorophenylalanine 
allowed incorporation of this NAA into β-galactosidase (Cohen and Munier 1956); 
selenomethionine was incorporated using a methionine auxotroph (Cowie and 
Cohen 1957) and various replacements of hydrogen with fluorine, methylene with 
oxygen or sulphur, and ring substitutions have all been performed (Brawerman and 
27 
 
Yčas 1957; Cowie et al. 1959; Rennert and Anker 1963; Richmond 1959).  This 
method relies on the close analogy between natural AA and NAA to be substituted.  
Therefore, to try to expand the variety of NAAs that can be used, the specificity of 
the aaRSs was relaxed using mutagenesis.  The A294G mutation in the PheRS 
increased the substrate binding pocket size allowing it to accommodate and 
subsequently incorporate a variety of Phe analogues, including p-bromo-, p-iodo-, 
p-cyano-, p-ethynyl-,and p-azidoPhe (Kirshenbaum et al. 2002; Sharma et al. 2000).  
Another method to increase the number of NAAs that can be incorporated included 
the attenuation of the proofreading ability of RSs (Döring et al. 2001).  Among a 
variety of applications, using aaRSs with relaxed substrate specificity has been 
particularly useful in incorporating NAAs that harbour heavy atoms, which aid in 
phase determination in X-ray crystallography.  For example, incorporating 
selenomethionine in place of methionine (Yang et al. 1990a; Yang et al. 1990b).  
Once again, the method is not site-specific as incorporation of NAA occurs 
throughout the proteome, therefore NAA is required to be tolerated at all these 
positions limiting the variety of NAAs that can be used.  Additionally, there is 
competition between the natural AA and it’s NAA analogue, and yields are variable. 
To overcome the limitations of the methods outlined above, the Schultz research 
team developed a method that allows genetic coding for NAAs resulting in the 
position specific incorporation of the specified NAA with high translational fidelity 
and efficiency (for review see Xie and Schultz 2006).  
1.11 Expanding the genetic code 
The genetic code allows incorporation of the 20 naturally occurring amino acids, 
and the rarely incorporated amino acids pyrrolysine and selenocysteine, with three 
translation termination codons (see section 1.5).  Expansion of this genetic code is 
possible by introducing an aaRS and tRNA orthogonal to the endogenous machinery 
of the cell.  The amber suppression method relies on the cellular process of 
translation (Figure 8).  The basis of the method developed by Schultz’s research 
group, is to recode the amber codon, UAG, to specify non-natural amino acids 
instead of terminating translation (Liu et al. 1997a; Liu et al. 1997b; Noren et al. 
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1989).  The amber translational termination codon is a prime candidate for this 
recoding because, most notably, it is rarely used in Escherichia coli (9 % bacterial 
proteins, very rarely used in essential genes; 23% in Homo sapiens (Nakamura 
2007)) and there are naturally occurring amber suppressors (Eggertsson and Soll 
1988).  For example, naturally occurring amino acids selenocysteine and pyrrolysine 
are incorporated into a growing peptide in response to stop codons when specific 
elements in the mRNA sequence and structure are present. 
To utilise amber suppression, a TAG mutation is introduced site-specifically into the 
gene of choice; and a unique transfer-RNA (tRNA) accommodating a CUA anticodon 
within the anticodon loop and a corresponding aminoacyl-tRNA synthetase (aaRS) 
are provided to the cell (Wang et al. 2000).  The tRNA must be constructed such 
that it is recognised by the orthogonal synthetase but not by endogenous 
synthetases.  The orthogonality of the synthetase is required in order to specifically 
aminoacylate the orthogonal tRNA and not any endogenous tRNAs and 
furthermore, should exclusively aminoacylate the specified non-natural amino acid.  
The orthogonal tRNA and aaRS must also perform efficiently during translation, and 
the non-natural amino acid must be transported efficiently into the cytoplasm from 
the culture medium and not confer toxicity to the cell. 
To achieve amber suppression in E. coli cells the tyrosyl tRNA (tRNATyr)/synthetase 
pair from the archaea Methanococcus jannaschii were imported orthogonally in to 
the E. coli (Wang et al. 2000). The M. jannaschii tyrosyl aaRS (MjTyrRS) and tRNATyr 
have properties that are favourable to produce an orthogonal pair for non-natural 
amino acid incorporation.  In particular, MjTyrRS has recognition elements for the 
C1:G72 tRNA eukaryotic recognition element as opposed to the G1:C72 tRNA 
prokaryotic recognition element (Figure 9), therefore it does not recognise 
endogenous E. coli tRNA (Fechter et al. 2001).  In addition, the identity elements 
outside the anticodon region are mainly responsible for recognition of the 
MjtRNATyr by MjTyrRS (Fechter et al. 2001; Steer and Schimmel 1999), thereby 
allowing mutation of the anticodon loop to allow amber suppression without 
perturbing its recognition by MjTyrRS (Wang et al. 2000).  Also to note is that  
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Figure 8.  Endogenous translation compared to orthogonal system used for incorporation of non-
natural amino acid during amber suppression.  Process of translation showing the reading of mRNA 
(gray) by the ribosome (green), to code for amino acids (yellow - natural; red - nonnatural), using 
tRNA charged with amino acid by a corresponding aminoacyl tRNA synthetase.  
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MjTyrRS has no editing mechanism and therefore aminoacylation is not subjected 
to proofreading (Jakubowski and Goldman 1992). 
1.11.1 Production of tRNA   
   
 
As noted above, the identity determinants of the anticodon region of tRNATyr are 
not crucial in recognition, and the presence of naturally occurring amber suppressor 
tRNATyr were important in the expansion of the genetic code using the amber 
suppression technology as developed by Schultz et al.   
A fully orthogonal suppressor tRNACUA for use in the expanded genetic code 
application developed by Schultz et al was required.  Wang et al (2000) have shown 
that an orthogonal amber suppressor can be generated using the MjtRNA   
   
 by 
mutating the anticodon to CUA, creating MjtRNA   
   
, (Figure 9). 
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Figure 9.  (a) Methanococcus jannaschii tyrosyl tRNA, (adapted from Wang and Schultz 2005). 
(b) Orthogonal amber suppressor MjtRNA
   
   
 (adapted from Xie and Schultz 2006).  Mutated 
residues are indicated in red.  Residues involved in tRNA library formation are indicated in blue 
circles.  These residues were randomised to optimise orthogonality of MjtRNA   
   
 within E. coli 
(Wang and Schultz 2001). 
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However, MjtRNA   
   
 was shown to be recognised by endogenous RSs in E. coli 
(Wang et al. 2000), therefore further mutations were required (Wang and Schultz 
2001).  Two libraries were created, one where only residues in the anticodon loop 
were mutated and a second where non-conserved residues within the loops were 
mutated (Figure 9).  A two-step selection was employed to select orthogonal tRNAs 
(Wang et al. 2001).  A negative selection step, where a plasmid encoding the toxic 
ribonuclease barnase gene harbouring a TAG at codon 3 was used to select against 
MjtRNA   
   
s that were aminoacylated by endogenous E. coli aaRSs (Figure 10).  The 
MjtRNA   
   
 would be aminoacylated by an endogenous aaRS, with a natural amino 
acid then subsequently incorporated, to produce full-length barnase, resulting in 
cell death.  The surviving cells would harbour an orthogonal or non-functional 
MjtRNA   
   
.  A subsequent positive selection step utilised the MjtRNA   
   
-
containing plasmids along with a plasmid encoding β-lactamase harbouring a TAG 
mutation and an MjTyrRS.  The E. coli were grown on ampicillin containing plates 
and therefore only cells harbouring a functional MjtRNA   
   
 that can be recognised 
and aminoacylated by MjTyrRS could produce full-length functional β-lactamase 
and survive.  Using this method, an MjtRNA   
   
was selected for incorporation of 
NAAs (Figure 9B). 
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Figure 10.  Two step method to select orthogonal MjtRNA   
   
 (Wang and Schultz 2001) 
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1.11.2 Production of aaRSs specific to NAAs 
MjTyrRSs that selectively charge mRNA with a specific non-natural amino acid (not 
tyrosine or any other natural amino acid), but maintain specificity to the tRNA, have 
been evolved in the process of directed evolution (Wang et al. 2000).  The structure 
of the active site of MjTyrRS was evaluated and residues that were responsible for 
coordinating Tyr were considered for mutation (Figure 11).  Originally the structure 
of the analogous Bacillus stearothermophilus TyrRS (Brick et al. 1989) was used 
because the structure of MjTyrRS had not been solved. 
Residues Tyr32, Asn123, Asp158, Ile159, and Leu162 were subjected to random 
mutagenesis (via NNK mutagenesis).  The library of mutant TyrRSs were subjected 
to a method of selection via iterative application of a two step process (Figure 12).  
A positive selection step utilised an Asp112TAG mutant of the chloramphenicol 
acetyltransferase (CAT) gene along with the plasmid encoded mutant MjtRNA   
   
 
and library of mutant MjTyrRS.  Cells containing these plasmid constructs were 
grown in the presence of the chosen NAA.  Surviving cells contained an MjTyrRS 
mutant that was able to aminoacylate MjtRNA   
   
 with amino acid (either natural 
or NAA).  These surviving colonies were replica plated, one grown in the absence of 
NAA, and the other in its presence.  Those that did not survive in the absence of 
NAA were isolated from the replica plate as these colonies encoded mutant TyrRSs 
which aminoacylated the orthogonal MjtRNA   
   
 with NAA and not any natural 
amino acid.  The subsequent negative step utilised a barnase gene with numerous 
TAG mutations.  The plasmids containing the positively selected library of mutant 
MjTyrRS and mutant MjtRNA   
   
were transformed into E. coli and grown in the 
absence of NAA.  Mutant MjTyrRSs not specific to NAA will charge MjtRNA   
   
 with 
natural amino acid and suppress the TAG mutations, producing toxic barnase that 
will result in cell death (Chin et al. 2002b; Pastrnak et al. 2000; Wang et al. 2001; 
Wang and Schultz 2005). 
A number of aaRSs have been evolved to incorporate numerous NAAs.  An aaRS 
specific for iodophenylalanine (iodoF) (Xie et al. 2004), azidophenylalanine (azF)  
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Figure 11.  Schematic representation of a tyrosine bound to MjTyrRS active site.  The residues 
within the binding pocket are shown.  It was these residues that were mutated in order to form 
aaRSs for specific NAAs.  Hydrogen bonds are shown with dashed lines and the distances are shown 
(Taken from Zhang et al. 2005b). 
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Figure 12.  Two step system for selecting aaRSs specific to a NAA for use in amber suppression 
technology in E. coli. 
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(Chin et al. 2002a) have previously been engineered and are used in the 
experimental work discussed within this Thesis. 
1.11.3 Applications of the amber suppression technology in E. coli 
It has previously been shown that the amber suppression method makes it possible 
to incorporate a wide variety of non-natural amino acids into specified positions in 
a variety of proteins with high translational fidelity and efficiency (Wang et al. 2001; 
Xie and Schultz 2006).  As a proof of principle, the close tyrosine analogue O-
methyl-L-Tyrosine (Figure 13, 3) was the first NAA to be incorporated using this 
method (Wang et al. 2001).  Subsequently, novel chemical, physical and biological 
properties can be introduced in to a protein via the introduction of NAAs.  This 
allows selective conjugation to peptic or nonpeptic molecules, for example dyes, 
drugs, polymers and carbohydrates; the study of protein-protein interactions and 
protein motions; the alteration of protein characteristics; study of protein 
localisation; the study or alteration of enzyme reactivities; and the introduction of 
therapeutic effect.  Therefore, this technology has been applied to a variety of 
applications; a few of which are detailed below. 
1.11.3.1 Post-translational modification (PTM) mimics 
The NAA p-Carboxymethyl-l-phenylalanine (Figure 14, 13) was incorporated into 
human signal transducer and activator of transcription-1 (STAT1) protein and used 
to mimic phosphotyrosine, which is important in signalling pathways.  NAA p-
Carboxymethyl-l-phenylalanine is resistant to hydrolysis, unlike phosphotyrosine 
and therefore eased functional analysis (Xie, Supekova and Schultz 2007).  Another 
PTM of proteins, sulfation, was mimicked by incorporating sulfotyrosine (Figure 15, 
34) into human thrombin.  The sulfation of proteins is not well understood and it 
was suggested that genetically encoding sulfotyrosine could elucidate its function 
(Liu and Schultz 2006).  The glycosylation of proteins is a PTM that can have 
important therapeutic applications.  Unlike protein expression using E. coli, 
expression using mammalian cells produces glycosylated proteins.  It would be 
beneficial to be able to produce glycosylated protein using the more cost effective 
E. coli expression system.  Despite the attempt to incorporate glycosylated NAAs 
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(GlcNAc-Ser and GalNAc-Thr) into proteins using amber suppression technology (Xu 
et al. 2004; Zhang et al. 2004), it was shown not to be possible (Antonczak et al. 
2009). 
1.11.3.2 Modulation of protein function 
The modulation of protein function has also been studied by site-specifically 
incorporating NAAs.  Tyrosine 66 within the chromophore of green fluorescent 
protein (GFP) has been modified with p-amino-L-phenylalanine (Figure 14, 2), p-
methoxy-L-phenylalanine (Figure 13, 3), p-iodo-L-phenylalanine (Figure 13, 4), p-
bromo-L-phenylalanine (Figure 13, 5), and L-3-(2-naphthyl)alanine (Figure 13, 6).  
These NAAs altered the absorbance and emission spectra of the resulting GFP 
(Wang et al. 2002). The bioluminescent photoprotein aequorin was also subjected 
to modulation of spectral characteristics via incorporation of the same NAAs in the 
H-bonding residue position (Y82) within the chromophore-binding site (Rowe et al. 
2010). 
The mechanism and modulation of enzymes has also been attempted using site-
specific NAA incorporation.  For example, the radical reaction ribonucleotide 
reductase was studied by the incorporation of 3-nitro-tyrosine (Figure 14, 14) 
(Yokoyama et al. 2010) and 3-amino-tyrosine (Figure 14, 18) (Minnihan et al. 2009).  
The reaction of Aristolochene Synthase has also been probed using site-specific 
incorporation of NAAs with increasing ring complexity in place of Trp 334 (Faraldos 
et al. 2011).  The redox-active amino acid 3,4-dihydroxy-l-phenylalanine (Figure 14, 
9) was incorporated into protein, and provided a means to monitor and control 
electron transfer in proteins, it was suggested that this could facilitate the study of 
electron transfer in proteins, as well as enable the engineering of redox proteins 
with novel properties (Alfonta et al. 2003).  The photoisomerisation of genetically 
encoded NAA phenylalanine-4‘-azobenzene (Figure 14, 12) has been shown to 
regulate the binding affinity of catabolite activator protein to its promoter (Bose et 
al. 2005).  The incorporation of an α-hydroxy acid, p-hydroxy-L-phenyllactic acid, 
allowed non-natural mutagenesis of the protein backbone that can be used in site-
specific backbone hydrolysis and probing of backbone stability (Guo et al. 2008a). 
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1.11.3.3 Structural determination 
Site-specific incorporation of radioactive labelled NAA into proteins can aid in 
elucidating protein structure via NMR.  For example, the NAAs 2-amino-3-(4-
(trifluoromethoxy) phenyl) propanoic acid (OCF3Phe, Figure 15, 25), 
13C/15N-labeled 
p-methoxyphenylalanine (OMePhe; Figure 13, 3), and 15N-labeled o-nitrobenzyl-
tyrosine (oNBTyr; Figure 15, 26) were incorporated individually into 11 positions 
around the active site of the 33 kDa thioesterase domain of human fatty acid 
synthase.  It was shown that this site-specific incorporation of labelled NAAs aided 
in structural determination of a large protein (Cellitti et al. 2008; Deiters et al. 2005; 
Jackson et al. 2007).  19F-NMR has also been shown to be possible via the 
incorporation of NAA trifluoromethyl-L-phenylalanine (tfm-Phe; Figure 14, 22).  
Incorporation of this NAA has aided in the study of substrate binding, inhibitors and 
cofactors, as well as in the reactions of the enzymes nitroreductase and histidinol 
dehydrogenase (Jackson et al. 2007).  The heavy iodine atom within the NAA p-
iodophenylalanine was used in single-wavelength anomalous dispersion phasing to 
elucidate the structure of T4 Lysozyme (Xie et al. 2004).  
1.11.3.4 Introduction of novel reactivity 
The alkynyl group containing NAA p-propargyloxyphenylalanine (Figure 15, 30) and 
the aryl azide containing NAA p-azidophenylalanine (azF; Figure 15, 31) show similar 
reactivity and applications.  The azide and alkyne groups are able to form triazoles 
by copper(I) catalysed cycloaddition reactions and therefore a variety of groups can 
be conjugated onto the proteins in a site-specific manner (Chin et al. 2002a).  For 
example, azF has been incorporated into proteins to allow attachment, via click 
reaction, of a polyethylene glycol (PEG) molecule (Chin et al. 2002a; Deiters et al. 
2004).  The attachment of PEG is therapeutically important as its presence has been 
shown to increase protein stability and bioavailability (Veronese and Pasut 2005).  
Incorporation of other photoactivatable NAAs, namely, p-benzoylphenylalanine 
(Figure 14, 15) (Chin et al. 2002b; Chin and Schultz 2002; Lee et al. 2009), 4’[3-
(trifluoromethyl)-3H-diazirin-3yl]-phenylalanine (TFMD; Figure 14, 21) (Tippmann et 
al. 2007) and p-(2-tetrazole)-phenylalanine (Figure 13, 8) (Wang et al. 2010a) can 
also be used to introduce orthogonal chemical “handles” into proteins in a site-
specific manner and allow mapping of peptide–protein interactions, allow 
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photocrosslinking of proteins, and the introduction of fluorescent probes.  
Fluorescent dyes have been conjugated to p-propargyloxyphenylalanine (Deiters 
and Schultz 2005).  The NAA O-allyl-l-tyrosine (Figure 15, 33) contains an allyl group 
which has been shown to be versatile in organic transformations and therefore 
allow conjugation of additional molecules (Zhang et al. 2002).  The incorporation of 
NAA p-boronophenylalanine (Figure 15, 32) also provides a method for selective 
chemical modification of proteins (Brustad et al. 2008a).  
1.11.3.5 Probes 
The reactive keto-containing NAA, p-acetylphenylalanine (Figure 14, 7) and its 
derivatives, have been used to attach fluorophores to proteins, for example Alexa 
Fluor488 hydroxylamine derivatives (Wang et al. 2003; Zeng et al. 2006).  The 
attachment of a fluorophore to a NAA and traditional incorporation at a cysteine 
residue could allow single molecule fluorescence resonance energy transfer 
(smFRET) and be used to study protein motions (Brustad et al. 2008b).  The NAAs L-
4-Cyanophenylalanine (pCNPhe; Figure 14, 16) and 4-ethynylphenylalanine 
(pENPhe) have also been used in an attempt to monitor protein conformational 
changes using FRET.  The two NAAs were incorporated in to the hydrophobic core 
(Phe153) of T4 Lysozyme and were positioned to allow FRET to occur between the 
NAAs and three local Tryptophans (Trps) (Miyake-Stoner et al. 2009).  p-
nitrophenylalanine (pNO2-Phe) was incorporated into GCN4 basic region leucine 
zipper (bZIP) protein and caused fluorescence quenching of a nearby Trp, allowing 
protein structure and function to be probed (Tsao et al. 2006).  A another approach 
is to incorporate the fluorescent amino acid L-(7-hydroxycoumarin-4-yl)ethylglycine 
(Figure 14, 24), which is sensitive to pH and polarity and can therefore be used to 
probe protein localisation and trafficking, protein conformation changes, and 
protein−protein interactions (Wang et al. 2006).  NAAs have also been utilised to 
introduce novel moieties that can be investigated using Infrared (IR) spectroscopy, 
for example pCNPhe (Schultz et al. 2006), and azF (Ye et al. 2009). 
1.11.3.6 Other applications 
In E. coli, the orthogonal aaRS/tRNA pair developed for incorporation of these NAAs 
is derived from a Methanococcus jannaschii tyrosine aaRS/tRNA pair, therefore the 
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NAAs are all tyrosine derivatives, namely, are composed of a phenyl ring with 
varying substituents.  However, other orthogonal pairs have been utilised to expand 
the chemically diversity of the incorporated NAAs, for example lysine (Guo et al. 
2008b), leucyl (Wu et al. 2004) and pyrrolysine (Hancock et al. 2010; Mukai et al. 
2008; Neumann et al. 2008) aaRS-tRNA pairs.  Amber suppression technology has 
also been applied to yeast (Deiters et al. 2003), C. elegans (Greiss and Chin 2011; 
Parrish et al. 2012), Drosophila (Bianco et al. 2012; Mukai et al. 2010b) and 
mammalian cells.  The use of the pyrrolysyl-tRNA synthetase (PylRS)–tRNACUA pair 
from Methanosarcina species is of particular importance because it is orthogonal to 
synthetases and tRNAs in E. coli, yeast, mammalian cells and C. elegans. 
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Figure 13.  NAAs incorporated into proteins using the amber suppression method.  NAA names are 
referred to within the main text.  Drawn using Isis draw (MDL Information Systems). 
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Figure 14.  NAAs incorporated into proteins using the amber suppression method.  NAA names are 
referred to within the main text.  Drawn using Isis draw (MDL Information Systems). 
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Figure 15.  NAAs incorporated into proteins using the amber suppression method.  NAA names are 
referred to within the main text.  Drawn using Isis draw (MDL Information Systems). 
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1.11.4 Amber suppression technology in mammalian cells 
As with the evolution of the amber suppression method in prokaryotes, the 
application of the method in eukaryotes started with the development of an 
aaRS/tRNA pair orthogonal to the endogenous eukaryotic aminoacylation system.  
As mentioned previously, the identity elements vary greatly between eukaryotes 
(and archaea) and prokaryotes.  Therefore, importing tRNA/synthetase pairs from 
prokaryotes was initially used to develop the method. 
1.11.4.1 Production of tRNA   
   
 
Edwards and Schimmel (1990) demonstrated the orthogonality of the E. coli 
TyrRS/tRNATyr pair within Saccharomyces cerevisiae.  The work by Yokoyama’s 
group made progress towards creating a method to incorporate NAA via amber 
suppression in eukaryotes by semi-rationally designing the E. coli TyrRS to recognise 
the NAA 3-iodo-L-tyrosine (Sakamoto et al. 2002).  Initially a mutant E. coli TyrRS 
and tRNA   
   
 orthogonal pair was used, as this system had previously been shown 
to be orthogonal and capable of NAA incorporation in a lower eukaryote (yeast) 
(Deiters et al. 2003).  However, the mutant E. coli tRNA   
   
 (EctRNA) does not 
contain the A box required for efficient transcription by RNA polymerase III in 
mammalian cells (Galli et al. 1981).  Introduction of a pseudo-A box resulted in a 
non-functional tRNA that is not recognised by EcTyrRS (Sakamoto et al. 2002; Wang 
et al. 2007b).  Bacillus. stearothermophilus tRNA    (BstRNA   ), however, does 
contain both the internal promoters (A and B box) in its native sequence, and the 
presence of these allows efficient expression within mammalian cells (Bedouelle 
1990).  Subsequently, mutant E. coli TyrRS and B. stearothermophilus tRNA   
   
 were 
shown to incorporate 3-iodotyrosine within mammalian cells (Kiga et al. 2002; 
Sakamoto et al. 2002).  
BstRNA   
   
 was created by mutating the anticodon to CUA (Liu et al. 2007).  Liu et al 
(2007) suggested this was possible because G34 of the anticodon is only a weak 
identity element for recognition by TyrRS (Hou and Schimmel 1989), therefore 
mutation to G34C did not perturb recognition by EcTyrRS.  Furthermore, it was 
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demonstrated that expression of BstRNA   
   
 in mammalian cells could be enhanced 
by addition of 5’ flanking sequence of human tRNATyr (Liu et al., 2007).  This mutant 
BstRNA in conjunction with the 5’ flanking region of human tRNATyr was therefore 
utilised within this Thesis. 
1.11.4.2 Production of aaRSs specific to NAAs 
Due to the complex nature of the mammalian system, aaRSs for NAAs were evolved 
in yeast.  As for amber suppression in E. coli, a library of mutant aaRSs were created 
based on the five residues in the active site of the homologous TyrRS from Bacillus 
stearothermophilus.  This library was introduced into the Saccharomyces cerevisiae, 
(S. cerevisiae) selection strain, MaV203:pGADGAL4 (2 TAG; uracil and histidine 
auxotroph) (Vidal et al. 1996) which were grown in the presence of NAA (and 
absence of uracil and histidine).  In the positive selection step, NAA is incorporated 
by aaRS to produce full-length functional transcriptional activator GAL4 and 
subsequent activation of the GAL4- responsive HIS3, URA3, and lacZ reporter genes 
(Figure 16).  Expression of these genes allows the cell to biosynthesise histidine and 
uracil and therefore survive.  During the subsequent negative selection step, the 
cells are grown on media containing 5-fluorootic acid (no NAA).  Those cells 
expressing URA3, as a result of suppression of the GAL4 amber mutations with 
natural amino acids, convert 5-FOA to a toxic product, killing the cell (Chin et al. 
2003a; Chin et al. 2003b). 
aaRSs for the NAAs, p-acetyl-L-phenylalanine, p-benzoyl-L-phenylalanine, p-azido-L-
phenylalanine, O-methyl-L-tyrosine, and p-iodo-L-phenylalanine, have been evolved 
using this approach (Hino et al. 2005; Liu et al. 2007).  The mutant E. coli azRS was 
utilised within this Thesis. 
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Figure 16.  Two step system for selecting aaRSs specific to a NAA for use in amber suppression 
technology in mammalian cells (Taken from Chin et al. 2003b). 
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1.11.4.3 Applications of the amber suppression technology in mammalian cells 
As with the production of NAA-containing proteins using E. coli, the proteins 
expressed using mammalian cells have been used for a variety of applications.  
Those applications utilising the evolved TyrRSs will be considered below.  Typically 
proteins not expressed well in E. coli or the study of proteins in-situ are situations 
where amber suppression technology in mammalian cells are required. 
Liu et al (2007), demonstrated that the newly evolved EcTyrRSs could incorporate 
cognate NAAs into GFP using CHO and HEK293T cells.  The incorporation of NAA 
was analysed by purifying the expressed protein and subjecting the sample to 
nanoscale reversed-phase liquid chromatography/ tandem mass spectrometry. 
Photocrosslinkable NAAs have been incorporated into proteins using mammalian 
cells in order to study in situ protein-protein interactions.  Hino et al incorporated 
the photoactive NAAs, p-benzoyl-L-phenylalanine (Hino et al. 2005) and p-
Trifluoromethyl-diazirinyl-L-phenylalanine (Hino et al. 2011) into the Src homology 
2 (SH2) domain of the adaptor protein Grb2 using CHO cells.  Upon irradiation with 
365 nm light, Grb2 variants containing NAA in the positions proximal to the ligand-
binding pocket could be cross-linked with the transiently expressed epidermal 
growth factor. 
Wang et al (2007b), applied NAA technology to investigate neuronal signalling.  
Although the group did demonstrate NAA incorporation within mouse hippocampal 
neurons, the study of NAA-potassium channels was performed using protein 
expression in HEK293 cells.  The NAAs were incorporated into the inactivation 
peptide of the potassium channel and used to study the bulkiness of the side chain 
on the rate of inactivation of the channel.  
The research performed by Ye et al (2009; 2008; 2010) has utilised amber 
suppression in mammalian cells (HEK293 cells) to incorporate a variety of NAAs 
into, and aid in the study of G protein-coupled receptors (GPCRs).  To introduce 
novel chemical reactivity into the proteins the keto-containing NAAs, p-acetyl-L-
phenylalanine and (Acp) and p-benzoyl-L-phenylalanine (Bzp), were used.  
Conjugation of keto-reactive hydrazide-fluorophore allowed study of rhodopsin 
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protein by UV-visible absorbance spectroscopy before and after photobleaching (Ye 
et al. 2008).  Incorporation of the azide-containing NAA, azF, has allowed further 
study by IR spectroscopy (Ye et al. 2009; 2010). 
Takimoto et al (2009) showed that further engineering of the anticodon-binding 
domain of the mutant TyrRS, via the mutation D265R, improved amber suppression 
in HEK293 cells.  To demonstrate that this aaRS could facilitate study of mammalian 
protein-protein interactions it was used to incorporate azF into E. coli glutathione S-
transferase (GST), in order to mediate photoactivated cross-linking between the 
two dimers of the GST homodimer. 
Shen et al (2011), used a lentiviral based system to stably deliver E. coli aaRS and 
the tRNA   
   
  (plus H1 promoter driven tRNA   
   
) expression cassette into neural 
stem cells (HCN-A94).  Typically, the cells used for amber suppression are robust 
cell lines, namely, HEK293, HeLa or CHO cells.  However, Shen et al, has shown that 
amber suppression can also be applied to specialised cells.  Firstly, to test amber 
suppression in the HCN-A94 cells, the group showed that the aaRS specific for 
benzoylphenylalanine (evolved E. coli TyrRS) could be used to incorporate 
benzoylphenylalanine into GFP.  For a more functional application, the group 
incorporated the fluorescent NAA, 2-amino-3-(5-(dimethylamino)-naphthalene-1-
sulfonamido)propanoic acid (DanAla) using the tRNA   
   
,/DanAlaRS pair, into the 
voltage sensing domain of Ciona intestinalis voltage-sensitive phosphatase, which 
was then used to optically monitor the membrane depolarization of neurons 
differentiated from HCN-A94 cells (Shen et al. 2011). 
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1.12   Studying reactive intermediates using a defined protein 
environment 
The third chapter within this thesis will address a novel application of amber 
suppression technology.  Namely, the site-specific incorporation of an NAA 
containing a photoreactive moiety into a defined protein environment.  The NAA p-
azido-L-phenylalanine was chosen as the reactive NAA and the well studied protein, 
T4 Lysozyme was chosen as the protein scaffold.  The photoreactions of the aryl 
azide was subsequently studied using spectroscopy. 
1.12.1 p-azido-L-phenylalanine 
The amino acid p-azido-L-phenylalanine (azF; Figure 15, 31) contains a 
photoreactive aryl (phenyl) azide moiety.  Aryl azides are used in a variety of 
chemical reactions that have many useful applications, for example in organic 
synthesis, production of photoimaging devices and a biochemical method of 
photoaffinity labelling.  Aryl azide chemistry has also been utilised to mediate 
crosslinking between biological molecules (Knowles 1972; Tanaka et al. 2008).  This 
photocrosslinking has been widely used in biology, for example, mapping RNA 
structural neighbours, crosslinking proteins, studying ligand : enzyme interactions 
and site selectively modifying protein by reaction with azide (Buchmueller et al. 
2003; Chen and Ebrigh 1993; Fleming 1995; Sugawara and Matsuda 1995; Zhang et 
al. 2005a).  Despite widespread use, the basic features of aryl chemistry in the 
context of an aqueous, roughly biological environment has not been widely 
investigated. 
1.12.2 Aryl azide photochemistry 
Put simply, photolysis of phenyl azide, at wavelengths 254 – 400 nm, results in loss 
of molecular nitrogen, which results in a species with the formula C6H5N (Huisgen 
1955; Huisgen et al. 1958).  However, the photoreaction of phenyl azide is more 
complex because different reactions occur depending on the temperature and 
substituents on the phenyl ring.  Previous work performed on phenyl azide, utilising  
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Figure 17.  Modern view of the mechanism of phenyl azide photochemistry.  UV photolysis of 
phenyl azide (1) produces singlet phenylnitrene 
1
3 and molecular nitrogen. In the liquid phase, 
1
3 
isomerises over a small barrier to form didehydroazepine / cyclic ketenimine, 5. This species can be 
trapped to produce azepine 2.  At cryogenic temperatures, (10 – 77 K) singlet phenyl nitrene (
1
3) is 
produced.  This species lacks the energy to undergo isomerisation and preferentially relaxes to 
triplet phenyl nitrene 
3
3 by intersystem crossing (ISC).  This process most likely has no barrier to 
surmount and therefore is favoured at very low temperature. Decay of triplet arylnitrenes and/or 
formation of corresponding azo-compounds occurs. 
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a variety of methods, implicates the production of a variety of intermediates (for 
review see Gritsan and Platz 2006; Schuster and Platz 1992).  Certain interesting 
points relating to the complexities of these reactions will be noted in the following 
text. 
At low temperature (4 – 100 Kelvin), particularly in rigid media, reactive 
intermediates are stabilised because their unimolecular reactions are slowed, and 
bimolecular reactions are prevented by inhibition of diffusion.  This increased 
stability enables the application of a variety of spectroscopic techniques that can 
aid in the determination of the structure of the intermediates, most notably EPR.  
Previously Wasserman photolysed a frozen crystalline solution of phenyl azide at 
77 K.  His observed spectrum showed a large new resonance absorption band at 
~6700 G, which was assigned to triplet phenyl nitrene (Smolinsky et al. 1962; 
Wasserman 1971).  Wasserman et al (1971), showed that it was a persistent species 
at this temperature.  Furthermore, studies using UV-vis and IR spectra at low 
temperature also indicated formation of triplet nitrene as the primary 
photoproduct (Reiser et al. 1966).  However, continued irradiation rapidly 
destroyed the triplet nitrene, and ketenimine was the product of secondary 
photolysis (Leyva et al. 1986).  This secondary photolysis was the cause for much of 
the controversy surrounding the intermediates of photolysis of phenyl azide. 
Previous work photolysing phenyl azide in solution at room temperature with a 
pulsed laser generated a reactive intermediate that absorbed strongly at 340 nm, 
formed rapidly (< 20 ns) and reacted slowly (over period of several hundred 
microseconds) to form tarry polymer and a small amount of azobenzene (Li et al. 
1988).  Li et al (1988), concluded that the reactive intermediate could be either 
triplet phenyl nitrene, dehydroazepine, benzazirine or some species not seen at low 
temperature. 
Final resolution of the reaction process was determined utilising a combination of 
multiple techniques, for example, absorption and emission spectroscopy along with 
flash photolysis techniques (Leyva et al. 1986), matrix IR spectrum (Chapman and Le 
Roux 1978), time-resolved IR and UV-vis spectroscopy (Li et al. 1988; Schrock and 
Schuster 1984).  In 1992, three research groups all proposed similar schemes to 
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explain the complex phenyl azide photochemistry (Budyka et al. 1992; Gritsan and 
Pritchina 1992; Schuster and Platz 1992).  Photolysis of phenyl azide in the 
condensed phase forms singlet phenyl nitrene and molecular nitrogen (Figure 17).  
The singlet species rapidly sheds excess vibrational energy by collisions with 
solvent, overcomes a small barrier leading to isomerisation to form dehydroazepine 
(cyclic ketenimine), a high energy species that can be chemically trapped and 
characterised by TRUV and TRIR spectroscopy.  Later computational work showed 
this to be a two-step process involving benzazirine (Karney and Borden 1997).  At 
cryogenic temperatures, (10 – 77 K) singlet phenyl nitrene is produced.  This species 
lacks the energy to undergo isomerisation and preferentially relaxes to triplet 
phenyl nitrene by intersystem crossing.  This process most likely has no barrier to 
surmount and therefore is favoured at very low temperature. 
1.12.3 Spectroscopy of NAAs 
The incorporation of NAAs containing spectroscopically active moieties makes it 
possible to track the incorporation of the non-natural amino acid by the presence of 
this spectroscopic signal.  The incorporation of the azide group containing amino 
acid, azF is an ideal candidate as the spectral properties of azide are distinct from 
those naturally found in proteins.  The azide group is of particular interest because 
the photoreaction of this moiety alters its spectroscopic signals, particularly the EPR 
spectra that arise due to the creation of unpaired electrons during photolysis of the 
azide group.  This technique allows the valuable study of the complex reactions of 
the azide group within a biological relevant setting, which is lacking from the 
literature.  AzF, and it’s photoreaction products, should also confer orthogonal IR 
and UV-vis spectra.  This study is relevant because the reactivity of aryl azides in a 
biological context is particularly important for the quality of structural information 
obtained from those experiments mentioned above. 
1.12.4 T4 Lysozyme 
T4 lysozyme (T4L) is a 164 amino acid endoacetylmuramidase enzyme that is 
expressed during the lytic phase when the T4 bacteriophage infects E. coli cells.  T4L 
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catalyses the hydrolysis of 1,4-β-linkages between N-acetylmuramic acid and N-
acetyl-D-glucosamine residues in peptidoglycan layer of the bacterial cell wall.  This 
cleavage ultimately causes lysis of the host cell and release of progeny phage 
particles.  Both wild type and numerous mutant T4 lysozymes from recombinant 
sources have been extensively studied (Dixon et al. 1992; Eriksson et al. 1993; 
Eriksson et al. 1992; Hurley et al. 1992; Matsumura et al. 1988).  The primary 
structure has been determined (Tsugita and Inouye 1968), the protein crystallised 
(Matthews et al. 1973) and the tertiary structure solved to 1.7 Å (Remington et al. 
1978; Weaver and Matthews 1987) (Figure 18).  In addition, the amber suppression 
technique has been applied to T4L.  Previous work utilising incorporation of NAAs in 
T4L include elucidation of protein structure using the heavy atom Iodine (p-
iodophenylalanine) in single-wavelength anomalous dispersion phasing (Xie et al. 
2004).  Also, incorporation of 4-cyano-phenylalanine and 4-ethynyl-phenylalanine 
at the same site to act as FRET donors with tryptophan has been utilised to probe 
the disruption of the hydrophobic core upon protein unfolding (Miyake-Stoner et al. 
2009). 
The wealth of knowledge regarding T4 lysozyme lends this protein to be used as a 
scaffold for utilisation within this study.  Substitution at position 153 places the NAA 
within the hydrophobic core of the large lobe of T4L (Figure 18).  It was 
hypothesised that the presence of the NAA, p-azido-l-phenylalanine, within this 
hydrophobic pocket can be exploited to study the reactive chemistry of the azide 
group without the complication of bimolecular reactions occurring.  In addition, the 
hydrophobic pocket may stabilise the reactive intermediates to allow their study. 
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Figure 18.  Structures of T4 Lysozyme (PDB ref: 1T6H).  
A) Surface structure of T4L.  The outer surface of T4L is coloured by element (C, grey; N, blue; O, red), the hydrophobic pocket within T4L is coloured yellow for clarity.  P-iodoPhe 
is coloured green.  Created using Pymol (DeLano and Lam 2006).  
B) Ribbon structure of T4L.  Helices (red) and beta sheet (yellow).  Position of azidoPhe shown as green stick structure, nitrogen, N is blue.  Figure created using Pymol (DeLano 
and Lam 2006) 
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1.13   Controlling phenotype by amber suppression 
The fourth, fifth and sixth chapters within this thesis will address another novel 
application of amber suppression technology.  In previous work using the amber 
suppression in mammalian cells, the cells are harvested and protein extracted and 
the protein studied in vitro or the non-natural amino acid is incorporated into GFP, 
luciferase and fluorescence or another visualisation technique is used to monitor 
protein after incorporation of non-natural amino acid.  Therefore, the main aim of 
the work presented within Chapters 4, 5 and 6 was to produce a system where the 
protein was expressed and studied intracellularly, linking the incorporation of NAA 
to a novel, easily read output.  Essentially, the hypothesis was to create a switch 
that was controllable by the presence or absence of NAA.  Therefore, allowing 
control over protein expression and subsequently control over the phenotype of 
the cell via the supplementation of the media with a NAA.  Modulation of motility 
was chosen for phenotypic control as it produces an easily read output and is 
applicable to both prokaryotes and eukaryotes.  It has been postulated that cellular 
motility is an ancient process with its origin 1 billion years ago (Pollard and Borisy 
2003) and that the default status for a cell is to be mobile and that it is the lack of 
space, the components of the extracellular matrix and cellular signalling that are 
responsible for inhibiting migration (Binamé et al. 2010). 
1.13.1 Bacterial motility 
The motility of E. coli is conferred by the rotating helical flagella filaments.  The 
bacterial flagellum consists of three distinct parts.  The basal body is embedded in 
the cell surface and forms part of the motor that produces the flagellar rotational 
force that propels the bacterium forward.  The hook, is a flexible linker that joins 
the basal body to the filament and transmits torque to the filament.  The filament, 
which protrudes into solution, converts this torque to thrust by means of its 
corkscrew shape (Macnab 2003) (Figure 19).  The filament is constructed entirely 
using flagellin proteins (<30,000 subunits), which self assemble to form a filament 
5 - 15 μm in length, with a diameter of about 200 Å. 
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Figure 19.  Structure of bacterial flagella 
A) The basal body comprising rotor and stator; the hook; the flagellin filament and the cap are shown (taken from Yonekura et al. 2002; Yonekura et al. 2003).  
B) Domains 0 (D0) and 1 (D1) promote polymerisation and form the inner core, domains 2 and 3 protrude into solution and form the outer ring (taken from Yonekura et al. 
2003). 
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A flagellin protein consists of domains which have distinct properties (Yonekura et 
al. 2003). The domains 0 and 1 are formed from the N- and C- terminal of the 
peptide and are responsible for initiating polymerisation of flagellin by forming 
stable coiled-coils upon polymerisation (Vonderviszt et al. 1991).  Domain 2 and 3 
protrude from the filament into solution.  Domain 3 is variable among strains and is 
responsible for antigenic properties (Kuwajima 1988b).  It has been previously 
shown that insertion of foreign proteins can be tolerated within domain 3 (Le 
Moigne et al. 2006; Lu et al. 1995). 
1.13.1.1 Flagellar export 
Typically proteins are exported by E. coli via type I or type II bacterial export 
pathway in which the signal for export is found within an N- or C- terminal peptide 
(Homma et al. 1987a; Homma et al. 1987b; Jones et al. 1989).  However, it is 
thought that flagellin protein and other proteins required for flagella assembly, 
namely the hook protein, the hook-associated proteins, and the component 
proteins of the basal body are exported via a flagellum-specific pathway (Type III).  
Kuwajima et al (1988a; 1989) performed a series of investigations utilising 
truncated flagella protein to ascertain which part of the protein encoded for export 
via this pathway.  The work showed that the middle portion could be deleted or the 
C-terminal severely truncated without affecting transport.  It has been suggested 
that the signal occurs in the N-terminal region of the protein itself and not present 
outside the coding region of flagellin gene (Kuwajima et al. 1989; Végh et al. 2006). 
1.13.2 Mammalian cell motility 
The ability for a metazoan cell to move is important for a variety of biological 
processes, whether it is, for example, embryonic axis patterning during 
development, wound healing, leukocyte migration from circulation into 
surrounding tissue during immune surveillance, axonal growth or metastasis and 
invasion of tumour cells (For review see Rørth 2009).  The molecular processes that 
occur during cell migration are also common to other cellular process, for example, 
adhesion, cytokinesis and endocytosis and this paints a complex picture within the 
cell.  
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1.13.2.1 Amoeboid motion 
The motility of a single cell depends on a variety of factors, such as, the strength of 
their adhesion; the type of substratum; external migratory signals; mechanical 
pliability, and the organization of the cellular cytoskeleton.  Differences in these 
factors results in different modes of migration.  For example, amoeboid motion 
describes the movement of a cell when the actin cytoskeleton is tending towards a 
disordered state and the adhesion to the substratum is weak (does not involve 
integrins).  This amoeboid motion is observed in leukocytes cells of the immune 
system (Friedl and Weigelin 2008), haematopoietic stem cells (Giebel et al. 2004) 
and some tumour cells.  This type of migration is studied by the model motility of 
Dictyostelium discoideum (Firtel and Meili 2000). 
1.13.2.2 Metazoan motion 
On the other hand, cells like fibroblasts display typical metazoan or mesenchymal 
motion (cell crawling) due to the elaborate cytoskeletal structures and adhesions.  
This motion is typically slow.  In simple terms, movement of a polarised cell is now 
widely accepted to be driven by the extension of flat sheet-like layer of cytoplasmic 
protrusion (~0.2 µm thick) at the leading edge of the cell (by actin polymerisation, 
see section 1.13.2.4), the lamellipodium, as described in the seminal work by 
Abercrombie in the 1970’s (Abercrombie 1980; Abercrombie et al. 1970, 1971).  
After protrusion of this lamellipodium, new adhesion sites to the substratum at the 
front are established (Figure 20).  This is followed by cell body contraction (and 
detachment of cell adhesions to the rear of the cell), which acts to translocate the 
cell body forward and retraction of the cell rear, and is mediated by actin- and 
myosin- based contractions.  As a result of this cyclical process the polarised cell 
tends to move in the same direction, until a random membrane protrusion makes 
stable contacts to substratum and can define a new direction of movement.  These 
changes in direction can allow long time scale random movements, which enable 
the cell to explore its environment (Petrie et al. 2009). 
This mesenchymal mode of migration is important for wound healing, and depends 
upon the activity of Rac GTPase (section 1.13.2.6) and therefore it is this type of 
motion that is considered in the following study. 
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Figure 20.  Schematic of the three stages of metazoan cell movement.  Initially the polarised cell 
produces a lamellipodium protrusion.  New adhesion sites to the substratum at the front, via focal 
adhesions, are established.  This is followed by cell body contraction and detachment of adhesions 
and subsequent retraction of the cell rear. 
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1.13.2.3 Scratch wound model 
The use of a 2D scratch model of a wound is a well established tool for use in the 
study of cell migration (Figure 21) (Vaughan and Trinkaus 1966).  A scratch wound is 
created by mechanically scratching away a broad section of cells from a confluent 
cell monolayer.  The response to the scratch involves both reaction to the cell injury 
and to the creation of a space within the scratched area (Nikolić et al. 2006; 
Poujade et al. 2007).  The cells bordering the wound sense the free space, polarise 
(by a process controlled by cdc42 (Etienne-Manneville and Hall 2003; Fairn et al. 
2011; Nobes and Hall 1995)), extend lamellipodia into this space to promote cell 
migration in this direction.  Typically, the movement of cells during the simple 
scratch wound assay move as a collective sheet to close the wound created.  The 
movement here is a collective migration based on the mesenchymal migratory 
mode.  However, there has been evidence produced that suggests that confluent 
fibroblastic cells can also respond to a scratch wound as independent cells 
(Matsubayashi et al. 2004). 
There is remaining discussions as to whether the cells behind the wound edge move 
forward as an act of passive dragging by the leading cells or whether they also 
orchestrate lamellipodia formation themselves (Fenteany et al. 2000; Ridley et al. 
1992).  It has previously been proposed that the leading cells recognise the scratch 
and produce the migratory force which pulls the sheet of cells in order to close the 
wound.  The passive dragging of cells has been proposed to be orchestrated by the 
link between adherens junctions of adjacent cells formed by homotropic 
interactions of cadherins, and the linking of actin filaments at these positions to 
create a continuum of cytoskeleton (Hartsock and Nelson 2008; Tsukita et al. 1992).  
More recent work demonstrates that cells at the leading edge of the wound and 
submarginal cells behind it, are both actively motile and are involved in the closing 
of the wound (Farooqui and Fenteany 2005; Fenteany et al. 2000; Poujade et al. 
2007; Vitorino and Meyer 2008).  However, those cells at the leading edge confer 
more protrusive and motile activity (Omelchenko et al. 2003). 
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Figure 21.  Scratch wound assay.  A monolayer of confluent cells is scratched using a p200 tip, the cells sense the space created, polarise and migrate in to the wound space.  The 
wound then starts to close, until a monolayer of confluent cells is apparent once more.  
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1.13.2.4 Motility and the role of actin 
Actin, microtubules and intermediate filaments make up the cytoskeleton of a 
metazoan cell.  Within the cell, actin filaments provide mechanical support for 
maintaining cellular shape; provide a path for the movement of intracellular cargo 
and polymerisation provides the driving force for cellular motility.  It has been 
shown that actin comprises approximately 10 % of total cellular protein in 
fibroblasts (Bray and Thomas 1975).  
The morphology and physical behaviour of migrating cells are predominantly 
orchestrated by the dynamics of the filamentous actin (F-actin) cytoskeleton which 
produce lamellipodia and are coupled to the substrate via focal adhesions.  The 
most extended region of the lamellipodia is composed of a network of highly 
branched actin filaments that are actively polymerising (Glacy 1983).  It is this 
polymerisation of actin beneath the plasma membrane that produces the physical 
force to push the membrane forward (For review see Gardel et al. 2010).  The 
current view, the dentritic-nucleation model (Figure 22), is that actin filaments form 
a branched network with actin filaments lying at an angle of 70° with branching 
mediated by Arp2/3 complex (Pollard 2007; Svitkina and Borisy 1999).  During 
polymerisation, globular G-actin is arranged head-to-tail to form F-actin in a process 
catalysed by ATP hydrolysis.  F-actin is created in such a way that the filament 
displays polarity, with one end termed “barbed” or “plus” end, where actin 
polymerisation predominantly occurs; and the other “pointed” or “minus” end.  The 
process of polymerisation can be stimulated by extracellular stimuli, for example, 
the creation of a scratch wound, which culminates in signalling cascades including 
Rac1 GTPase signalling. 
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Figure 22.  The dentritic-nucleation model for protrusion of lamellipodia.  Extracellular signals (1) 
activate signalling pathways that lead to activation of GTPases (2), for example Rac1.  These then 
activate Wiskott–Aldrich syndrome protein (WASP) and related proteins (3), which in turn activate 
Arp2/3 complex.  Arp2/3 complex initiates filament branching on the side of an existing filament (4).  
Each new filament grows (5), fed by a high concentration of profilin-bound actin stored in the 
cytoplasm, and this pushes the plasma membrane forward (6).  Capping protein binds to the 
growing ends, terminating elongation (7).  Actin-depolymerising factor (ADF)/cofilin then severs and 
depolymerises the ADP filaments, mainly in the ‘older’ regions of the filaments (8, 9).  Profilin re-
enters the cycle at this point, promoting dissociation of ADP and binding of ATP to dissociated 
subunits (10).  ATP–actin binds to profilin, refilling the pool of subunits available for assembly (11).  
(Taken from Pollard 2003). 
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1.13.2.5 GTPases and their role in cell migration 
The spatiotemporal regulation of the physical structures associated with cell 
migration is regulated by a variety of signalling molecules and their downstream 
effectors, namely, the Rho family GTPases (For review see Raftopoulou and Hall 
2004).  GTPase activity of Rho is required to maintain cell adhesion during 
movement and Ras orchestrates the production of contractile actomyosin 
structures (stress fibres) and focal adhesions (Nobes and Hall 1995; Ridley and Hall 
1992).  Cdc42 is required to maintain cell polarity, which includes the localisation of 
lamellipodial activity to the leading edge and the reorientation of the Golgi 
apparatus in the direction of movement, and orchestrates production of filopodia 
(Nobes and Hall 1995, 1999).  Rac is essential for protrusion of lamellipodia which is 
important in forward cellular migration (Nobes and Hall 1995; Ridley et al. 1992).  
When functional Rac1 is withheld from fibroblast cells, either by the presence of 
dominant negative (N17Rac1) Rac1 protein (Nobes and Hall 1999; Ridley et al. 
1992), siRNA knockdown (Monypenny et al. 2009), or Rac1 knockout (Guo et al. 
2006; Vidali et al. 2006), the cells display reduced ability to produce membrane 
ruffles and lamellipodia;  thus limiting the migratory abilities of the cells.  However, 
injection of constitutively active V12Rac1 in to fibroblasts was sufficient to induce 
lamellipodia and membrane ruffles (Ridley et al. 1992). 
1.13.2.6 Ras-related C3 botulinum toxin substrate 1 (Rac1) 
Ras-related C3 botulinum toxin substrate 1 (Rac1) is a small (~21 kDa) signalling 
GTPase protein, and is a member of the Rac subfamily of the Rho family and Ras 
superfamily of small GTP-binding proteins (Raftopoulou and Hall 2004).  The GTPase 
functions by cycling between active plasma membrane associated GTP-bound form 
and inactive GDP-bound state.  When activated, Rac1-GTP can bind to a variety of 
effector proteins to illicit numerous and varied responses, for example, secretory 
processes, phagocytosis of apoptotic cells, epithelial cell polarisation and most 
importantly its role in mediating actin-induced lamellipodial formation and 
subsequent cell migration.  Rac1 is activated by tyrosine kinases and G-protein 
coupled receptors and is often dependent on phosphoinositide 3-kinase (PI 3-
kinase) activity. 
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1.13.2.6.1 Overall structure 
The Rac1 protein tertiary structure consists of a six strand (five parallel, one anti-
parallel) central β-sheet and with six α-helices and two 310 helices (Hirshberg et al. 
1997).  This overall structure is similar to that of members of the Ras superfamily, 
however, Rac1 contains an additional 13 residue insertion, residues 123 – 135, 
between β5 and α4.  The nucleotide binding pocket of all Ras GTPases consists of 
highly conserved loops, namely, the two guanine recognition loops 115TKLD and 
158SAL and two phosphate binding loops 10GDGAVGKT and 57DTAG (Hirshberg et al. 
1997).  Two regions, switch I (residues 28-40) and switch II (residues 59-74), of the 
Rac1 GTPase have been shown to be important in GTP binding and undergo 
conformational changes during the GDP-GTP exchange reaction (see section 
1.13.2.6.2) (Rapley et al. 2008; Worthylake et al. 2000).  Also involved in GTP 
binding is a hydrogen bond between the side chain of Cys 18 and the O2 atom of 
the α-phosphate.  Phe 28 also interacts with the guanine base of the bound GTP.  
The Mg2+ ion is bound by the hydroxyl of Thr 35, within switch I (Grizot et al. 2001).  
The C-terminal region of Rac1, including the polybasic region and prenylation 
domain, is important in its association with the plasma membrane (see section 
1.13.2.6.3).   
Rac1 makes interactions with numerous protein factors, such as guanine nucleotide 
exchange factors (GEFs) and GTPase-activating proteins (GAPs), which are involved 
in GDP-GTP exchange.  The region between amino acids 53 – 72 of Rac1 is required 
for specific recognition and activation by the GEFs with residue Trp 56 within β3 
important in specific recognition of Rac1 by Rac1-specific GEFs (Gao et al. 2001).  
Rac1 also interacts with Rho guanosine nucleotide dissociation inhibitors (RhoGDIs) 
through hydrogen bonds which involve a number of residues of Rac1 mainly within 
the switch II region, namely, Thr 35, Tyr 64, Arg 66, His 103, and His 104, but also 
via hydrophobic interactions involving Leu 67 and Leu 70 (Grizot et al. 2001).  The 
Rac1-RhoGDI complex is also involved in the activation of the NADPH oxidase 
complex (Grizot et al. 2001; Lapouge et al. 2000). 
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Figure 23.  Ribbon structure of Rac1, PDB structure 2RMK (deposited by Modha et al. 2008).  
Switch 1 - light blue, Switch 2 – blue, Rac1 important determinant Trp56 – yellow, Polybasic region – 
pink, prenylation sequence (CLLL) – light pink, Mg2+  -grey sphere, Phosphomethylphosphonic acid 
guanylate ester (GTP analogue) – CPK colouring.  Figure was produced using Pymol (DeLano and Lam 
2006). 
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1.13.2.6.2 GTP exchange of Rac1 
As the name suggests, Rac1 GTPases can exchange and hydrolyse GTP in reactions 
catalysed by guanine nucleotide exchange factors (GEFs) and GTPase-activating 
proteins (GAPs), respectively (Figure 24) (For review see Van Aelst and D’Souza-
Schorey 1997).  Many GEFs activate Rac1, for example, α/β-PIX, Tiam1, DOCK180 
and some members of the Vav subfamily (Rapley et al. 2008; Worthylake et al. 
2000).  It has been demonstrated that Dbl-homology (DH) and pleckstrin-homology 
(PH) domains within GEFs, such as Tiam1, are responsible for catalysis of nucleotide 
exchange and the activation of G proteins by interacting with the two switch 
regions and causing their displacement and remodelling (Worthylake et al. 2000).  
More specifically, the interactions are mediated via hydrogen bonds to the amide 
nitrogens of Thr 35 and Val 36 and the hydroxyl of Tyr 32 of Rac1.  The induced 
conformation changes disrupt binding of the nucleotide and Mg2+ ion, and thereby 
promote their release (Rapley et al. 2008; Worthylake et al. 2000). 
1.13.2.6.3 Post-translational modification of C-terminal of Rac1 
As for the majority of the Ras superfamily of proteins, Rac1 is post-translationally 
modified by attachment of a lipid moiety (more specifically, a geranylgeranyl group) 
to its C-terminal cysteine in response to the consensus C-terminal CAAX (C = Cys, 
A = aliphatic, X = any amino acid; CLLL for Rac1) tetrapeptide sequence.  The C-
terminal tetrapeptide undergoes a process of prenylation, proteolysis, and carboxyl 
methylation in association with a cytosolic chaperone, Rho guanosine nucleotide 
dissociation inhibitors (RhoGDIs) (Michaelson et al. 2005; Michaelson et al. 2001) 
(Figure 25).  In addition, RhoGDIs bind Rac1 to prevent its interaction with the 
plasma membrane by shielding the geranylgeranyl group (Fukumoto et al. 1990; 
Michaelson et al. 2001).  It is this proteolysed/prenylated/carboxylated cysteine 
residue, which, when coupled with the polybasic residues immediately upstream, 
comprise the membrane-targeting sequence (Clarke 1992).  Once correctly 
modified, bound to GTP and associated with the plasma membrane, Rac1 can elicit 
signalling cascades, for example, those involved in the formation of actin 
protrusions and orchestrate directed migration (Figure 26) (For review see 
Raftopoulou and Hall 2004). 
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Figure 24.  The GTPase cycle of Rac1.  The GTPase functions by cycling between active plasma 
membrane associated GTP-bound form and inactive GDP-bound state.  When activated, Rac1-GTP 
can bind to a variety of effector proteins to illicit numerous and varied response.  The intrinsic 
GTPase activity of the Rac1 can hydrolyse GTP to GDP, with catalysis from GTPase activating proteins 
(GAPs),  GTP exchange factors (GEFs) facilitate exchange of GDP with GTP and thus favour the active, 
GTP-bound state. 
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Figure 25.  Post translational modification of the C-terminal of Rac1.  In the cytoplasm, 
Geranylgeranyltransferase (GGTase) adds a geranylgeranyl group to the cysteine residue of CLLL 
motif.  At the cytosolic leaflet of the endoplasmic reticulum Ras and a-factor converting enzyme 
(Rce1) removes the LLL tripeptide and isoprenylcysteine carboxyl methyltransferase (Icmt) 
methylates the cysteine in a process requiring S-adenosylmethionine (SAM).  Rac1 then travels to 
the plasma membrane (PM), where the geranylgeranyl group inserts into, and the polybasic region 
associates with, the PM. 
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1.13.2.6.4 Signalling cascades elicited by Rac1 
Most notably, Rac1 activates the scaffold protein WAVE/Scar complex, which 
includes the components WAVE, Abi, Nap125, Sra-1 and HSPC-300 (Figure 26).  It 
has been suggested that Rac1 activates the WAVE/Scar complex by inducing the 
dissociation of the Abi-Nap125-Sra-1 trimer from WAVE (Vartiainen and Machesky 
2004).  Phosphorylation has also been implicated in the activation of WAVE/Scar 
(Ardern et al. 2006; Cory et al. 2003).  Activated WAVE/Scar in turn activates the 
Arp2/3 complex (Machesky et al. 1999) (see section 1.13.2.4; Figure 22).  Both the 
Arp2 and Arp3 subunits can bind ATP and this ability has been suggested to be 
involved in the activation of Arp2/3-initiated actin polymerisation (Dayel and 
Mullins 2004; Kiselar et al. 2007).  Recent work has suggested that activation of the 
Arp2/3 complex is brought about by the conformational changes within Arp2 
stimulated by its phosphorylation (Narayanan et al. 2011).  Activated Arp2/3 then 
functions to create branched actin by associating with an existing actin filament and 
creating a nucleation point for polymerisation of actin by forming an actin-like 
heterodimer that mimics the barbed end of an actin filament (Robinson et al. 2001).  
Rac1 signalling via a phosphatidylinositide 4-phosphate 5-kinase (PIP 5-kinase) to 
induce the formation of PIs(4,5)P2 has also been shown.  PI(4,5)P2 can act to 
promote actin polymerisation by removing capping proteins from the barbed ends 
of existing actin filaments at the plasma membrane (Carpenter et al. 1999).  
PI 3-kinases and their lipid product PI(3,4,5)P3 have also been implicated in Rac1-
induced control of cell migration (Reif et al. 1996).  The production of PI(3,4,5)P3 
leads to an increase in GTP-Rac in many cell types and is thought to act via direct 
interaction with Rac GEFs, for example Tiam-1.  It has been suggested that a major 
role of PI(3,4,5)P3 is the induction of membrane translocation via GEFs PI(3,4,5)P3–
binding pleckstrin homology (PH) domain (Raftopoulou and Hall 2004).  Rac1-GTP is 
also capable of activating PI 3-kinase, resulting in production of PI(3,4,5)P3, which 
establishes a positive feedback loop.  
In addition, Rac1 can activate a variety of downstream targets, for example p21-
activated serine/threonine kinases (PAKs) that phosphorylate a plethora of 
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substrates implicated in cell migration (For review see Bokoch 2003), including 
MLCK (inhibitory) (Sanders et al. 1999), RLC (activating) (Chew et al. 1998), LIMK 
(activating, which inhibits cofilin, regulating its actin-severing activity) (Yang et al. 
1998), and stathmin (which controls microtubule stability) (Wittmann et al. 2004). 
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Figure 26.  A diagram displaying a model for Rac-induced lamellipodium extension.  Rac signalling 
stimulates Arp2/3 complex-induced actin polymerisation by interacting with a complex of IRSp53 
and WAVE proteins.  Arp2/3 complex acts as a nucleation point for the formation of new actin 
filament branches.  Rac can also induce actin polymerisation via filament uncapping, which 
generates phosphatidylinositol 4,5-bisphosphate and inhibit cofilin-induced depolymerisation (via 
PAKs-LIMK signalling).  Cross-talk of Rac with Cdc42 pathways via IRSp53 and/or PAKs may act to 
regulate Rac signalling.  (Taken from Ridley 2001). 
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1.14   Aims 
The aims of the work presented within this Thesis were to expand upon the current 
applications of amber suppression technology and incorporation of NAAs into 
proteins, as are discussed above.  Despite having a vast range of applications in 
inserting chemical, physical or biological reactivities into proteins, there is potential 
to apply this method to disparate applications.  
Firstly, the aim was to use amber suppression technology to site-specifically 
incorporate a specific chemical moiety into a defined environment within a protein.  
The hypothesis was that this protein scaffold could be used to stabilise, shield and 
therefore allow exploration the chemical reactivity of photoreactive moieties.  The 
well studied protein, T4 lysozyme was used to provide the defined chemical 
environment, and the photoreactive, aryl azide containing NAA azidophenylalanine 
was used as an example of a highly reactive species. 
In the second application, the amber suppression method itself was the basis for 
the novel application rather than the chemical reactivity of the NAA.  It was 
explored whether the amber suppression method could be used to create a 
biological switch controlled by the presence or absence of NAA.  This would provide 
a novel method to control protein expression and could be linked, therefore, to 
modulation of a specific phenotype.  The flagellin protein was chosen as the target 
protein within E. coli for modulation of motility.  The Rac1 GTPase was chosen as a 
target protein in mammalian cells because it is involved in the production of 
lamellipodia, which has the potential to control cell migration. 
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2 CHAPTER 2: GENERAL MATERIALS AND 
METHODS 
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2.1 Instruments 
Electroporation of bacterial cells was performed using ECM 399 Electroporator 
system (BTX Harvard Apparatus, 45-0000).  Protein purification was performed 
using AKTApurifier UPC10 (28-4062-68, GE Healthcare) using a Superdex 75 10/300 
GL size exclusion column (17-5174-01, GE Healthcare).  Polymerase chain reactions 
were performed using a TC-300 Thermal cycler (Techne, VWR 731-1501).  DNA and 
protein concentration measurements were obtained using a NanoDrop ND-1000 
UV-vis spectrophotometer (Thermo Scientific).  ddH2O was obtained using a 
PURELab Option S-R-7-15 (ELGA) water purifier, which produced water up to 
15 MΩ-cm. Gel images and motility assays were visualised using a UV-
transilluminator (UVP) and images were captured using a Canon PowerShot G10 
camera with UV-filter (Canon).  UV-Vis spectra were recorded using a Jasco 630 UV-
visible spectrophotometer equipped with a Peltier temperature controller (Jasco). 
2.2 Materials 
The chemicals, plastic and glassware were purchased from Sigma Aldrich, VWR, 
Melford and Fisher unless otherwise stated. 
2.2.1 Non-natural amino acids 
The non natural amino acids (NAAs) p–azido-L-phenylalanine and p-iodo-L-
phenylalanine were obtained from BACHEM.  NAAs were dissolved in sterile ddH2O 
with 5 M NaOH added until fully dissolved. 
2.2.2 Bacterial antibiotics 
Bacterial antibiotics were made up as indicated in Table 1, aliquoted and stored at -
20 °C until required.  The desired concentration of antibiotic was added to 
microbiological media for immediate use. 
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Table 1.  Bacterial antibiotics 
Antibiotic Manufacturer 
Stock 
solution 
concentration 
Solute 
Working 
concentration 
Carbenicillin disodium Melford 100  mg / ml ddH2O 100  µg / ml 
Chloramphenicol Fluka 34  mg / ml ethanol 34  µg / ml 
Kanamycin Sulphate Applichem 50  mg / ml ddH2O 50  µg / ml 
Tetracycline 
hydrochloride 
Applichem 5  mg / ml ethanol 25  µg / ml 
 
2.2.3 Buffers 
2.2.3.1 Buffers for preparation of chemically competent cells 
TFB I buffer contained 30 mM KOAc, 50 mM MnCl2, 100 mM RbCl, 10 mM CaCl2, 
15 % Glycerol, was adjusted to pH 5.8 with acetic acid; sterile filtered and stored at 
4 °C. 
TFB II contained 10 mM MOPS, 75 mM CaCl2, 10 mM RbCl, 15 % Glycerol, adjusted 
to pH 7.0, sterile filtered, and stored at 4 °C. 
2.2.3.2 Buffers for DNA preparation 
Buffer P1 (resuspension buffer) contained 50 mM Tris-Cl, 10 mM EDTA, 100 μg/ml 
RNase A, pH 8.0 and was sterile filtered and stored at 4 °C. 
Buffer P2 (lysis buffer) contained 200 mM NaOH, 1 % SDS (w/v).  The solution was 
sterile filtered and stored at room temperature.  
Buffer P3 (neutralisation buffer) contained 3 M Potassium acetate, pH 5.5.  The 
solution was sterile filtered and stored at room temperature.  Prior to use buffer P3 
was pre-chilled to 4 °C. 
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The composition of Buffer N3 (neutralisation buffer), Buffer ERC, and the wash 
buffers, Buffer PB and Buffer PE are confidential, proprietary components of the 
QIAprep spin miniprep kit (Qiagen). 
Buffer QBT (equilibration buffer; Qiagen) contained 750 mM NaCl, 50 mM MOPS, 
pH 7.0, 15 % isopropanol (v/v) and 0.15 % Triton® X-100 (v/v).  Buffer was stored at 
room temperature. 
Buffer QC (wash buffer; Qiagen) contained 1.0 M NaCl, 50 mM MOPS, pH 7.0 and 
15 % isopropanol (v/v).  Buffer was stored at room temperature. 
Buffer QF (elution buffer; Qiagen) contained 1.25 M NaCl, 50 mM Tris-Cl, pH 8.5 
and 15 % isopropanol (v/v).  Buffer was stored at room temperature. 
Buffer EB (Elution buffer, Qiagen) contained 10 mM Tris-Cl, pH 8.5. 
TE buffer contained 10 mM Tris·Cl, 1 mM EDTA, pH 8.0.  Buffer was stored at room 
temperature. 
2.2.3.3 Buffers for enzymatic reactions 
Antarctic phosphatase buffer (for dephosphorylation of DNA) contained 50 mM Bis-
Tris-Propane-HCl, 1 mM MgCl2, 0.1 mM ZnCl2, pH 6.0. 
Quick Ligation reaction buffer contained 132 mM Tris-HCL, 20 mM MgCl2, 2 mM 
dithiothreitol, 2 mM ATP, 15 % Polyethylene glycol (PEG 6000) , pH 7.6. 
NEBuffer 1 contained 10 mM Bis-Tris-Propane-HCl, 10 mM MgCl2, 1 mM 
Dithiothreitol, pH 7.0.  NEBuffer 2 contained 50 mM NaCl, 10 mM Tris-HCl, 10 mM 
MgCl2, 1 mM Dithiothreitol, pH 7.9.  NEBuffer 3 contained 100 mM NaCl, 50 mM 
Tris-HCl, 10 mM MgCl2, 1 mM Dithiothreitol, pH 7.9.  NEBuffer 4 contained 50 mM 
Potassium Acetate, 20 mM Tris-acetate, 10 mM Magnesium Acetate, 1 mM 
Dithiothreitol, pH 7.9. 
2.2.3.4 Buffers for DNA electrophoresis 
A 50 x stock of Tris-Acetate-EDTA (TAE) buffer contained 2 M Tris-acetate, 50 mM 
EDTA, 57.1 ml acetic acid, pH 8.  A 1 x working solution was prepared in ddH2O and 
used for DNA gel electrophoresis (section 2.3.2.7) 
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A 6 x stock of DNA electrophoresis loading buffer was made using 0.25 % 
bromophenol blue, 0.25 % xylene cyanol, 1 mM EDTA, 30 % glycerol, pH 8.0.  DNA 
samples were diluted to an appropriate concentration using ddH2O and the stock 
DNA loading buffer. 
2.2.3.5 Buffers for microbiological media 
M9 salts stock solution contained 42 mM Na2HPO4, 24 mM KH2PO4, 9 mM NaCl, 
19 mM NH4Cl. 
A 1000 x stock of trace metal solution contained 50 mM FeCl3, 20 mM CaCl2, 10 mM 
MnCl2 10 mM ZnSO4, 2 mM CoCl2, 2 mM CuCl2, 2 mM NiCl2, 2 mM Na2MoO4, 2 mM 
Na2SeO3, 2 mM H3BO3 in ddH2O.  The stock was sterilised by syringe filtration 
through a 0.2 µm membrane. 
2.2.3.6 Buffers for sodium dodecyl sulphate polyacrylamide gel 
electrophoresis 
Buffers for making and running SDS-PAGE gels are indicated in Table 2.  Buffers 
were made using ddH2O and stored at room temperature. 
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Table 2.  SDS-PAGE buffers 
Buffer Components Concentration Use 
SDS-PAGE gel 
buffer 
Tris-HCl 3 M Making Tricine gels 
SDS 0. 3 % 
pH 8.45 
Acrylamide/bis-
acrylamide 37.5 : 1, 
30 % solution 
Acrylamide/bis-
acrylamide 37.5 : 1 
30 % Making all protein gels 
Cathode buffer 10 x Tris-HCl 1 M Cathode buffer when 
running tricine protein 
gels 
Tricine 1 M 
SDS 1 % 
pH 8.25 
Anode buffer 10 x Tris-HCl 2.1 M Anode buffer when 
running tricine protein 
gels 
pH 8.9 
Laemmli buffer 1 x Tris 3 % Running buffer for 
glycine protein gels 
Glycine 14.4 % 
SDS 1 % 
Sample buffer 4 x Tris-HCl 150 mM Dilute protein samples 
for SDS-PAGE 
Coomassie blue G-
250 
0.05 % 
Glycerol 30 % 
β-mercaptoethanol 6 % 
SDS 12 % 
SDS-PAGE Stain 
solution 
Coomassie blue G-
250 
1 g / L Staining SDS-PAGE 
gels for visualisation 
Acetic acid 10 % 
Ethanol 40 % 
ddH2O 50 % 
SDS-PAGE destain 
solution 
Acetic acid 10 % Destaining SDS-PAGE 
gels for visualisation 
Ethanol 40 % 
ddH2O 50 % 
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2.2.4 Restriction enzymes 
All restriction enzymes were supplied by New England Biolabs (Table 3).  Double 
digests were designed using the Double Digest tool on NEB website (New England 
Biolabs). 
Table 3.  Restriction enzymes 
Enzyme 
Recognition 
sequence 
Buffer 
Digestion 
temperature 
Inactivation 
AgeI-HF ACCGGT 4 + BSA 37 °C 65°C, 20 min 
ApaI GGGCCC 4 + BSA 25 °C 65°C, 20 min 
BamHI-HF GGATTC 4 37 °C - 
BglII AGATCT 3 37 °C - 
DpnI GA(Me)TC 4 37 °C 65°C, 20 min 
EcoRI-HF GAATTC 4 37 °C 65°C, 20 min 
HindIII AAGCTT 2 37 °C 65°C, 20 min 
KpnI-HF GGTACC 4 37 °C - 
NcoI-HF CCATGG 4 37 °C 65°C, 20 min 
NdeI CATATG 4 37 °C 65°C, 20 min 
NheI-HF GCTAGC 4 + BSA 37 °C 65°C, 20 min 
NotI-HF GCGGCCGC 4 + BSA 37 °C 65°C, 20 min 
SspI-HF AATATT 4 37 °C 65°C, 20 min 
XbaI TCTAGA 4 + BSA 37 °C 65°C, 20 min 
XhoI CTCGAG 4 + BSA 37 °C 65°C, 20 min 
 
2.2.5 Other enzymes 
T4 Polynucleotide Kinase (PNK), Antarctic Phosphatase, and Quick T4 DNA ligase 
were purchased from New England Biolabs. 
2.2.6 Escherichia Coli Cells 
Top10 (Invitrogen) genotype F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 
recA1 araD139 ∆(ara-leu)7697 galU galK rpsL endA1 nupG were used for cloning, 
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plasmid preparation and protein expression using pBAD plasmids.  NEB 10-beta 
Competent E. coli (High Efficiency) (New England Biolabs) genotype  araD139 ∆(ara-
leu)7697 fhuA lacX74 galK (ϕ80 ∆(lacZ)M15) mcrA galU recA1 endA1 nupG 
rpsL (StrR) ∆(mrr-hsdRMS-mcrBC) were used for cloning of mammalian plasmids.  
BL21 Star™(DE3) (Invitrogen) genotype F- ompT hsdSB (rB
– mB
–) gal dcm rne131 
(DE3) and BL21 Gold(DE3) (Stratagene) genotype E. coli B F– ompT hsdS(rB
– mB
–) 
dcm+ Ter gal λ(DE3) endA were used for protein expression using pET plasmids and 
other plasmids requiring T7 polymerase expression.  KAF95 is a K12 derivative, 
AW405 (Armstrong et al. 1967) constructed by Karen Fahrner (Berg and Turner 
1993).  The cell line carries the fliC726 allele, with a non-flagellate phenotype 
(Silverman and Simon 1973) and a cheY deletion so is smooth swimming and non-
chemotactic.  Further details can be found in Appendix A5.  KAF95 was used in 
experiments to try to restore motility using a plasmid encoded FliC gene.  The 
JW1908 strains of the Keio collection were created by Baba et al (2006).  The strain 
has the genotype, AG1[recA1 endA1 gyrA96 thi-1 hsdR17(rK-mK+) supE44 relA1].  
The group systematically made a set of precisely defined, single-gene deletions of 
all nonessential genes in Escherichia coli K-12 BW25113.  The clone used in this 
study is a FliC knock-out strain and therefore has a non-flagellate phenotype and 
are therefore non-motile.  Keio cells were used in experiments to try to restore 
motility using a plasmid encoded FliC gene. 
2.2.7 Media 
Lysogeny broth (LB) media contained 1 % tryptone, 1 % NaCl, 0.5 % Yeast extract.  
LB agar contained components as listed for LB, but with addition of 1 % agar.  Agar 
was autoclaved, stored at room temperature and melted and plated as required, 
with addition of specified antibiotics when agar was hand-hot.  LB media and LB 
agar was used for routine bacterial culture.  LB medium containing 0.3 % agar was 
used for E. coli motility assays. 
Super Optimal broth (SOB) with Catabolite repression (SOC) media contained 0.5 % 
Yeast Extract, 2 % Tryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4 
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with addition of 20 mM filter sterilised glucose after autoclaving.  SOC was used to 
rescue E. coli transformations. 
Terrific broth (TB) autoinduction media contained 1.2 % Tryptone, 2.4 % yeast 
extract, 0.4 % glycerol which was then autoclaved.  Sterile filtered 17 mM KH2PO4, 
72 mM K2HPO4, 0.05 % glucose and 0.2 % α-lactose was added when cool.  TB was 
used for protein expression media. 
ZYM-5052 autoinduction medium contained 1 % Tryptone, 0.5 % yeast extract, 
25 mM Na2HPO4, 25 mM KH2PO4, 50 mM NH4Cl, 5 mM Na2SO4, 2 mM MgSO4, 1× 
trace elements (section 2.2.3.5), 0.5 % glycerol, 0.05 % glucose and 0.2 % α-lactose.  
ZYM-5052 was used for protein expression.  For induction from araBAD promoter, 
0.2 % arabinose was added directly to the growing culture. 
PSI broth contained 5 % yeast extract, 20 % tryptone, 5 % MgSO4 and was adjusted 
to pH 7.6.  Psi broth was used in bacterial culture to make chemically competent 
cells. 
M9 minimal media contained 1 x M9 salts (section 2.2.3.5), 1 mM MgSO4 , 0.1 mM 
CaCl2 , 2.0 % glucose, 0.5 µg/ml thiamine and 0.4 % glycerol. 
All media was made up in ddH2O.  Autoclaving was performed at 121 °C for 15 
minutes.  Media was stored at room temperature until required. 
2.2.8 Plasmids 
Specific plasmid details are detailed within the text at the relevant sections and 
listed in the Appendix A1. 
2.2.9 Primers 
Primers were designed using the DNAstar program (DNAStar Inc. 1999).  Melting 
temperatures, length and GC content were calculated using the online Finnzymes 
Tm calculator.  Primers were produced by Integrated DNA technologies (IDT).  The 
primers were designed optimally to have a melting temperature of between 60 and 
70 °C, length of 20 – 30 nucleotides and GC content between 40 and 60 %.  Primers 
are listed in Appendix A2.  
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2.3 Methods 
2.3.1 Microbiology 
2.3.1.1 Preparation of electrocompetant E. coli cells 
A single colony from an agar plate containing required E. coli cells was used to 
inoculate a 5 ml LB culture, which was grown overnight (37 °C, with shaking).  Fresh 
LB medium was inoculated with 1 ml of this overnight culture per 250 ml fresh LB 
medium, appropriate antibiotics were added where necessary and the culture 
grown until an OD600 of 0.5 - 0.8 was reached.  The culture was placed on ice for 
15 minutes and cells harvested by centrifugation (4000 x g for 15 minutes).  All 
subsequent steps were carried out at 4 °C using pre-cooled materials.  The pellet 
was then washed three times with 15 % glycerol (autoclaved); first wash the cells 
were resuspended in 1/1 culture volume, second with 1/2 volume and for the final 
wash with 1/5 volume.  After the final wash, the pellet was resuspended in 3/250 
volume 15 % glycerol, aliquoted in to 100 µl aliquots in pre-cooled tubes, frozen in 
liquid nitrogen and stored at - 80 °C. 
2.3.1.2 Preparation of chemically competent E. coli cells 
A single colony from an agar plate containing required E. coli cells was used to 
inoculate a 5 ml LB culture, which was grown overnight (37 °C, with shaking).  PSI 
broth was inoculated with 1 ml of this overnight culture per 250 ml fresh medium, 
appropriate antibiotics were added where necessary and the culture was grown 
until an OD600 of 0.5 - 0.8 was reached.  The culture was placed on ice for 
15 minutes and cells harvested by centrifugation (4000 x g, for 15 minutes).  All 
subsequent steps were carried out at 4 °C with pre-cooled materials.  The pellet 
was resuspended in 0.4 x volume TFB I buffer (section 2.2.3.1), incubated for 15 min 
(ice) and pelleted by centrifugation (4000 x g, for 15 minutes).  The pellet was 
resuspended in 0.04 x volume TFB II (section 2.2.3.1); aliquoted in to 100 µl aliquots 
in pre-cooled tubes, frozen in liquid nitrogen and stored at -80 °C. 
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2.3.1.3 Transformation of DNA in to electrocompetant E. coli 
An aliquot of electrocompetant E. coli cells was thawed on ice.  Electroporation 
cuvettes (0.2 µm, Bio-Rad) were pre-cooled on ice.  Plasmid DNA (section 2.3.1.6), 
typically 1 µl, was added to the cells, and the mixture transferred to the cuvette and 
electorporated at 2400 mV.  Immediately post electroporation, 400 µl SOC medium 
was added and the cell suspension was transferred to a 2 ml Eppendorf tube.  After 
a recovery time of 1 hour (37 °C, with shaking), the cells were plated on to LB agar 
plates containing the required antibiotic and incubated overnight at 37 °C. 
2.3.1.4 Transformation of DNA in to chemically competent E. coli 
An aliquot of chemically competent Top10 cells was defrosted on ice.  1 – 5 µl of 
ligation reaction (section 2.3.2.6) or plasmid DNA (section 2.3.1.6) was added to this 
aliquot of cells and incubated on ice for 30 minutes.  The aliquots were then heat 
shocked at 42 °C for 1 – 2 minutes (digital heatblock, VWR).  400 µl SOC media was 
added and the suspension pipetted into a clean 2 ml or 1.5 ml Eppendorf tube.  The 
transformed cells were then incubated at 37 °C, with shaking, for 1 hour.  After 
incubation, all cells were plated on to a 14 cm diameter LB agar plate containing the 
required antibiotic, spread to dry and incubated overnight at 37 °C. 
2.3.1.5 Preparation of bacterial stocks  
An 810 µl aliquot of E. coli growing in exponential growth phase (OD600 = >1) was 
added to a cryovial containing 190 µl sterile 80 % glycerol (final concentration 15 % 
glycerol).  Aliquots were snap-frozen in liquid nitrogen and stored at -80 °C. 
2.3.1.6 Isolation of plasmid DNA 
Plasmid DNA was used to transform competent cells as described above, and plated 
on to agar plates containing the specific antibiotic required to select for the specific 
plasmid.  Individual colonies were picked from the plate using a sterile p200 tip and 
dropped into a 25 ml universal tube containing 5 – 10 ml LB media containing the 
specific antibiotic.  The starter culture was incubated overnight in an incubator at 
37 °C with shaking.   
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For plasmid used in microbiological molecular biology experiments the cells were 
pelleted by centrifugation at 4000 x g for 10 – 15 minutes.  The plasmid DNA was 
then isolated from the cell pellet using a QIAprep spin miniprep kit (Qiagen), 
following the manufacturers protocol.  More specifically, the cells were 
resuspended in Buffer P1 (section 2.2.3.2), subjected to alkaline lysis (Buffer P2; 
section 2.2.3.2) and neutralised (Buffer N3; section 2.2.3.2).  The solution was 
subjected to centrifugation (10 minutes at 17,900 x g) and the supernatant applied 
to a QIAGEN silica-gel–membrane by centrifugation at 17,900 x g for 1 minute.  
Nucleic acids were adsorbed on to the silica-gel membrane in the presence of 
chaotropic salts, which removed water from hydrated molecules in solution.  
Polysaccharides and proteins were not adsorbed and were removed via wash steps 
with Buffer PB followed by Buffer PE (section 2.2.3.2).  Pure nucleic acids were 
eluted under low-salt conditions using Buffer EB (section 2.2.3.2). 
Plasmid DNA for use in mammalian cell transfection was isolated using a QIAGEN 
Plasmid Midi Kit according to manufacturers’ protocol.  Briefly, the starter culture 
was used to inoculate 50 – 200 ml LB containing the appropriate antibiotic, which 
was grown for another 8 - 16 hours.  The cells were harvested, resuspended in 
Buffer P1 (section 2.2.3.2) and subjected to alkaline lysis using Buffer P2 (section 
2.2.3.2) for 5 minutes at room temperature.  The lysis reaction was quenched by 
addition of chilled Buffer P3 (section 2.2.3.2) and incubated on ice for 15 minutes.  
The resulting suspension was subjected to centrifugation at ≥ 20,000 x g for 
30 minutes at 4 °C.  The supernatant was removed and subjected to further 
centrifugation at ≥ 20,000 x g for 15 minutes at 4 °C.  The supernatant was applied 
to a Qiagen Anion-Exchange Resin column previously equilibrated using Buffer QBT 
(section 2.2.3.2), where the highly negatively charged phosphates of the nucleic 
acid backbone interact with the positively charged DEAE groups on the surface of 
the resin.  The resin was washed using Buffer QC (section 2.2.3.2).  The nucleic acid 
was eluted from the column using high-salt buffer, Buffer QF (section 2.2.3.2).  The 
DNA was concentrated and desalted by isopropanol precipitation, collected by 
centrifugation (≥15,000 x g for 30 minutes at 4 °C), washed with 70 % ethanol, dried 
and finally resuspended in TE buffer (section 2.2.3.2). 
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2.3.1.7 Motility assay 
A 1 μl drop of culture growing in exponential growth phase (OD600 = >1) was added 
to the centre of a plate containing LB plus 0.3 % agar.  The plate was sealed using 
Parafilm to prevent the agar from drying out and then incubated at 37 °C.  Images 
were acquired periodically to monitor growth of the halo of E. coli cells that spread 
from the drop in the centre. 
2.3.2 Molecular Biology 
2.3.2.1 Polymerase Chain Reaction (PCR) 
2.3.2.1.1 Colony PCR 
Colony PCR was used to screen colonies for the required inserted DNA plasmid of 
interest during DNA cloning.  PCR was performed using EconoTaq®  PLUS GREEN 2X 
Master Mix (0.1 units/µl of EconoTaq DNA Polymerase, Reaction Buffer (pH 9.0), 
400 µM dATP, 400 µM dGTP, 400 µM dCTP, 400 µM dATP, 3 mM MgCl2, and a 
proprietary mix of PCR Enhancer/Stabilizer and blue and yellow tracking dyes; 
Lucigen).  PCR reactions were set up as described in manufacturer’s manual.  
Briefly, an aliquot of mastermix was diluted 1/2 with ddH2O, the required primers 
were added (1 µM) mixed, and the solution aliquoted into 0.2 ml PCR tubes.  
Colonies from an agar plate were picked and transferred into the aliquots.  
Typically, thermocycling was performed as indicated in Table 4.  The products were 
analysed by agarose gel electrophoresis (section 2.3.2.7). 
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Table 4.  Thermocycler parameters for EconoTaq PCR 
Cycling step Temperature Time # of cycles 
Initial denaturation 94 °C 2 min 1 
Denaturation 94 °C 30 s 
25 - 35 Annealing 50 – 65 °C 30 s 
Extension 72 °C 1 min / Kb 
Final extension 72 °C 10 min 1 
Hold 10 °C Indefinitely 1 
 
2.3.2.1.2 General and Mutagenic PCR 
TAG and other codon mutagenesis, deletion and addition mutagenic PCR were 
performed using Phusion DNA polymerase (Finnzymes™), as suggested by 
manufacturer’s protocol.  For a TAG mutagenesis, typically, a reaction was set-up 
containing 1 x Phusion HF buffer, 200 µM each dNTP, 0.5 µM forward primer, 
0.5 µM reverse primer, 1 ng template DNA (in ddH2O) and 0.02 U/µl Phusion DNA 
polymerase.  For complex templates, or when initial mutagenic reaction failed to 
produce correctly sized product, a variety of conditions were screened.  These 
included the use of the GC buffer, additional primer (2 µM), additional template 
(<5 ng), additional MgCl2 or addition of DMSO.  Typically, thermocycling was 
performed as indicated in (Table 5).  The products were analysed by agarose gel 
electrophoresis (2.3.2.7), purified (2.3.2.2) and utilised in future ligation reactions 
(2.3.2.6).  Consensus Kozak sequences were maintained at initiation sites of 
translation for all target genes, or mutated post-cloning using mutagenic Phusion 
polymerase PCR, using primers as indicated in Appendix A2. 
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Table 5.  Thermocycler parameters for Phusion mutagenic PCR 
Cycling step Temperature Time # of cycles 
Initial denaturation 98 °C 30 s 1 
Denaturation 98 °C 5 - 10 s 
25 – 35 
Annealing 65 – 72 °C 20 s 
Extension 72 °C 
15 -  30 s / 
Kb 
Final extension 72 °C 10 min 1 
Hold 10 °C Indefinitely 1 
 
2.3.2.2 Purification of DNA products 
DNA from PCR reactions or digestions was purified using either a Qiagen MinElute 
PCR Purification Kit or MinElute Reaction Cleanup Kit (if the product was <4 Kb) and 
QIAquick PCR Purification Kit (if products were > 4 Kb) following manufacturer’s 
protocols.  Briefly, DNA was adsorbed onto a silica membrane, in the presence of 
high concentrations of salt (Buffer PB or Buffer ERC; section 2.2.3.2).  The 
membrane was washed with ethanol-containing Buffer PE (section 2.2.3.2) which 
removed impurities and salts, the ethanol was removed using a spin step and the 
DNA eluted with Buffer EB (section 2.2.3.2).  Purified DNA was analysed by agarose 
gel electrophoresis (section 2.3.2.7), stored at -20 °C until used in ligation reactions 
(section 2.3.2.6). 
In the circumstances where digestion of the DNA yielded more than 2 products (for 
example, restriction digest of plasmid DNA during the cloning process, see section 
2.3.2.4), agarose gel electrophoresis was performed (section 2.3.2.7) and the 
required band excised from the gel under UV-light.  The DNA was purified from the 
agarose gel slice using Gel Extraction Kit using the provided proprietary buffers 
(E.Z.N.A Omega Bio-tek).  Briefly, 1:1 w/v XP2 Binding buffer was added to the gel 
slice and the gel melted by incubating the mixture at 65 °C for 10 minutes.  The 
solution was monitored for pH, and 5 µl 5 M sodium acetate was added to bring 
down the pH (pH ≤7.5).  DNA was adsorbed onto a HiBind® DNA mini column, 
90 
 
washed using 300 µl of XP2 binding buffer, further washed with 2 x 700 µl of SPW 
wash buffer to remove impurities and the DNA eluted using Buffer EB (section 
2.2.3.2).  
2.3.2.3 Phosphorylation of PCR products  
After mutagenic PCR, when the primers were not bought ready-phosphorylated, 
PCR products were phosphorylated using T4 Polynucleotide Kinase (PNK).  The 
reaction was performed by adding 1 µl PNK to the ligation reaction mixture, set up 
as described in section 2.3.2.6, and incubated at 37 °C for 30 mins.  The mixture was 
then subjected to ligation reaction without any prior enzyme inactivation or DNA 
purification.  
2.3.2.4 Digestion of plasmid DNA by restriction enzymes  
Restriction digests were performed to prepare DNA for ligation during DNA cloning.  
Typically, 0.5 - 5 µg plasmid or purified PCR DNA was digested in the appropriate 
buffer (NEBuffer1, 2, 3 or 4; section 2.2.3.3) using 1 - 5 U enzyme/µg DNA for 1 –
 6 h at 37 °C (or 25 °C; see Table 3).  Digestion was deemed complete when a single 
band (or two, for when an insert was being cut out) was visible when a sample was 
analysed by gel electrophoresis.  The band was also compared to that of uncut 
DNA.  Enzyme inactivation was performed after digestion steps by heating as 
indicated in Table 3 or DNA was purified (2.3.2.2) before subsequent use. 
DpnI digestion was used to digest methylated DNA that was present in purified PCR 
products, namely original template plasmid DNA generated in E. coli, before ligation 
into target plasmid, when the target plasmid carried the same resistance maker as 
the original plasmid.  This was performed as for restriction enzymatic digests and 
typically performed after preparative restriction digestion. 
2.3.2.5 Dephosphorylation of DNA  
Re-ligation of digested plasmid DNA was prevented by treating the DNA with 
Antarctic Phosphatase in 1 x Antarctic phosphatase buffer (section 2.2.3.3).  The 
DNA was not purified following restriction enzymatic digest inactivation.  The 
reaction was allowed to proceed for 15 minutes at 37 °C for 5´ extensions or blunt-
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ends and 60 minutes for 3´ extensions.  The enzyme was inactivated by incubating 
for 5 minutes at 65 °C.  Linearised and dephosphorylated vectors were applied to 
preparative agarose gels and the band corresponding to required DNA purified 
(2.3.2.2).  The purified DNA was used in ligation reactions (2.3.2.6). 
2.3.2.6 Ligation 
Ligation reactions were carried out using Quick T4 DNA ligase from the Quick 
Ligation™ kit (NEB).  For PCR products from Phusion mutagenic reactions, 25 ng 
purified DNA was diluted in ddH2O to a final volume of 5 µl, 5 µl Quick Ligation 
reaction buffer was added (section 2.2.3.3), followed by 0.5 µl Quick T4 DNA ligase 
enzyme.  For cloning reactions where DNA was to be inserted into a 
complimentarily digested plasmid, 50 ng plasmid was used and 1:3 ratio 
plasmid : insert was utilised.  The volume was increased to 10 µl using ddH2O, and 
10 µl Quick T4 DNA ligase added.  For both, the reaction was mixed by flicking the 
tube, it was then subjected to pulse centrifugation to settle the contents and 
incubated for 5 minutes at 25 °C.  The reaction was then stored on ice until required 
for transformation into chemically competent cells (see section 2.3.1.4).  
2.3.2.7 Agarose Gel electrophoresis 
Agarose gel electrophoresis was performed for either analytical or preparative 
purposes by preparing 0.8 - 2.0 % agarose gels in 1 x TAE containing ethidium 
bromide at final concentration 0.5 µg/ml (see section 2.2.3.4).  The agarose was 
added to the TAE buffer, melted (microwave) and allowed to cool to hand-hot 
temperature before the ethidium bromide was added.  The gel was then poured 
into the cast and allowed to set.  The gels were run in 1 x TAE at 50 – 100 V using a 
horizontal VWR tank and visualised using a UV transilluminator (Syngene) and 
camera (Canon) or a GelDoc System (Bio-Rad).  Samples and the standards were 
prepared prior to loading by the addition of 6 x DNA loading buffer. 
2.3.2.7.1 DNA electrophoresis standard 
The 1 Kb ladder was purchased from New England Biolabs (N3232).  The ladder was 
diluted in DNA loading buffer and loaded onto the agarose gel. 
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2.3.2.8 DNA quantification 
A NanoDrop ND-1000 UV-vis spectrophotometer was used to determine the 
concentration of all DNA.  A 1 – 2 µl sample or buffer was pipetted directly onto the 
optical measurement surface connected to one end of a fibre optic cable.  During 
operation, the sample liquid bridges the gap.  A pulsed xenon flash lamp was used 
as a light source and a spectrometer utilising a linear CCD array was used to analyse 
the light after passing through the sample at either a 1 mm or 0.2 mm pathlength.  
A computer running DNA NanoDrop software was used to analyse the output and 
calculate concentration.  The 260/280 ratio was used as a guide to quantify purity, 
along with visualisation on an agarose gel.  Only plasmid DNA with 260/280 ratio 
> 1.90 was used in downstream applications.  
2.3.2.9 DNA sequencing 
DNA sequencing was carried out by the in-house DNA sequencing Core, Molecular 
Biology Unit (Cardiff University) or by Eurofins MWG Operon. 
2.3.2.10 Non-natural amino acids 
For incorporation of non-natural amino acids into proteins expressed using 
microbiological organisms, non-natural amino acids were prepared by dissolving 
the required amount in ddH2O and enough concentrated NaOH (<5 M) to dissolve 
the powder.  For large expressions (> 1 L) the NAA powder could be added straight 
to the inoculated culture.  Non-natural amino acid was added either at inoculation, 
when OD600 = 0.3 or approximately 1 hour – 30 minutes prior to induction.  
2.3.3 Protein Analysis 
2.3.3.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) protein 
tricene (Table 6) or glycine (Table 7) gels  were used to analyse protein after the 
purification steps.  Typically, mini gels (7 cm x 10 cm x 0.75 mm) were prepared.  
Electrophoresis was performed using Mini-PROTEAN tetra cell system (Bio-rad 165-
8003).  Depending on the size of the protein for analysis, a suitable separating gel 
was assembled between ethanol-cleaned minigel plates.  Ethanol was overlaid to 
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enable formation of straight edge by eliminating bubbles.  After polymerisation of 
the separating gel, the stacking gel was prepared (on top of the separating gel), a 
comb was inserted and the gel allowed to polymerise.  Gels were stored at 4 °C 
until required.  The samples were run at 60 – 120 V in either cathode and anode 
buffer for tricine gels or Laemmli buffer for glycine gels (Table 2).  The gels were 
subjected to electrophoresis until the tracking dye of the loading buffer came out 
the bottom of the gel. 
 
Table 6.  Tricine protein gel solutions 
Solutions Separating gel, 10 % Separating gel, 16 % Stacking gel, 4 % 
Acrylamide/bis-
acrylamide 37.5 : 1, 
30 %  solution 
10 ml 16 ml 1.6 ml 
Gel buffer (see Table 
2) 
10 ml 10 ml 3 ml 
70 % glycerol 3 ml 4 ml - 
ddH2O 7 ml 0.2 ml 7.4 ml 
10 % APS 150 µl 133 µl 90 µl 
TEMED 15 µl 13.2 µl 9 µl 
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Table 7.  Laemmli protein gel solutions 
Solutions Separating gel, 10 % Separating gel, 12 % Stacking gel, 6 % 
Acrylamide/bis-
acrylamide 37.5 : 1, 
30 %  solution 
5 ml 6 ml 1 ml 
ddH2O 3.8 ml 2.6 ml 2.65 ml 
1 M Tris-HCl pH 8.8  
1 M Tris-HCl pH6.8  
6 ml 
- 
6 ml 
- 
- 
1.25 ml 
10 % SDS 150 µl 150 µl 50 µl 
10 % APS 150 µl 150 µl 50 µl 
TEMED 15 µl 15 µl 5 µl 
 
 
2.3.3.1.1  SDS-PAGE electrophoresis standard 
The Protein Marker, Broad Range (2-212 kDa; New England Biolabs (P7702S)) was 
diluted in loading buffer, prepared as outlined in section 2.3.3.1.2 and loaded on to 
the gel.  It was used to estimate the molecular weight and purity of protein samples 
also run on the gel. 
2.3.3.1.2 Sample preparation for SDS-PAGE 
Samples (typically a 15 µl sample) and 15 µl molecular weight marker for SDS-PAGE 
were boiled with 1 x SDS-containing sample buffer (Table 2; 10 minutes) cooled to 
room temperature, collected by brief centrifugation and loaded in to wells of the 
assembled gel. 
2.3.3.1.3 Visualisation of SDS-PAGE gels 
After electrophoresis, the gels were removed from the plates and added to 
Coomassie stain solution (Table 2) for 0.5 – 1 hour, with rocking.  The gels were 
washed with water and then destained using destain solution (Table 2) by 
repeatedly adding fresh destain solution and rocking until protein bands were 
visible. 
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2.3.3.2 Concentration of protein 
Protein in large volumes was concentrated using solvent absorption technique 
utilising a Vivapore 10/20, MWCO 7500 (Satorius Stedim) or Amicon Ultra-15 ml 
centrifugal filter unit in conjunction with centrifugation at 4000 x g.  For ultra-
concentration or for small volumes (500 µL down to 15 µL), for example for 
crystallisation, an Amicon Ultra-0.5 ml device in conjunction with centrifugation at 
14,000 x g was utilised.  
2.3.3.3 Determination of protein concentration 
Protein concentration was determined using the NanoDrop ND1000 as described in 
section 2.3.2.8, utilising the protein analysis NanoDrop software.  The 
concentration was calculated using the absorption at 280 nm along with the 
extinction coefficient specific to the protein being analysed.  This extinction 
coefficient was calculated using the ExPASy Protparam online tool (Gasteiger et al. 
2005), which utilises the presence of aromatic amino acids present within the 
protein sequence. 
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3 CHAPTER 3: PHOTOCHEMISTRY OF ARYL 
AZIDES IN DEFINED PROTEIN ENVIRONMENTS 
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3.1 Introduction 
This chapter explores whether the incorporation of a reactive moiety into a protein, 
in the form of a non-natural amino acid via amber suppression technology, can aid 
in the elucidation of reactive intermediates by creating a defined and stabilising 
environment and reducing the complications of bimolecular reactions that occur 
when studying highly reactive intermediates.  More detailed examination of the 
photochemistry of aryl azides within a biological environment would also aid in 
expanding the utility of aryl azide chemistry in biology. 
The amber suppression method can incorporate non-natural amino acids that 
contain reactive moieties not naturally found in proteins or biological situations.  
The non-natural, azide group containing amino acid, azidophenylalanine (azF; 
Figure 27), is of particular importance due to the wide use of aryl azide based 
photocrosslinking in biological applications, namely, in photoaffinity labelling, 
mapping RNA structural neighbours, crosslinking proteins, studying ligand : enzyme 
interactions and site selectively modifying protein by reaction with azide 
(Buchmueller et al. 2003; Chen and Ebrigh 1993; Fleming 1995; Sugawara and 
Matsuda 1995; Zhang et al. 2005a).  Despite widespread use, there is still 
considerable scope for applying the unique chemistry of the aryl azide to biological 
systems.  For example, aryl azide photochemistry involves much more than just 
crosslinking.  
 
Figure 27.  Azidophenylalanine 
The incorporation of non-natural amino acids possessing spectroscopically active 
moieties makes it possible to track the incorporation of the non-natural amino acid 
by the presence of this spectroscopic signal.  The incorporation of the azF is an ideal 
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candidate as the spectral properties of azide are distinct from those naturally found 
in proteins.  The azide group is of particular interest because the photoreaction of 
this moiety alters its spectroscopic signals, particularly the electron paramagnetic 
spectroscopy (EPR) spectrum that arises due to the creation of unpaired electrons 
during photolysis of the azide group.  EPR is not only sensitive but also highly 
informative with regards to the structural information that is elucidated for the 
transient radicals formed from the azide. 
The use of amber suppression allows the position specific incorporation of the 
azide-containing non-natural amino acid into the target protein.  The use of a 
protein scaffold allows the environment surrounding the azide to be determined.  It 
was thought that surrounding the azide with hydrophobic residues, for example, 
within the hydrophobic pocket of T4 Lysozyme, would trap the reactive species and 
protect against the bimolecular reactions that complicate the study of the azido 
group’s photochemical reaction intermediates. 
The specific aims of this part of the project were to; 
 Incorporate the non-natural amino acid, azF, into a protein scaffold using 
the amber suppression technology 
 Use spectroscopic techniques to assess the incorporation of the azido group. 
 Irradiate the azido-substituted protein to produce the triplet nitrene 
species, using conditions known to favour this product, namely the 
photolysis of the mutant protein at 77 K.  The production of this triplet 
nitrene was then monitored using EPR.   
 Further investigate whether other spectroscopic techniques could be used 
to study the photo-reactive intermediates, namely ultraviolet-visible (UV-
vis), infrared (IR) and Raman spectroscopy.   
 To investigate whether x-ray crystallography could be used to visualise the 
azido group and possibly the reactive intermediates or reacted product after 
photolysis. 
Firstly, a reproducible, high-yielding protein expression system was required to 
express protein.  Expression of wild type (WT) protein, iodoF-substituted and azido-
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substituted protein was investigated.  A variety of conditions were investigated, 
which included, the plasmid system utilised for expression, the media and the 
growth temperature.  Secondly, the purification of the protein was investigated.  
Subsequently, the purified protein was used in crystallisation screens and the 
spectroscopic investigations. 
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3.2 Materials and methods 
3.2.1 T4 lysozyme Expression 
Electrocompetant BL21(DE3) gold E. coli cells were cotransformed with the 
previously constructed plasmids; pET101T4L153 / pSUPiodoRS, 
pETT4L153TAG / pAAazRS, pBADT4L153TAG / pDULEazRS or pBADT4LWT (details of 
which found in Appendix A1).  A dual resistant colony was picked and used to 
inoculate a seed culture of LB containing the appropriate antibiotics.  Seed cultures 
were grown overnight in LB at 37 °C and 1 : 250 dilution used to inoculate 
expression cultures.  Cultures were either grown in LB media, TB autoinduction 
media or ZYM-5052 media containing appropriate antibiotics.  1 mM final 
concentration non-natural amino acid was added at an appropriate time, 
depending on expression conditions.  Induction of expression was performed either 
by adding 0.5 mM final concentration isopropyl-β-D-thiogalactopyranoside (IPTG) at 
OD600 = 0.5, or via glucose/lactose auto-induction (lacO regulation) or via addition 
of arabinose (araC regulation) at OD600 = 4 - 7.  Protein expression was carried out 
at 37 °C for 4 hours, 30 °C for 8 hours or at 25 °C overnight.  Cells were pelleted by 
centrifugation at 4000 x g for 20 minutes at 4 °C, resuspended in lysis buffer 
(50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0) and frozen at – 80 °C.  
3.2.2 T4 lysozyme extraction 
Pellets were defrosted, 1 mM phenylmethanesulfonylfluoride (PMSF) and 2 μl per 
250 ml culture benzonase nuclease added and incubated for 30 minutes on ice.  The 
expressed lysozyme lysed the cells and this provided evidence of production of 
functional lysozyme.  Cells were further lysed by sonication (Vibra cell, Sonics) and 
the insoluble fraction was pelleted by centrifugation at 10,000 rpm, 40 minutes, 
4 °C (rotor 5615, Rotanta 460R, Hettich). 
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3.2.3 T4 lysozyme purification 
3.2.3.1 Nickel affinity chromatography 
Full-length T4 lysozyme was purified from the supernatant collected from 
centrifugation step outlined in “T4 lysozyme extraction” using affinity purification 
between the histag on the C-terminal of the expressed protein and Ni-NTA beads.  
The supernatant was incubated with 1 ml / 1 L culture Ni-NTA (Novagen) for 1 hour 
(4 °C), with rotation.  The mixture was applied to a filter column, washed with 
buffers containing increasing concentrations of imidazole (50 mM NaH2PO4, 
300 mM NaCl, 20 / 30 / 50 / 75 mM imidazole, pH 8.0) to remove impurities and 
weakly bound peptide.  Protein was eluted using 50 mM NaH2PO4, 300 mM NaCl, 
250 mM imidazole, pH 8.0.  Wash steps and elution were analysed by SDS-PAGE, as 
described in general materials and methods. 
3.2.3.2 Size exclusion chromatography (SEC) 
T4 Lysozyme was further purified using either Superdex 75 size exclusion column 
(Amersham Biosciences) on AKTApurifier, previously equilibrated with 100 mM 
NaH2PO4, 0.55 M NaCl, pH 6.7.  All buffers were filtered and de-gassed to ensure no 
precipitation or bubbles were introduced into the Superdex column.  Protein was 
concentrated and loaded, in 250 – 500 µl aliquots onto the SEC column, using a 1 ml 
injection loop.  The flow rate was 0.7 ml / minute and 1 ml fractions were collected 
until 1 column volume had passed through the column. 
3.2.4 T4 Lysozyme crystallisation 
Hanging drop and sitting drop plates were used.  Possible buffers for crystallisation 
included 2.0 - 2.2 M aqueous sodium/potassium phosphate buffer, pH 6.7 - 7.1 with 
15 mM hydroxyethyl disulfide (Xie et al. 2004) and 0.55 M NaCl, 14 mM 
mercaptoethanol, 1 mM MgCl2, 0.01 M sodium phosphate, pH 6.7, using varying 
2.2 M NaH2PO4, 1.8 M K2HPO4, pH 6.7 (Remington et al. 1978).  
The crystallisation screen is summarised in Table 8. 
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Table 8.  Crystallisation screen parameters 
buffer component variable 
crystallisation Sodium/potassium phosphate 1.0 – 2.5 M 
 pH 6.3 – 7.3 
 hydroxyethyl disulphide 15 mM 
4 – 8 µl/ml 
 NaCl 0 – 0.35 M 
protein concentration 27 – 10 mg/ml 
 : buffer ratio 5 : 5 – 5 : 1; 
1 : 1 µl  
temperature 4, 11, 25 °C 
 
3.2.5 Spectroscopic analysis 
3.2.5.1 Protein photolysis for EPR 
Purified T4L153azF protein (8 mg/ml) was snap frozen in liquid nitrogen at 77 K in 
50 % glycerol solution to maintain a glassy nature, so the light during photolysis 
could penetrate the sample and to reduce noise in the EPR spectrum.  Photolysis in 
quartz – suprasil 4 mm EPR tubes with a 500W Oriel Instruments UV lamp, 
incorporating a Hg/Xe arc lamp (250 nm to >2500 nm) was used for all irradiations 
in the presence of a water filter.  The UV output below 280 nm accounts for only 4 –
 5 % of the total lamp output.  The samples were irradiated for 2 min at 77 K in an 
EPR liquid N2 finger dewar (Wilmad Glass) and rapidly transferred to the pre-cooled 
cryostat (10 K) for EPR measurements. 
3.2.5.2 Electroparamagnetic resonance spectroscopy (EPR) 
The continuous wave (CW)-EPR spectra were recorded on an a Bruker ESP300e 
series spectrometer operating at X-band frequencies (9.75 GHz), 100 kHz field 
modulation, 10 G modulation depth, mW microwave power and equipped with a 
high sensitivity cavity (ER 4119HS).  The measurements were obtained by Dr 
Damien Murphy (Cardiff University).  Measurements were taken at 10 K in an 
Oxford liquid helium cryostat.  Twenty-five measurements were taken to increase 
103 
 
signal to noise ratio, scanning 1000 – 8000 G.  EPR simulations were performed by 
Dr Jamie Platts (Cardiff University) using the Easyspin software (Stoll and Schweiger 
2006), and the commercially available Bruker SIMFONIA software. 
3.2.5.3 Ultraviolet-visible spectroscopy 
A 625 μM solution of azF in water plus NaOH or 100 μM protein was irradiated at 
302 nm for 30 minutes total with spectra taken at 30 second intervals to 5 minutes, 
then after 10 and 30 minutes.  Spectra were taken using Jasco 630 UV-visible 
spectrophotometer. 
3.2.5.4 Fourier transform infrared spectroscopy 
Fourier transform infrared spectroscopy (FTIR) spectra were obtained using a 
Bruker IFS-66 FTIR Spectrometer.  Solutions of Phe and azF NAA were prepared at 
20 mM in NaOH and sandwiched between CaF2 plates with a pathlength of 25 μm. 
3.2.5.5 Circular dichroism 
Solutions of 50 μM WT and T4L153azF protein were dialysed in to degassed 
100 mM NaH2PO4, pH 6.7.  A 2 µm pathlength quartz cuvette (Helma) was used to 
take measurements on an Applied Photophysics Chirascan Circular Dichroism 
Spectrometer.  Measurements were taken at 20 °C under N2.  
3.2.5.6 Raman spectroscopy 
Various concentrations of azF and iodoF were prepared in aqueous NaOH (1, 2, 5, 
10, 20, 50, 100 mM).  Samples were sandwiched between Quartz plates with a 1 µm 
spacer.  Raman spectroscopy was performed by Dr Elisabetta Canetta (School of 
Bioscience, Cardiff University). 
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3.3 Results 
3.3.1 Expression optimisation 
A number of plasmid systems were available for the expression of mutant T4L, and 
the complementary synthetase and tRNA   
   
 containing plasmid, to incorporate the 
non-natural amino acids by the amber suppression technology.  These plasmid 
systems were investigated to find the optimal expression system. 
3.3.1.1 Plasmids pT4L153TAG/pAAT4L153TAG and pBKiodoRS 
Plasmid pT4L153TAG encodes a Phe153  TAG mutant cysteine-free T4 lysozyme 
under the control of a bacteriophage T5 promoter and t0 terminator, and the 
tRNA   
   
 gene under the control of the lpp promoter and rrnC terminator.  Plasmid 
pBK-iodoRS encoded the iodoF-specific tRNA-aminoacyl synthetase (iodoRS) under 
the control of the constitutive E. coli GlnRS promoter and terminator (Figure 28).  It 
had been shown that this system of plasmids could successfully incorporate iodoF 
into codon 153 of T4L and therefore the expression of T4L153iodoF was attempted, 
using the conditions as described by Xie et al (2004).  Protein expressions were 
performed using E. coli BL21(DE3) co-transformed with pT4L153TAG and pBK-
iodoRS.  A variety of media were used, namely, LB, TB, 2YT, M9 minimal media with 
IPTG induction and autoinduction, however, the yield of mutant protein was low 
(data not shown).  In addition, it was thought that for ease of purification of the 
truncated protein from the non-natural amino acid-containing full-length protein, a 
C-terminal histag would be useful.  Therefore other plasmid systems were 
investigated. 
The pAAT4L153TAG plasmid had been previously created (Dr A. Antonczak), that 
encoded a codon optimised Phe153  TAG mutant cysteine-free T4 lysozyme, with 
a C-terminal histag sequence, under the control of a bacteriophage T5 promoter 
and t0 terminator, with lacO repression, and the tRNA
   
   
 gene under the control of 
the lpp promoter and rrnC terminator (Figure 28).  This plasmid was similar to the 
pT4L153TAG, however during the construction by Epoch Life Science the DNA  
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Figure 28.  Plasmid maps of pBKiodoRS and pAAT4L153TAG/pT4L153TAG. 
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sequence used was codon optimised for use in E. coli.  It was thought that the 
codon optimisation would allow increased expression of the mutant protein by 
reducing the depletion of amino acid charged tRNA for specific codons. 
A variety of expressions were performed using plasmids, pAAT4L153TAG and 
pBKiodoRS, co-transformed into BL21(DE3) E. coli.  However, the plasmid was not 
tolerated by the E. coli as there was limited growth of the cultures and cell death 
after approximately 1 hour in culture (Figure 29).  
The T4L gene was re-sequenced and it was determined that during gene 
construction, the codon Thr152 of the T4L gene was omitted (Figure 31).  There was 
also R154K mutation, and a GGSFG linker region between the T4L gene and 
hexahistidine tag, which may have affected the expression of the protein.  Potential 
issues are discussed below.  Due to the missing Thr152, mutagenic PCR was 
performed to try to re-introduce the missing codon.  Three different primer 
combinations were tried, pAAT4L153TAG+ACG FP/RP, JLMt4l003-F/004-R and 
JLMt4l005-F/006-R (Appendix A2).  However, the plasmid appeared to be refractory 
to the insertion of the codon, as no correctly-sized PCR could be obtained.  
Therefore other plasmid systems were investigated.  
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Figure 29.  Graph showing growth curve of BL21(DE3)  E. coli co-transformed with plasmids 
pAAT4L153TAG and pBKiodoRS.  Seed cultures were grown in LB plus appropriate antibiotics 
overnight using a colony picked from a plate containing BL21(DE3) E. coli co-transformed with the 
plasmids.  This seed culture was then used to inoculate LB containing the appropriate antibiotics, a 
sample was taken from the culture and an OD600 reading taken at the specified timepoints.  The cell 
densities were plotted.  
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3.3.1.2 Plasmids pETT4L153TAG and pSUPiodoRS 
The previously constructed ampicillin resistant pETT4L153TAG plasmid (Tippmann, 
E, 2008) encodes mutant cysteine-free bacteriophage T4 lysozyme, harbouring 
Phe153TAG mutation, under the control of an IPTG inducible T7 promoter and 
terminator.  The chloramphenicol resistant pSUPiodoRS (Figure 30) plasmid 
encodes a p-iodophenylalanine-specific tRNA aminoacyl synthetase (iodoRS) under 
the control of glnS’ promoter and terminator, and 2 x 3 tRNA   
    
gene sequences 
under the control of ProK promoter and terminator (Ryu and Schultz 2006).  The 
presence of a C-terminal hexahistidine tag would, as mentioned previously, simplify 
purification of NAA-containing protein.  The plasmid harboured a L99F, a M102A 
mutation and a GGSG linker region between the T4L and the hexahistidine tag 
(Figure 31).  This plasmid system was more promising and effectively expressed 
mutant protein when co-transformed into E. coli BL21(DE3).  Therefore these 
plasmids were used for subsequent expression optimisations. 
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Figure 30.  Plasmid maps of pSUPiodoRS and pET101T4L153TAG 
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Figure 31.  Comparison of T4L protein encoded by plasmids.  The DNA sequence obtained was 
translated into protein sequence using ExPASy translate tool (Artimo P et al. 2012), these sequences 
were then compared using the ClustalW2 tool (Larkin et al. 2007). 
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BL21(DE3) gold E. coli cells were cotransformed with the plasmids pETT4L153TAG 
and pSUPiodoRS and used to express T4L153iodoF.  The media was either 
supplemented with, or without, 1 mM iodoF.  Cellular lysate from the two cultures 
were isolated and samples applied to an SDS-PAGE gel.  Comparing the intensity of 
the band corresponding to the size of full-length T4L, it was demonstrated that 
when iodoF was supplemented in the media, full-length T4L was present (Figure 
32).  When iodoF was withheld from the media the band, corresponding to the size 
of full-length T4L, was dramatically lower in intensity.  The band just above the size 
of full-length T4L was presumed to be truncated T4L (at codon 153).  The intensity 
of this band in the culture not supplemented with iodoF was greater than that seen 
in the culture supplemented with iodoF. 
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Figure 32.  SDS-PAGE gel comparing cellular lysate of cultures harbouring plasmids pETT4L153TAG 
and pSUPiodoRS.  Cultures were either grown with or without addition of iodoF.  Arrow indicated 
size of full-length T4L protein. 
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Small scale expression cultures (200 ml) were used to find a robust method for 
expression of T4L153iodoF protein.  Growth media LB with IPTG induction, TB 
autoinduction and ZYM-5052 autoinduction media; a variety of expression 
temperatures (25, 30, 37 °C) and time period of expression were tested.  The 
soluble protein, from these expressions, was extracted, purified by Ni-NTA and 
analysed by SDS-PAGE, as described in materials and methods.  The yields, ease of 
expression protocol and time of expression were evaluated and it was found that 
using ZYM-5052 autoinduction media, growing the cultures at 30 °C for 20 hours 
gave optimal expression.  Therefore these plasmids were used to express protein to 
perform purification optimisation.  The results of the investigation into the plasmids 
systems in their ability to express NAA-substituted T4 Lysozyme are summarised in 
Table 9  
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Table 9.  Summary of plasmid systems and their ability to express NAA-substituted T4Lysozyme 
Plasmid – T4L 
(provider) 
Complementary 
plasmid – aaRS 
Expression 
E. coli 
Notes Issues Yield Action 
pT4L153TAG 
 
(Dr J. Xie) 
pBKiodoRS BL21(DE3) T5 promoter 
Not optimised sequence 
tRNA 
Low expression 
No histag 
0.3 
mg/L 
pure 
Different medias investigated 
 
pAAT4L153TAG 
 
(Dr A. Antonczak) 
pBKiodoRS BL21(DE3) T5 promoter 
lacO regulation 
Optimised sequence – T4L 75% 
nt sequence similarity to pT4L 
or pET plasmids 
Histag 
2 x tRNA 
Missing ACG codon at 
152, thereby 
producing protein with 
NAA exposed on 
exterior of protein 
No growth 
- Could not re-introduce 
missing codon by site-directed 
mutagenesis 
No remedy 
pET101T4L153TAG 
 
(Dr Eric Tippmann) 
pSUPiodoRS 
(+ 6 x tRNA) 
 
BL21(DE3) T7 promoter 
LacO regulation 
Histag 
 
Only iodo RS available 
Low yield expression 
Lots of truncated 
protein produced 
<3 
mg/L 
pure 
Optimisation of expression 
conditions 
Optimisation of purification  
pBADT4L153TAG 
(Dr S. Miyake-Stoner) 
pDULEazRS 
(tRNA) 
Top10 araBAD promoter 
araC regulation 
histag 
High yield 
Efficient incorporation 
of azF 
<8 
mg/L 
pure 
Expression of WT T4L and 
T4L153azF for spectroscopic 
evaluations 
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3.3.2 Purification optimisation  
3.3.2.1 Nickel affinity chromatography 
T4L153iodoF protein expressed using BL21(DE3) gold E. coli cells cotransformed 
with the pETT4L153TAG and pSUPiodoRS plasmids was used during optimisation of 
purification.  The use of nickel affinity chromatography was utilised to purify full-
length NAA-containing T4L (19 kDa) away from whole cell lysate and in particular, 
truncated T4L protein (17.1 kDa).  Only full-length protein should harbour a 
hexahistidine tag and therefore bind to the nickel affinity chromatography column.  
Analysis using SDS-PAGE demonstrated that binding of T4L153iodoF to the column 
was efficient as there was no band corresponding to full-length T4L (Lane 1, Figure 
33).  T4L153iodoF protein was eluted from the column in a purer form, however 
one major contamination remained (Lane 5, Figure 33). 
This result demonstrated that NAA-containing T4L could be purified from whole cell 
lysate using Nickel affinity chromatography, subsequently this technique was used 
routinely as a first step purification after protein expression. 
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Figure 33.  SDS-PAGE gel showing Ni-NTA purification of T4L153IodoF.  Expression of T4L153IodoF 
was performed using LB, with IPTG induced expression for 3.5 hours at 37 °C.  Cell culture lysate was 
incubated with Ni-NTA for 1 hr at 4°C, loaded onto filter column (flow-through lane 1), washed with 
20 mM (lane 2), 30 mM (lane 3), 50 mM (lane 4) imidazole wash buffer, protein was eluted in 6 ml 
250 mM imidazole buffer (lane 5).  Lane 7 represents T4L44IodoF previously purified.  A 15 μl sample 
of each wash was loaded onto 12 % tricene gel. 
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3.3.2.2 Size exclusion chromatography 
Protein eluted from nickel column was considerably purer, but other bands were 
still present, as determined by SDS-PAGE gel.  Therefore protein was further 
subjected to using size exclusion chromatography (SEC), using a Superdex75 column 
on an AKTApurifier, as described in materials and methods.  The major impurity was 
of a considerably larger mass, therefore it was thought that SEC would be the most 
effective method to further purify NAA-containing T4L.  Ni-NTA purified protein was 
concentrated and loaded onto the SEC column.  The UV trace was monitored and 
fractions with peak UV, corresponding to the correct size protein, were analysed by 
SDS-PAGE.  A typical SDS-PAGE gel (A) and AKTA trace (B) are shown in Figure 34.  
The fractions containing pure T4L, as identified by SDS-PAGE, were pooled and the 
yield equated to 0.29 mg purified protein / L culture. 
This result demonstrated that using Nickel affinity chromatography followed by SEC 
purification step, NAA-containing protein could be purified effectively. 
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Figure 34.  Purification of T4L153iodoF by size exclusion chromatography.  A) A representative SDS-
PAGE gel of nickel affinity purified T4L153iodoF (lane 1), sample of size exclusion 1ml fractions  
(Superdex75) 13, 14, 15.  
B) Corresponding size exclusion chromatography trace.  2L ZYM-5052 media was used to express 
T4L153iodoF, T4L, protein was subjected to Ni-NTA purification, concentrated to 600 μl then applied to 
Superdex75 column in 2 x 300 μl aliquots.  Peak UV (solid blue line) fractions, 13, 14, 15 were run on 
SDS-PAGE gel.  
A 
B 
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3.3.3 Investigation in to the expression of T4L153azF 
Using the pET101T4L153/pSUPiodoRS system, an expression and purification 
system has been optimised to produce purified T4L153iodoF.  However, the project 
aim was to produce T4L harbouring the azF amino acid within the protein’s 
hydrophobic pocket, therefore, a system to incorporate the azF was required.  
There were a few possible methods to perform expression of T4L153azF, and these 
were investigated.  
3.3.3.1 Using pSUPiodoRS to incorporate azF 
It has been shown previously, that the synthetases engineered for a specific amino 
acid display cross-reactivity to other non-natural amino acids (Antonczak 2012 
Thesis).  This promiscuity was investigated by expressing T4L, using the plasmids 
pET101T4L153TAG and pSUPiodoRS, but supplementing the media with azF in place 
of iodoF.  T4l153azF was successfully expressed, however the expression levels 
were low and other expression systems became available. 
3.3.3.2 Using pAAazRS to incorporate azF 
The plasmid, pAAazRS had previously been created and shown to successfully 
incorporate azF into proteins using amber suppression (Personal communication, 
Dr Matt Edmundson 2010). The ability of this plasmid to express azRS to allow 
incorporation of azF into T4L at codon 153 was also investigated.  Analysis by SDS-
PAGE demonstrated that T4l153azF was successfully expressed, the expression 
levels were compared to that expressed using the pDULEazF / pBADT4L153TAG 
system described in section 3.3.3.3 (Figure 36). 
3.3.3.3 Using pDULEazF to incorporate azF 
The plasmids pBADT4LWT, pBADT4L153TAG and pDULEazRS were kindly donated 
by Ryan Mehl (Oregon State University).  The tetracycline resistant pDULE plasmid 
encoded an azF-specific synthetase, under an lpp promoter and rrnB terminator 
and tRNA under an lpp promoter and rrnC terminator (Figure 35).  pDULEazF 
plasmid along with pBADT4L153TAG plasmid has been shown previously to produce  
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Figure 35.  Plasmid maps of pBADT4L153TAG and pDULEazRS. 
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high yields of NAA-containing protein (Farrell et al. 2005; Tian et al. 2004), including 
T4L153NAA (Miyake-Stoner et al. 2009).  The plasmids were sequenced and the 
protein encoded by these plasmids was compared to the previously used 
pET101T4L153TAG.  The pBADT4LWT / pBADT4L153TAG plasmids encoded the 
cysteine-free T4LWT / 153TAG, under the control of araBAD promoter with araC 
regulation.   
Comparing the protein sequences (determined by translation of DNA sequence 
data) it was noted that the pBAD T4L genes harboured a number of mutations that 
may have affected the expression levels.  Namely, a N2D mutation, F99L and no 
linker region joining the protein to the hexahistidine-tag (Figure 31).  In addition, it 
was thought that using the tightly regulated araBAD promoter, by the araC gene 
product, would permit more control over expression and therefore allow higher 
expression levels of T4L. 
 
3.3.3.4 Comparison of plasmid systems, pET vs. pBAD 
Due to the low-yielding expression using the plasmids system pETT4L153TAG and 
pSUPiodoRS or pAAazRS, the use of the plasmid system, pBADT4L153 and pDULEazF 
was investigated.  A protein expression using the two plasmids along with the 
corresponding aaRS expressing plasmid (pETT4L153TAG and pAAazRS; pBADT4L153 
and pDULEazF) were performed side-by-side.  Miyake-Stoner et al, (2009) argues 
that because expression of T4L causes lysis of the host cell, the use of autoinduction 
media is contraindicated.  Therefore, the method described by the group suggests 
that growing the cultures to high density followed by manual induction, 
recapitulated the conditions present during autoinduction, without the presence of 
the inducing component that could cause leaky production of T4L.  
An expression using 200 ml ZYM-5052 media was used, the culture was grown at 
37 °C, azF was added at OD600 = 0.9, expression was induced by addition of 0.2 % 
arabinose or lactose for the pBAD and pET cultures respectively at OD600 = ~5.  
Protein expression was allowed to proceed for 4 hours.  The protein was extracted 
and protein subjected to Ni-NTA affinity purification.  An SDS-PAGE gel was used to 
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compare the expression levels (Figure 36).  It was demonstrated that using the 
expression conditions, as suggested by Miyake-Stoner (2009), using the pBAD 
system gives greater yields when compared to the pET system, when using the 
same expression method.  It was therefore decided that the pBAD system should be 
utilised for expressing protein for use in spectroscopic evaluations. 
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Figure 36.  SDS-PAGE gel comparing the expression levels of T4L153azF using pETT4L153TAG (+pAAazRS) vs. pBADT4L153TAG (+pDULEazRS). 200 ml ZYM-5052 media was used, 
the culture was grown at 37 °C, azF was added at OD600 = 0.9, expression was induced by addition of 0.2 % arabinose or lactose for the pBAD and pET cultures respectively at 
OD600 = ~5, expression was allowed to proceed for 4 hours. The protein was extracted and protein subjected to Ni-NTA affinity purification, 20 30 and 50 mM imidazole 
concentrations were used in wash-steps, elution (250 mM imidazole) is representative of 15 µl sample from 2 ml. 
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3.3.4 Expression and purification of WT T4L 
Plasmid pBADT4LWT, expressing WT T4L was used to produce a robust and high 
yielding protein expression method.  The conditions that gave a high yield of 
protein was found to use the method developed by Miyake-Stoner (2009), in 
ZYM5052 media with manual induction by addition of arabinose (Studier 2005), as 
described in materials and methods.  Protein was purified by nickel affinity 
chromatography and size exclusion chromatography to purity according to SDS-
PAGE (Figure 37).  Mass determined by ESI-MS (19511.8 ± 8.57), demonstrated that 
WT T4L had been isolated (Table 10; appendix A4).  This purified protein was used 
in crystallisation optimisation, and spectroscopic analysis. 
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Figure 37.  Purification of T4L WT by size exclusion chromatography.  A) Representative SDS-PAGE gel 
of nickel affinity purified WT T4L (lane 1), sample of size exclusion 1ml fractions  (Superdex75) 17, 18, 
19, 20.  
B) Corresponding size exclusion chromatography trace.  ZYM-5052 media was inoculated with a 1 : 250 
volume of saturated culture containing E. coli Top10 transformed with the plasmid pBADT4LWT. The 
culture was grown at 37 °C with expression induced by addition of 0.2 % arabinose at OD600 = 5 - 7, 
expression was allowed to proceed for 4 hours. The protein was extracted and subjected to Ni-NTA 
affinity purification. The elution fraction was further purified by size exclusion chromatography.  Peak 
fractions (UV, blue line) were loaded onto 12 % SDS-PAGE gel. 
A 
B 
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3.3.5 Fidelity of aaRS 
To establish the fidelity of the synthetase (expressed by the pDULEazRS plasmid) 
and tRNA towards azF, parallel expressions plus and minus amino acid were 
performed.  ZYM5052 media containing Top10 E. coli cells cotransformed with 
pBADT4L153TAG and pDULEazRS were grown as indicated in materials and 
methods.  One culture contained 1 mM azF, while the NAA supplement was 
withheld from the other.  Protein expression and Ni-NTA purification was 
performed as described in materials and methods.  Analysis by SDS-PAGE gel 
indicated the fidelity of pDULEazRS for incorporating azF into T4L at position 153 
was > 99 % (Figure 38). 
3.3.6 Expression and purification of T4L153azF 
Using the expression conditions optimised using expression of the wild type protein 
(pBADT4LWT), azF substituted T4L was expressed, purified by Ni-NTA and SEC 
(Figure 39).  A typical yield of T4L153azF was 7.5 mg purified protein / L culture.  An 
accurate mass spec could not be obtained (Table 10), most probably due to the 
presence and reactivity of the azide group. 
For spectroscopic analysis, protein expression, purification and handling was 
performed in the dark or under red light.  This was done to try to limit the amount 
of UV-light that could allow the photoreaction of the azido group.  
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Figure 38.  SDS-PAGE gel exploring the fidelity of the expressed synthetase for the NAA, azF.  
Parallel expressions plus and minus amino acid were performed.  ZYM5052 media containing Top10 
E. coli cells cotransformed with pBADT4L153TAG and pDULEcyanoRS were grown as indicated in 
materials and methods.  One culture was supplemented with 1 mM azF, while the other was grown 
in the absence of NAA supplement.  Expression in both cultures was induced by addition of 0.2 % 
arabinose.  Protein was extracted and subjected to nickel affinity purification as described in 
materials and methods.  Protein was concentration to 0.1 x, 10 x or 100 x. 
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Figure 39.  Purification of T4L153azF by size exclusion chromatography.  A) Representative SDS-PAGE 
gel of nickel affinity purified T4L153azF (lane 1), sample of size exclusion 1ml fractions  (Superdex75) 14, 
15, 16, 17.  
B) Corresponding size exclusion chromatography trace.  ZYM-5052 media was inoculated with a 1 : 250 
volume of saturated culture containing E. coli Top10 co-transformed with the plasmids pBADT4L153TAG 
and pDULEazRS.  The culture was grown at 37 °C with expression induced by addition of 0.2 % arabinose 
at OD600 = 5 - 7, expression was allowed to proceed for 4 hours.  The protein was extracted and 
subjected to Ni-NTA affinity purification.  The elution fraction was further purified by SEC.  Peak 
fractions (UV, blue line) were loaded onto 12 % SDS-PAGE gel. 
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3.3.7 Investigating the promiscuity of azRS 
As mentioned previously, it has been shown that some of the synthetases are 
promiscuous towards the non-natural amino acids that they incorporate in 
response to TAG-containing target genes.  The ability of pDULEazRS to incorporate 
iodoF into T4L153TAG was investigated.  It was thought that if, using the same 
expression conditions, an accurate mass for iodoF-substituted T4L could be 
obtained the result would provide some evidence that the incorporation of NAAs 
into T4L using this plasmid and expression system was successful.  The expression 
and purification of T4L153iodoF was performed using pBADT4L153TAG and 
pDULEazF supplementing the media with iodoF, as described in materials and 
methods.  The mass obtained was 19638.95 ± 4.88 Da, demonstrating that 
incorporation of iodoF had occurred (Table 10; Appendix A4).  
 
Table 10.  Expected and observed mass of NAA-substituted T4L 
Protein Expected mass Observed mass 
T4L153iodoF 19638.1 19638.95 ± 4.88 
T4L153azF 19553.2 19510 ± 3  
19535 ± 6 
WTT4L 19512.2 19511.8 ± 8.57 
 
3.3.8 Crystallisation of WT and mutant T4L 
Crystal screens were set up based on conditions used by Xi et al (2004) or other 
previous work crystallising WT T4L (Matthews et al. 1973; Remington et al. 1978; 
Weaver and Matthews 1987).  Specifically, a vapour diffusion method, using 
sodium/potassium phosphate buffer containing hydroxyethyl disulphide.  
Hydroxyethyl disulphide has been shown to be crucial in T4L crystallisation as it 
required at interface of monomers.  Purified WT, T4L153azF and T4L153iodoF were 
all used in crystal screens.  
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Crystals of WT protein were obtained in protein buffer: 100 mM NaH2PO4, 0.55 M 
NaCl, pH 6.7, reservoir buffer: 2 M NaH2PO4, 2 M K2HPO4, 15 mM hydroxyethyl 
disulphide, pH 6.7.  Crystals of two shapes were obtained.  These crystals diffracted 
to approximately 2.3 Å, but because the structure of WT T4L is so well studied, the 
structure was not solved (Appendix A10). 
Very small crystals of T4L153azF were obtained in buffer 5:5 protein : reservoir, 
1.5 M K/NaPO4, 0.25 M NaCl pH 6.4, 6 µl / ml hydroxyethyl disulphide.  However, 
these crystals did not diffract well as they were considered disordered.  
3.3.9 Circular Dichroism of T4L 
To ensure that the structure of T4 lysozyme was not perturbed by the incorporation 
of the NAA, azF and because of the difference in crystallisation efficiency, CD 
measurements were performed to check that the T4L153azF protein was correctly 
folded and comparable to that of wild type protein.  The CD spectra were similar 
and indicated that both proteins contain α-helix, due to the presence of a peak at 
208 and 222 nm, and β-sheet, due to the presence of a peak at 216 nm (Figure 40). 
This result demonstrated that T4L153azF was folded similarly to WT. 
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Figure 40.  CD spectra of T4L and T4L153azF.  Purified WT T4L and T4L153azF were concentrated to 
50 μM and dialysed into degassed 100 mM NaH2PO4, pH 6.7.  The samples were subjected to circular 
dichroism within a 0.2 um quartz cuvette.  Buffer was used as blank. 
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3.3.10 Spectroscopic evaluation of azido substituted T4L 
The aims of this chapter were to explore whether using a protein scaffold is an 
effective method to shield and therefore simplify the study of the photoreaction of 
the azido group.  After a robust method to express and purify T4L153azF was 
determined, it was used to produce protein for spectroscopic investigations. 
3.3.10.1 EPR of T4L153azF 
As mentioned above, the reaction pathway taken by irradiation of phenyl azide is 
dependent on the temperature at which the reaction occurs (Figure 17).  At 77 K, 
the major pathway taken is thought to lead to the formation of triplet nitrene.  
Therefore, the formation of triplet nitrene was probed for using continuous wave 
(CW) EPR, which was performed by Dr Damien Murphy (Cardiff University).   
A sample of T4L153azF (8 mg/ml in 50 % glycerol to maintain glassy at low 
temperature) held within a quartz EPR tube, was frozen in liquid nitrogen and 
irradiated for 1 minute using a 400 W xenon arc lamp.  The EPR measurements 
were taken at 10 K, with the system cooled by liquid helium.  Twenty-five 
measurements were taken to increase signal to noise ratio, scanning 1000 – 8000 G. 
The EPR spectra of T4L153azF showed a peak at 6869, which was representative of 
triplet nitrene formation (Figure 41).  The inequality in the peak height and trough 
at 6869 were also classical of triplet nitrene.  A spectrum was simulated by Dr 
James A. Platts (Cardiff University; Figure 41) and compared to the experimental 
spectrum.  The spectrum was simulated using a g value of 2.0023 and 
D’ = 1.0007 cm-1.  The experimental signal at 6869 G aligns to that of the simulated 
spectrum (Figure 41).  However, the complexity of the experimental spectrum is 
most probably due to the presence of the protein. 
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Figure 41.  Experimental (black) and simulated X-band (red) CW EPR spectra.  * = cavity artefact in 
the free spin region, • = background signal from sample.  EPR spectra were obtained using azF 
substituted T4L (8 mg/ml in 50% glycerol to maintain glassy at low temperature).  The sample was 
frozen in liquid nitrogen and irradiated for 1 minute using a 400 W xenon arc lamp.  The EPR 
measurements were taken at 4 Kelvin, with the system cooled by liquid helium.  Twenty-five 
measurements were taken to increase signal to noise ratio, scanning 1000 - 8000 G.  
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3.3.10.2 Ultraviolet-visible spectroscopy 
To investigate the reactions of the azide group that could not be monitored using 
EPR some further spectroscopy was performed. 
3.3.10.2.1 UV-vis of amino acid, azF 
UV-vis spectral measurements were obtained using a solution of azF amino acid 
(625 μM; in NaOH).  The sample was irradiated and spectra obtained at various 
timepoints, as described as in materials and methods.  It was noted that there were 
a number of changes during photolysis (Figure 42).  The initial absorption spectrum 
of azF showed a large absorption at approximately 250 nm, with a shoulder at 
approximately 280 nm.  Upon irradiation the absorption at 250 nm decreased along 
with general increase at wavelengths 290 – 600 nm.  The absorbance at 280 nm 
remained similar. 
3.3.10.2.2 UV-vis of T4L153azF 
UV-vis spectra of T4L153azF and WT T4L protein were also obtained (Figure 43).  
The UV spectra demonstrated similar absorbance, except T4L153azF showed higher 
absorbance at wavelengths approximately 250 – 270 nm.  
The protein solutions were irradiated and spectra measured as described in 
materials and methods and UV-vis spectrum obtained throughout irradiation at 
specified timepoints.  The spectra showed there was a change in absorption as the 
T4L153azF was irradiated (Figure 45) in a similar manner to the experiments with 
amino acid.  There was a general increase in absorption over the entire range of 
measurements (260 – 460 nm), but the main increase in signal was between 300 
and 340 nm.  Whereas there was no change in the spectrum measured when WT 
T4L was irradiated, as the spectrum overlay similarly (Figure 44).  The difference 
between spectra measured using WT and T4L153azF indicated that some changes 
occurred throughout irradiation and this was due to the presence of azide moiety.  
This data suggests that the azide group, present in the T4L153azF and not in WT, 
may have undergone some photoreaction during photolysis 
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Figure 42.  UV-vis spectra of azF.  A solution of azF (625 µM; in NaOH) was irradiated using a UV lamp with wavelength 302nm for a total of 30 minutes and recording spectra 
every 30 seconds for the first 5 minutes then 10 minutes and 30 minutes. 
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Figure 43.  UV-vis spectrum WT T4L and T4L153azF.  Protein at 50 μM in 100 mM NaH2PO4, pH 6.7 
(degassed) was used to obtain spectra using a 0.2 µm quartz cuvette. 
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Figure 44.  UV-vis spectra of irradiated WT T4L protein.  Spectra of T4L153pazF (100 μM) were obtained, the solution was then irradiated (302nm) for a total of 30 minutes and 
spectra recorded every 30 seconds for the first 5 minutes then 10 minutes and 30 minutes. 
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Figure 45.  UV-vis spectra of irradiated T4L153azF protein.  Spectra of T4L153pazF (100 μM) were obtained, the solution was then irradiated (302nm) for a total of 30 minutes and 
spectra recorded every 30 seconds for the first 5 minutes then 10 minutes and 30 minutes. 
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3.3.10.3 Infrared spectroscopy 
Infrared spectroscopy is another powerful technique used to study reactions of 
azides.  To test whether this technique could be applied to the study of the azide 
moiety present within the protein backbone, T4L, solutions of amino acid were 
used for IR measurements.  A weak signal at approximately 2100 cm-1, 
corresponding to azide, was obtained using 20 mM solutions of azF, which was not 
present in the spectrum for phenylalanine (Figure 46).  The difference spectrum 
shows a difference of about 2 % transmittance at 2100 cm-1.  Although a peak 
corresponding to azide was obtained using a solution of azF, the concentration was 
too high (20 mM) to be obtained using protein as T4L forms precipitate at high 
concentrations. 
 
3.3.10.4 Raman Spectroscopy 
It was investigated whether Raman spectroscopy could be used to visualise the 
azide group.  Spectra was measured and data analysed by Dr Elisabetta Canetta 
(School of Bioscience, Cardiff University).  Spectra using NAA (in ddH20 + NaOH) was 
obtained initially to ascertain the threshold of detection.  It was encouraging that 
the symmetric stretching of the azide group, at 1289 cm-1, could be visualised 
(Figure 47).  However, this signal reduced as the concentration decreased and was 
no longer detectable at 5 mM.  To be able to detect this peak in a protein sample, 
the concentration required was once again unobtainable. 
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Figure 46.  IR spectra of amino acids.  Solutions of azF (Pink) and Phe (Blue; 20mM dissolved in H2O + NaOH) were used with CaF2 plates with a pathlength 25 μm to measure IR 
spectra.  The difference spectrum was obtained to try to identify the peak corresponding to the azido group. 
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Figure 47.  Raman spectroscopy of aqueous azF.  Raman spectra were obtained for samples of azF (in ddH20 + NaOH) at the specified concentrations.  The samples were 
sandwiched between quartz slides, using a 1 mm spacer. 
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3.4 Discussion 
3.4.1 T4L expression 
3.4.1.1 Plasmid systems 
The expression of WT and NAA-containing T4L was performed using numerous 
plasmid constructs.  Each of these expressed protein with varying efficiency.  Slight 
or major differences in plasmid construction could explain these differences.  
Namely, the differences in promoters used to drive expression of the target gene; 
mutations within the T4L gene; the presence/absence of a purification tag (for 
example, a hexahistidine tag); and differences in linker region between T4L and 
purification tag (Table 11). 
 
Table 11.  Differences between T4L-expressing plasmids 
Plasmid T4L 
promoter 
Mutations Linker  Purification 
tag 
pT4L153TAG T5  - - 
pAAT4L153TAG T5 R154K  
ΔThr152 
Optimised 
sequence 
GGSG histag 
pET101T4L153TAG T7 L99F 
M102A 
GGSG histag 
pBADT4L153TAG araBAD N2D S histag 
 
Before expression of T4L substituting azF at position 153, optimisation of 
expression and purification techniques were optimised using the cheaper and more 
photostable amino acid p-iodophenylalanine.  Also, incorporation of iodoF was 
undertaken first as it had been shown previously that T4L153iodoF could be 
expressed, purified and crystallised (Xie et al. 2004). 
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The use of a T5 or a T7 promoter appeared to make little difference to the 
efficiency of protein expression.  These are both exogenous promoters and this 
could explain the similarities in protein expression levels.  The use of the T7 
promoter limited the use of the E. coli(DE3) strains as these strains express the T7 
polymerase.  It was thought that the leaky expression of T4L before induction could 
have been detrimental to cell viability and protein production.  Any expression of 
T4L could have caused lysis of the E. coli host cell and loss of the expressed protein 
to the media.  Also, this would have limited the overall culture growth and 
subsequent protein production.  It was thought that using the autoinduction 
medias, leaky expression from lac operon of pET plasmid would be limited due to 
the presence of glucose in the media (Studier 2005).  This would reduce any 
problems caused by leaky expression of T4L and the subsequent lysis of the host 
cell.  However, T4L production was still low. 
Leaky expression from the T5 promoter controlling T4L expression on the 
pAAT4L153TAG plasmid could have occurred due to small amounts of lactose in the 
growth media.  This leaky expression of Δ152 mutant protein could have been toxic 
to the host cell, causing cell death.  This is especially important if any natural amino 
acid was incorporated at the TAG codon, (which is always a possibility, especially 
without any competition from the TAG-aaRS specific NAA) (Nehring et al. 2012), as 
this would have produced a full-length Δ152 mutant T4L which could have had a 
number of outcomes: retained T4L functionality and caused lysis of the host cell; 
conferred altered T4L functionality and caused lysis of the host cell; produced a 
non-functional toxic protein capable of aggregation, altered tertiary structure or 
other function conferring toxicity.  Other explanations could include the reduced 
tolerance of the codon optimised sequence, the formation of an inaccessible 
plasmid due to the change in sequence, or the non-functional resistance gene.  
Even if growth occurred, the product of Δ152 mutant T4L would have placed the 
azido group of the azF on the surface of the protein, not in the hydrophobic region 
as anticipated.  There was also R154K mutation, and a GGSFG linker region between 
the T4L gene and hexahistidine tag, which may have affected the expression of the 
protein.  The issues relating to the attempted insertion of the missing codon into 
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the non-functioning of the plasmid, pAAT4L153TAG, strengthens the argument that 
the plasmid had formed an in-accessible form. 
It had been shown previously that the pT4L153TAG and pBKpIodo plasmid system 
could successfully incorporate iodoF into codon 153 of T4L (Xie et al. 2004).  
Expression of T4L153iodoF protein was possible using these plasmids, however the 
presence of the histag on the other constructs made these more favourable.  In 
addition, the expression of T4LiodoF was low.  
The pBAD system appeared to express NAA-containing protein with the best 
efficiency.  The notable changes in these T4L genes compared to the others 
included the araBAD promoter, the N2D, F99L mutations and the short S linker to 
the hexahistidine-tag.  The araBAD promoter was likely to have had an impact on 
expression, because it is a tightly regulated promoter, via the doubly regulated araC 
(Guzman et al. 1995).  Put simply, when arabinose is absent but glucose is present, 
there is very little transcription from the promoter due to the doubly regulated 
regulon (Lee et al. 1987).  Presence of glucose represses expression, while addition 
of arabinose causes transcriptional activation and expression is induced quickly 
(Miyada et al. 1984).  This tight regulation would have limited the leaky expression 
of T4L prior to induction, may have increased culture growth resulting in higher cell 
density that can then express protein when the arabinose is added and limited the 
issues mentioned above.  
The N2D mutation may have increased expression due to the change in N-terminal 
methionine cleavage.  A process known to occur when expressing proteins using E. 
coli (Frottin et al. 2006; Hirel et al. 1989).  The cleavage efficiency of the N-
methionine is determined by the length of the side chain of the second amino acid.  
Although the mutation of an asparagine residue to aspartic acid within T4L does not 
increase the length of the side chain, it does alter the chemical properties of this 
residue, which might, in turn, alter the N-terminal methionine cleavage efficiency.  
The presence/absence of the N-terminal Met might alter the stability of the 
protein.  This, and the other mutations, could have acted to increase the stability, 
and therefore allow accumulation of the protein  
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Expression from pBAD plasmids requires the use of the Top10 E. coli strain as 
opposed to the traditional protein expression strain BL21(DE3) because Top10 
carries a araD139 mutation which alters arabinose metabolism and allows control 
over protein over-expression (Gendron and Sheppard 1974).  The use of Top10 may 
have also increased amber suppression as it has been demonstrated previously that 
incorporation of natural amino acid in response to TAG codon is lower than that 
observed in BL21 strains (O’Donoghue et al. 2012).   
3.4.1.2 Plasmid encoding orthogonal aaRS and tRNA   
   
 
The plasmid expressing the synthetase was also varied due to a number of reasons.  
Firstly, whether the tRNA   
   
, was present on the same plasmid as the synthetase or 
the target gene.  Both aaRS and tRNA   
   
, were required for amber suppression.  
Also to note was that the number of copies of tRNA   
   
, varied among the plasmids.  
It appeared that the number of tRNAs encoded on a plasmid had little impact on 
efficiency of production of NAA-containing protein, because the pDULE plasmid 
encodes only 1 tRNA   
   
, and this was the plasmid used in the most efficient 
system.  The number of copies of tRNA   
   
, or which plasmid harboured the tRNA 
could have influenced expression.  In fact, the presence of more than 1 tRNA   
   
, on 
a plasmid may have been detrimental to protein expression, possibly due to toxicity 
(Young et al. 2010)  It was also required that the plasmid pairs had compatible 
origins of replication, to ensure both plasmids were maintained in daughter 
plasmids after cell division; and this hindered the use of certain plasmid pairings. 
Both the pBK and pSUP RS-containing plasmids used a glnS’ promoter to express 
the synthetase.  However the pDULE plasmid used and lpp promoter and this could 
explain the increase in expression when this plasmid was used to express azRS to 
incorporate azF into T4L.  The aaRS in pDULE was originally engineered to 
incorporate cyanophenylalanine (Figure 48), not azF as for the other RSs used in 
expression of T4L153azF (see section 3.4.1.3).  This also could have increased the 
expression of target protein by more efficient recognition, aminoacylation or 
incorporation of azF.  The pAAazRS plasmid used a T5 promoter.  The inducible 
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expression of azRS via this T5 promoter was not beneficial as the most efficient 
pDULE plasmid used a constitutive promoter.   
 
 
Figure 48.  Cyanophenylalanine 
 
3.4.1.3 Promiscuity of NAA-RSs 
It was considered that the promiscuity of the orthogonal synthetases could be 
utilised to incorporate azF into T4L153TAG using the synthetase engineered for 
iodoF.  The premise for considering this was based on previous work performed by 
group members (Antonczak 2012 Thesis) and other groups (Miyake-Stoner et al. 
2010; Stokes et al. 2009).  The work demonstrated that it was possible to use a 
variety of synthetases to incorporate a particular tyrosine-based non-natural amino 
acid.  The differences in size and charge of the NAA were accommodated by the 
removal of the tyrosine-specific residue, Y32, within the AA binding pocket of aaRS 
and replacement with a smaller, non-charged amino acid (Appendix A3).  This 
promiscuity was particularly important because  the synthetase used to incorporate 
the azF in the pDULE plasmid was originally engineered for aminoacylating 
cyanophenylalanine, another nitrogen containing phenylalanine derivative (Figure 
48).  
3.4.1.4 Fidelity of amber suppression 
Full-length protein was still apparent in cultures grown in the absence of NAA.  This 
could be due to incorporation of a naturally occurring amino acid, typically tyrosine, 
as this was the original cognate amino acid for the engineered orthogonal RS and 
tRNA (Nehring et al. 2012).  Although the synthetases have been engineered to 
recognise the specific NAA, and during the engineering process synthetases that 
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aminoacylate natural amino acids were selected against, it is possible that tyr has 
been incorporated at position 153 when NAA was withheld from the media.  
Tyrosine was the cognate amino acid for these synthetases therefore the probable 
choice for aminoacylation with a natural amino acid.  Nehring et al (2012) have 
shown by in vitro catalysis experiments that these NAA-specific engineered 
synthetases show preference for tyrosine over the NAAs they were engineered for.  
The group suggested that accumulation of metabolically inert NAAs in the cell 
accounted for why the engineered aaRSs were charged with NAA and NAA 
incorporation occurred, despite the NAAs being weak substrates (Nehring et al. 
2012).  When NAA was withheld from the media, the engineered aaRSs 
preferentially charged tyrosine and incorporated tyr at the TAG position.  Following 
this argument, it could be assumed that although Tyr incorporation occurred at a 
certain level when NAA was absent for the cells, this may not be representative of 
the Tyr incorporation seen in experiments when NAA was present.  Therefore, 
T4L153Tyr should be at lower levels in the population of protein produced from 
experiments where NAA was present.  The work presented within this chapter 
demonstrated that fidelity of NAA incorporation was approximately 99 %. 
3.4.1.5 Functionality of mutant T4L 
The functionality of the T4L protein was assayed by the ability of the protein to lyse 
the cells in which the protein was overexpressed.  The output from this assay was 
the production of a thick cellular lysate, similar to that typically seen after hen egg 
lysozyme lysis.  The initial freeze-thaw step after harvesting the culture would cause 
lysis of some of the cells, this would release the cellular contents, including T4L, and 
further aid in cell lysis.  This simplified the protein isolation procedure, and ensured 
no exogenous lysozyme was used in culture lysis which would require removal via 
purification.  This simple assay indicated that the presence of NAA had not altered 
the ability of the protein to fold, and T4L153azF/iodoF was still able to confer the 
typical function of T4L, namely, the lysis of E. coli cells.  
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3.4.2 T4L purification 
The purification of expressed protein was crucial for the downstream applications, 
namely, to ensure the spectroscopic data obtained could be attributed to the 
T4L153azF protein and not any other contaminating protein.  In addition, purity was 
also important during crystallisation as contaminating protein can prohibit the 
formation of well ordered crystals of pure protein.   
Nickel affinity purification was an ideal first purification step as, in theory, this 
method should purify full-length, NAA-containing protein away from truncated 
protein.  Truncated protein was produced where NAA incorporation had failed and 
the TAG codon had been “read” as a translation termination codon.  This truncated 
protein did not contain a hexahistadine tag at the C-terminal of the protein.  As the 
TAG codon was at codon 153 of 164 i.e. near the C-terminal, the truncated protein 
(17.1 kDa) was only 2.54 kDa smaller than full-length protein (19. kDa) and this 
method provided an easy way to separate these two populations of protein.  Other 
purification methods might not distinguish between the slightly smaller protein, 
which has the same primary structure codon 1 to 152 and therefore similar 
properties.  This purification step rendered the protein quite pure.  The major 
contaminating protein was of a much larger mass which could easily be purified 
away using a SEC purification step. 
The expression and purification of T4L153azF was performed, as much as possible, 
in the dark or under red light.  The protein was expressed in a incubator with the 
glass covered, with the light off.  Also, expression was typically performed in the 
evening or at night to ensure a light-free environment.  A specially created dark 
room, with a red light, was used to purify and handle the protein; and red 
eppendorfs or aluminium foil coverings were used for intermediate steps.  Although 
care was taken to only handle the protein in the dark, inevitably some protein 
handling could not be performed in the dark, for example, the centrifugation of 
culture or protein, therefore it was possible some photoreaction of the azide could 
have occurred prior to the experiments.   
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3.4.3 Crystallisation of T4L 
It was thought that visualising NAA-containing T4L by x-ray crystallography would 
provide further evidence that NAA had been incorporated.  It was also thought that 
the reactions that occur during photolysis could be probed using this method.  Well 
diffracting crystals of WT T4L were obtained, but T4L containing NAA was more 
complex.  Only small crystals of T4L153azF were isolated and these did not generate 
good diffraction patterns.  It was considered that the crystals were disordered.  
It has been shown previously that iodoF-containing T4L has been crystallised and 
the structure solved (Xie et al. 2004).  In fact the presence of the heavy atom-
containing NAA, iodoF was utilised in solving the structure of the protein.  Xie et al, 
demonstrated that when using iodoF considerably less data was required to solve 
the protein structure when compared to an equivalent experiment utilising cysteine 
or methionine. 
Purity of protein was particularly important in the crystallisation experiments, 
where any small amount of protein with a different structure or chemical make-up 
could reduce crystallisation efficiency.  It is possible that even the smallest traces of 
contaminating protein prevented formation of ordered crystals.  In addition, 
alterations in structure could have arisen from photoreaction of the azide and 
subsequent reaction with any part of the lysozyme protein.  This would result in a 
new bond causing the alteration of protein structure to accommodate this.   Any 
misfolded protein in the sample could interrupt crystal formation and this could 
explain the disorder seen in the collected protein crystals that were used for 
diffraction.  Also an issue was that, due to the long crystal formation time, any light 
exposure could have caused re-arrangement in the protein subunits already 
incorporated into the protein crystal, this once again, could explain the disorder in 
the crystal.  Even if the crystals were not exposed to light, any reacted protein 
monomers could have propagated structural rearrangements in the remaining 
subunits of the crystal.  Although CD measurements indicated that the majority of 
the T4L153azF was folded similarly to WT any subtle differences may not have been 
seen or it is possible that the solution of T4L153azF was heterogeneous, but at a 
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low level as not to be detected by the CD.  Evidence that the azido group was 
perturbing protein crystallisation was that WT crystals were easily isolated and 
were able to diffract well.  In addition, Xie et al (2004) have previously obtained 
well-diffracting crystals of 153-iodo substituted T4L.  This hypothesis could be 
investigated by performing CD measurements on the protein throughout the 
crystallisation process; or after irradiation of the protein.  
3.4.4 EPR of T4L153azF 
The EPR spectrum obtained using T4L153azF was compared to those obtained 
previously using other aryl nitrene species, specifically, the azido-functionalised 
cryptand investigated by Bucher et al (Bucher et al. 2005).  It was apparent that the 
formation of triplet nitrene within T4L153azF had been captured by comparing the 
characteristic signal at 6869 G to the signal at 6680 G recorded for Bucher’s 
cryptand.  Further evidence came from comparing the observed spectra to the 
simulated spectrum, where the signals at 6869 G align well.  However, owing to the 
large zero-field splitting term, a reliable value of G was difficult to extract from the 
simulated data using just the X-band frequency.  Therefore an exact comparison 
cannot be made.  Both of the spectra were also similar to that found by Wasserman 
in the paper originally describing the EPR signal of phenyl triplet nitrene at low 
temperatures (Wasserman 1971).  The differences in spectra were due to 
differences in the chemical environment surrounding the azide.  The complexity of 
the spectra was no doubt due to the presence of the protein that harboured the 
nitrene.  
The azide was buried within the hydrophobic environment of T4L to shield the 
nitrene group from bimolecular reactions (i.e. dimerisation with azo formation) that 
has typically plagued previous attempts to study the photoreaction of this group 
(Gritsan and Platz 2006; Schuster and Platz 1992; Li et al. 1988).  It was thought that 
trapping the highly reactive species in this pocket would aid the study of the 
intermediates.  It was also thought that the hydrophobic pocket would result in 
stabilisation of the reaction intermediates.  It was noted that the EPR 
measurements took approximately 30 minutes, therefore it was apparent that the 
151 
 
triplet nitrene was stable for at least 30 minutes.  Further EPR studies could be used 
to study the stability of the triplet species by following the intensity of the peak at 
6689 G throughout a length of time or possibly as the temperature was increased.  
Smolinsky et al, showed that an EPR spectrum was detectable for numerous azides 
at 77 K and the signal for phenylazide remained at a similar intensity for at least 
18 hours after irradiation (Smolinsky et al. 1962).  
It was thought that the hydrophobic environment of T4L could be used to stabilise 
the reactive intermediates produced during the irradiation of azide and thereby 
facilitate their study.  This was explored by comparing the EPR spectrum of 
T4L153azF with spectra observed using irradiated protein with the azido group 
presented on the surface, and within the chromophore cavity of GFP (Reddington 
2013 Thesis).  As expected, the azide group, when present on the surface of GFP, 
did not show production of triplet nitrene after irradiation; or any other species 
detectable by EPR (Morris et al 2012).  If any EPR-detectable species was produced, 
it would quickly react with components of the solution surrounding the protein.  
Interestingly, the GFP protein displaying the azido group within the chromophore 
(Phe66azF) produced an EPR profile with a predominant five-line pattern which was 
attributed to production of an anilino radical.  This anilino radical was supposed to 
be produced as a result of hydrogen abstraction (Scheme 1) from the imidazolinone 
ring of His148.  This assignment was supported by simulation data, which also 
revealed not only spin delocalization over the entire chromophore, but more 
importantly, a slight electron donating influence of the GFP chromophore group.  
This electron donating influence increased the spin density on the terminal N atom 
and resulted in hydrogen abstraction and formation of a complex system in 
conjugation with the imidazolinone ring.  It was hypothesised that this 
intramolecular rearrangement seen was due to the close proximity of the other 
residues (< 3 Å) and this resulted in hydrogen abstraction that could have been 
promoted by the initial formation of either the singlet or triplet states.  This was 
possible as both states are open shelled (Borden et al. 2000). 
EPR was used exclusively to detect the formation of triplet phenyl nitrene which is 
proposed to form following intersystem crossing after the formation of singlet 
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nitrene; therefore the formation of other reactive intermediates cannot be 
excluded.  The possible reaction pathways are proposed in Scheme 1, and are 
considered. 
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Scheme 1.  Proposed reaction scheme of azF within T4L153azF.  Drawn using ISIS draw. 
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Singlet nitrene was immediately produced following photolysis, but at this low 
temperature, this species lacks the energy to undergo isomerisation and 
preferentially relaxes to triplet phenyl nitrene by intersystem crossing, however, 
some singlet nitrene may have persisted.  The production of the ketenimine, known 
to be produced from prolonged photolysis, was limited by photolysing the sample 
for a short time (2 minutes).  This was performed in accordance with Platz and Wirz 
who observed a maximum relative intensity of a triplet EPR signal from phenyl azide 
after approximately 3 minutes of photolysis (Leyva et al. 1987).  However some 
ketenimine species may have persisted.  The production of the azobenezene 
bimolecule was reduced by the shielding of the reactive nitrenes and by the 
prevention of diffusion at this low temperature, therefore was unlikely to be 
present.  Calculations by Sankaranarayanan et al (2010) suggested that there is a 
significant barrier for triplet phenyl nitrene to abstract a hydrogen 
(Sankaranarayanan et al. 2010).  This in conjunction with the analysis of the 
distances between the putative nitrene and the nearest residues, from the T4L 
protein, provide evidence that hydrogen abstraction is unlikely to occur in this 
system.  By analysing the T4L153iodoF crystallographic structure (PDB 1T6H), the 
internuclear distances between the putative aryl nitrene, N, and the proximal 
residues were calculated.  It was shown that the nearest six residues were all non-
polar and therefore not likely to provide an easily abstracted hydrogen.  Also to 
note was that the approximate distances between the nitrene N and proximal C–H 
bonds range from ~ 3.3  5.5 Å (Figure 49).  At this distance hydrogen abstraction 
was also shown to be unlikely.  
Although the study of the photoreaction of azide at low temperatures has provided 
information regarding the possible reactions of the azide group and explored how a 
protein environment can be used to study azide reactions, the reactions discussed 
above are not those that would typically predominate at a biologically relevant 
temperature.  Therefore, no conclusions can be made regarding the reactions of the 
azide that would occur within a biological setting.  Exploration of the reaction at 
room temperature would help elucidate these reactions. 
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Figure 49.  Hydrophobic pocket of T4L with the putative triplet nitrene shown in relation to closest 
residues.  Distances to residues are shown.  Drawn using Isis draw. 
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3.4.5 Further spectroscopic investigations 
Other spectroscopic techniques were used to investigate the incorporation of the 
photoactive moiety into the protein.  It was hypothesised that by performing these 
measurements of unreacted and reacted species at room temperature, this would 
represent those reactions that occur within the typical biological setting.  However, 
due to the low abundance of azide within the protein, and the low levels of 
detection of the spectroscopic techniques used, it was possible to see only general 
differences in spectroscopic properties, or only detection of the azide group when 
solutions of amino acid were used. 
3.4.5.1 CD spectroscopy 
The CD spectra obtained during this study was representative of the PDB structure 
(Chapter 1, Figure 18) and similar to CD spectra previously obtained (Billsten et al. 
1995; Zhang et al. 1993).  Therefore the structure of the T4Ls utilised within this 
study were comparable to those previously studied.  Furthermore, the presence of 
the NAA did not perturb structure and folding. 
3.4.5.2 Mass spectrometry 
An accurate mass was obtained for WT T4L and T4L153iodoF, using ESI, but not for 
T4L153azF.  Thermoreaction of the azide group was most likely occurring and could 
explain why an accurate mass could not be obtained.  This was concurrent with 
previous work (Chin et al. 2003a; Liu et al. 2007; Nehring et al. 2012).  In contrast, 
ESI has been used to isolate mass of azF-containing protein (Chin et al. 2002a; 
Deiters et al. 2003).  This difference could be explained by differences in the protein 
preparation and ESI measurement protocols.  The production of T4L153iodoF and 
mass analysis using the same expression conditions as used in the production of 
T4L153azF, gave some evidence that NAA incorporation was occurring.  Using iodoF 
for mass analysis had the advantage that its high molecular weight would give 
T4L153iodoF a mass much different to that of WT T4L. 
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3.4.5.3 UV vis spectroscopy 
When the UV-vis spectrum obtained for azidophenylalanine was compared to that 
published for phenyl azide, the shape was similar but the slight difference could be 
attributed to the difference in substituents on the phenyl ring (Tomioka et al. 1993).  
After irradiation of the solution, the increase in absorption at wavelengths 290 –
 600 nm, suggested the increase in double bond, the formation of bimolecular 
product or “tarry polymer”.  The change in colour from pale to dark yellow solution 
also indicated this.  The reduction in signal at 250 nm and increase in signal at 
wavelengths 320 – 550 nm after irradiation was also seen by Tomioka et al (1993).  
Comparing the spectrum of azF to that of phenylalanine suggested that the 
photoreactivity demonstrated by the azido group is responsible for the change in 
absorption at wavelengths of 300 nm and above (Linstrom and Mallard 2005). 
The UV-vis spectrum obtained using WT T4L shows typical protein UV-vis 
absorbance.  Namely, the absorption in the far-UV range by peptide groups and 
aromatic side chains; absorption in the 240 – 300 nm region due to aromatic side 
chains (Table 12).  There was very little absorption at wavelengths greater than 
310 nm.  The UV-vis spectrum obtained using T4L153azF also showed typical 
absorption of a protein, but when compared to that of WT protein, there appeared 
to be increased absorption at 240 – 260 nm.  This could be attributed to the azF 
moiety.  When irradiated, the absorbance at approximately 250 nm was drastically 
reduced over the period of irradiation.  This could correspond to the photoreaction 
of the azide. 
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Table 12.  Absorbance of protein moieties.  As determined in water at neutral pH (data from Eftink 
1991) 
Moiety Wavelength (nm) 
Peptide groups 180 – 230 
Disulfide bonds ~ 260 
Aromatic sidechains  180 – 230 
240 – 300 
λmax  
    Trp 
    Tyr 
    Phe 
280 
275 
258 
 
 
The UV-vis data showed evidence that incorporation of azF in to the protein was 
successful and that the moiety displayed some photoreactivity.  The changed in 
spectrum observed during irradiation suggested an increase in double bond 
content, due to the increase in absorption at wavelengths above 300 nm.  This may 
be due to the formation of the dehydroazepine, which has a broad peak absorption 
at 320 to 380 nm (Leyva et al. 1986; Schrock and Schuster 1984).  Of course, there 
will be limited formation of azobenzene-type products or tar because the azido was 
trapped within the hydrophobic pocket and reactive intermediates were shielded 
from each other.  Therefore, this may explain why there was no increase in 
absorption at the higher wavelengths.  
It was possible that the observed UV-spectrum did not represent the reaction of the 
azido group, but changes in the protein structure due to the reaction of the azido 
group.  The formation of a new bond from the abstraction of a hydrogen could 
result in major protein structural rearrangements.  Although the protein was 
expressed and purified in the dark as mentioned earlier, this could have caused this 
re-arrangement in the protein structure.  
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3.4.5.4 IR spectroscopy 
A weak IR signal corresponding to azide was observed when a solution of 20 mM 
azF amino acid was used.  The difference between Phe and azF at this wavelength 
was only 2 % transmittance.  The background signals were also large.  In order to 
visualise the spectrum of T4L153azF, an unobtainable concentration would be 
required, therefore these measurements were not undertaken.   
Typically, a very strong characteristic IR peak at approximately 2100 cm-1 has been 
recorded for organic azides (Buchmueller et al. 2003) or protein-iron-azide 
complexes (Bogumil et al. 1994).  The weak signal obtained within this study could 
be due to the aqueous environment of azF.  However, this aqueous environment is 
required for the measurements of protein as T4L was not very soluble in organic 
solvents.  The IR spectrum of H2O within this stretch is not great and it was thought 
that visualisation of the azide would be possible. 
Previous work has demonstrated that measurement of the IR spectrum of azide-
containing protein was possible (Ye et al. 2009).  Ye et al (2009) also incorporated 
an azide moiety (via azF) using amber suppression into the G protein–coupled 
receptor, rhodopsin.  The group observed a peak at approximately 2100 cm-1 which 
corresponded to the antisymmetric stretch vibration of azide and demonstrated 
that the azide was sensitive to its electrostatic environment.  These changes were 
used to monitor the change in electrostatic environments of specific interhelical 
networks during receptor activation.  The sensitivity of the spectrometer used and 
the specific use of a photoactivatable protein may have influenced the ability to 
measure IR spectrum of the azide group. 
Infrared measurements have been extensively used to study the binding of azide to 
myoglobin and haemoglobin (Alben and Fager 1972; Lim et al. 1998; McCoy and 
Caughey 1970).  Once again the signal obtained from the azide group was strong.  
This could have been due to the use of sodium azide, which has a very strong signal.  
This combined with the ionic coordination to iron-containing haem groups could 
explain the difference in the ability to obtain good spectra.  The haemoglobin 
protein used was isolated in large quantities from blood, for example from horse 
blood, therefore high concentrations could be easily reached. 
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3.4.5.5 Raman Spectroscopy 
The use of Raman spectroscopy to investigate reactivity of the azide moiety within 
T4L153azF was also attempted.  The symmetric stretching of the azide group, at 
1289 cm-1, could be visualised at concentrations above 10 mM.  The signal was not 
visible at 5 mM.  As seen for IR measurements, the concentration required to 
visualise the azide group within the T4L153azF protein was unobtainable.  
Therefore using Raman spectroscopy to investigate the photoreaction of azide 
within T4L153azF was not investigated further.  
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3.5 Conclusion 
Using the amber suppression method, as developed by Schultz et al, it has been 
shown that it is possible to produce T4 Lysozyme protein harbouring an azide group 
within the protein’s hydrophobic pocket.  The use of this technique provided a 
method to incorporate an orthogonal, highly reactive moiety into a defined position 
within the protein.  It was shown that spectroscopic techniques could be used to 
investigate whether the incorporation of NAA had been achieved.  It was also 
shown that EPR is a technique that could be used to investigate the reaction of the 
azide group and more importantly that the use of a hydrophobic pocket within a 
protein could be used to investigate the reactive intermediates of azides.  Namely, 
by shielding the reactive intermediates from one another to remove the possibility 
of production of azobenzene-type products that have typically plagued 
investigations into the reactions of azides.  By comparing the data obtained using 
the hydrophobic pocket of a protein, to the use of surface exposed positions and 
the incorporation of the azide within the chromophore of GFP it appeared that the 
protein “matrix” surrounding the azide could be defined in such a way to influence 
the reaction. 
Despite the widespread use of aryl azides in biological experiments, for example, 
photoaffinity labelling, no detailed examination of photochemical intermediates 
has been reported.  This study has shown that generating reactive intermediates 
derived from non-natural amino acids within the hydrophobic pocket of a protein 
interior provides a novel, but also practical technique to generate and study highly 
reactive intermediates. 
The observed EPR spectra appear to be strongly correlated to the protein “matrix” 
surrounding the nitrene.  Thus, it was proposed that generating reactive 
intermediates derived from noncanonical amino acids within the tuneable “matrix” 
of a protein interior appears to be a novel, but also practical approach to generate 
and study highly reactive intermediates. 
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The work presented within this chapter, especially the EPR spectra generated using 
T4L153azF and azF present within other defined protein environments (see section 
3.4.4) has been accepted for publication in the ACS journal, Organic Letters. 
163 
 
4 CHAPTER 4: UTILISATION OF THE AMBER 
SUPPESSION TECHNOLOGY TO CONTROL A 
FUNCTIONAL BACTERIAL READOUT SYSTEM 
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4.1 Introduction 
The second novel application of amber suppression explored within this thesis is 
the creation of a biological switch controllable by the presence of NAA.  The 
creation of a switch would provide a novel method to control protein expression 
and could be linked, therefore, to modulation of a specific phenotype.  Modulation 
of motility was chosen as a simple, visual output.  In this chapter, the application of 
this technology to a prokaryotic system was explored; in Chapters 5 and 6 the 
application to a eukaryotic system was explored. 
The amber suppression technology has the benefit that two scenarios occur 
depending on the presence/absence of the non-natural amino acid.  Ideally, when a 
non-natural amino acid is supplied to cells capable of performing amber 
suppression, the non-natural amino acid is incorporated in response to the UAG 
codon, read-through of the entire gene occurs, full-length, functional protein is 
produced, and the cell displays the specific phenotype (Figure 50).  Conversely, 
when non-natural amino acid is withheld from the cells, the UAG codon is read as a 
translation termination signal, protein is truncated and therefore no functional 
protein is produced, and the cell does not display the specific phenotype.  Thus, the 
aim of this chapter is to explore the duality of the amber suppression method to 
produce a biological switch, which can control the phenotype of an E. coli cell.  In 
this case the presence/absence of the non-natural amino acid is the switch which is 
linked to an easily read output, namely, the modulation of the motility of E. coli. 
The production of a biological switch is interesting in itself, however, the creation of 
read-out system has other consequences that can be exploited.  Namely, the NAA 
concentration and the efficiency of the aaRS could be used as “handles” that can be 
used to fine-tune the expression efficiency, which would, in theory, correlate to the 
efficiency of swimming.  It would be possible to use this read-out system to select 
new efficient aaRSs specific for NAAs (Link et al. 2006).  The selection procedure 
would be similar to the positive selection method as outlined in Chapter 1 (Figure 
12) but the selection of efficient aaRSs could be achieved by picking E. coli 
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Figure 50.  The two scenarios that occur during amber suppression technology depending on the presence/absence of a non-natural amino acid; and application in controlling 
cellular phenotype. 
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cells that display efficient swimming ability, namely, those from the outside of the 
swimming halo on a motility assay plate. 
The addition of a NAA at an exposed position along the entirety of the flagella has 
interesting consequences, for example the ability to alter serotype and therefore 
antigen binding and immunological responses.  In addition, the incorporation of azF 
at this position may allow the attachment of other factors, for example fluorogenic 
dyes, via click chemistry to the azF moiety (Beatty et al. 2005).  Thus allowing site-
specific labelling and visualisation of flagella, which can aid in investigations into 
flagella function (Turner et al. 2000).  
The motility of E. coli is dependent on the formation of functional flagella.  Without 
flagella the E. coli cell is non-motile.  The multiple flagella, which are found on the 
cell surface, are composed of flagellin subunits that assemble to form flagella.  The 
basal complexes that hold, and create rotational force to turn flagella, are located 
in the plasma membrane and associate with the flagella filament.  The FliC gene 
encodes the flagellin protein.  Strains of E. coli lacking functional FliC are non-
motile.  These non-motile strains provide a phenotypic background suitable for 
introducing plasmid-encoded FliC and observing the motility phenotype of the cell 
which will be contingent on the presence of nonnatural amino acid. 
Specifically, the investigations within this chapter sought to: 
 Establish that there were differences in motility between E. coli strains 
that exhibit wild type motility and those that are FliC-deficient 
 Investigate whether plasmid-encoded FliC could restore motility to non-
motile E. coli strains 
 Investigate whether it was possible to control a bacterial phenotype (i.e. 
migration) as a function of the presence/absence of non-natural amino 
acid utilising the amber suppression technology. 
 Investigate the applications of NAA display on an E. coli surface.  
Namely, the selection of new NAA-aaRSs, reaction of reactive moieties 
within NAAs displayed on E. coli cell surface. 
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4.2 Results 
4.2.1 Analysis of E. coli motility 
4.2.1.1 Functional FliC gene is required for motility 
As the cell-based readout system required was centred on modulation of cell 
migration, firstly it was important to confirm that without a functional FliC gene, 
cells were nonmotile. 
The E. coli strain BL21(DE3) were shown to be motile, as assayed by an agar plate 
motility assay, using a 1 µl drop of saturated culture onto a 0.3 % agar plate (Figure 
51).  The motile cells swam away from the inoculation point and spread over the 
agar to create a halo of cells surrounding the inoculation drop in the centre of the 
plate.  
The KAF95 strain, previously constructed by Karen Fahrner (Berg and Turner 1993), 
was an E. coli K12 derivative, AW405 (Armstrong et al. 1967) which carried the 
fliC726 allele, with a nonflagellate phenotype (Silverman and Simon 1973).  The 
strain also carried a cheY deletion, so would display smooth swimming motility and 
no chemotaxis.  The KAF95 strain was shown to be non-motile, due to the lack of 
halo radiating from the inoculation drop in the centre of an agar plate motility assay 
(Figure 51).  Instead, the growth of the colony occurred within a few millimetres of 
the inoculation point. 
The JW1908 strain of the previously created Keio collection was an E. coli K-12 
BW25113 derivative.  The Keio collection was created by systematic construction of 
single gene knock-out mutants of all genes/ORFs (Baba et al. 2006) using Wanner's 
method (Datsenko and Wanner 2000).  The clone, JW1908, used in this study was a 
FliC knock-out strain and therefore had a non-flagellate phenotype and was 
therefore non-motile.  The strain will be subsequently referred to as “Keio”.  The 
strain was shown to be non-motile (Figure 51). 
These results demonstrated the non-motility of the two cell strains, KAF95 and 
Keio.  These cell lines therefore, provided the basis for the investigations into 
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whether the motility of a bacterial cell could be controlled via the amber 
suppression method.  The lack of the FliC gene and therefore lack of flagella gave 
the required background for the experiments introducing FliC gene back into these 
cells. 
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Figure 51.  Comparison of motility; BL21(DE3), Keio, KAF95.  A 1 µl drop of saturated culture containing either BL21(DE3), Keio or KAF95 was added to the centre of a 0.3 % agar 
plate (9 cm diameter).  Ability of culture to swim was determined by taking photos at time points specified and monitoring halo of cells radiating from inoculation point. 
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4.2.2 Restoration of motility by plasmids-encoded FliC 
To express plasmid encoded flagellin in the Keio and KAF95 strains, it was necessary 
to clone the FliC under the control of a promoter that could recognise by the 
endogenous E. coli machinery.  This was because, unlike the BL21(DE3) strain, these 
strains do not harbour the T7 polymerase gene.  The viral T5 promoter was 
therefore suitable, as it is recognised by the endogenous E. coli machinery.  The 
plasmid pAA was chosen as this plasmid contains a T5 promoter driving expression 
of cloned genes and also, has previously been used in the application of the amber 
suppression method and in fact harboured the tRNAs required.  Therefore this 
plasmid made an ideal vector for carrying the FliC gene for the subsequent 
implementation of amber suppression technology.  
4.2.2.1 Cloning FliC into pAA plasmid 
The FliC gene was amplified from the plasmid pCA24N-FliC by PCR using EconoTaq 
polymerase.  The primers used were JLMFliC008 and JLMFliC010 which flanked the 
FliC gene, and added an XmaI and NotI to the 5’ and 3’ ends respectively (Appendix 
A2).  Digested PCR product was ligated into the XmaI and NotI sites of 
complementarily digested and purified pAA plasmid.  Colony PCR, using the primers 
rb_pAA_for and rb_pAA_rev, was used to screen the colonies for incorporation of 
the FliC gene (Figure 52).  Putative positive colonies gave a PCR product of 1.5 Kb.  
Sequencing confirmed the insertion of FliC into plasmid pAA (Appendix A7).  This 
resulted in the plasmid, pAAFliC (Figure 53). 
4.2.2.2 Introduction of pAAFliC into non-motile strains 
pAAFliC was used to transform Keio cells and used to perform a motility assay.  
However, motility was not restored to the non-motile Keio cells (Figure 54). 
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Figure 52.  Agarose gel of colony PCR screening colonies for insertion of FliC gene into pAA using 
primers rb_pAA_for and rb_pAA_rev.  Putative positive colonies gave a PCR product of 1.5 Kb.  1 Kb 
ladder (NEB) was used to approximate size of DNA fragments.  
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Figure 53.  Plasmid maps of FliC-containing constructs used in investigations, namely, pAAFliC, 
pQE60FliC and pFDFliC. 
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Figure 54.  Swim assay of Keio + pAAFliC.  Keio cells were transformed with plasmid pAAFliC.  A 
colony was picked , grown to saturation and used to inoculate a 0.3 % agar motility assay plate (9 cm 
diameter).  Images were captured at the specified timepoints.  
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4.2.2.3 Cloning FliC into pQE60 plasmid 
Because pAA was an in-house produced plasmid, it was thought that either some 
complexity of the plasmid interrupted transcription or translation of the target 
gene.  Therefore, FliC was cloned into the commercially available plasmid, pQE60 
(Qiagen).  This plasmid also controls expression of the target gene under the T5 
promoter.  The FliC gene was amplified from the plasmid pCA24N-FliC using PCR 
and primers JLMFliC014 and JLMFliC015 which flanked the FliC gene and added an 
NcoI and BglII to the 5’ and 3’ ends respectively.  Digested PCR product was ligated 
into the NcoI and BglII sites of complementarily digested, de-phosphorylated and 
purified pQE60 plasmid.  Colony PCR was used to screen the colonies for 
incorporation of the FliC gene, using primers pQE60 seq for and pQE60 seq rev, 
which were specific to the plasmid and therefore did not amplify endogenous FliC 
(Figure 55).  A PCR product of 1.5 Kb indicated insertion of FliC into pQE60.  DNA 
sequencing confirmed the incorporation of FliC gene into pQE60 plasmid.  This 
created the plasmid pQE60FliC (Figure 53).  The FliC gene contained the following 
mutations; Q76R, D121V, T400A (Appendix A7). 
4.2.2.4 Introduction of pQE60FliC into non-motile strains 
Keio cultures harbouring pQE60FliC were used in motility assays.  Once again 
plasmid encoded FliC was not able to restore motility to the non-motile strains 
(Figure 56).  Various inducing media was used to try to modulate the expression of 
flagellin, as it was thought that over expression could be detrimental to production 
of functional flagella.  Cultures were grown in cultures containing either no added 
inducer, 0.2 % lactose, 0.5 mM or 25 µM IPTG (de Boer et al. 1989).  In each case, 
the motility of the Keio cells could not be restored (Figure 56). 
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Figure 55.  Agarose gel of colony PCR to screen for insertion of FliC into pQE60 (lanes 1-9), negative 
control colony (lane 10).  PCR was performed using primers pQE60 seq for and pQE60 seq rev. 
Product of 1.5 Kb indicated insertion of FliC into MCS.  1 Kb ladder (NEB) was used to approximate 
size of DNA fragments. 
176 
 
 
Figure 56.  Swim assays of Keio plus pQE60FliC, investigating induction substrate and 
concentration.  Keio were transformed with pQE60FliC, colonies picked and used to inoculate LB 
cultures with either lactose, 0.5 mM or 25 µM IPTG.  After growth, saturated liquid cultures were 
used to drop a 1 µl drop into the centre of a swim assay plate (9 cm diameter) containing the same 
concentration of inducer.  Photos were taken 1 day after inoculation. 
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4.2.3 Plasmid pFD313 and pFDFliC 
To ascertain whether the issues with the plasmids encoding cloned FliC were 
related to the use of the T5 promoter, the use of the previously constructed 
pFD313-derived plasmid was investigated.  The pFD313 plasmid was kindly donated 
by Dr Richard Berry (Rotary molecular motors group, The Oxford Biological Physics 
Group, Oxford University) and had previously been used in conjunction with the 
non-motile KAF95 strain of E. coli to produce motile E. coli with sticky flagella.  
These sticky flagella were encoded by the FliC gene with a deletion spanning codons 
245-301.  The plasmid is a pBR322 based cloning plasmid, harbouring the genomic 
fragment containing the FliC gene (Kuwajima 1988a).  This fragment therefore 
includes the natural promoter and terminator of the FliC gene.  The pFD313 plasmid 
was shown to restore motility to the two non-motile strains, KAF95 and Keio 
(Appendix A6).  
4.2.3.1 Creation of the plasmid pFDFliC 
Firstly, the section missing from the FliC gene, namely codons 245-301, was re-
inserted into plasmid pFD313.  During the deletion mutagenesis to create pFD313, a 
BglII and HindIII restriction site was inserted into the regions of the FliC gene 
flanking the deletion; therefore, these sites were used to re-insert the missing 
section.  The primers, pFD313FliC FP and pFD313FliC RP (Appendix A2), were used 
to amplify the missing section of the FliC gene using PCR (template pCA24N) which 
added a BglII and HindIII site to the respective 5’ and 3’ ends of the PCR product.  
Digested PCR product was ligated into complementarily digested plasmid pFD313.  
Because of the small size of the insert, a difference could not be seen by colony PCR 
or by agarose gel electrophoresis of the purified plasmid, therefore sequencing was 
used to identify the presence of the inserted fragment.  Sequencing confirmed that 
the plasmid pFDFliC contained full-length FliC.  This created plasmid pFDFliC (Figure 
53).  The sequence contained a few mutations, namely Y246R, A247S, A301K, 
V302L, due to the presence of the BglII and HindIII sites at the ligation position 
(Appendix A7).  The mutations were tolerated as they were present within the 
variable region of the flagellin and were therefore unlikely to alter the structure or 
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function of the flagellin molecule or the flagella.  Also, these mutations were 
present in the FliC gene within the pFD313 plasmid that had previously been shown 
to produce functional flagella. 
4.2.3.2 Restoration of motility using pFDFliC 
The ability of the plasmid, pFDFliC, to restore motility to the non-motile strains 
KAF95 and Keio was investigated.  The motility of both strains was restored using 
the pFDFliC plasmid (Figure 57).  This was evident by the halo of migrated cells 
radiating from the inoculation point on the motility agar plate inoculated with cells 
transformed with pFDFliC.  Whereas, no halo was observed on the motility assay 
plate containing cells not transformed with pFDFliC. 
This result showed that plasmid encoded FliC (pFDFliC) could restore motility to the 
non-motile E. coli strains.  Therefore the plasmid pFDFliC was further investigated 
for use in the application of the amber suppression technology. 
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Figure 57.  Comparison of the motility of Keio and KAF95 and Keio and KAF95 harbouring the plasmid pFDFliC.  The two non-motile strains were transformed with pFDFliC, 
colonies were picked and used to inoculate LB cultures., a 1 µl drop of the saturated liquid cultures were used to inoculate 0.3 % motility assay plate (9 cm diameter).  Photos were 
taken at specified timepoints. 
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4.2.4 Implementation of amber suppression in FliC 
4.2.4.1 Introduction of TAG mutation into FliC 
For the implementation of the amber suppression technology in the E. coli cells, a 
TAG mutation was required in the FliC gene.  As addressed in Chapter 1, the 
flagellin protein is composed of domains, each with a specific function, therefore 
the position of the NAA substitution within the flagellin protein was considered. 
4.2.4.1.1 Structural and positional considerations 
The N- and C- terminal of the flagellin protein, domain 0 and 1, are required for 
formation of the functional flagellin tertiary structure (Figure 58).  Although 
presence of a TAG mutation close to the N-terminal has benefits, namely, short 
truncated protein that should not confer function, mutation of codons within 
domain 0 and 1 was not immediately considered as perturbing the structure here 
could prevent formation of functional flagella.  The variable region, domain 3, of 
the flagellin protein provides an ideal position for insertion of a NAA.  As the name 
suggests, this region has been shown to possess a number of variations between 
species, which account for different serotypes (Schoenhals and Whitfield 1993).  
Also, numerous mutagenic studies have investigated the function of this variable 
region.  In fact it has been shown that this region can be entirely deleted and the 
flagellin retains function (Kuwajima 1988a).  Another point to note is that Lu et al 
(1995) have demonstrated that an entire protein can be inserted into the flagellin 
protein at position 239.  
Therefore a site within the variable region of flagellin site was an ideal position for 
mutagenesis as there should be limited perturbation of the protein’s ability to fold 
correctly.  Specifically, position 239 was chosen as an ideal target.  The threonine at 
codon 239 is within a loop and points into the solvent.  This was an ideal position 
because, as the flagellin is created the NAA would be placed in a solvent exposed 
position along the entirety of the flagella.  
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Figure 58.  Structure of FliC, domains and putative site for NAA incorporation.  PDB structure 1UCU 
was used (Yonekura et al. 2003), N- and C- terminal coils of domain 0 and 1 are coloured yellow, 
antigenic domain 3 is coloured blue and residue 239 is coloured red.  Structure was produced using 
Pymol (DeLano and Lam 2006). 
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4.2.4.1.2 Creation of plasmid pFDFliC239TAG 
The TAG mutagenesis was performed using site-directed mutagenic PCR, using 
primers pFD313frag16 TAG FP/RP that introduced a TAG codon at position 239 of 
FliC within plasmid pFDFliC (Appendix A2).  Sequencing of the plasmid DNA 
confirmed that the Thr239TAG mutagenesis had been successful.  This created 
plasmid pFDFliC239TAG. 
4.2.4.2 Introduction of pFDFliC239TAG in to KAF95 strain 
The FliC gene contained an in-frame TAG codon within its sequence, therefore, full–
length protein should not be produced, subsequently there should not be 
restoration of motility when the plasmid pFDFliC239TAG was introduced into the 
non-motile strains.  When the pFDFliC239TAG plasmid was introduced into the 
KAF95 strain, motility was restored (Figure 59).  This was an unexpected result.  To 
eliminate the possibility that contamination of the culture with a cell strain 
displaying WT motility, the experiment was repeated several times, however, in 
each case the same result occurred.  
To investigate the possibility that the incorporation of natural amino acid into 
position 239 was occurring and this resulted in full-length protein and functional 
flagella, a similar experiment was performed using minimal media for inoculation 
culture and motility assay plates.  It was thought that limiting the concentration of 
nutrients and most importantly, amino acids, the cells would have limited natural 
amino acid to incorporate into the flagellin protein in response to the TAG codon.  
However, the cells still showed restoration of motility (Figure 59). 
4.2.4.3 Introduction of pFDFliC239TAG in to Keio strain 
When the pFDFliC239TAG plasmid was introduced into the Keio strain, the cells 
remained non-motile (Figure 60).  The Keio strain was therefore taken forward for 
further investigations in to whether the amber suppression technology could be 
used to modulate the phenotype of a bacterial cell. 
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Figure 59.  Motility assays investigating the ability of the plasmids pFDFliC and pFDFLIC239TAG to restore motility to KAF95.  The non-motile strain KAF95 was transformed with 
either pFDFliC or pFDFliC239TAG.  Colonies were picked and used to inoculate LB cultures., a 1 µl drop of the saturated liquid cultures were used to inoculate 0.3 % motility assay 
plate (9 cm diameter).  A motility assay inoculated with untransformed KAF95 was also performed.  Photos were taken at specified timepoints. 
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Figure 60.  Motility assays investigating the ability of the plasmids pFDFliC and pFDFLIC239TAG to restore motility to Keio..   The non-motile strain Keio was transformed with 
either pFDFliC or pFDFliC239TAG.  Colonies were picked and used to inoculate LB cultures., a 1 µl drop of the saturated liquid cultures were used to inoculate 0.3 % motility assay 
plate (9 cm diameter).  A motility assay inoculated with untransformed Keio was also performed.  Photos were taken at specified timepoints. 
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4.2.4.4 Investigations into the control of motility via amber suppression 
technology  
To investigate whether the amber suppression technology could be used to control 
the motility phenotype of the E. coli cultures, the pFDFliC239TAG construct was co-
transformed into the non-motile strains with one of the NAA-RS-encoding plasmids.  
The pAAazRS, pSUPiodoRS and pDULEazRS plasmids, all encoded a NAA-specific 
aaRS (iodoF or azF) and tRNA   
   
, which provided the machinery for amber 
suppression and incorporation of NAA into protein. 
Despite the utilisation of different aaRS/tRNA constructs, NAA used and position of 
TAG mutation within FliC, in each case the same result was obtained; KAF95 
remained motile despite the absence of NAA (Figure 61) and motility could not be 
restored to the Keio strain in the presence of NAA (Figure 62).  It was thought that 
possibly the truncated protein produced by the low efficiency of NAA incorporation 
was blocking the formation of functional NAA-containing full-length flagella.  
Therefore a construct harbouring a TAG mutation at Ile4TAG was created, plasmid 
pFDFliC4TAG.  It was shown that this construct was unable to restore motility to 
KAF95 or Keio strains when introduced with a NAA-RS-containing plasmid.  
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Figure 61.  Motility assay of KAF95 co-transformed with either pFDFliC4TAG, pFDFliC239TAG or pFDFliC318TAG and either pSUPiodoRS, pAAazRS or pDULEazRS.  Colonies were 
picked, grown to saturation in media either with or without NAA, and used to inoculate a 0.3 % agar motility assay plate (9 cm diameter) either with or without NAA. 
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Figure 62.  Motility assay of KAF95 co-transformed with either pFDFliC4TAG, pFDFliC239TAG or pFDFliC318TAG and either pSUPiodoRS, pAAazRS or pDULEazRS.  Colonies were 
picked, grown to saturation in media either with or without NAA, and used to inoculate a 0.3 % agar motility assay plate (9 cm diameter) either with or without NAA. 
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4.3 Discussion 
4.3.1 FliC gene is required for motility of E. coli 
The motility assay, utilising 0.3 % agar plates (Kondoh and Ozeki 1976) was shown 
to be useful in the elucidation of the motility of E. coli.  Motile cells, namely E. coli 
strain BL21(DE3), were shown to be motile due to the presence of a halo of 
swimming cells radiating out from an inoculation point on a 0.3 % agar motility 
assay plates.  This halo was not present in the E. coli strains containing no FliC gene, 
Keio, and mutant FliC gene, KAF95.  The Keio and KAF95 strains were therefore 
used in experiments to restore motility via plasmid encoded FliC. 
4.3.2 Plasmids encoding FliC 
A variety of plasmid constructs were created that encoded FliC in attempt to 
restore motility to the non-motile strains.  The failure of the plasmids pAAFliC and 
pQE60FliC to restore motility to non-motile strains indicated that plasmid 
construction was important for expression of functional flagellin.  Although the use 
of a T5 promoter should have allowed expression of protein within any E. coli strain 
via use of the endogenous RNA polymerase, it was possible that in this instance its 
use to control expression of flagellin was not ideal.  The pAA plasmid has previously 
been shown to express protein (pAAazRS; within Chapter 3) and pQE60 was 
commercially available, therefore a more specific issue was considered.  Possible 
explanations include that protein was not expressed from these plasmids; it was 
possible that the plasmids could overexpress protein, but cells could not export or 
form functional flagella using this expressed protein.  This could be due to 
overexpression of flagellin, that blocks the export mechanism, or that the cell does 
not recognise the protein as WT flagellin and therefore was unable to export the 
protein or form functional flagella.  It is possible that flagellin was expressed, 
flagella were produced, but these flagella were non-functional or too few formed 
for the cells to swim.  Isolating overexpressed protein using these constructs could 
determine whether protein was, in fact, being expressed.  
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However, the use of exogenous promoters to express flagellin protein within E. coli 
has been shown to be possible.  Lu et al (1995) produced flagellin monomers from a 
bacteriophage λ pL promoter that were exported to the cell surface and shown to 
form partially functional flagella (not WT motility due to insertion of thioredoxin) as 
determined by observing rotation of tethered cell to a microscope slide.  Goudarzi 
et al (2009) have also expressed flagellin using an exogenous promoter on a pET 
plasmid (T7 polymerase).  However, the flagellin was overexpressed and purified 
and therefore, whether functional flagella were formed was not ascertained.  
pFDFliC, with the natural FliC promoter and terminator, was able to restore motility 
to both non-motile strains.  This result was as anticipated and reinforced the idea 
that the exogenous promoters within pAAFliC and pQE60FliC were responsible for 
the failure of previous attempts to restore motility to non-motile strains via 
plasmid-encoded FliC.  The use of the natural promoter allowed the formation of 
flagellin and production of flagella in response to cognate signalling.  This may have 
explained why this construct produced functional flagella whereas the other 
constructs had not.   
It has been introduced in Chapter 1 that flagellin monomers are exported from the 
cytoplasm to the polymerisation point on the flagella via a flagellum-specific 
pathway (Type III) with the export signal being present within the N-terminal 
portion of the flagellin protein itself.  Therefore, it can be supposed that the export 
signal for flagellin would have been present regardless of plasmid construction.  
However, if not intact within the plasmids harbouring exogenous promoters this 
could explain why these plasmids were unable to restore motility to the non-motile 
strains.  For the pFD plasmids, utilising the natural FliC 5’ and 3’ DNA sequence of 
the gene, should have provided any signal sequence if not present within the 
expressed protein.  This construct was shown to produce functional WT flagella and 
this provides evidence that the export machinery within the cells was functional.  
This suggests that the issue with restoring motility to non-motile E. coli under the 
control of NAA technology was the non incorporation of NAA itself. 
190 
 
4.3.3 KAF95 could not be used to modulate motility via amber 
suppression 
The production of the non-flagellate KAF strain was due to ethyl methanesulfonate 
mutagenesis of the FliC gene (Berg and Turner 1993).  This is a position-non-specific 
chemical mutagenesis and therefore produces non-defined mutations within the 
genome (for review see Sega 1984).  The KAF95 strain was therefore not ideal for 
genetic manipulation using plasmid technologies.  This inactivation, and not 
deletion of FliC, could explain some of the unexpected data produced using 
plasmid-encoded FliC. 
The use of KAF95 was initially promising as introduction of FliC encoded on the 
pFDFliC plasmid restored motility to the strain.  However, when pFDFliC239TAG was 
introduced into the KAF95 cells, motility was still restored.  This was not as 
anticipated because full-length flagellin protein and therefore functional flagella 
should not have been expressed.  A likely explanation for this is that incorporation 
of natural amino acid at position 239 had occurred, typically Tyr, which allowed 
read-through of the entire FliC gene and production of functional protein (Nehring 
et al. 2012).  This may be possible without the presence of NAA-RS or tRNA   
   
- 
containing plasmid utilising the endogenous system entirely.  Previous work within 
Chapter 3 of this Thesis has shown that incorporation of natural amino acid in 
response to the TAG codon is low due to the orthogonal nature of the Mj NAA-
machinery; however, if any incorporation of natural amino acid has occurred, 
functional full-length flagellin would be produced.  It could be argued that a 
sufficient amount of flagellin was produced and that functional flagella were 
formed.  However, because the pFDFliC239TAG construct did not confer motility to 
the Keio cells other reasons are considered. 
It was possible that full-length flagellin was produced as combination of the two 
aberrant FliC genes; some portion from the plasmid-encoded flagellin and the other 
from the inactivated endogenous FliC.  It is also possible that during the 
transformation or motility assay process a motile strain had been selected from a 
mixed population or that spontaneous reversion of the mutation had occurred 
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rendering the cell motile once again (Armstrong et al. 1967; Lu et al. 1995).  The 
presence of unequal motility rings on the motility assay plates inoculated with 
KAF95 (Figure 61) suggested that the population of cells was heterogeneous (i.e. 
cells had different propensity to swim).  Also to note was that the KAF strain has no 
selection marker and therefore any contamination of the growth media with 
bacteria displaying WT-like motility would skew the results.  The fact that when the 
pFDFliC239TAG plasmid was introduced into the Keio strain, the cells remained 
non-motile reinforced the supposition that it was in fact the FliC inactivation within 
the KAF strain which had somehow caused the aberrant results when introducing 
the FliC-TAG encoding plasmid. 
When amber suppression technology was attempted in the KAF95 strain motility 
was observed when NAA was absent or present in the media.  Interestingly, the 
addition of NAA appeared to reduce the motility observed when compared to when 
NAA was absent.  This could be due to toxicity of the NAA which retarded culture 
growth either in liquid culture or during swim assay.  Possibly, the incorporation of 
NAA at UAGs found at the termination of endogenous genes had reduced cell 
growth. 
Due to these considerations, the results using the KAF95 strain cannot be 
considered with any certainty. 
4.3.4 Keio had the potential to be used to modulate motility via 
amber suppression 
The Keio strain had an entire FliC deletion and insertion of kanamycin resistance 
gene in place, which had two benefits.  Firstly, the entire deletion of FliC provided a 
FliC deficient background in which results were more easily interpreted.  More 
specifically, it could be ascertained more easily whether the plasmid encoded FliC 
was responsible for restoration of motility.  Secondly, the resistance to kanamycin 
supplied within the growth media and swim plates helped to reduce the possibility 
that contamination of the culture was responsible for the motility observed.   
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The ability to insert plasmid-encoded FliC, via transformation, into this FliC 
knockout background meant that the FliC gene could easily be mutated prior to 
transformation.  Also important was that the flagella would be entirely created 
from mutant flagellin derived from FliC.  This is important in showing the motility 
phenotype of the cells is due to the plasmid-encoded FliC. 
Motility assays demonstrated that introduction of WT FliC, via plasmid pFDFliC, 
restored motility to Keio.  Therefore Keio was selected for further analysis using 
amber suppression technology. 
4.3.5 Implementation of amber suppression technology 
When the TAG-containing FliC gene construct (pFDFliC239TAG) was introduced into 
the Keio strain, the outcome was as anticipated.  Namely, the cessation of 
restoration of motility to the cells.  Therefore, the Keio strain, in combination with 
plasmid pFDFliC239TAG was selected to implement amber suppression technology 
in order to try to restore motility to the non-motile strain.  However, when the 
orthogonal tRNA   
   
 and NAA-RS-containing plasmids, along with NAA, were 
introduced into the Keio cells, motility could not be restored.  This result suggested 
that the technology to incorporate NAA was non-functioning in the Keio cells.  
There are numerous suggestions as to why motility was not restored and these will 
be considered.  
Three different plasmids were used in combination with pFDFliCTAG plasmids, 
namely pAAazRS, pSUPiodoRS and pDULEazRS.  The use of different RSs developed 
to incorporate different NAAs allowed use of both iodoF and azF NAAs.  This 
allowed investigations into whether the efficiency of uptake or incorporation of the 
NAA would affect the ability to produce function protein and therefore phenotype.  
However, neither RSs, tRNAs or NAA increased the ability to restore motility to 
Keio.  Although these plasmids and NAAs have been used for amber suppression in 
E. coli, the use of specialist cell strains has not been investigated.  Although 
differences in amber suppression efficiency have been noted between certain E. 
coli strains (O’Donoghue et al. 2012). 
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The incorporation of NAA could have perturbed the structure of flagellin so no 
functional flagella could be produced, however the position of incorporation of NAA 
was considered.  The position initially chosen (codon 239) was within the variable 
region of flagellin, where variations are tolerated, and, in fact, entire protein 
insertions have been successfully performed and functional flagella produced (Lu et 
al. 1995).  Also taken into account was that the chosen site was exposed to the 
solvent (Figure 58) and not crucial in structural integrity of the flagellin protein.  To 
investigate whether the position of the incorporation of the NAA affected the 
folding or the ability of the protein to form functional flagella, three positions 
within the FliC gene were mutated to TAG.  Positions Ile4TAG, Gly239TAG and 
318TAG were used.  It appeared that position of NAA incorporation had no effect 
on the application. 
The efficiency of incorporation of NAA could have been so low that an excess of 
flagellin truncates were produced.  If truncated protein were to accumulate, this 
could block the export machinery and hinder formation of functional flagella.  
However, the use of the pFDFliC4TAG construct provided evidence that truncated 
protein was not responsible because the three amino acid long truncate produced 
with this system should not have been long enough to block any export machinery.  
Due to the reduced efficiency of protein expression during amber suppression, it is 
possible that this limited the production of functional flagellin and therefore not 
enough flagella were produced to restore motility to the non-motile cells.  Higher 
concentrations of NAA could be utilised to investigate whether the presence of NAA 
was limiting protein production.  However, previous work has shown that 2 mM 
NAA (as used in experiments) does not limit protein expression (Antonczak 2012 
Thesis).  
Salmonella typhimurium cells present one flagellum on their cell surface and have 
previously been used for bacterial motility analysis (Aizawa et al. 1990; Homma et 
al. 1987a; Homma et al. 1987b; Jones et al. 1989; Muramoto et al. 1999; Rosqvist et 
al. ; Yoshioka et al. 1995).  If production of protein had limited the use of this 
application, using Salmonella would be beneficial because less NAA-containing 
flagellin would be required to restore motility. 
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The use of motility assay plate to determine restoration of motility requires that 
protein expression was high enough to produce functional flagella, and enough cells 
within the population were capable of creating a large enough response to move 
away from the inoculation point of the agar plate.  Although motility plates were 
chosen as a simple assay for motility, the use of high magnification or electron 
microscopy could be used to visualise cells to ascertain ability to swim or the 
presence of flagella respectively.  The use of microscopy to monitor motility of 
single cells would allow observation of slight movements if flagella production was 
low or motility limited. 
Implementation of amber suppression to incorporate NAA into FliC required the 
presence of two plasmids within the cell.  Both are required for the successful 
implementation of amber suppression.  These were selected for using antibiotics.  
At each step of the motility assay, fresh antibiotics were used.  However, after a 
certain time on the motility assay plate the cells could have lost either of the 
plasmids during replication and created satellite colonies, which would be unable to 
produce full-length flagellin (Sambrook et al. 1989).  The presence of the 
pFDFliC239TAG plasmid was selected for using carbenicillin and although this 
antibiotic is more stable and less quickly broken down by β-lactamase enzyme 
(produced by the E. coli harbouring plasmid) than ampicillin, it is possible that 
secretion of β-lactamase into the surrounding agar could provide a habitat where E. 
coli not containing pFDFliC239TAG could grow.  To circumvent this problem, a one 
plasmid system harbouring the target gene, the synthetase and tRNA would be 
beneficial.  Although the formation of satellite colonies and loss of the plasmid 
could still occur, using a one plasmid system, it may be reduced.  It also may be 
possible to reduce its occurrence by choosing a bactericidal antibiotic as a selection 
agent. 
Production of a FliC-GFP fusion construct could have provided a mechanism to try 
to visualise the production of full-length protein.  Although the presence of the GFP 
would probably perturb formation of functional flagella, it would allow simple 
visualisation of whether full-length NAA-containing protein was being expressed. 
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4.3.5.1 Improving amber suppression 
The function of orthogonal aaRSs are important in achieving fidelity of amino acid 
incorporation, however these are just one of several components that contribute to 
the overall efficiency.  In order to improve the efficiency of amber suppression, the 
effect certain factors involved in translation have on the efficiency of NAA 
incorporation have been considered.  As mentioned in Chapter 1, release factor 1 
(RF-1) is the only molecule that ultimately terminates protein synthesis due to 
recognition of the UAG codon, therefore this posed a possible target.  Short 3rd et al 
(1999) examined the effect of RF-1 during incorporation of NAAs.  The group 
demonstrated that the incorporation of NAA in response to UAG was increased 
when in vitro translation using E. coli extracts containing partially deactivated RF-1 
was used.  This effect was especially noted for NAA exhibiting low incorporation 
efficiency.  Sakamoto and co-workers furthered this work by creating a conditional 
knockout of RF-1 in E. coli (Mukai et al. 2010a; Ohtake et al. 2012).  Using this RF-1 
deficient strain the group successfully reassigned the UAG stop codon to a universal 
sense codon.  A similar approach by Johnson et al (2011) demonstrated that 
knockout of RF-1 allowed incorporation of NAA at multiple sites within a gene.  
The work performed by Rackham and Chin (2005) and Wang et al (2007a) sought to 
develop an orthogonal ribosome that functions to incorporate NAA in response to 
UAG codons via orthogonal aaRS/tRNA systems which functions alongside the 
cognate ribosome/translation.  Wang et al’s orthogonal ribosome, ribo-X, was 
shown to increase the efficiency of site-specific NAA incorporation from ~20 % to 
>60 % using a single amber codon and from <1 % to >20 % for two amber codons 
within a gene.  It was hypothesised that the decreased recognition of RF-1 by ribo-X 
accounted for the increase in NAA incorporation efficiency. 
The elongation factor Tu (EF-Tu) exhibits reduced binding efficiency for tRNAs 
aminoacylated with large aromatic amino acids (Hohsaka et al. 1999; Nakata et al. 
2006).  This reduced binding efficiency suppresses the delivery of NAA-tRNA in to 
the ribosome and also shortens its lifetime due to spontaneous ester hydrolysis and 
this leads to inefficient incorporation into peptide.  To address this inefficiency, 
Ohtsuki, Sisido and coworkers have created EF-Tu mutants that drastically 
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improved the efficiency of incorporation of large aromatic NAA for example, 1-
pyrenylalanine and 2-anthraquinonylalanine (Doi et al. 2007; Ohtsuki et al. 2010).  
The E215A and D216 mutations appeared to enlarge the aa-tRNA binding pocket 
and remove unwanted contacts between EF-Tu and the large-NAA-tRNAs.  
Using the improved systems outlined above, or investigating possible new targets 
within the translation machinery, the efficiency of NAA incorporation could be 
improved and may prove beneficial in the application discussed within this chapter. 
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4.4 Conclusion 
The basis for creating a read-out system for controlling the motility of an E. coli cell 
has been created.  Restoration of motility via plasmid-encoded FliC has been shown 
to be possible using the non-motile strain, Keio.  However complexities regarding 
the implementation of amber suppression in order to control this motility via the 
presence/absence of NAA limited the functionality of this readout system.  More 
detailed investigations into whether full-length NAA-containing protein was being 
expressed or functional flagella produced could aid in uncovering the specific issues 
with this application. 
The use of another readout system, one that does not involve such complex protein 
export, quaternary structure or large amounts of NAA-containing protein could still 
be used to control cellular phenotype via presence of NAA using amber 
suppression. 
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5 CHAPTER 5.  DEVELOPMENT OF A 
FUNCTIONAL MAMMALIAN CELL READ OUT 
SYSTEM 
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5.1 Introduction 
As described in Chapter 4 using a prokaryotic system, the second novel application 
of amber suppression explored within this Thesis is the creation of a biological 
switch controllable by the presence of NAA.  This, and the following chapter seek to 
develop this application using a eukaryotic system.  The creation of a eukaryotic 
cellular readout system is described within this Chapter and the application of 
amber suppression technology utilising this readout system is described within 
Chapter 6. 
The creation of a novel way to control eukaryotic phenotype has interesting 
applications.  In theory this technology could be used to control the production of 
any protein and therefore provides control over display of the phenotype conferred 
by the target protein.  This could include the production of a therapeutic protein, 
the levels of which could be tuned to provide optimal concentrations by varying 
NAA concentration or efficiency of aaRS charging or NAA incorporation.  The 
ultimate goal would be to produce a self regulating mechanism where a negative 
feedback system can limit the over expression of target protein.  This could be 
achieved by NAA-directed proteolysis which cleaves NAA-protein at high 
concentrations, releasing NAA for re-incorporation when protein levels are low.  
However, for a proof-of-principle application within this thesis, the modulation of 
eukaryotic motility was chosen.  
For this novel application of the amber suppression technology, a mammalian 
cellular readout was required that could be easily assayed.  Cellular motility was 
chosen as the specific phenotype to modulate as this can be easily and reproducibly 
monitored and assessed utilising live cell imaging.  As part of the amber suppression 
control pathway Rac1 was chosen as the target gene as this gene product is critical 
in cellular signalling, culminating in production of lamellipodia and subsequent 
motility of the cells (Nobes and Hall 1995).  As evidence of this, it has been reported 
that knockout of Rac1 results in reduced ability to produce membrane ruffles and 
lamellipodia and aberrant cell migration which is clearly discernible form the Rac1-
wild type control (Guo et al. 2006; Monypenny et al. 2009; Vidali et al. 2006).  
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Therefore, the aim of this chapter was to develop this cellular readout system in 
controlling the expression of RAC1 and in turn control the phenotype of a 
mammalian cell. 
Specifically, the investigations presented within this chapter sought to: 
 Establish that there were differences in motility between the Rac1 KO cell 
line and Rac1 control fibroblasts. 
 Investigate whether plasmid-encoded Rac1 could restore motility to Rac1 
KO cells, via transient and stable transfection. 
Firstly, the morphological characteristics and growth of the previously created Rac1 
control and KO Rac1 fibroblast cell lines were evaluated.  Utilising these cell lines, it 
was investigated whether scratch wound assays in conjunction with timelapse 
microscopy could be utilised to monitor the differences in migratory abilities of the 
two cell lines.  The requirements of Rac1 for cellular migration was then 
investigated utilising these methods.  Secondly, the re-introduction of Rac1 via 
plasmid was investigated.  These investigations included optimisation of the 
transient transfection process utilising two GFP tagged Rac1 constructs, in 
conjunction with fluorescent microscopy.  Stably expressing cell lines were also 
created utilising a third plasmid construct, harbouring a selection marker.  The 
evaluation of motility restoration was investigated by quantitative analysis of 
scratch wound closure and individual cellular movement utilising fluorescent 
timelapse microscopy. 
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5.2 Materials and methods 
5.2.1 Tissue culture plastic 
All tissue culture plastic was obtained from Sarstedt.  24 well plates used for 
timelapse microscopy were obtained from BD Biosciences, Oxford.  
5.2.2 Instruments 
A Leica AF 6000 live cell imaging confocal laser scanning microscope was utilised for 
timelapse and fluorescent microscopy.  The microscope was equipped with a BOX 
and CUBE2 temperature control system, a BRICK gas mixer (Life Imagine Services), a 
Leica CTR6500 electronics box (Leica) and an ebq100 powered UV box. 
A BioDoc-It® Imaging System (UVP) was used to capture agarose gel images. 
A Panasonic DMC-G1 camera was used to capture brightfield images. 
5.2.3 Software 
The Leica Application suite was used to capture images using the Leica AF 6000 live 
cell imaging confocal laser scanning microscope.  
ImageJ was used to create and analyse images (Java 1.6.0_20, 64-bit, Wayne 
Rasband, National Institutes of Health, USA).  Analysis included using the tools and 
plugins as indicated in the text. 
Data collection and analysis was performed using Microsoft Excel.  
5.2.4 Molecular biology 
Molecular biology was performed as defined in Chapter 2.  Details of plasmids can 
be found in Appendix A1.  Details of Primers can be found in Appendix A2. 
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5.2.5 Mammalian Cell Culture 
5.2.5.1 Cell lines 
Rac1 knockout (Rac1 KO) and Rac1 control fibroblasts were a kind gift from Dr 
Klemens Rottner (Institute of Genetics, University of Bonn).  Human Embryonic 
Kidney (HEK) 293 cells were a kind gift from Lea Bauer (Dr Vera Knauper’s group, 
School of Dentistry, Cardiff University). 
5.2.5.2 Media 
All tissue culture media was obtained from Invitrogen.  Various media were used as 
specified in Table 13.  Media was prepared as needed, stored at 4 °C and pre-
warmed using a water bath at 37 °C prior to use. 
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Table 13.  Mammalian tissue culture media 
Media name Base Additives Use 
Growth media DMEM 41965 
high glucose 
L-glutamine 
(580 mg / L) 
Phenol red 
10 % (v/v) heat inactivated 
foetal bovine serum (FBS) 
1 % (v/v) nonessential amino 
acids  
1 mM sodium pyruvate 
Routine culture 
of Rac1 KO, 
control 
fibroblasts and 
HEK293 
Transfection 
media 
DMEM 41965 
high glucose   
L-glutamine  
Phenol red 
10 % FBS 
1 mM sodium pyruvate 
At transfection 
Selection media DMEM 41965  
high glucose   
L-glutamine  
Phenol red 
10 % FBS 
1 % nonessential amino acids  
1 mM sodium pyruvate 
100 µg/ml Zeocin 
For selection of 
Rac1 KO stable 
colonies 
Maintenance 
media for stably 
transfected cells  
DMEM 41965  
high glucose   
L-glutamine  
Phenol red 
10 % FBS 
1 % nonessential amino acids  
1 mM sodium pyruvate 
50 µg/ml Zeocin™ 
Maintenance 
media for stably 
transfected 
cells 
Phenol red free DMEM 21063 
high glucose   
L-glutamine  
10 % FBS 
1 % nonessential amino acids  
1 mM sodium pyruvate 
Viewing GFP 
positive cells 
Opti-MEM™ MEM 11058  Transfection 
complex 
formation 
Freezing media HI-FBS 10 % DMSO Resuspension of 
cells for 
cryostorage 
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5.2.5.3 Recovery from cryostorage 
The cells were recovered from cryostorage by thawing rapidly at 37 °C.  The cells 
were added to approximately 10 ml of pre-warmed (37 °C) growth media and 
pelleted by centrifugation at 600 x g for 5 minutes (room temperature).  The 
supernatant was discarded and the cells resuspended in approximately 10 ml 
growth media.  A cell count and viability assay by trypan blue exclusion was 
performed in conjunction with a Neubauer counting chamber and 1 x 106 cells were 
added to a T75 flask.  Cultures were incubated at 37 °C in a humidified 
5 % CO2/95 % air atmosphere.  
5.2.5.4 Cell sub-culture 
Every other day or at approximately 90% confluence, the cells were sub-cultured by 
decanting the media, washing in 10 ml Phosphate buffered saline (PBS) (which was 
subsequently removed) and then incubating the cells with 1 ml of Trypsin solution 
(0.05 % (w/v) trypsin, 0.53 mM EDTA) at 37 °C for 5 minutes.  The cells were 
dislodged by gentle tapping and then suspended in 10 ml growth media.  Cells were 
pelleted by centrifugation at 600 x g for 5 minutes (room temperature).  A viable 
cell count was performed using trypan blue exclusion in conjunction with a 
Neubauer counting chamber.  1 x 106 cells were used to inoculate a sterile T75 flask 
containing approximately 10 ml growth media.  Cultures were regularly tested for 
mycoplasma infection using the in-house service (School of Dentistry, Cardiff 
University).  Only mycoplasma negative cells were utilised in experiments. 
5.2.5.5 Preparation of cells for cryostorage 
At intervals, aliquots of pelleted cells were resuspended in freezing media (Table 
13) transferred into labelled cryovials and frozen by placing them in a Mr Frosty 
(Nalgene; containing isopropyl alcohol), which was then placed at -80 °C.  After 
approximately 24 hours, the cryovials were moved to liquid nitrogen for long-term 
storage.  
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5.2.5.6 Cellular Transfection  
Tissue culture multi-well plates (BD) were seeded with a specified cell number per 
well.  During a typical transfection, a 24 well plate was used and seeded with 
4 x 104 cells /well.  The multi-well plates were then incubated overnight at 37 °C 
with 5 % CO2 /95% air (humidified).  The following day the media was removed, the 
wells washed with PBS and transfection media (Table 13) added. 
Lipofectamine 2000 (Invitrogen) or FugeneHD (Roche, Promega) were utilised for 
transfection of cells.  The reagents were stored at 4 °C and used following the 
manufacturers’ protocols.  Typically, Lipofectamine 2000 (2 : 1 
(Lipofectamine : DNA ratio)) and DNA (1 µg / well) were independently diluted in 
OptiMEM media.  After 5 minutes, the diluted Lipofectamine and DNA were mixed 
and incubated for 20 minutes to allow for the formation of complexes.  The solution 
containing complexes was mixed by pipette and aliquots added to wells containing 
cells accordingly. 
For a typical transfection using FugeneHD, DNA (1 µg / well) was added to 
Optimem, followed by Fugene reagent (typically 3 : 1 or 3.5 : 1 ratio Fugene : DNA).  
The solution was incubated for 5, 10 or 15 minutes and then this solution 
containing complexes was mixed by pipette and aliquots added to wells containing 
cells accordingly. 
5.2.5.7 Creation of monolayer scratch wound 
The in vitro scratch wound model assays were performed as described previously 
(Stephens et al. 2004).  Twenty-four well plates were seeded with cells, as 
described above (4 x 104 / well), and allowed to reach 95 % confluency over a 
period of 24 hours.  The monolayers were scratch wounded by scoring through the 
centre of the confluent monolayer with a 200 µl pipette tip either (a) immediately 
before transfection or (b) the day following transfection.  Following scratch 
wounding the wells were washed twice with PBS and 1 ml growth media or 500 µl 
transfection media was added. 
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5.2.5.8 Stable selection 
Zeocin™ antibiotic, a member of the glycopeptide bleomycin antibiotic family, was 
utilised for cell selection.  It was defrosted on ice, diluted in growth media to the 
required concentration and added to the cells.  
5.2.5.9 Creation of stable cell lines 
To create stably transfected cell lines, 1 µg DNA per 2 cm2 tissue culture plastic was 
used to transfect cells plated the previous day at an initial cell seeding of 4 x 104 per 
well of a 24 well plate.  A DNA to Fugene ratio of 3.5 : 1 and a complex formation 
time of 5 minutes (room temperature) was utilised (as determined using results 
obtained during the chapter).  Complexes were added to the well and were 
incubated overnight.  The following day, the cells were removed from the plate by 
trypsinisation, diluted in growth medium and re-plated into, typically, 2 x 6 well 
plates.  This was to obtain clones derived from one cell and allow easy picking of 
these clones.  The following day, the growth medium was removed, the wells 
washed with PBS and selection media added (Growth media + 100 µg / ml Zeocin; 
Table 13).  The selection media was removed as required, typically every other day, 
the wells washed with PBS twice and fresh selection media added.  This was 
repeated until identifiable individual colonies were growing, this was typically 
approximately 1 - 2 weeks.  The plates were then viewed using fluorescent 
microscopy and the GFP-positive colonies marked. 
5.2.5.9.1 Picking GFP-positive stably transfected colonies 
After the GFP-positive colonies were marked, the media was removed from the 
well, followed by PBS wash.  Cloning rings were created using cut and autoclaved 
200 L tips.  These cloning rings were placed over the marked colonies using high 
vacuum grease (Dow Corning) to create a seal.  Trypsin (0.05 %; 50 – 100 µl) was 
pipetted into the cloning ring and left on the cells until the cells were rounded and 
starting to come off the well plate (approximately 5 minutes).  The cells were 
resuspended in the trypsin, then pipetted into clean wells of a 24 well plate 
containing fresh stable colony maintenance medium (Table 13).  The cloning ring 
was washed with medium to collect any remaining cells.  The maintenance medium 
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was replaced as necessary and the colonies were expanded.  Aliquots were 
prepared for cryostorage as described above and cells were used in subsequent 
experiments.  Cells were monitored for GFP-positivity throughout growth, using 
fluorescence microscopy. 
5.2.5.10 Live Cell Imaging 
A Leica AF6000 microscope was used to monitor the scratch wounds in real time.  
The inverted microscope was held within a chamber that allowed conditions to be 
controlled for cell growth.  The chamber was pre-warmed to, and maintained 
throughout experiments at, 37 °C, with 5 % CO2 /95 % air (humidified).  A 10 x 
magnification was used throughout timelapse. 
Typically, positions in each well were chosen, and images taken every 15 minutes 
for 48 hours.  For transfected cells, both brightfield and GFP fluorescence was 
monitored.  
5.2.5.11 RNA extraction 
All steps using RNA were performed at a designated “RNA only” lab bench, using 
“RNA only” reagents and plasticware.  In between each step, the RNA-containing 
solutions were kept on ice.  Centrifugation steps were performed at 4 °C. 
Cells for RNA extraction were disrupted using TRIzol® Reagent (Invitrogen) typically 
with 1 ml TRIzol per approximately 1 x 106 cells.  After incubation (approximately 
5 minutes), the cells were scraped from the tissue culture plastic and the 
suspension collected into an eppendorf and frozen at -80 °C overnight or until 
required.  The samples were defrosted and phase separation was performed by 
adding 200 µl chloroform per 1 ml TRIzol®, the solutions were mixed by inverting 
the tube several times and incubated for 3 minutes (RT).  A phase lock gel tube 
(PLG; Eppendorf) was pelleted by microcentrifugation at 12,000 x g for 30 seconds.  
The TRIzol®/chloroform mixture was added to the PLG, mixed by inverting and then 
subjected to centrifugation at 12,000 x g for 5 minutes.  The RNA-containing 
aqueous upper phase was removed by pipette into a fresh tube.  500 µl isopropanol 
was added to the RNA-containing aqueous phase, mixed by inverting and left at -
20 °C overnight for the RNA to precipitate.  The RNA was pelleted by centrifugation 
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at 12,000 × g for 10 minutes, the supernatant was decanted and the pellet washed 
using ice-cold 75 % ethanol, flicking the tube to remove pelleted RNA from the tube 
wall.  RNA was re-pelleted by centrifugation at 7500 × g for 5 minutes.  The ethanol 
was removed and the pellet left to air dry for < 1 hour.  The RNA was resuspended 
in 50 µl Diethylpyrocarbonate (DEPC) treated H2O (ddH2O plus 0.1 % DEPC left 
overnight and autoclaved).  
5.2.5.11.1 DNase treatment 
Extracted RNA was subjected to DNase treatment (Promega).  A typical 50 µl 
reaction contained 1 x buffer, 40 U RNAsin inhibitor (Promega) and 1 U DNase.  The 
reactions were incubated at 37 °C for 15 minutes.  The RNA was then isolated from 
the reaction using an RNeasy Minelute cleanup kit (Qiagen), utilising the proprietary 
buffers provided.  Briefly, the samples were made up to 100 µl with DEPC water, 
350 μl Buffer RLT (containing guanidine isothiocyanate) supplemented with 10 μl β-
mercaptoethanol per 1 ml Buffer RLT was added to the sample; this promoted the 
selective binding of RNA to a silica-membrane RNeasy MinElute membrane.  250 μl 
ethanol was added to the diluted RNA and mixed.  RNA-mixture was then applied to 
a RNeasy MinElute membrane by centrifugation at ≥8000 x g for 30 seconds.  
Contaminants were removed by washing the column twice with 500 μl Buffer RPE 
and RNA was eluted in 20 µl DEPC water.  
5.2.5.11.2 Quantification of RNA 
RNA concentration was measured using a NanoVue (GE Healthcare).  260/280 ratios 
were monitored for purity.  RNA with values above 2 was used. 
5.2.5.12 Reverse transcription polymerase chain reaction (RT-PCR) 
5.2.5.12.1 cDNA synthesis 
First-strand cDNA synthesis was performed using recombinant Moloney murine 
leukaemia virus reverse transcriptase (MMLV-RT; Promega), random hexamer 
primers (Promega) and total RNA prepared from cells (as described above).  A 
typical reaction contained 0.5 µg RNA, 0.5 µl random hexamer primers (0.5 µg/µl) 
and DEPC water up to a volume of 6.5 µl. Reactions were incubated at 70 °C for 
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5 minutes, then ice for 5 minutes.  20 U RNAsin, 1 x MMLV buffer (50 mM Tris-HCl 
(pH 8.3 @ 25 °C), 75 mM KCl, 3 mM MgCl2, 10 mM DTT), 2 mM dNTPs and 100 U 
MMLV RT were then added and a thermocycler used to cycle the reactions; 25 °C 
for 10 minutes, 42 °C for 60 minutes and 95 °C for 5 minutes. 
5.2.5.12.2 PCR amplification 
PCR reactions were performed using Platinum® Blue PCR Supermix (Invitrogen; 
22 U/mL complexed recombinant Taq DNA polymerase with Platinum® Taq 
Antibody, 22 mM Tris-HCl (pH 8.4), 55 mM KCl, 1.65 mM MgCl2, 220 μM dGTP, 
220 μM dATP, 220 μM dTTP, 220 μM dCTP, and stabilisers).  Amplification of β-
actin, using primers β-actin forward and reverse, was used as a housekeeping gene 
control, to check to integrity of the cDNA.  A typical reaction contained 20 µl 
Supermix, 200 nM forward primer, 200 nM reverse primer and 1 µl cDNA per 
reaction.  All PCR reactions were set up on ice.  To screen for Rac1 gene, primers 
racFP and racRP3 were used; to screen for azRS, primers EcTyrRS FP and EcTyrRS 
RP2 were used; to screen for Zeocin resistance gene primers zeoFP and zeoRP were 
used (see Appendix A2).  A thermocycler (UnoCycler, VWR) was used to cycle 
between temperatures as indicated in (Table 14).  Temperatures used for annealing 
were optimised for each primer combination.  
Agarose gel electrophoresis, as described in Chapter 2, was used to visualise PCR 
products.  Molecular weight was approximated by comparison to 100 bp ladder 
(Promega). 
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Table 14.  PCR parameters for Platinum PCR supermix 
Cycling step Temperature Time # of cycles 
Initial denaturation 94 °C 3 min 1 
Denaturation 94 °C 20 s 
30-40 Annealing 
β-actin   60 °C 
Rac 1   60 °C 
azRS   56 °C 
zeo    55 °C 
20 s 
Extension 72 °C 30 – 60 s 
Final extension 72 °C 5 - 10 min 1 
Hold 4 °C Indefinitely 1 
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5.2.6 Image Analysis  
5.2.6.1 Creation of merged image 
The brightfield channel and GFP fluorescence channel images of static and 
timelapse images were imported into ImageJ (Rasband 1997). The background of 
the GFP fluorescence channel was reduced using the Process…Reduce Background 
tool of ImageJ and then overlaid with the brightfield channel using the 
Image…Colour…Merge Channels tool.  
5.2.6.2 Calculation of transfection efficiency 
Approximately 24 hours post-transfection, a bright field and UV-fluorescence image 
was taken of the cells.  Transfection efficiency was calculated by counting the 
number of total number of GFP positive cells within the frame of the image and the 
percentage transfection efficiency calculated by dividing this GFP positive cell count 
by the total number of cells per frame.  Cell counting was performed using the 
analyze…cell counter tool in ImageJ.  Where the number of cells exceeded a 
number that could be accurately counted, transfection efficiency was reported as 
number of GFP positive cells per frame. 
5.2.6.3 Quantification of wound closure 
Quantification of wound closure was obtained by measuring the remaining wound 
area over the time course of the wound experiment by drawing a line following the 
wound edge and using the Measure tool to calculate the area (ImageJ).  The wound 
area was measured at specified timepoints throughout the 48 hour period and 
plotted.  The regression line was used to calculate rate of wound closure.  For those 
curves that followed a sigmoidal curve, the rate was obtained using those points 
that followed a straight line, the fastest rate for an experiment was always taken.  
This typically was the middle section of the graph.  The R2 value was used to 
establish whether the portions of the graph used were accurately fitted.  An R2 
value above 0.9 was accepted. 
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5.2.6.4 Quantification of the total distance moved and directionality of cells 
Quantification of the total distance, speed and direction moved by individual GFP 
positive cells was performed using the Manual Tracking plug-in of ImageJ.  The 
position of individual cells was monitored throughout the course of the timelapse 
experiment, plotting the position of the cell at every frame (i.e. every 15 or 
20 minutes).  The Measure tool was then used to measure the total distance for the 
cell. 
The directionality of the cell movement was visualised by plotting the cells’ 
trajectories, as measured using the Chemotaxis and Migration plug-in of ImageJ, on 
a circular graph, where the initial position of the cell is taken as position 0 , 0.  Using 
these data, the Chemotaxis and Migration plug-in was used to calculate average 
directionality of cells, as defined in Figure 63. 
 
5.2.7 Statistical analysis 
Statistical analyses were undertaken using Microsoft Excel.  Data were compared 
using a Student's t-test, and a one-way ANOVA used for group analysis.  Results 
were expressed as a mean average and standard deviation (S.D.).  All p values were 
two-tailed.  Statistical significance was considered at a probability of p ≤ 0.05.  To 
test that data was normally distributed and therefore could be subjected to these 
statistical tests, histograms were plotted using Excel. 
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Figure 63.  Calculation of directionality 
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5.3 Results 
5.3.1 Analysis of control and Rac1 KO cell lines 
5.3.1.1 Loss of Rac1 alters cell morphology and proliferation 
For the development and testing of the non natural amino acid technological 
application, a cell-based instant readout system was required; namely the ability to 
restore cell migration.  Specifically, a cell line was selected which had a gene 
knocked-out that was crucial for its motility which could then be re-introduced, 
encoded on a plasmid, to restore wild-type-like motility.  The mouse fibroblast cell 
line, Rac 1A pEGFP-N3_puro was utilised as a control (referred to as Rac1 control 
cells in subsequent text) and a Rac1 knockout (Rac1 KO) as the test cell population.  
Both cell lines were a kind gift from Klemens Rottner, University of Bonn. 
The two cell lines were regularly subcultured and population doublings determined 
in order to monitor the growth of these cells.  Whilst cell proliferation was observed 
for both cell lines, it was clear that the Rac1 control cells grew faster than the Rac1 
KO cell line (Figure 64A) 
Typically, the control cells were an evenly distributed size and shape, whereas the 
Rac1 KO cells were more varied (Figure 64B).  The control cell line was easily 
subcultured, and could be split to a low confluency.  The cells were able to become 
an evenly spread confluent monolayer of cells.  Unlike the control cells, the Rac1 KO 
cells tended to be more extended and did not form an evenly spread confluent 
monolayer of cells if the culture was initially seeded at low confluency.  Once 
divided, the daughter cells tended to remain attached to the parental cell.  This 
squashing could have caused some cell abnormalities or cell stress, therefore the 
Rac1 KO cell line was passaged every other day, maintaining a high seeding density, 
to reduce this effect. 
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Figure 64.  (A) Population doubling levels of control and Rac1 KO fibroblasts.  Cultures were 
routinely passaged and a cell count performed.  Population doubling was calculated and this was 
plotted against time. 
(B) Brightfield images of Rac1 control cells and Rac1 KO cells.  Scale bar represents 75 µm. 
A 
B 
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5.3.1.2 Optimisation of scratch wound assay 
Wells of a 24-well plate were inoculated with differing numbers of Rac1 KO cells 
using serial dilution (8x104, 4x104, 2x104, 1x104).  One day post-inoculation the 
plates were scratched and imaged to ascertain the confluency and therefore the 
suitability for scratch assay (Table 15, Figure 65).  For a successful scratch assay, it 
was shown that inoculating a well at 4x104 gave a cell monolayer at 80 % 
confluency one-day post-inoculation.  Scratching at this density provided optimal 
cell density to create a straight and complete scratch wound edge suitable for 
monitoring cellular motility via the rate of scratch wound repopulation.  
 
5.3.1.3 Normal cell migration is dependent on the expression of Rac1 
As the cell-based readout system required for future studies was centred on 
modulation of cell migration, firstly it was important to confirm that the Rac1 KO 
cells were in fact deficient in their ability to migrate.   
Rac1 control mouse fibroblasts were grown to approximately 80 % confluency, a 
scratch wound created and monitored by time-lapse microscopy (Figure 66, Movie 
1).  12 hours post wounding there was clear evidence of cell migration into the 
wound space.  Over the following 24 hours the remaining wound space was 
progressively diminished due to further cell migration and proliferation such that it 
was closed by 36 hours.  In contrast, for wounds made within the monolayer of 
Rac1 KO cells there was no evidence of independent cell migration (i.e. cells 
breaking free of the bulk cell population) over the entire time course of the 
experiment (Figure 66, Movie 2).  Furthermore, at all time points analysed, it was 
clear that the Rac1 KO wounds were much larger than the control wounds such that 
by 48 hours the Rac1 KO wounds had still not closed.  Some diminution of wound 
size was evident within Rac1 KO wounds presumably due to the contributions of 
cell proliferation at the edges of the wound.   
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Table 15.  Optimisation of scratch wound assay. 
Cell number 
at inoculation 
Confluency one-
day post-
inoculation 
Suitability for 
scratch assay 
Scratch assay outcome 
8x104 100 % 
Cells already 
overgrown 
Cells behind leading edge get very 
overconfluent 
4x104 80 % 
Good 
confluency 
Leading edge of wound is straight and 
complete and cell migration represents 
that of wound repopulation 
2x104 50 % Sub-confluent 
Scratch edge is not quite complete, 
resulting in uneven edge of wound 
1x104 20 % 
Cells too sparse 
to form even 
scratch 
Scratch edge is not complete, cells 
grow as colonies instead of migrating 
into wound area 
 
 
Figure 65 and Table 15.  Optimisation of scratch wound assay.  The number of cells used to 
inoculate wells of a 24-well plate was varied as indicated.  One day post-inoculation the plates were 
scratched and imaged to ascertain the confluency and therefore the suitability for scratch assay. 
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Figure 66.  Brightfield photos of scratch wounds created in Rac1 control cells and Rac1 KO cells, at 
indicated time points.  Coloured lines represent tracks moved by individual cells.  Scale bar (lower left 
corner) represents 75 µm. 
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5.3.1.4 Quantitative analysis of wound closure 
Quantitative analysis of the differences in wound closure was undertaken from 
time-related wound area measurements.  The data demonstrated that the rate of 
wound closure was significantly faster for scratch wounds created in Rac1 control 
cells than in Rac1 KO cells (p < 0.0001; Figure 67A). 
5.3.1.5 Quantitative analysis of motility of individual cells  
Furthermore, to determine deficiencies in cell migration at the cellular level, the 
Manual Tracking tool along with the Chemotaxis and Migration tool (ImageJ) was 
used to analyse the migration of individual cells throughout the 48 hour timelapse 
period.  The analysis demonstrated that the control cells migrated further than the 
Rac1 KO cells (p<0.0001; Figure 67B).  
The trajectories of a number of selected cells throughout the 48 hour timelapse 
microscopy period were plotted (Figure 68).  The Rac1 control fibroblasts clearly 
demonstrated tracks typical of directional movement (away from an overlaid 
common starting point) into the wound area post scratch.  Conversely, the Rac1 KO 
cell line demonstrated significantly reduced movement as evidenced by their 
limited track lengths.  However, the directionality of the movement shown by the 
control cells and Rac1 KO was similar (Figure 67C). 
These results clearly demonstrate that knockout of the Rac1 gene has a detrimental 
effect on cellular migration and thus such a cell line is a suitable system for the 
further investigations within the Thesis. 
220 
 
 
Figure 67.  Graphs showing (A) averages of rate of wound closure (n=3), (B) distance travelled by individual cells (n=35), (C) directionality of individual cells (n=35).  Scratch 
wounds were created in monolayers of either Rac1 control or KO cells.  Timelapse microscopy was used to monitor the cells over a 48 hour period.  Analysis of motility of 
individual cells was calculated using the Manual Tracking and Chemotaxis and Migration tool (ImageJ).  Mean average values for each condition was calculated and plotted.  Errors 
bars represent standard deviation. 
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Figure 68.  Trajectories of Rac1 Control and Rac1 KO mouse fibroblasts during scratch wound 
healing.  Scratch wound assays were performed in monolayers of Rac1 control and Rac1 KO cells and 
monitored by timelapse microscopy.  The trajectories of individual cells at the wound edge were 
followed using the manual tracking plugin and plotted using the Chemotaxis and Migration plugin of 
ImageJ.  All cell tracks were overlaid onto a common starting point for clarity. 
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5.3.2 Restoration of motility to Rac1 KO cells 
5.3.2.1 Plasmid constructs for transfection in to Rac1 KO cells 
The next aim of the investigation was to restore motility to Rac1 KO cells.  To do 
this plasmid constructs encoding Rac1 were required.  The previously created 
peGFP-Rac1-C2 plasmid (based on the commercially available plasmid peGFP-C2 
(Clontech); referred to as peGFPRac1 herein) was kindly donated by Prof. Klemens 
Rottner, University of Bonn.  The plasmid encoded a GFP-Rac1 fusion protein under 
the control of a strong constitutive CMV promoter, and terminating with a SV40 
polyA (Figure 70).  The GFP tag was used to visualise the expression of the target 
protein.   
5.3.2.2 Creation of peGFP plasmid for transfection into Rac1 KO cells 
The plasmid peGFP was required as a control to complement experiments using 
peGFPRac1.  Transfecting the cells with a plasmid not containing Rac1 (i.e. the 
peGFP) was an important control to (a) demonstrate transfection had successfully 
occurred and (b) that the GFP itself was not responsible for any alteration in cell 
motility. 
Plasmid peGFP was created by digesting peGFPRac1 with the restriction enzyme 
EcoRI-HF, sites of which flanked the inserted Rac1 gene (Figure 70).  The band 
corresponding to peGFP (4.7 kb) was extracted from a preparative agarose gel, the 
DNA purified and re-ligated.  Comparison of prepared DNA on an analytical agarose 
gel suggested that peGFP had been isolated (Figure 69).  The putative peGFP 
plasmid was smaller (4.7 Kb) than peGFPRac1 (5.3 Kb).  Sequencing confirmed the 
isolation of peGFP plasmid. 
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Figure 69.  peGFPRac1 (5.3 Kb) and peGFP (4.7 Kb) plasmid DNA was isolated and analysed by 
agarose gel electrophoresis.  The three bands reflect the three forms of DNA, supercoiled, nicked, 
relaxed (bottom to top).  MW ladder represents 1 Kb ladder (NEB). 
 
 
 
Figure 70.  Plasmid maps of peGFPRac1 and peGFP. 
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5.3.2.3 Introduction of plasmid-encoded Rac1 to Rac1 KO cells 
Experiments were performed to transiently transfect the Rac1 KO cell line with the 
plasmids peGFP and peGFPRac1.  In order to maximise any potential restoration of 
migration it was decided that a high transfection efficiency would be needed.  
Therefore, two commercially available transfection reagents (Lipofectamine2000 
[Invitrogen] and Fugene HD [Roche]) were utilised for optimisation of the 
transfection procedure. 
5.3.2.3.1 Optimisation of transfection conditions – Lipofectamine 2000 
Variables investigated included the amount of DNA added per well, the ratio of 
DNA : reagent and the cell confluency at transfection (Dalby et al. 2004).  The data 
demonstrated that using a DNA : Lipofectamine ratio 1 : 2, adding 1 µg DNA per 
well containing cells seeded at 6 x 104 / well of 24 well plate, gave the highest 
number of GFP positive cells (Figure 71).  Seeding the cells at 6 x 104 gave, not only 
the highest number of green cells, but also gave a useful cell confluency to perform 
the scratch assays approximately 24 hours post transfection (Figure 72). 
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Figure 71.  Graph comparing the transfection efficiency of transfecting Rac1 KO cells with the 
plasmid peGFPRac1 using Lipofectamine 2000 at varying ratios, 2 different DNA amounts and cell 
number per well.  Rac1 KO cells were seeded in a 24 well plate at either 6, 8 or 16 x 10
4
/well.  A day 
later, the cells were transiently transfected with the plasmid peGFPRac1 using Lipofectamine.  A day 
post transfection fluorescence microscopy was used to obtain images of the plates.  The number of 
GFP positive cells per frame was counted and plotted.  Error bars represent standard deviation of 
the mean of n= 3 repeats. 
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Figure 72.  Composite brightfield/fluorescent image showing representative GFP fluorescence at scratch wound area.  Rac1 KO cells were seeded at 6 x 10
4
 / well 1 day before 
transfection, cells were transfected with 1 µg peGFPRac1 plasmid using 2 µl Lipofectamine. 3 frames / well were taken, using brightfield and fluoroscent microscopy, and overlaid.  
Scale bar represents 75 µm. 
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5.3.2.3.2 Optimisation of transfection conditions – Fugene 
The formation of Fugene / DNA complexes was investigated.  The size of complex 
formed, and therefore the ability to penetrate the cell and effectiveness of DNA 
release into the cell may depend on the ratio and the time the complex was 
allowed to form.  Therefore, these variables were investigated.  It was shown that 
transfection efficiency increased as FugeneHD : DNA ratio increased up to a 
maximum transfection efficiency seen with a 3.5 : 1 Fugene : DNA ratio.  At a ratio 
of 4 : 1, the transfection efficiency was seen to decrease.  Ratios lower than 3 : 1 
appear ineffective at transfecting the fibroblast cells.  It was shown that the optimal 
time of complex formation using a ratio 3.5 : 1 was 5 minutes. 
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Figure 73.  Graph comparing transfection efficiency of complexes formed using different 
Fugene:DNA ratios and complex formation times.  Rac1 KO cells were seeded in a 24 well plate at 
either 4 x 10
4
/well.  A day later, the cells were transiently transfected with the plasmid peGFPRac1 
using FugeneHD.  A day post transfection fluorescence microscopy was used to obtain images of the 
plates.  The number of GFP positive cells per frame was counted and plotted.  Error bars represent 
standard deviation of the mean of n=3 repeats. 
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5.3.2.3.3 Comparison of Lipofectamine and Fugene transfection 
Transfections performed using FugeneHD were compared to those using 
Lipofectamine.  The previously optimised conditions for Lipofectamine 2000, 
namely 1 µg  DNA / well, ratio 1 : 2 (DNA : Lipofectamine 2000), were used.  Fugene 
was used at ratio 3.5 : 1, with 5 minute complex formation time.  Brightfield and 
fluorescent microscopy was utilised to analyse the number of GFP positive cells 
(Figure 74).  These data showed that although the Lipofectamine transfection gave 
higher number of GFP positive cells initially (p < 0.01), the number had decreased 
dramatically two days post transfection.  Transfections performed using Fugene 
gave lower initial transfection efficiencies, and although the number of GFP positive 
cells decreased after two days post transfection, this reduction was smaller 
compared to the reduction seen using Lipofectamine 2000.  After three days post-
transfection, the number of GFP-positive cells for transfection using 
Lipofectamine 2000 had again reduced drastically.  However, the number of GFP 
positive cells was maintained for transfections using FugeneHD.  Another issue 
regarding comparison of transfections using Lipofectamine 2000 versus Fugene was 
that visual analysis of the photos indicated that Lipofectamine conferred toxicity.  
Therefore, FugeneHD was selected for further investigations to improve 
transfection efficiencies. 
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Figure 74.  Graph comparing transfection efficiency using either Lipofectamine or Fugene.  Cells 
were transfected with plasmid 1 µg peGFPRac using either Lipofectamine 2000 (Lipo2000) or Fugene 
HD (Fugene) using optimised protocols, as indicated in materials and methods.  Brightfield and 
fluorescent microscopy was used to capture images of the cells at the indicated timepoints, the 
number of green cells per frame was counted and plotted.  Error bars represent standard deviation 
of the mean of n=6 measurements  
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5.3.2.4 Optimisation of scratch wound assay 
It was hypothesised that transfection efficiency could be increased by scratching 
the cell monolayer prior to transfection.  It was thought that the scratch wounding 
process would increase the permeability of the cells, particularly those at the 
scratch edge (Abbaci et al. 2008; Geddes et al. 2003).  It was demonstrated that 
scratch wounding the cell monolayer before transfection did increase the 
transfection efficiency (Figure 75, Figure 76).  This effect was seen for both 
transfections with Lipofectamine 2000 and FugeneHD.  There was significantly more 
GFP-positive cells in Rac1 KO cells scratched before transfection with peGFPRac1 
(p < 0.005).  In addition, there was significantly more GFP positive cells when 
transfected with peGFPRac using Fugene compared to Lipofectamine 2000 
(p < 0.01). 
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Figure 75.  Composite images comparing transfection efficiency of transfections using FugeneHD, when the cells were transfected then scratched (A) or scratched then transfected 
(B).  Scale bar represents 75 µm. 
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Figure 76.  Graph comparing transfection efficiency of transfections using Lipofectamine2000 
(Lipo) or FugeneHD, when the cells were transfected then scratched (transfection), or scratched 
then transfected (scratch).  Error bars represent standard deviation of the mean of n=4 scratch 
wounds.  
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5.3.2.5 Restoration of motility via plasmid encoded Rac1 
Using the optimised conditions, as described above, scratch wounds were made in 
monolayers of Rac1 KO fibroblasts which were then transfected with either peGFP 
or peGFPRac1.  Despite thorough optimisation of the transfection procedure, not all 
cells were GFP-positive.  Repopulation of the scratch wounds was then monitored 
by timelapse microscopy.  Compared to the Rac1 KO-peGFP (control) cells, the Rac1 
KO-peGFPRac1 cells demonstrated clear evidence of migration into the wound 
space (Figure 77; Movie 3) with repopulation and complete wound closure by 36 
hours (similar to the Rac1 control fibroblast [Figure 66 above]).  For cells 
transfected with GFP alone, wounds were still not fully closed at 48 hours (Figure 
77; Movie 4); similar to untransfected Rac1 KO cells [Figure 66 above]). 
It was noted that Rac1 KO cells transfected with the control plasmid, peGFP, 
migrated much as for untransfected Rac1 KO cells, namely the closure of the wound 
due to the force developed during cell division. 
It was notable (particularly in Movie 3) that cells expressing GFPRac1 (green cells) 
were able to break away from the confluent cell mass at the wound edge and 
clearly migrate into the wound space.  This movement provides good evidence that 
the introduction of plasmid encoded Rac1 can restore motility to Rac KO fibroblasts. 
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Figure 77.  Scratch wound closure of Rac1 KO cells transiently transfected with either peGFPRac1 or 
peGFP.  A monolayer of Rac1 KO cells were grown in 24 well plates, scratch wounded and then 
transfected with 1 µg peGFP or pGFPRac1 plasmid DNA using Fugene.  The closure of the wound was 
monitored by fluorescent timelapse microscopy over a 48 hour period.  Images at 20 minute intervals 
were captured; the brightfield and GFP fluorescent channels were overlaid using ImageJ.  Coloured lines 
represent tracks moved by individual cells.  Scale bar = 75 µm. 
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5.3.2.6 Quantitative analysis of wound closure 
To quantify the rate of closure of the wound, the timelapse images were analysed 
by measuring the wound area at timepoints throughout the 48 hour image 
collection.  The mean average rates of closure were calculated for the wells 
transfected with either plasmid peGFP or peGFPRac1 (Figure 78A).  The rate of 
wound closure demonstrated that the Rac1 KO cells transfected with peGFPRac1 
closed more efficiently than Rac1 KO cells transfected with peGFP (p < 0.01). 
5.3.2.7 Quantitative analysis of motility of individual cells  
The movement of the wound edge did not fully represent the restoration of motility 
observed, namely there was an increase in motility observed for single cells 
compared to the slow gradual movement of the wound edge.  The analysis of 
individual cell movement demonstrated that Rac1 KO cells transiently transfected 
with peGFPRac1 migrated further than the Rac1 KO cells transfected with peGFP 
(p < 0.0001; Figure 78B). 
The trajectories of a number of selected cells throughout the 48 hour timelapse 
microscopy period were plotted (Figure 79).  The Rac1 KO cells transfected with the 
peGFP plasmid (encoding eGFP only), showed limited movement, similar to the 
Rac1 KO cells.  There appeared to be similar directionality, in the cells moving into 
the wound area.  Rac1 KO cells transfected with peGFPRac1 demonstrated 
increased motility and there was a general directionality, with the cells moving into 
the wound area.  Although the motility was increased, the directionality of some of 
the cells was slightly erratic.  However, this difference was not statistically 
significant (Figure 78C). 
These results demonstrate that the reduced motility of the Rac1 KO cells can be 
partially restored via transient transfection of a plasmid encoding Rac1, using the 
plasmid peGFPRac1. 
237 
 
 
Figure 78.  Graphs showing (A) averages of rate of wound closure (n=12), (B) distance travelled by individual cells (n=121), (C) directionality of individual cells (n=121).  
Scratch wounds were created in Rac1 KO cells transfected with either peGFP or peGFRac1, using Fugene.  Fluorescent timelapse microscopy was used to monitor the cells 
over a 48 hour period.  Analysis of motility of individual green cells was calculated using the Manual Tracking and Chemotaxis and Migration tool (ImageJ).  Mean average 
values for each condition was calculated and plotted.  Errors bars represent standard deviation. 
238 
 
 
Figure 79.  Trajectories of Control and Rac1 KO mouse fibroblasts during scratch wound assay.  
Scratch wound assays were performed in monolayers of control and Rac1 KO cells.  The scratches 
were monitored by timelapse microscopy.  And the trajectories of individual cells at the wound edge 
were followed using the manual tracking plugin and plotted using the Chemotaxis and migration 
plugin of ImageJ. 
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5.3.2.8 Creation of a Rac1-GFP fusion 
The plasmid peGFPRac1 encodes a GFP-Rac1 fusion protein with the GFP N-terminal 
to the Rac1.  To use GFP as a visualisation tool to monitor the expression of Rac1 
under the control of the amber suppression technology it was required that a Rac1-
GFP fusion was created (Figure 80).  This would indicate whether a cell was 
expressing full-length (NAA containing) Rac1 as GFP would only also be expressed if 
read-through of the TAG occurred and therefore incorporation of the NAA.  Protein 
products truncated at the TAG within the Rac1 gene would theoretically not 
produce GFP.   
Furthermore, Rac1 contains a sequence (CLLL) that signals the prenylation and 
cleavage and methylation of the cysteine to allow plasma membrane association of 
Rac1 (see section 1.13.2.6.3).  In addition, Rac1 contains a polybasic region just 
upstream of the CLLL signal.  Due to the post-translational modification of Rac1 
protein, i.e. the isoprenylation, proteolysis and methylation of the C-terminal CAAX 
motif (CLLL in Rac1), the position of this signal sequence during the design of the 
Rac1-GFP construct, was considered.  It was thought that, to retain the ability of 
Rac1 to associate with the plasma membrane, the CLLL was required to be at the C-
terminal of the fusion protein. 
It was decided that two constructs would be made, one, that encoded Rac1-GFP-
CLLL (prenylation, proteolysis and methylation of C (of CLLL) at C-terminal of GFP) 
and two, that encoded Rac1-GFP-polybasic (RK)-CLLL (polybasic and CLLL C-terminal 
to GFP). 
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Figure 80.  The outcomes when a Rac1-GFP fusion (A) or a GFP-Rac1 fusion (B) construct is used 
during amber suppression. 
A 
B 
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5.3.2.9 Creation of pRacGFPCL plasmid for transfection into Rac1 KO cells 
To produce a Rac-GFP fusion, Rac1 was cloned into the AgeI site upstream of eGFP 
in the plasmid peGFP (Figure 82).  PCR was used to amplify the Rac1 gene from 
pCMVTnTRac (details found in Appendix A9) using Phusion DNA polymerase, using 
primers racGFP005 forward and either racGFP004, racGFP006 or racGFP007 reverse 
(Appendix A2).  The reverse primers used in the PCR to isolate the Rac1 gene were 
designed to remove either the stop sequence to create a Rac-GFP fusion protein; 
the prenylation and stop sequence; or the polybasic region, prenylation and the 
stop sequence.  The purified PCR products and peGFP plasmid were subjected to 
AgeI-HF restriction digest and the vector was dephosphorylated.  The purified 
products were ligated together, transformed into Top10 E. coli and plated onto agar 
containing kanamycin.  Colonies harbouring the plasmid encoding RacGFP were 
identified using colony PCR (Figure 81).  Positive colonies were determined by the 
presence of a band corresponding to 1.2 Kb. Rac1 insertion was confirmed 
sequencing (Figure 83). 
242 
 
 
Figure 81.  Agarose gel of PCR products from colony screen.  PCR was performed using colonies (1 –
 9) from plate containing E. coli transformed with ligation mixture of AgeI digested peGFP and Rac1 
PCR product.  –ve represents colony from a plate containing E. coli transformed with un-ligated 
mixture of digested peGFP and Rac1 PCR product. 
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After cloning of the RacGFP construct, the linker between Rac1 and GFP was 
modified to GGSGGS by site-directed mutagenesis (primers racGFP012 and either 
racGFP013 (for template minus polybasic and prenylation region) or racGFP014 (for 
template minus prenylation region)), as it was thought that this would enable some 
degree of flexibility to aid in correct protein folding and production of functional 
proteins and also, to ensure that the two genes were in-frame.  This mutagenesis 
was confirmed by DNA sequencing (Figure 83). 
In consideration of the signalling sequences located at the C-terminal of the Rac1 
protein, two constructs were made, one that would encode a protein with the 
prenylation (CLLL) sequenced moved to the C-terminal end of the Rac1-eGFP fusion 
(RacGFPCL) and the other encoding a protein with the polybasic region and the 
prenylation sequence moved to the C-terminal end of the Rac1-eGFP fusion 
(RacGFPRKCL).  These constructs were created by performing site-directed 
mutagenesis using primers that annealed to the 3’ end of eGFP containing the 
relevant signalling sequences present at the 3’ end of Rac1 (primers racGFP016 and 
either racGFP015 (addition of prenylation sequence) or racGFP017 (addition of 
polybasic and prenylation sequence)).  The addition of these sequences was 
confirmed by DNA sequencing.  This gave plasmid pRac1-eGFP (pRac1-eGFPCL 
(prenylation signal 3’ of GFP), and pRac1-eGFPRK (polybasic region and prenylation 
signal 3’ of GFP) (Figure 82).  Figure 83 shows the protein sequence as determined 
using the protein translation tool (ExPASy) using the DNA sequencing, the 
difference in sequence between RacGFPCL and RacGFPRK are indicated.  
It was then tested whether these constructs could be transfected and functional 
protein produced in the Rac1 KO cell line. 
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Figure 82.  Cloning scheme to create plasmids peGFP and pRac1-eGFP (either pRac1GFPCL (CLLL 
sequence added to C-terminal of GFP) or pRac1GFPRK (polybasic region and CLLL signal sequence 
added to C-terminal of GFP). 
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Figure 83.  Protein sequence of RacGFP constructs.  DNA sequence from RacGFPCL and RacGFPRK 
construct was translated to protein sequence (ExPASy, translate tool) and compared (ClustalW2).  
mRac1 
Linker region 
eGFP 
Polybasic region 
Prenylation signal 
246 
 
5.3.2.10 Transient transfection of plasmids pRacGFPCL and pRacGFPRK 
The construction of the Rac-GFP fusion gene was complex, namely, in the 
construction of the C-terminal plasma membrane signalling sequences.  Also 
important was whether the GGSGGS linker region introduced as a linker region 
between the Rac1 and eGFP would provide the flexibility for the correct folding and 
function of the two proteins.  Therefore, it was investigated whether these 
constructs would indeed be expressed and a functional product produced when 
transfected into the Rac1 KO cells.  Fluorescent microscopy demonstrated that GFP-
positive cells were obtained after transient transfection (optimised Fugene 
protocol) of the plasmid pRacGFPCL and pRacGFPRK into Rac1 KO cells (Figure 84).  
It appeared that the pRacGFPRK construct was not well tolerated, as over time the 
green cells appeared to undergo cell death.  The pRacGFPCL construct was chosen 
as the preferred construct for motility assays. 
 
5.3.2.11 Restoration of motility – transient expression of RacGFPCL 
To ascertain whether the RacGFPCL construct could restore motility to the Rac1 KO 
fibroblasts, scratch wounds in conjunction with timelapse fluorescent microscopy 
was performed.  The microscopy revealed that the RacGFPCL construct was capable 
of increasing motility when compared to cells expressing peGFP (Figure 85).  The 
scratch wounds in the wells transfected with pRacGFPCL were closed by 37 hours 
(Movie 5); whereas the scratch wounds in the wells transfected with pGFP were still 
not closed by 48 hours (Movie 6).  There was a visually apparent increased 
movement of GFP positive cells into the scratch wound area in those cells 
transfected with pRacGFPCL. 
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Figure 84.  Transient transfection of Rac1 KO cells with pGFPRac, pRacGFPCL, pRacGFPRK and peGFP.  Scale bar represent 75 µm. 
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Figure 85.  Scratch wound closure of Rac1 KO cells transiently transfected with either pRacGFPCL or 
pGFP.  A monolayer of Rac1 KO cells were grown in 24 well plates, scratch wounded and then 
transfected with 1 µg peGFP or pGFPRac1 plasmid DNA using Fugene.  The closure of the wound was 
monitored by fluorescent timelapse microscopy over a 48 hour period.  Images at 15 minute intervals 
were captured; the brightfield and GFP fluorescent channels were overlaid using ImageJ.  Coloured lines 
represent tracks moved by individual cells.  Scale bar = 75 µm. 
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5.3.2.12 Quantitative analysis of wound closure 
The mean average rates of closure were calculated for wells transfected with either 
plasmid peGFP or pRacGFPCL (Figure 86A).  The rate of wound closure by Rac1 KO 
cells transiently transfected with pRacGFPCL was significantly faster than that of the 
Rac1 KO cells transfected with peGFP (p < 0.001). 
5.3.2.13 Quantitative analysis of motility of individual cells  
It was immediately apparent that the green cells at the wound edge had increased 
in motility, could break-away from the cell mass and move into the wound space 
freely.  To try to capture the increase in motility of individual cells, the total 
distance moved by green cells in the 48 hour period were measured (Figure 86B).  
The analysis demonstrated that Rac1 KO cells transiently transfected with 
pRacGFPCL migrated further than the Rac1 KO cells transfected with peGFP 
(p < 0.001).  
To further analyse the motility of the cell populations, the directionality of the cells’ 
movements was analysed using data from the manual cell tracking.  Plotting the 
trajectories demonstrated that the Rac1 KO-pRacGFPCL cells showed greatly 
increased motility, however the movement of the cells appeared to be 
predominantly erratic (Figure 87).  Analysis of cell directionality demonstrated that 
the movement of the Rac1 KO-pRacGFPCL cells was more erratic than that 
displayed by Rac1 KO-peGFP cells (p < 0.0001; Figure 86C). 
These results demonstrated that transient transfection with the Rac-GFPCL 
construct (prenylation sequence at the C-terminal of the GFP) could also restore 
motility to the Rac1 KO cell line.  Therefore, the RacGFPCL construct could be used 
in further investigations in this study. 
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Figure 86.  Graphs showing (A) averages of rate of wound closure (n=4), (B) distance travelled by individual cells (n=75), (C) directionality of individual cells (n=75).  
Scratch wounds were created in Rac1 KO cells transfected with either peGFP or pRacGFPCL, using Fugene.  Fluorescent timelapse microscopy was used to monitor the 
cells over a 48 hour period.  Analysis of motility of individual green cells was calculated using the Manual Tracking and Chemotaxis and Migration tool (ImageJ).  Mean 
average values for each condition was calculated and plotted.  Errors bars represent standard deviation. 
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Figure 87.  Trajectories of Rac1 KO mouse fibroblasts transiently transfected with pRacGFPCL.  
Scratch wound assays were performed in monolayers of Rac1 KO cells transiently transfected with 
pRacGFPCL.  The scratches were monitored by timelapse microscopy and the trajectories of 
individual cells at the wound edge were followed using the manual tracking plugin and plotted using 
the Chemotaxis and migration plugin of ImageJ.  
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5.3.2.14 Evidence for expression of Rac1 gene  
Although the visualisation of GFP during the transfection experiments provided 
some evidence that the Rac1 protein was expressed (as the expression was a GFP-
fusion protein), further evidence for expression of Rac1 was sought.  To do this, 
RNA was extracted from control cells (for positive control), Rac1 KO cells and Rac1 
KO cells transfected with either peGFP, peGFPRac, pRacGFPCL or pRacGFPRK.  Using 
reverse-transcription PCR (RT-PCR), cDNA was synthesised utilising the RNA 
extraction.  PCR was performed using primers that annealed to the ubiquitous gene 
β-actin were used to ensure cDNA had been successfully isolated (Appendix A8).  
Primers, racFP and racRP3 annealed to nucleotides 1 - 17 and 531 - 546 of the Rac1 
gene respectively and were used to amplify Rac1 gene from the cDNA using PCR.  
An agarose gel of the products was analysed for correct sized products.  The PCR 
products were purified and DNA sequencing was used to confirm amplification of 
the Rac1 gene.  As expected the control cells and Rac1 KO cells transfected with 
plasmid encoding Rac1 gave a product of 546 bp.  cDNA synthesised using RNA 
extracted from Rac1 KO cells and Rac1 KO cells transiently transfected with peGFP 
did not give product corresponding to Rac1 (Figure 88). 
 
5.3.3 Stable transfection of RacGFP constructs  
To further investigate the constructs’ efficiency to restore Rac1 function and 
motility to the Rac1 KO cell line; it was thought that a plasmid could be used to 
create stable transfectants.  This would provide a situation where scratch wounds 
would show maximum increase in motility due to the entire population expressing 
Rac1.  Therefore, Rac1-eGFP was cloned into a Zeocin resistant plasmid, namely the 
pcDNA3.1/zeo plasmid (Invitrogen).  This would provide a situation where 
successfully transfected cells could be selected, grown and used solely in scratch 
wound assays. 
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Figure 88.  RT-PCR analysis of Rac1.  Agarose gel (2%) of PCR to amplify Rac1 gene from cDNA 
synthesised from RNA extracted from control cells (lane 1), Rac1 KO cells (lane 2), and Rac1 KO cells 
transfected with peGFP (lane 3), peGFPRac1 (lane 4), pRacGFPCL (lane 5), pRacGFPRK (lane 6) and 
plasmid pRacGFPCL (lane 7).  
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Zeocin was chosen for the selection marker for a number of reasons.  Firstly, the 
Rac1 KO cell line was made geneticin (G418) resistant during the production of the 
cell line (confirmed by growth in < 500 mg / ml G418), making this selection 
unsuitable.  Secondly, puromycin was used transiently during the production of the 
cell line, thereby making this antibiotic unfavourable.  Thirdly, Zeocin uses a 
different mode of action to G418 and puromycin, namely the inhibition of protein 
synthesis by disruption of translocation and promotion of mistranslation at the 80S 
ribosome.  Fourthly, the previously created pSWAN plasmids (Liu et al. 2007) used 
in application of the multi-plasmid system for incorporation of NAAs in mammalian 
cells are also based on the pcDNA3.1/zeo plasmid.  Therefore, it was also possible 
to create a selectable plasmid containing all the components needed for the 
incorporation of NAA (BstRNA, aaRS, and RacGFPCL).  In consideration of these 
factors, the pcDNA3.1/zeo plasmid was used as a basis for the cloning of a Zeocin 
selectable, Rac1-expressing construct for use in this study. 
5.3.3.1 Creation of a selectable plasmid expressing Rac1-GFP 
The RacGFPCL cassette was cloned into the previously created plasmid, 
pcDNA3.1/zeo-RS, which is based on the commercially available plasmid, 
pcDNA3.1/zeo (Invitrogen).  PCR was used to amplify the RacGFPCL construct, using 
primers that placed a NotI (racGFP021) and AgeI site (racGFP-IRES007) at 5’ and 3’ 
terminal, respectively, of RacGFPCL (Appendix A2).  Digested PCR product was 
ligated into complementarily digested, dephosphorylated and gel extracted plasmid 
pcDNA3.1/zeo.  A colony PCR screen, using primers racGFP021 and BGHpA RP 
identified colonies that harboured the RacGFPCL containing pcDNA3.1/zeo plasmid 
(Figure 89).  A PCR product of 1.4 Kb corresponded to insertion of RacGFPCL in to 
pcDNA3.1/zeo and DNA sequencing confirmed the insertion.  This produced a 
Zeocin selectable plasmid expressing RacGFPCL, plasmid pzeoCL (Figure 90). 
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Figure 89.  Agarose gel of colony PCR, screening colonies for insertion of RacGFPCL into plasmid 
pcDNA3.1/zeo.  PCR was performed using primers racGFP021 forward and BGHpA reverse.  A PCR 
product of 1.4 Kb corresponded to insertion of RacGFPCL in to pcDNA3.1/zeo.   
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Figure 90.  Plasmid cloning scheme to create pzeoCL and pzeoGFPCL. 
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5.3.3.2 Creation of a selectable plasmid expressing eGFP 
To create a population of stably transfected cells that were not expressing Rac1 
that could act as a control, a plasmid that had the same backbone as pzeoCL, but 
encoded GFPCL instead of RacGFPCL was created. This was important to ensure the 
re-introduction of Rac1 was responsible for the restoration of motility and not the 
process of producing a stably transfected cell line.  
The Rac1 gene was removed from the pzeoCL using site-directed deletion 
mutagenic PCR with primers pUAA001-2 and pzeo002, which annealed to the 
beginning of the GFP gene and plasmid sequence upstream of the Rac1 gene 
respectively (Appendix A2).  The kozak sequence (ACCATG) was preserved at the 
GFP start site and the prenylation sequence was conserved at the 3’ terminal to 
ensure localisation of expressed products was similar to RacGFP construct.  DNA 
sequencing confirmed the deletion of Rac1.  This created a Zeocin selectable 
plasmid encoding GFPCL, pzeoGFPCL (Figure 90). 
5.3.3.3 Zeocin kill curve 
Because intrinsic Zeocin sensitivity varies among cell lines, the concentration for 
selection in the Rac1 KO cell line was optimised.  Concentrations ranging from 
1000 – 25 µg / ml in DMEM growth media were used to create a kill curve (Figure 
91).  A concentration of 100 µg/ml was chosen for selection of stably transfected 
Rac1 KO cells because little growth of wild type Rac1 KO cells occurred after 
addition and all were killed after 7 days incubation. 
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Figure 91.  Zeocin selection kill curve for Rac1 KO.  24 well plates were inoculated with Rac1 KO 
cells at 2 x 10
4
 / well.  One day post inoculation, media was replaced with media containing Zeocin at 
the specified concentration.  Every two days the selection media was replaced.  Images were 
captured every day and the number of cells per frame was counted and plotted. 
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5.3.3.4 Rac1 KO cells stable expression 
5.3.3.4.1 Expression of target genes from Zeocin-resistant plasmids 
To investigate whether the plasmids pzeoCL and pzeoGFPCL would express in Rac1 
KO, the plasmids were transiently transfected into the cells.  It was shown that the 
plasmids pzeoCL and pzeoGFPCL could express GFP after transient transfection in 
Rac1 KO cells.  Therefore, transfections were performed to create stably 
transfected cells, as described in materials and methods.  
It was demonstrated that not all the stable clones were positive for GFP expression; 
therefore the colonies were screened using fluorescence microscopy.  A number of 
GFP-positive clones were picked and grown.  Each clone was assessed for their rate 
of growth, cell health as determined visually, and checked for GFP expression (via 
fluorescence microscopy) periodically throughout cellular amplification.  This was 
undertaken to ensure that the expression of target genes was retained throughout 
cell amplification; that silencing had not occurred; and that the population was not 
contaminated with non-GFP positive cells that may out-compete the GFP-positive 
cells.  Two clones expressing RacGFPCL, pzeoCL1.3 and pzeoCL10, and two clones 
expressing GFP, pzeoGFPCL1 and pzeoGFPCL3, were chosen and used in subsequent 
experiments.  After analysis of wound closure, the clones pzeoCL1,3 and 
pzeoGFPCL3 were used in further analysis and will subsequently be referred to as 
Rac1 KO + pzeoCL and Rac1 KO + pzeoGFPCL. 
5.3.3.4.2 Restoration of motility – stable expression of RacGFPCL 
The resistant clones, harbouring either pzeoCL (Rac) or pzeoGFPCL (GFP) were 
grown, aliquots were cryopreserved and were used in scratch wound assays.  It was 
apparent from microscopy that the Rac-expressing stable cell line had altered visual 
appearance and increased motility (Figure 92; Movie 7).  The cells were more able 
to form projections, break away from the cell mass and could be seeded at lower 
densities than the Rac1 KO cell line.  Timelapse microscopy of the scratch wounds 
showed that the Rac1 KO cells stably expressing Rac1 were more motile, readily 
moved away from the cell mass and into the wound space and therefore closed the  
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Figure 92.  Scratch wound closure of stable cell lines expressing RacGFPCL (Rac1 KO + pzeoCL) and 
GFPCL (Rac1 KO + pzeoGFPCL).  Rac1 KO cells were transfected with plasmids pzeoCL or pzeoGFPCL; 
resistant and GFP-positive colonies were selected using 100 µg/ml Zeocin antibiotic and fluorescent 
microscopy respectively.  Stable cells were used to inoculate 24 well plates, scratched and viewed using 
timelapse microscopy over a 48 hour period.  Images at 15 minute intervals were captured; the 
brightfield and GFP fluorescent channels were overlaid using ImageJ.  Coloured lines represent tracks 
moved by individual cells.  Scale bar = 75 µm. 
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scratch wound after approximately 45 hours (Figure 92; Movie 7).  Whereas the 
GFP transfected cells still had a sizeable scratch wound after 45 hours (Movie 8).  
The cells stably expressing GFP had a visual appearance and motility much like that 
of the parent Rac1 KO cell line. 
5.3.3.4.3 Quantitative analysis of wound closure 
The rate of wound closure demonstrated that cells stably expressing Rac1 closed 
more efficiently than Rac1 KO cells stably expressing eGFP (Figure 93A; p < 0.0001). 
5.3.3.4.4 Quantitative analysis of motility of individual cells  
To try to capture the increase in motility of individual cells, total distance and 
directionality moved by individual cells in the 48 hour period were analysed.  The 
analysis demonstrated that Rac1 KO cells stably expressing Rac1 migrated further 
than the Rac1 KO stably expressing eGFP (p < 0.0001; Figure 93B). 
Plotting the trajectories demonstrated that the Rac1 KO stably expressing Rac1 
showed greatly increased motility however, the movement of the cells appeared to 
be predominantly erratic (Figure 94).  Analysis of cell directionality demonstrated 
that the movement of the Rac1 KO stably expressing Rac1GFPCL was more erratic 
than that displayed by Rac1 KO-peGFP cells (p < 0.01; Figure 93C). 
These results demonstrated that the Rac1 KO cells could be used to create stably 
transfected cell lines using the pcDNA3.1/Zeo plasmid (denoted pzeo-based 
plasmid).  Using stable expression of the Rac1-GFPCL construct, it was 
demonstrated to restore motility to the Rac1 KO cell line.  
5.3.3.4.5 Expression of target genes 
To verify that components of the plasmid were indeed being transcribed, RT-PCR 
was performed. RNA was extracted from the stable cell lines and PCR was 
performed to check for transcription of β-actin, Rac and Zeocin resistance genes 
(zeor).  Agarose analysis of PCR products showed that β-actin, Rac and zeor were 
transcribed (Figure 95). 
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Figure 93.  Graphs showing (A) averages of rate of wound closure (n=6), (B) distance travelled by individual cells (n=141), (C) directionality of individual cells (n=141).  
Scratch wounds were created in Rac1 KO cells stably transfected with either pzeoCL (Rac1) or pzeoGFPCL (GFP).  Fluorescent timelapse microscopy was used to monitor 
the cells over a 48 hour period.  Analysis of motility of individual cells was calculated using the Manual Tracking and Chemotaxis and Migration tool (ImageJ).  Mean 
average values for each condition was calculated and plotted.  Errors bars represent standard deviation. 
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Figure 94.  Trajectories of Rac1 KO mouse fibroblasts stably transfected with pzeoCL or pzeoGFPCL, 
during scratch wound assay.  Scratch wound assays were performed in monolayers of Rac1 KO cells 
stably transfected with either pzeoCL or pzeoGFPCL.  The scratches were monitored by timelapse 
microscopy.  The trajectories of individual cells at the wound edge were followed using the manual 
tracking plugin and plotted using the Chemotaxis and Migration plugin of ImageJ. 
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Figure 95.  Agarose gel (2%) of PCR to amplify β-actin, Zeocin resistance gene (zeo
r
) and Rac1 genes 
from cDNA synthesised from RNA extracted from Rac1 KO cells stably transfected with pzeoCL (lane 
1), Rac1 KO cells stably transfected with pzeoGFPCL (lane 2), negative water control (lane 3), positive 
control (lane 4). 
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5.3.4 Comparison of motility between WT Rac1 expression and 
plasmid encoded Rac1 
Plasmid encoded Rac1 was not able to restore WT-like wound closure such as 
observed in Rac1 control cells (p < 0.0001; Figure 96A).  The Rac1 KO cells 
transiently (pRacGFPCL) and stably-expressing Rac1-GFPCL (pzeoCL) gave the 
highest rate of wound closure, however this rate was only approximately half of the 
rate seen for the Rac1 control cells.  The Rac1 KO transiently expressing GFP-Rac1 
(peGFPRac1) demonstrated a slower rate of wound closure than that demonstrated 
by the cells expressing Rac1-GFPCL (p > 0.0001). 
While none of the plasmid constructs restored WT motility (comparable to that 
seen by Rac1 control cells) to the Rac1 KO cells with regards to rate of wound 
closure, the Rac1 KO cells transfected transiently and stably with plasmids 
expressing the construct Rac1-GFPCL showed increased motility at the individual 
cell level compared to Rac1 control cells (Figure 96B).  Rac1 KO cells transiently 
expressing Rac1-GFPCL showed a moderate increase in individual cell motility 
compared to Rac1 control cells (p < 0.05), but when this construct was stably 
expressed there was an approximate two fold increase in distance travelled by 
individual cells (p < 0.0001).  Interestingly, the distance travelled by Rac1 KO cells 
transiently expressing GFP-Rac1 was lower than that observed for Rac1 control cells 
(p < 0.005); however, the average distance was greater than that observed for the 
Rac1 KO cells (Figure 78). 
The Rac1 control cells, Rac1 KO cells and the Rac1 KO cells transiently transfected 
with plasmids peGFPRac1 and peGFP all showed similar directionality (Figure 97).  
However, the Rac1 KO cells transiently and stably transfected with plasmids 
expressing Rac1-GFPCL showed decreased directionality (p < 0.0001). 
Rac1 KO cells, when expressing plasmid-encoded Rac1 demonstrated the presence 
of lamellipodia in the direction in which they appeared to be moving, which is 
another good indication that Rac1 has restored motility to the fibroblasts via the 
canonical lamellipodia pathway and not some other signalling pathway (Figure 98). 
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Figure 96.  A) Graph comparing of rate of wound closure between Rac1 control cells and Rac1 KO 
cells transfected with Rac1-containing plasmids. 
B) Graph comparing distance travelled by individual cells between Rac1 control cells and Rac1 KO 
cells transfected with Rac1-containing plasmids. 
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Figure 97.  Graph comparing directionality of Rac1 control cells and Rac1 KO cells transfected with 
Rac1-containing plasmids. 
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Figure 98.  Lamellipodia formation.  Rac1 KO cells were transiently transfected with pRacGFPCL and 
monitored using timelapse fluorescent microscopy. 
269 
 
5.4 Discussion 
5.4.1 Affect of Rac1 knockout 
5.4.1.1 Growth rate 
The Rac1 KO fibroblast cell line used within this Chapter demonstrated reduced 
growth rate when compared to the Rac1 control cell line.  Utilising DN mutants, 
Rac1 has previously been implicated in the regulation of cell cycle progression 
(Joyce et al. 1999; Olson et al. 1995; Westwick et al. 1997) and the reduction in 
proliferation in Rac1-null fibroblasts as seen within this work compared to 
previously obtained results (Guo et al. 2006; Vidali et al. 2006). 
Vidali et al (2006) suggested that the reduced growth observed for both primary 
and immortalised Rac1 null Mouse embryonic fibroblasts (MEF) cells was due to 
reduced cell proliferation and not increased apoptosis rates (as determined using 
TUNEL and annexin V staining).  Utilising Bromodeoxyuridine (BrdU) labelling, the 
group determined that this was due to reduction in DNA synthesis and that cells 
were shifted to the G1 phase with a reduction of cells in S phase, when compared 
to Rac1-WT control cells.  The group determined that this observation was due to 
the depletion of Rac1 and not due to the treatments used within the study. 
Guo et al (2006), also demonstrated that Rac1 deletion in primary MEFs resulted in 
slowed cell growth.  However, the group demonstrated that the reduction in 
growth rate was related to increased apoptosis rates, as determined using annexin 
V staining in conjunction with FACS analysis.  Further analysis utilising 
immunofluorescence staining of active caspase 3 confirmed this phenotype and 
also, re-introduction of Rac1 reconstituted normal growth rates.  Guo et al 
suggested that the increase in apoptosis might be attributed to both anoikis-
dependent (because Rac1 deletion reduced cell adhesion to fibronectin and the 
focal adhesion plaque formation) and anoikis independent pathways involved in cell 
survival. 
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5.4.1.2 Morphology 
The Rac1 KO fibroblast cells used within this Chapter exhibited altered morphology 
when compared to the Rac1 control fibroblasts.  Namely, the Rac1 KO cells were 
larger, and were more rounded in appearance.  This was in contrast to that of other 
Rac1 null fibroblasts used within other studies (Guo et al. 2006; Monypenny et al. 
2009; Vidali et al. 2006).  Vidali et al’s (2006) Rac1 null MEFs were shown to have 
different morphology when compared to the typical well-spread polygonal shape of 
Rac1-WT cells.  The Rac1 null fibroblasts were generally smaller, most probably due 
to the lack of lamellipodia, and displayed predominantly elongated morphology, 
but triangular and small cell morphology was also observed.  These different 
morphologies could represent the mixed population present as a result of the 
preparation of the conditioned Rac1 knockout.  The group reported a 90 % 
depletion of Rac1 during the Cre-treatment, and therefore 10 % could display WT 
morphology and could account for the mixed morphological population.  The Rac1 
null MEFs studied by Guo et al (2006) and Rac1 knocked-down MEFs studied by 
Monypenny et al (2009) also displayed a contracted and elongated morphology, 
consistent with that reported by Vidali et al (2006).  However, this morphology was 
in contrast to that observed within the work presented within this Chapter.  It is 
possible that during the process of immortalisation of the Rac1 KO cell line utilised 
within this study, a specific clone with altered morphology had been selected and 
this differed to the MEFs used within these previous studies.  In addition, genomic 
changes that occur throughout repetitive cell passage could have resulted in a Rac1 
null cell line with altered morphology. 
5.4.1.3 Motility 
Despite the difference in morphology shown in Rac1-null MEFs used in previous 
studies and Rac1 KO cells used within this work, the reduction in Rac1 had similar 
effects on motility.  Specifically, a significant difference in cell migration rates and 
rate of wound closure between Rac1-deficient and control fibroblasts (Monypenny 
et al. 2009; Vidali et al. 2006). 
Vidali et al (2006), utilised scratch wound assays to establish the migratory ability of 
their Rac1 null MEFs.  Although, the method used to measure rate of wound closure 
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differed between work presented within this chapter and that of Vidali et al’s, in 
both cases the rate of wound closure for Rac1-deficient fibroblasts was 
approximately half of the rate demonstrated by Rac1-WT cells.  As demonstrated 
within this study and that of Vidali et al, the tracking of individual cells also 
demonstrated that Rac1 null fibroblasts displayed reduced motility.  When the 
velocity of individual cell migration was compared, the similarities were notable 
(Table 16).  Similarly, it was also noted that tethering of cells to one another 
retarded migration. 
 
Table 16.  Velocity of individual cell movement, comparing Rac1 WT and Rac1 KO cells 
  Individual cell velocity (µm/min) 
  Rac1 WT 
 
Rac1 KO 
This study 0.15 ± 0.076  0.07 ± 0.025 
                
Vidali et al 0.16 ± 0.022   0.07 ± 0.004 
 
Monypenny et al (2009), utilised short interfering RNAs (siRNA) to knockdown Rac1 
in MEFs. The affect on the individual cell motility was assessed using chemotactic 
responses to a platelet derived growth factor (PDGF) gradient within a Dunn direct 
viewing chamber by timelapse microscopy.  The group demonstrated that 
knockdown of Rac1 reduced the migratory capabilities of the cells to approximately 
30 % of Rac1-WT cells.  This reduction is in concurrence with the finding within this 
study, however, the reduction observed within this study was over 50 %.  The 
reduction by 30 % could be attributed to that fact that some Rac1 might still be 
present in the cells where Rac1 had been knocked down using siRNA.  Also to note 
is that the response to PDGF induced chemotaxis may be different to that of scratch 
wound induced migration. 
During the scratch wound assay, the Rac1 KO cells demonstrated some migration 
into the wound space.  This was in contrast to the function of Rac1 as determined 
by Nobes and Hall (1999) utilising microinjection of either DN Rac1 mutant protein 
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or expression vector encoding DN mutant.  The group showed that cell movement 
of fibroblasts (rat EF) was inhibited by 98 % using DN mutants and concluded that 
Rac activity was essential for motility.  Although the limited migration 
demonstrated within the work presented within this Chapter appeared to be due to 
cell proliferation at the wound edges, the cells may have displayed limited motility 
due to non-lamellipodial motility.  Limited migration and chemotaxis was also 
observed in the more recent studies utilising Rac1-null MEFs (Monypenny et al. 
2009; Vidali et al. 2006).  It has been suggested that when Rac1 is depleted, the 
cells were still able to migrate via compensatory mechanisms, namely by the 
extension of filopodia and other thicker membrane extensions mediated by other 
GTPases, such as Cdc42 (Allen et al. 1998; Chen et al. 2000; Pankov et al. 2005) or 
RhoG.  These observations were similar to that seen in dermal fibroblasts from 
gelsolin (downstream effector of Rac1) null mice (Azuma et al. 1998). 
The results using Rac1 knockout should be more indicative of the function of Rac1 
compared to studies using DN T17N mutants, which has reduced affinity for GTP 
and sequesters GEFs (Feig 1999).  This is because these DN proteins may bind to 
multiple GEFs in a promiscuous manner, which may result in impaired general 
GTPase function, for example, other Rac isoforms, Cdc42 and other rho family 
members (Guo et al. 2003; Schmidt and Hall 2002). 
The effect of Rac1 deficiency on other cell types has also been important in 
elucidating its function.  Although Rac1-null macrophages are unable to produce 
membrane ruffles, they were able to migrate probably due to the presence of Rac2 
which may contribute to motility mediation (Wells et al. 2004; Wheeler et al. 2006).  
On the other hand, it has been shown that neutrophils exhibit much reduced 
motility, reduced chemotaxis and no lamellipodia formation when both Rac1 and 
Rac2 were knocked-out (Sun et al. 2004). 
5.4.1.4 Directionality 
The work presented within this Chapter demonstrated no difference in the 
directionality of cell motility into the wound space displayed by the Rac1 KO 
compared to the Rac1 control fibroblast cells.  No difference in directionality was 
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demonstrated by Monypenny et al’s (2009) Rac1 null fibroblasts in response to 
PDGF chemotaxis.  In contrast, Vidali’s results indicated that Rac1-null MEFs 
demonstrated reduced directionality into a scratch wound compared to cells WT for 
Rac1.  The work by Pankov et al (2005) sought to explore the differences in 
directional migration, where the cell rapidly moves between points and random 
migration, where the cells are allowed to explore their local environment.  The 
group suggested a Rac1-based mechanism distinct from the mechanism controlling 
cellular chemotaxis that allows the cells to switch between the two modes of 
migration.  The work used RNA interference to modulate the levels of Rac1 activity 
in fibroblasts (50 – 80 %).  It was shown that lowering Rac1 activity switched the 
migration from random to directionally persistent in a process that did not require 
phosphatidylinositol 3 kinase activity.  It was suggested that by decreasing Rac1 
activity the production of peripheral lamellae was suppressed therefore causing the 
leading lamellae to become more pronounced and the subsequent mediation of 
directional migration.  To explain the decrease in directional migration, as 
demonstrated by Vidali’s Rac1 null cells, it was suggested that the complete loss of 
Rac1 had abolished the presence of a leading lamellae therefore motility preceded 
via an alternative mechanism.  In the case of the work presented in this Chapter, 
neither an increase or decrease in directionality was observed between Rac1 KO 
and control cells therefore a combination of the two or a third hypothesis could be 
suggested.  The use of a chemotactic gradient within the motility assay would affect 
the cellular responses involved in motility when compared to scratch wound 
induced motility, which could alter the need for specific directional movement.  
Differences in migration could be explained by differences in local chemotactic 
gradients that may have been present during the scratch wound assays, the 
difference in scratch wound assay themselves and differences in media or the cells 
used.  The directionality is considered further below in respect to the introduction 
of plasmid-encoded Rac1. 
5.4.1.5 Biochemical analysis 
Previous work looked deeper into the cellular and biochemical differences in the 
Rac1 null cells and Rac1-WT fibroblast cells, namely, in the visualisation of F-actin, 
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spreading assays, and response to chemotactical gradients (Guo et al. 2006; 
Monypenny et al. 2009; Vidali et al. 2006).  Work performed using Rac1 null 
fibroblasts (Guo et al. 2006; Monypenny et al. 2009; Vidali et al. 2006) and studies 
utilising DN Rac1 protein (Nobes and Hall 1999; Ridley et al. 1992) demonstrated 
that Rac1 is an absolute requirement for the formation of lamellipodia and dorsal 
and lateral ruffles. However, in contrast to work performed using DN mutants 
(Anand-Apte et al. 1997; Berrier et al. 2000; Clark et al. 1998; Fenteany et al. 2000; 
Nobes and Hall 1999; Price et al. 1998), the ability of Rac-null cells to perform 
chemotaxis, spread on fibronectin and ability to close wounds was only reduced 
(Guo et al. 2006; Vidali et al. 2006).  It would be interesting to further investigate 
these points using the Rac1 KO cells utilised within this study and therefore 
compare these findings to previous work, however, for the application required 
within this Thesis this in-depth characterisation was considered surplus. 
5.4.2 Restoration of motility via plasmid encoded Rac1 
5.4.2.1 Transient transfection of Rac1 plasmids 
Optimisation of transient transfection was performed to try to obtain high 
transfection efficiency.  A high transfection efficiency was required to obtain a high 
number of Rac1-expressing cells and therefore enable visualisation of a large 
difference in rate of scratch wound closure.  Optimisation was performed using two 
commercially available transfection reagents, Lipofectamine 2000 and FugeneHD.  
Although Lipofectamine 2000 typically gave higher transfection efficiencies, 
FugeneHD was utilised for transfections as the toxicity conferred was lower.  
Survival of the cells and sustained expression of Rac1 was vital during the 
timecourse of the timelapse experiment to maintain the phenotype conferred by 
the transfected gene.  After optimisation, a sufficiently high transfection efficiency 
(approximately 40 %) was achieved.  This transfection efficiency was high enough to 
visualise difference in cell motility for experiments using plasmids harbouring Rac1. 
Interestingly, the transfection efficiency was higher in monolayers which had 
recently been scratched when compared to transfection of a typical monolayer.  
The scratching process may have caused mechanical deformation of the cell 
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membranes increasing their permeability to exogenous particles, namely the 
transfection complexes (Abbaci et al. 2008; Geddes et al. 2003).  Another possibility 
was that the uncovering of the negatively charged tissue culture treated plastic, 
due to the scratching, attracted the plasmid complexes, which are surrounded by 
cationically charged transfection reagent.  The attraction of plasmid complexes into 
the scratch wound area would have allowed the cells adjacent to the scratch to 
uptake the plasmid more easily.  
5.4.2.2 Stable transfection of Rac1 plasmids 
The use of stable cell lines sought to remove the heterogeneity observed in cell 
monolayers transiently transfected.  By selecting cells which have integrated the 
plasmid DNA into their genome, a population of cells expressing target gene (Rac1 
or eGFP) were obtained.  As a consequence of using Rac1 stably transfected cell 
lines an increased rate of migration and wound closure was observed. 
However, during the selection of the stably expressing cell lines, not all of the 
resistant colonies appeared to express GFP.  The linearisation of the plasmid for 
incorporation into the host genome occurs randomly; therefore, in those stable 
cells not expressing GFP, the GFP could have been transected, thus allowing 
incorporation of full-length Zeocin resistance gene, but not the target gene.  
Linearisation of the plasmids by restriction digest could have decreased transection 
of target gene and increased efficiency of stable selection.  Also to consider is that 
incorporation of the plasmids into the host genome occurs randomly and therefore 
other genes could have been disrupted during the incorporation process, this could 
have affected growth and ability to survive the selection procedure.  Also to note is 
that during the incorporation into the genome parts of the plasmid can be 
replicated, cleaved and this may have affected the efficiency of GFP-expression. 
5.4.2.3 Comparison of GFP-Rac1 and Rac1-GFP constructs 
Two Rac1-containing plasmid constructs were tested for their ability to restore 
motility to Rac1 KO fibroblasts, namely pGFPRac1 and pRacGFPCL.  pGFPRac1 was 
initially used as this construct had previously been used in transient transfection of 
Rac1 KO cells (Personal communication, Klemens Rottner).  The Rac1-GFP construct 
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was created in anticipation of implementation of the amber suppression 
technology.  The Rac1-GFP fusion would be a readout system to visualise whether 
read-through of the TAG codon had occurred.  However, the function of this 
construct required testing prior to use with TAG mutagenesis.  Two constructs were 
made, one where the polybasic and prenylation sequence were moved to the C-
terminal of the Rac-GFP fusion (RKCL) and another where only the prenylation 
sequenced were moved (CL).  It was hoped that moving the prenylation sequence 
to C-terminal of the Rac1-GFP fusion protein, would allow the Rac1-GFP fusion 
protein to be correctly tagged for association with the plasma membrane where the 
Rac1 activity is required for the actin-based formation of lamellipodia and 
consequent cell motility.  If the CLLL signal was maintained at the C-terminal of 
Rac1 within the Rac1-GFP fusion, cleavage of GFP would occur and therefore GFP 
presence would not be representative of Rac1 levels.  In addition, the C-terminal 
extension (i.e. GFP) might inhibit processing of the CLLL sequence.  It was shown 
that the presence of the polybasic region and prenylation sequence at the C-
terminal was not optimal.  However, it was shown that the Rac1-GFPCL was 
functional and able to restore motility to the Rac1 KO fibroblasts. 
The technique of targeting proteins to plasma membrane using prenylation 
sequences has been used previously (Aronheim et al. 1994; Hancock et al. 1990).  In 
addition, a commercially available plasmid peGFP-F has been constructed with the 
20 amino acid farnesylation signal from c-Ha-Ras fused to the C-terminus of eGFP 
(Clontech).  This plasmid produces a C-terminal GFP tagged protein of interest 
which is directed to the plasmid membrane. 
5.4.2.4 Rate of wound closure 
The rate of wound closure using plasmid-encoded Rac1 (for both GFPRac1 and 
RacGFPCL constructs) was increased when compared to cells expressing eGFP.  
However, using plasmid-encoding Rac1 did not fully restore WT-like motility to the 
Rac1 KO cells concerning rate of wound closure.  The rates obtained were 41 %, 
50 % and 58 % of that observed for Rac1 control cells, for pGFPRac1, pRacGFPCL 
and stable pzeoCL respectively.  The difference could be attributed to the different 
transfection efficiencies of the two transiently transfected plasmids, levels of 
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expressed protein or effectiveness of the fusion protein produced.  It is interesting 
that the C-terminal GFP fusion protein was most successful because the 
construction of this fusion was most complex.  It was encouraging that the stably 
expressing cell lines gave the greatest rate of wound closure, most probably 
because the entire cell population were contributing to the closure of the wound. 
This difference in observed motility could be explained by the use of the 
noncognate promoter driving the expression of the Rac1 construct.  The expression 
of Rac1 was constitutive and was therefore not subject the cognate transcriptional 
control seen for the Rac1 gene within the Rac1 control cells.  The Rac1, both 
endogenously and exogenously produced, should have been subject to protein-
based regulation, however, the presence of the GFP tag could have perturbed the 
recognition of Rac1 by GEFs and other interacting proteins; altered the GTPase’s 
ability to bind or hydrolyse GTP; perturbed PM localisation and thereby altered the 
action and subsequent signalling related to Rac1 protein. 
Guo et al (2006) have demonstrated that reconstitution of Rac1 into a Rac1 null 
fibroblast via a retroviral construct was possible.  Although not a direct fusion 
protein, the expression of Rac1 was linked to expression of eGFP for visualisation 
via a bicistronic approach.  The group showed that the loss of lamellipodia, 
reduction in cell spreading and increase in spontaneous apoptosis due to Rac1 
knockout could be reconstituted via exogenous Rac1 expression.  However, the 
group did not perform any motility assays to ascertain whether Rac1 deficient or 
Rac1 reconstituted cells were capable of migration. 
5.4.2.5 Individual cell motility 
While none of the plasmid constructs restored WT motility (comparable to that 
seen by Rac1 control cells) to the Rac1 KO cells with regards to rate of wound 
closure, the Rac1 KO cells transfected with plasmids expressing the construct Rac1-
GFPCL demonstrated increased motility at the individual cell level.  More 
specifically, 125 % and 190 % of that of Rac1 control cells, for transient and stable 
expression respectively.  Rac1 KO cells transiently transfected with pGFPRac1 
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demonstrated individual cell motility approximately 70 % of that of Rac1 control 
fibroblasts. 
The measurement of rate of wound closure and individual cell motility captured 
different modes of motility.  The results suggest that the motility observed in 
individual cells was not efficiently translated into the mass movement of the 
monolayer to close the scratch wound.  The movement of individual cells away 
from wound edge was not captured when measuring rate of wound closure, this 
was because measurement was taken using the wound front that was created by 
the mass of cells of the monolayer.  This could explain the difference in rate of 
wound closure and the motility observed at the individual cell level.  As mentioned 
previously, the use of a noncognate promoter to control expression of Rac1 would 
have perturbed the regulation of Rac1.  This could have upset the ability of the cells 
to orchestrate the directed cell movement to close the wound; this loss of 
directionality is discussed further below in section 5.4.2.6. 
Also to consider is that during the experiments using transient expression of Rac1-
containing constructs, not all the cells were GFP-positive therefore the population 
of cells was heterogeneous.  There were GFP-negative cells, which would probably 
display migration similar to Rac1 KO cells, cells expressing non-detectable levels of 
GFP and those that were clearly GFP-positive, each displaying various abilities to 
migrate.  In addition to the limited wound closure ability of the GFP-negative cells, 
the cells could have interrupted the migration of those expressing Rac1. 
5.4.2.6 Directionality 
The directionality of migration for Rac1 KO, Rac1 control cells and cells transiently 
expressing GFP-Rac1 or eGFP were similar, more specifically ~0.7.  This indicated 
that the movement of the cells was directed into the wound space.  However, the 
increase in individual cell motility when compared to rate of wound closure 
indicated the movement of the cells expressing Rac1-GFPCL was not directed into 
the wound space.  This was also suggested by the reduced directionality shown by 
the Rac1 KO cells transiently and stably expressing the Rac1-GFPCL construct (~0.4; 
Figure 97).  As mentioned above, the constitutive promotion of Rac1 expression 
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could result in very high expression levels of Rac1 compared to WT expression.  In 
addition, the expression was not under control of the cognate transcriptional 
regulation.  If the random migration seen was due to overexpression of Rac1, this 
may support Pankov’s hypothesis that decreased Rac1 levels induces directional 
migration in fibroblasts (Pankov et al. 2005).  Using Pankov’s reasoning, it can be 
suggested that cells containing high levels of Rac1 are not responsive to polarisation 
of the cell, lots of alternative lamellae initiation sites are created, therefore 
movement occurs in varying directions depending on which lamellae is 
predominant.  Although measurements of levels of Rac1 expression would need to 
be ascertained to determine whether this hypothesis can be extrapolated.  
It has been suggested that during chemotaxis to PDGF stimulation an initial 
upregulation of Rac1 activity occurs at PDGF stimulation, causing mobilisation of 
the actin polymerisation machinery which allows the cells to make the transition 
from quiescent state to a motile state (Monypenny et al. 2009).  After this initial 
burst of Rac1 activity, the levels are downregulated to prevent excessive activation, 
and subsequent local alterations in Rac1 activity maintain the steady treadmilling of 
actin cytoskeleton during migration.  Although the creation of a wound does not 
initiate the chemotactic response, it is possible that a similar Rac1 regulation occurs 
in response to the wound which enables the cells to migrate into the wound space.  
Therefore, the initial and continued expression of Rac1 from the plasmid constructs 
could cause excessive Rac1 signalling.  Thus, causing non-WT migration activity into 
the wound and this could explain the increase in individual cell motility compared 
to the rate of wound closure. 
280 
 
5.5 Conclusion 
The Rac1 KO fibroblast cell line was shown to have decreased motility when 
compared to Rac1 control fibroblasts.  This was evident by the decreased rate of 
wound closure and decreased motility of individual cells, as determined by scratch 
wound assays.  These data addressed the first aim of this work.  To address the 
second aim, a selection of plasmid constructs were designed, created and used to 
transfect the Rac1 KO cells.  These constructs encoded either a GFP-Rac1 or a Rac1-
GFP fusion protein.  Both via transient and stable transfection, it was demonstrated 
that plasmid-encoded Rac1 could restore motility to the Rac1 KO cells.  The 
restoration of motility was evident by an increased rate of wound closure and 
motility of individual cells.  When the Rac1-GFP construct (RacGFPCL) was 
introduced stably into Rac1 KO cells, the cells displayed the largest restoration of 
cell motility.  However, the rate of wound closure was only 58 % of that 
demonstrated by endogenous Rac1 expression, as seen with the Rac1 control cells.  
Interestingly, the motility of individual Rac1 KO cells stably expressing Rac1 was 
shown to be 190 % of that displayed by Rac1 control cells and this was as a result of 
a loss of directionality (0.4 compared to 0.7 displayed by Rac1 control cells). 
The work presented within this chapter has demonstrated the development of a 
functional mammalian cell readout system.  This provided the basis for further 
investigation into whether this readout system could be used in the application of 
amber suppression to control the motile phenotype of a mammalian cell using the 
supplementation of NAA.  The development of this technique is the subject of 
Chapter 6. 
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6 CHAPTER 6: UTILISATION OF THE AMBER 
SUPPRESSION TECHNOLOGY TO CONTROL A 
FUNCTIONAL, MAMMALIAN CELL READ OUT 
SYSTEM 
282 
 
6.1 Introduction 
Chapter 5 demonstrated the effective utilisation of scratch wound assays in 
conjunction with fluorescent timelapse microscopy to monitor cellular motility.  It was 
also demonstrated within Chapter 5 that Rac1 KO fibroblasts display reduced motility 
(compared to Rac1 control cells) and that plasmid-encoded Rac1 could restore this 
motility, both transiently and using stably transfected cell lines.  These results formed 
a cellular readout system, namely, the modulation of cellular motility controlled by the 
absence (Rac1 KO cells, limited motility) and presence of Rac1 (encoded via plasmid, 
increased motility).  Chapter 6 aims to utilise the cellular readout system established 
within Chapter 5 and apply this method in an attempt to modulate cellular motility via 
implementation of amber suppression technology, as described in Chapter 4. 
Therefore, the work presented within this Chapter sought to: 
 Produce a selectable single plasmid that encoded the orthogonal machinery 
(BstRNA   
   
, azido specific aminoacyl tRNA synthetase (azRS)) and target 
gene (RacGFPCL construct containing a TAG mutation) required in the 
implementation of amber suppression technology within mammalian cells 
 Investigate whether it was possible to control a mammalian cellular 
phenotype (i.e. migration) as a function of the presence/absence of non-
natural amino acid utilising the amber suppression technology 
Firstly, a complex multi-step cloning strategy was designed and implemented in order 
to create a one-plasmid system required for the application of amber suppression 
within mammalian cell lines.  More specifically, a plasmid harbouring a bicistronic 
cassette encoding the two genes (azRS and racGFP) separated by an Internal Ribosome 
Entry Site (IRES) within the multi-cloning site (MCS) of a Zeocin-selectable plasmid, and 
the insertion of the BstRNA   
   
 (along with internal promoter) into a site upstream of 
the MCS.  Secondly, this plasmid was tested for function within the Rac1 KO cell lines 
(along with Rac1 control cells and HEK293 cells), utilising GFP tagged protein and 
fluorescent microscopy to ascertain function (along with RT-PCR).  A TAG mutation was 
introduced in to a chosen position within the Rac1 gene and the ability of amber 
suppression to control cellular motility was ascertained. 
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6.2 Materials and methods 
6.2.1 Molecular biology 
Molecular biology was performed as defined in Chapter 2 
6.2.2 Mammalian cell culture 
Mammalian cell culture was performed as defined in Chapter 5. 
6.2.3 Medium supplementation with non-natural amino acids 
Iodophenylalanine (iodoF; BACHEM) or azidophenylalanine (azF; BACHEM) were 
prepared either by addition to growth media using sonication to dissolve or pre-
dissolved in NaOH as set out below. 
NAA were dissolved (to varying final concentrations) in growth medium prior to 
addition to the wells transfected with TAG-containing plasmids.  Sonication was 
performed in order to dissolve the NAA and was thought to sterilise the solution.  
This was typically 3 x 5 minute sonications, with mixing in between sonication steps.  
Sonication was performed at 37 °C.  Dissolved NAA was used immediately and 
made fresh for each experiment. 
Stock solutions of 100 mM iodoF or azF were created by dissolving in 200 mM 
NaOH.  Solutions were sterile filtered (0.2 µm syringe sterile filters) and stored at 
4 °C wrapped in aluminium foil to reduce exposure to light and subsequent 
photoreactions. 
Addition of NAA during experiments occurred 2 – 24 hours after transfection.  The 
volume of media in the 24 wells was increased to 1 ml and the specified 
concentration of NAA added.  Concentrations used in experiments ranged from 
0.5 – 7.5 mM.  For experiments minus NAA, the same volume of 200 mM NaOH was 
added as a control. 
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6.2.4 DNA Electroporation 
For electroporation of DNA into mammalian cells an ECM 630 Exponential Decay 
Wave Electroporation System (BTX) was used.  Cells to be electroporated were 
removed from culture flask, pelleted and counted as described in Chapter 5.  The 
cells were resuspended at 4 x106 / ml and 30 µg DNA was added to the cells.  800 µl 
of cells/DNA was added to a 4 mm cuvette (BTX) on ice.  Cells were electroporated 
using 250 – 350 V, for approximately 30 ms using 75 Ω resistance/2000 µF 
capacitance.  Cells were then recovered from the cuvette and added directly to well 
plates.  The cuvettes were washed out with medium to ensure all cells were 
collected. 
6.2.5 Liposomal transfection 
Liposomal transfections were performed using Lipofectin®.  Lipofectin® reagent is a 
1:1 (w/w) liposome formulation of the cationic lipid N-[1-(2,3-dioleyloxy)propyl]-
n,n,n-trimethylammonium chloride (DOTMA) and dioleoyl 
phophotidylethanolamine (DOPE) and was purchased from Invitrogen.  The 
DNA/liposomal mixture was prepared as suggested by Manufacturers.  Briefly, DNA 
(1 µg /well) and Lipofectin (2 -20 µl) were diluted in 100 µl OptiMEM medium 
separately.  The diluted DNA and Lipofectin were then combined at a ratio 1 : 2 to 
1 : 20 µg DNA to µl Lipofectin and incubated for 15 – 45 minutes (RT).  The cells to 
be transfected were washed with 2 x 2 ml PBS and then 0.8 ml growth medium 
minus FBS was added.  Complexes (200 µl) were then added to cells.  Cells plus 
Lipofectin/DNA were then incubated at 37°C.  Approximately 5 hours post 
transfection an equal volume of growth medium containing 20 % FBS was added. 
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6.3 Results 
6.3.1 Creation of a single plasmid system for use in amber 
suppression in mammalian cells 
To optimise transfection and ultimately the success of amber suppression in Rac1 
KO cells a single plasmid system harbouring all genes required was designed (Figure 
99).  After consideration it was decided that the azF-specific synthetase (azRS) and 
Rac1-GFP construct would be expressed using the same promoter (constitutive 
CMV promoter).  The two genes were separated by an internal ribosome entry site 
(IRES) which created a ribosome binding site within the mRNA transcript, thereby 
allowing expression of the two genes under the same promoter (Houdebine and 
Attal 1999).  The Zeocin resistance gene would be driven by a separate promoter 
and used to select stably transfected cell lines.  The BstRNA   
   
 contained an 
internal promoter in its sequence and therefore could be placed within any position 
within the plasmid sequence.  The BstRNA   
   
 sequence was preceded by the 
5’addition of the human tRNATyr leader sequence which was included to improve its 
expression (Ye et al. 2009; Ye et al. 2008). 
The pBluescript-IRES plasmid (a gift from Dr Xiao-Qing Wei, School of Dentistry, 
Cardiff University), contained the IRES sequence inserted into the middle of MCS 
between the BamHI and EcoRI sites (Figure 100).  To create the azRS-IRES-RacGFP 
construct, the RacGFP construct was inserted into the EcoRI and XhoI sites of 
pBluescript-IRES, followed by the addition of azRS into the XbaI and NotI sites (see 
section 6.3.1.1, 6.3.1.2 and Figure 101). 
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Figure 99.  Plasmid map of a single plasmid system harbouring all genes required for amber 
suppression, pUAACL.  The CMV promoter (pCMV, red) drives the expression of the azFs-specific 
aminoacyl tRNA synthetase (azTyrRS, red) and the target Rac-GFP construct (red).  The orthogonal 
BstRNA (BstRNA
   
   
, yellow) contains an internal promoter sequence and was preceeded by the 
human tRNA
   
 leader sequence.  
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Figure 100.  A)  Plasmid map of pBluescript-IRES  
       B)  MCS showing insertion of IRES sequence. 
A 
IRES insertion 
B 
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Figure 101.  Plasmid cloning scheme for creation of a single plasmid system harbouring all genes 
required for amber suppression, pUAACL.  To create the azRS-IRES-RacGFPCL construct, the RacGFPCL 
construct (from pRac1GFPCL) was inserted into the EcoRI and XhoI sites of pBluescript-IRES, followed by 
the addition of azRS into the XbaI and NotI sites.  This azRS-IRES-RacGFPCL cassette was then inserted 
into the NotI and AgeI sites of pcDNA3.1/zeoRS, followed by insertion of the BstRNA
   
   
  between the 
SspI and NdeI sites. 
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6.3.1.1 Cloning RacGFPCL into pBluescript-IRES 
The RacGFPCL construct was amplified from pRacGFPCL using primers that added a 
5’ EcoRI site (racGFPIRES004) and a 3’ XhoI (racGFPIRES005) to the PCR product 
(Appendix A2).  The digested PCR product was ligated into complementarily 
digested and dephosphorylated pBluescript-IRES.  Colonies were screened for insert 
using colony PCR with the primers rac FP and eGFP RP.  Products of size 1.4 Kb 
corresponded to successful incorporation of RacGFPCL into pBluescript-IRES (Figure 
102).  Colonies giving no PCR product did not harbour the RacGFPCL insert and 
therefore were not used in further analysis.  The DNA from four positive clones was 
isolated and the insertion position was sequenced to confirm successful insertion of 
the RacGFPCL construct.  One plasmid, harbouring the correct sequence was used 
in subsequent cloning.  This created plasmid pBluescript-IRES-RacGFPCL (Figure 
101). 
 
6.3.1.2 Cloning azRS into pBluescript-IRES-RacGFP 
The synthetase gene specific for azF (azRS) was amplified from the plasmid 
TPS192_RS-V1 (a kind gift from Dr Thomas Sakmar, Rockefeller University) using 
primers that added a NotI (azRSIRES001) and XbaI (azRSIRES002) site to the 5’ and 
3’ ends respectively (Appendix A2).  The digested purified PCR product and 
complementarily digested, dephosphorylated and gel extracted pBluescript-IRES-
RacGFPCL plasmid were ligated together.  Colonies were screened for azRS insert 
using T7 and T3 primers, sites of which flank the MCS in pBluescript-IRES.  A PCR 
product of 2.7 Kb indicated the insertion of azRS into pBluescript-IRES-RacGFPCL 
plasmids (Figure 103).  A product smaller than the expected product of 2.7 Kb (2 Kb) 
indicated that these colonies harboured plasmid without insertion of RacGFPCL 
(most probably amplification of IRES sequence present in original pBluescript-IRES 
plasmid).  The DNA from the four clones was isolated and the insertion position was 
sequenced to confirm successful cloning.  One plasmid, harbouring the correct 
sequence was used in subsequent cloning.  This created plasmid pBluescript-azRS-
IRES-RacGFPCL (Figure 101). 
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Figure 102.  Agarose gel of colony PCR to screen for insertion of RacGFPCL into pBluescript-IRES.  7 
randomly picked colonies (lanes 1-7) were screened for insert using primers rac FP and eGFP RP.  
Product of size 1.4 Kb corresponded to successful incorporation of RacGFP into pBluescript-IRES.  
MW was 1 Kb ladder.  –ve control = colony from plate transformed with un-ligated plasmid + DNA 
insert. 
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Figure 103.  Agarose gel of colony PCR to screen for insertion of azRS into pBluescript-IRES-
RacGFPCL.  10 randomly picked colonies (lanes 1-10) and negative control colony (lane 11; colony 
from plate transformed with un-ligated plasmid + DNA insert) were screened for azRS insert using T7 
and T3 primers, sites of which flank the MCS in pBluescript-IRES.  A PCR of product of 2.7 Kb 
indicated the insertion of azRS into pBluescript-IRES-RacGFPCL.  MW was 1 Kb ladder. 
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6.3.1.3 Cloning azRS-IRES-RacGFPCL into pcDNA3.1/zeo-RS 
This entire azRS-IRES-RacGFPCL construct was then cloned into the NotI and AgeI 
site of pcDNA3.1/zeo-RS.  PCR was used to amplify the azRS-IRES-RacGFPCL 
construct using primers (AzRSIRES001 and racGFPIRES007) that added a NotI and 
AgeI to the 5’ and 3’ ends of the PCR product respectively.  Complementarily 
digested and prepared PCR products and pcDNA3.1/zeo-RS were ligated.  Colonies 
were screened for the azRS-IRES-RacGFPCL insert using primers CMV for (plasmid 
specific) and eGFP RP (insert specific).  A PCR of product of approximately 3.28 Kb 
indicated the insertion of azRS-IRES-RacGFPCL into pcDNA3.1/zeo-RS plasmid 
(Figure 104).  Colonies that gave PCR products of lower molecular weight and those 
that gave no product were not taken forward for further analysis.  DNA from four 
colonies determined to harbour the azRS-IRES-RacGFPCL construct (by colony PCR) 
was isolated and subjected to DNA sequencing.  Sequencing confirmed the 
insertion of azRS-IRES-RacGFPCL into pcDNA3.1/zeo-RS. 
The sequencing for each plasmid demonstrated the presence of a few mutations in 
the DNA sequences.  For the plasmid harbouring the least mutations, analysis of the 
translated protein sequence (ExPASy Translate tool) demonstrated that the 
mutations were a silent glycine (GGTGGC) mutation at position 191 and a silent 
leucine (TTACTA) mutation at position 410 within azRS and Ser3Gly 
(AGCGGC) mutation in GFP (Figure 105).  The silent mutations were not 
detrimental to protein sequence and the Ser3Gly mutation within GFP was 
tolerated therefore, this plasmid DNA was utilised for subsequent cloning. 
This gave a plasmid conferring Zeocin resistance, the synthetase specific for azF and 
the RacGFPCL construct, pUAAracGFP (Figure 101). 
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Figure 104.  Colony PCR of azRS-IRES-RacGFPCL insertion into pcDNA3.1/zeo.  15 randomly picked 
colonies (lanes 1-15) were screened for azRS-IRES-RacGFPCL insert using primers CMV for (plasmid 
specific) and eGFP RP (insert specific).  A PCR product of approximately 3.28 Kb indicated the 
insertion of azRS-IRES-RacGFPCL into pcDNA3.1/zeo-RS plasmid.  No colonies were present on the 
agar plate containing E. coli cells transformed with un-ligated digested pcDNA3.1/zeo  + azRS-IRES-
RacGFPCL insert, therefore there was no  –ve control colony.  MW was 1 Kb ladder (NEB). 
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Figure 105.  Analysis and comparison of azRS-IRES-RacGFP protein sequence determined from 
DNA sequence in cloned construct pUAAracGFP and wild type protein sequences (Clustalw2, 
ExPASy) 
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6.3.1.4 Cloning BstRNA   
   
 into pUAAracGFP 
The Bacillus stearothermophilus tRNA   
   
 with the human tRNATyr leader sequence 
was amplified by PCR from the plasmid TPS136_pSVB-Yam (a kind gift from Dr 
Thomas Sakmar, Rockefeller University) using primers BstRNA FP and BstRNA RP 
that added an SspI site and NdeI site to the 5’ and 3’ ends of the PCR product 
respectively (Appendix A2).  The PCR product was ligated into complementarily 
digested, dephosphorylated and gel extracted plasmid pUAAracGFP.  Insertion of 
BstRNA   
   
 into pUAAracGFP was determined using colony PCR, using primers CMV 
RP and BstRNA FP (Figure 106).  A product of 500 bp indicated the insertion of 
BstRNA   
   
 into pUAAracGFP.  DNA from the one colony determined to harbour the 
BstRNA insertion (by colony PCR) was isolated and subjected to DNA sequencing.  
Colonies that gave PCR products of higher molecular weight and those that gave no 
product were not taken forward for further analysis.   
Sequencing confirmed the insertion of BstRNA   
   
 into pUAARacGFP.  This produced 
a plasmid conferring Zeocin resistance, the synthetase specific for azF, the 
RacGFPCL construct and the BstRNA    
   
, plasmid pUAACL (Figure 101). 
6.3.1.5 Creation of pUAAGFP 
To create a complementary plasmid encoding only eGFP, the Rac1 gene was 
removed from the pUAAracGFP plasmid using Phusion site-directed deletion 
mutagenic PCR.  The PCR was performed using primers, pUAA001-2 and pUAA002-
3, which annealed to the beginning of the GFP gene and 3’ end of the IRES 
sequence respectively.  PCR product of the expected size (7.9 Kb) was obtained, as 
determined by agarose gel electrophoresis (Figure 107), purified, ligated and used 
to transform Top10 E. coli cells.  Four colonies were picked, grown and the DNA 
prepared and sequenced.  One plasmid encoding the azRS-IRES-GFPCL construct 
was selected and utilised in further experiments.  This created a Zeocin selectable 
plasmid encoding azRS-IRES-GFPCL and BstRNA   
   
, pUAAGFPCL. 
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Figure 106.  Agarose gel of colony PCR, screening for insertion of BstRNA
   
   
 into pUAAracGFP.  
Insertion of BstRNA into pUAAracGFP (product ~ 500 bp) was determined using colony PCR (7 
randomly selected colonies), using primers CMV RP and BstRNA FP.  Colony 7, a colony from a 
transformation of un-ligated digested pUAARacGFP + insert, represents –ve control.  MW was 1 Kb 
ladder (NEB). 
297 
 
 
Figure 107.  Agarose gel of purified PCR product from PCR to remove Rac1 from plasmid pUAACL, 
to give plasmid pUAAGFPCL.  Phusion site-directed deletion mutagenic PCR was performed using 
primers pUAA001-2 and pUAA002-3, which annealed to the beginning of the GFP gene and 3’ end of 
the IRES sequence respectively.  The PCR product of 7.9 Kb indicated the amplification of pUAACL 
minus the Rac1 gene.  MW was 1 Kb ladder (NEB). 
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6.3.2 Mutagenesis of Rac1 
6.3.2.1 Analysis of Rac1 protein - placement of non-natural amino acid 
TAG mutations were required in the Rac gene in order to implement the 
incorporation of non-natural amino acids using the amber suppression technology.  
Because Rac1 is involved in a variety of signalling pathways, it has to make 
numerous interactions with a wide variety of proteins.  It was important that 
incorporation of a NAA did not significantly interfere with any of these interactions.  
A literature search was used to ascertain some of the key signalling interactions 
that Rac1 makes (outlined in Chapter 1) (for review see Bishop and Hall 2000).  
The PDB structure, 2RMK (Modha et al. 2008), was analysed for suitable speculative 
positions for the incorporation of the non-natural amino acid.  It is optimal to 
position the TAG codon, and therefore the NAA, near the 5’ end of the gene.  This 
means that there are limited possibilities of the truncated protein remaining active 
or indeed inhibitory, due to its short length, by a competitive manner or other, to 
its cognate signalling, or acting in another manner.  Due to the similarities between 
the NAAs, namely, azF, and tyrosine, it was thought that a Tyr would be a good 
substitution position for the NAA.  Phenylalanines were also considered as 
substitution positions, for the same reason.  The Phe and Tyr residues were 
highlighted in the PDB structure (Figure 108).  Those N-terminal (residues 1 - 70), in 
loops, not present within important regions (as outlined in Chapter 1) and pointing 
away from hydrophobic core were most highly considered.  It was demonstrated 
that tyrosine 23 fulfilled these criteria and was not present within the regions 
important for GTPase function and was therefore selected for mutagenesis.  
However, because Tyr residues are often phosphorylated and the presence of an 
azido group would absolutely perturb this modification, other bulky, hydrophobic 
amino acid substitutions were considered. 
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Figure 108.  Ribbon structure of Rac1 highlighting Phe and Tyr residues within N-terminal 70 
residues, PDB structure 2RMK (deposited by Modha et al. 2008).  The switch I, switch II and 
important GTP-binding residues are indicated in blue colours.  Phe and Tyr residues are shown in 
colour indicated by area.  Tyr, Y23 is indicated in red.  Polybasic region – pink, prenylation sequence 
(CLLL) – light pink.  Figure was produced using Pymol (DeLano and Lam 2006). 
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6.3.2.2 Creation of plasmids with TAG mutation 
A TAG mutation was made at position Y23 within Rac1 utilising plasmid pUAACL.  
Phusion polymerase mutagenic PCR was used to mutate Y23 in Rac1 to TAG codon 
using primers mRac1Y23TAG FP and mRac1Y23TAG RP (Figure 109).  After 
mutagenesis, the DNA from 3 colonies was purified and sequenced.  Analysis of the 
DNA sequences demonstrated that all 3 clones harboured the required TAG 
mutation.  One clone harbouring the TAG mutation along with no other mutations 
was used in further experiments.  This produced plasmid pY23TAG. 
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Figure 109.  Agarose gel of purified PCR product from PCR to introduce a TAG mutation at Y23 
within Rac1 gene, to give plasmid pY23TAG.  Phusion site-directed deletion mutagenic PCR was 
performed using primers mRac1Y23TAG FP and mRac1Y23TAG RP, which annealed to the sequence 
flanking codon Y23.  The PCR product of approximately 8.4 Kb indicated the amplification of the 
entire plasmid introducing the Y23TAG mutation Lane 1 and 2 represent two PCR reactions.  MW 
was 1 Kb ladder (NEB). 
302 
 
6.3.3 Introduction of plasmids into Rac1 KO cells 
6.3.3.1 Transient transfection of pUAACL, pUAAGFPCL and pY23TAG into Rac1 
KO 
The plasmids, pUAACL, pUAAGFPCL and pY23TAG were used to transiently transfect 
Rac1 KO cells to ensure that the plasmids were capable of expressing target genes.  
Fluorescent microscopy showed that cells transiently transfected with pUAACL and 
pUAAGFPCL showed GFP fluorescence (Figure 110), whereas Rac1 KO cells 
transiently transfected with pY23TAG did not.  This result demonstrated that the 
constructed plasmids, pUAACL and pUAAGFPCL, were capable of expressing GFP, 
indicating the use of the IRES sequence allowed expression of two genes from the 
same promoter.  Importantly, when a TAG mutation was introduced into the 
racGFPCL construct, GFP fluorescence was no longer seen (Figure 110). 
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Figure 110.  Fluorescent microscopy images of Rac1 KO cells transiently transfected with plasmids pUAACL4, pUAAGFP or pY23TAG.  Scale bar = 75 µm. 
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6.3.3.2 Transcription of genes Rac1, zeor and azRS  
To ensure that RacGFP, azRS and the Zeocin resistance gene (zeor) were successfully 
transcribed from the created plasmid constructs, RNA extraction, cDNA synthesis, 
PCR for these genes and agarose gel electrophoresis was performed using Rac1 KO 
cells that had been transiently transfected with either pUAACL, pUAAGFPCL or 
pY23TAG (Figure 111). 
PCR products corresponding to approximately 550 bp corresponded to Rac1 and 
were obtained from cellular extracts transfected with plasmids pUAACL and 
pY23TAG.  Cells transfected with pUAAGFP showed no production of Rac1 
transcript (Figure 111). 
The cells transfected with plasmids pUAACL, pUAAGFPCL and pY23TAG showed 
production of zeor transcript (PCR products approximately 375 bp) and azRS 
transcript (PCR products approximately 1.3 Kb; Figure 111). 
6.3.3.3 Stable transfection of pUAACL 
The production of a stably expressing cell line was undertaken in an attempt to 
achieve optimal numbers of cells expressing NAA-containing RAC1 and therefore 
give a significant response during wound healing.  As demonstrated in Chapter 5, 
the production of stable cells lines using Zeocin selection was shown to be possible 
by the creation of Rac1 KO cell lines stably expressing Rac1 and eGFP from plasmids 
using the commercially available plasmid, pcDNA3.1/zeo.  The plasmids pUAACL 
and pUAAGFPCL (also based on the commercially available plasmid, pcDNA3.1/zeo) 
were transfected into Rac1 KO cells and selection pressure (Zeocin) applied.  One 
resistant, GFP-positive colony harbouring the plasmid pUAACL was isolated, 
however, the growth of the colony was slow and the GFP fluorescence was lost over 
time.  For the other plasmid constructs (pUAAGFPCL, pY23TAG), there were many 
resistant colonies, but none of the colonies displayed GFP fluorescence, as 
determined by fluorescent microscopy.   
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Figure 111.  Agarose gel of RT-PCR screening for β-actin Rac1, zeo
r
, azRS.  cDNA was synthesised 
from RNA extracted from Rac1 KO cells transiently transfected with pUAAGFPCL (lane 1), pY23TAG 
(lane 2), pUAACL (lane 3); -ve water control (lane 4), plasmid (pUAACL) positive control (lane 5).  MW 
is 100 bp ladder (Promega). 
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6.3.3.4 Amber suppression in Rac1 KO cells 
The plasmid pY23TAG was used to transfect Rac1 KO cells utilising the optimised 
Fugene transfection method as determined in Chapter 5, and the medium was 
supplemented with NAA.  Whilst there was visualisation of some GFP-positive cells 
(Figure 112; indicating that amber suppression had occurred) the efficiency was too 
low to produce enough cells to perform a scratch wound assay (the functional 
cellular output assay). 
Electroporation was therefore, utilised in an attempt to improve the efficiency of 
NAA incorporation (it was postulated that electroporation would allow increased 
uptake of NAA) and thereby increase production of NAA-containing RAC1.  
Electroporation was performed either in the presence of NAA and pY23TAG DNA or 
in the presence of NAA followed by subsequent transfection of DNA by Fugene.  In 
each case no improvement in the number of GFP positive cells was observed.  
Following a similar hypothesis, liposomal transfection using Lipofectin was utilised.  
However, still no improvement in number of GFP positive cells was observed.  
In another attempt to improve the uptake of NAA, the Rac1 KO cells were cultured 
in medium without the supplementation of non-essential amino acids.  It was 
hypothesised that when NAA was supplemented into the media the ‘starved’ cells 
would increase the uptake of amino acids and thereby increase uptake of NAA.  The 
time at which NAA was added to the cells was varied (3 hours before transfection, 
at transfection or 3 hours post-transfection).  However, no improvement in number 
of GFP positive cells was observed after starving the cells of non-essential amino 
acids.  
These results demonstrated that the plasmid constructs without TAG mutation 
(pUAACL, pUAAGFPCL) produced GFP positive cells when introduced in to Rac1 KO 
cells.  However, when amber suppression was attempted using the TAG containing 
plasmid, pY23TAG, the results indicated that the Rac1 KO fibroblasts were 
refractory to amber suppression.  Also demonstrated was that NAAs, iodoF and AzF, 
appeared to have limited toxicity to the cells.  There was no immediate extensive 
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Figure 112.  Brightfield/fluorescence composite image demonstrating amber suppression in Rac1 
KO cells.  Rac1 KO cells were transiently transfected with pY23TAG and the growth media was 
supplemented with 1 mM IodoF dissolved in NaOH.  Images were capture two days post 
transfection.  Red arrows indicate GFP-positive cells, that are expressing NAA-containing Rac1-GFP.  
Scale bar = 75 µm. 
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death, in fact, very little cell death, and the cultures seemed to tolerate the NAA for 
the duration of the experiments. 
 
6.3.4 Amber suppression in HEK293 cells 
It had been demonstrated (see above) that the amber suppression had low 
efficiency in the Rac 1 KO cell line.  Therefore, a number of variables were 
investigated to try to identify the issue and subsequently increase the incorporation 
of NAA in to RAC1.  The HEK293 cell line was selected to investigate these 
considerations because these cells have previously been used successfully in the 
implementation of amber suppression.  HEK293 cells were kindly donated by Lea 
Bauer of the Tissue Engineering and Reparative Dentistry group, School of 
Dentistry, Cardiff University. 
6.3.4.1 Amber suppression using previously created plasmids 
pSWANGFP37TAG and TPS92azRS 
Firstly, a GFP37TAG construct was used to investigate whether amber suppression 
could be implemented in the HEK293 cell line.  The previously created 
pSWANGFP37TAG (Liu et al. 2007) plasmid encoded GFP with a TAG mutation at 
position 37, under the control of a CMV promoter and the orthogonal BstRNA   
    
(three copies; see Appendix A1).  This was co-transfected with another previously 
created plasmid that encoded the orthogonal azF-specific synthetase under a CMV 
promoter (TPS192azRS_V1) (Ye et al. 2009).  Fluorescence microscopy was used to 
analyse expression of GFP.  It was shown that there were green cells in wells 
transfected with the plasmids, plus azF; and no green cells in wells transfected, but 
not containing azF (Figure 113).  This result indicates that cells in wells containing 
non-natural amino acid were expressing GFP37azF.  It was shown that 0.5 mM azF 
was sufficient to allow expression of GFP37azF. 
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Figure 113.  Composite brightfield/fluorescence microscopy images of HEK293 cells performing amber suppression.  HEK23 cells were transiently transfected with previously 
created plasmids pSWANGFP37TAG and TPS194_RS.V1 using Fugene.  0.5 mM azF was added or withheld from the growth media.  Scale bar = 75 µm. 
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The consideration that either azRS protein, BstRNA   
   
, azF or GFP37azF protein 
might confer toxicity to the cells was addressed by carrying out timelapse 
microscopy on cells transfected with pSWANGFP37TAG and TPS192azRS_V1, with 
the addition of 0.5 mM azF.  Although the transfection efficiency was low, the 
timelapse microscopy showed that GFP fluorescence was observed approximately 
9 hours after addition of NAA with the GFP fluorescence intensifying up to 
approximately 24 hours (Figure 114, Movie 9).  Throughout this time it appeared 
that the cells were healthy as they were not balled up or floating.  The timelapse 
analysis also indicated that the GFP-positive cells were also able to divide.  At 
41 hours the addition of a second green cell in close proximity to the first, which 
appears to bleb from the original cell, indicates that the original GFP-positive cells 
had undergone division.  After 48 hours, the cell still appeared healthy. 
These experiments demonstrated that HEK293 cells were capable of incorporating 
NAA via the amber suppression method.  In addition, azF and the expression of 
azRS and GFP37azF were well tolerated as demonstrated by the timelapse 
microscopy of GFP positive cells. 
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Figure 114.  Composite brightfield/fluorescence timelapse images of HEK293 cells performing 
amber suppression to produce GFP37azF.  HEK293 cells were transiently transfected with previously 
created plasmids pSWANGFP37TAG and TPS194_RS.V1, and 0.5 mM azF was supplemented in the 
media.  Images were captured at specified timepoints.  Scale bar = 75 µm. 
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6.3.4.2 Transient transfection of plasmids pUAACL and pUAAGFPCL into 
HEK293 
The plasmids pzeoCL, pzeoGFPCL, pUAACL, pUAAGFPCL were used to transiently 
transfect HEK293 cells to ascertain whether these plasmids would express protein.  
It was demonstrated by fluorescent microscopy that all the plasmids were capable 
of expressing GFP (Figure 115).   
The transfection efficiency was lower for the pUAA-based plasmids than the pzeo-
based plasmids (p < 0.01; Figure 116).  However, the transfection efficiency was 
higher than that obtained using the Rac1 KO cells (see above); therefore using 
HEK293 cells makes the investigations into the functionality of the plasmids more 
accessible. 
These results demonstrate that HEK293 cells were able to express racGFP or GFP 
from the plasmids constructed as described within this Chapter. 
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Figure 115.  Composite brightfield/fluorescent microscopy images of HEK293 cells transient transfected with plasmids pzeoCL, pzeoGFPCL, pUAACL4 or pUAAGFP.  Scale bar = 
75 µm. 
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Figure 116.  Graph showing transfection efficiency of HEK293 cells transfected with either pzeoCL, 
pzeoGFPCL, pUAACL or pUAAGFPCL, using Fugene.  Images were captured using fluorescent 
microscopy and number of GFP-positive cells counted.  Errors represent average of n=4 
transfections. 
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6.3.4.2.1 Optimisation of transfection 
To try to give the best possible chance of NAA incorporation, a variety of conditions 
were varied to try to optimise the transfection of HEK293 cells.  Namely, the 
Fugene : DNA ratio and the time allowed for Fugene : DNA complexes to form.  
Plasmid pzeoGFPCL was used to optimise the transfection.  It appeared that to 
obtain a significant number of GFP-positive cells a Fugene : DNA ratio of 3 : 1 was 
required (Figure 117).  However, using a ratio of 4 : 1 did not increase the 
transfection efficiency further.  A ratio of 3 : 1 was therefore used for subsequent 
transfections.  The time for Fugene/DNA complex formation determines the size of 
the complexes and this can affect the uptake of the complexes into the cells.  The 
optimal size of complex can vary between cell lines, therefore this was also 
investigated.  It was demonstrated that using a Fugene : DNA ratio 3 : 1, a complex 
formation time of 5, 10 or 15 gave equivalent transfection efficiency (Figure 16). 
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Figure 117.  Graph comparing transfection efficiency of Fugene : DNA complexes formed using 
varying amount of DNA, ratio Fugene : DNA and complex formation time.  1 µg DNA was added per 
well.  The errors bars represent the standard deviation of average (n=3 experiments). 
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6.3.4.3 Amber suppression in HEK293 cells using one plasmid system, 
pY23TAG 
To investigate the functionality of the one plasmid system created as described 
within this Chapter (expressing azRS, BstRNA   
   
 and target gene, RacGFPCL 
harbouring at TAG mutation at Y23), the HEK293 cells were transiently transfected 
with the pY23TAG plasmid using Fugene.  The media was supplemented with 0, 0.5 
or 1 mM azF and fluorescent microscopy was used to investigate whether NAA 
incorporation had occurred.  GFP-positive cells were visualised, whereas there were 
no GFP-positive cells in the wells transfected with pY23TAG where no NAA had 
been added to the media (Figure 118).  This indicated the high fidelity of the azRS to 
incorporate NAA.  The TAG codon was located within the Rac1 gene, which was 
upstream of the GFP, therefore expression of full-length GFP provided some 
evidence that read-through of the TAG codon, and subsequent incorporation of 
NAA into protein, had occurred. 
 
6.3.4.4 Promiscuity of NAA recognised by azRS 
As mentioned previously (Chapter 3, 4), the Mj aaRS used in E. coli amber 
suppression are promiscuous towards the NAA that they charge.  No previous work 
has been performed to investigate the promiscuity of the engineered amber 
suppressor E. coli synthetases used in the mammalian system however, it seems 
likely that the same promiscuity is evident within the evolved E. coli aaRSs.  
Therefore, it was investigated whether the E. coli azRS could incorporate iodoF 
during amber suppression.  Also of note is that azF is notoriously both thermo- and 
photoreactive and therefore the use of iodoF in place of azF would dispel any issues 
regarding breakdown of the azF during preparation or storage prior to addition to 
the cells.  Therefore, HEK293 cells were transiently transfected with the plasmid 
pY23TAG and the media was supplemented with iodoF.  Fluorescent microscopy 
showed GFP-positive cells (Figure 118). 
Therefore, this experiment demonstrated that the E. coli aaRS developed for 
incorporation of azF via amber suppression in mammalian cells also shows
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Figure 118.  Composite brightfield/ fluorescent images of HEK293 cells transiently transfected with plasmid pY23TAG, plus/minus nonnatural amino acid.  Scale bar = 75 µm. 
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promiscuity towards the NAA it recognises and successfully charges.  Therefore, 
iodoF could be used in subsequent experiments. 
6.3.4.5 pY23TAG expresses sufficient levels of azRS and BstRNA   
   
 for amber 
suppression 
To investigate whether efficiency of NAA incorporation using the plasmid pY23TAG 
was limited by the levels of azRS or BstRNA   
   
 present in the cell, additional azRS 
and/or BstRNA   
   
 was supplied by transfecting the HEK293 cells with plasmid 
pY23TAG plus plasmid TPS192azRS_V1 and/or TPS136_pSVB-Yam respectively.  The 
data demonstrated that there was some increase in number of green cells when 
both azRS- and BstRNA   
   
-containing plasmids were added to the transfection, 
however the difference was not significant (Figure 119; p > 0.05).  No increase in 
GFP-positive cells was observed when either extra BstRNA   
   
 or azRS–containing 
plasmid was added to the cells.  There appeared no benefit in adding 1 mM NAA as 
opposed to 0.5 mM.  Some GFP-positive cells were visualised in the wells containing 
no NAA however, the GFP expression was much lower than that seen in the well 
containing NAA (p < 0.05).  No GFP-positive cells were observed in wells not 
transfected but supplemented with NAA. 
These experiments demonstrated that the pY23TAG plasmid was sufficient to allow 
amber suppression in mammalian cells.  Stable transfections could not be 
performed using this cell line as the genetic manipulation of this HEK293 cell line, 
rendered the cell line resistant to Zeocin antibiotics and the pY23TAG plasmid 
confers Zeocin resistance.  
To further investigate expression of azRS, pY23TAG plasmid was transiently 
transfected into control cells that had a weak Kozak consensus at the azRS 
translational start site (Appendix A1).  This was compared to transfections using the 
pY23TAG plasmid with the strong Kozak consensus sequence at azRS (Figure 120).  
There was no statistically significant difference between the number of GFP-
positive cells obtained when the Kozak sequence at the azRS was altered (p > 0.05). 
It was therefore demonstrated that the pY23TAG plasmids, along with the HEK293 
were capable of expressing NAA-containing RAC1 protein. 
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Figure 119.  Graph comparing the number of GFP-positive cells per frame of HEK293 cells transiently transfected with pY23TAG, and supplemented with plasmids containing 
BstRNA (TPS136) or azRS (TPS192).  HEK293 cells were transfected with either plasmid pY23TAG, pY23TAG + TPS136 + TPS192, pY23TAG + TPS136, or pY23TAG + TPS192.  3 hours 
post-transfection 0.5, 1 or 0 µM iodoF was supplied to the cells in the growth media.  2 days post transfection fluorescent microscopy was used to image the wells.  Number of 
GFP-positive cells was calculated by counting the number of green cells per frame.  The errors bars represent the standard deviation of average of n=3. 
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Figure 120.  Graph comparing the number of GFP-positive cells obtained when plasmid harbouring strong or weak Kozak consensus sequence control translation of azRS.  Error 
bars represent standard deviation of average of n= 6. 
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6.3.5 Amber suppression in Rac1 control cells 
Using HEK293 cells, it was demonstrated that the pY23TAG plasmid was functional 
(see above).  It was thought that the issues regarding the use of Rac1 KO cells might 
be because the experiments were conducted utilising fibroblasts.  Therefore, it was 
investigated whether the pY23TAG plasmid was functional in the Rac1 control cells.  
The control cells were the cells from which the Rac1 KO cell line was initially derived 
(kind gift from Klemens Rottner, University of Bonn).  Whether or not the pY23TAG 
plasmid was functional in this cell line would help to elucidate whether the issues 
regarding the implementation of the NAA technology in Rac1 KO cells was due to 
the refractory nature of the fibroblast cell line; or whether during the creation of 
these Rac1 KO fibroblasts something had occurred that had rendered the KO cell 
line specifically refractory to implementation of NAA technology.  
6.3.5.1 Transient transfection of plasmids pUAACL and pUAAGFPCL into Rac1 
control cells 
Firstly, the plasmids pzeoCL, pzeoGFPCL, pUAACL, pUAAGFPCL were introduced 
transiently into Rac1 control cells to test the function of these plasmids.  
Fluorescent microscopy showed that all were capable of expressing GFP (Figure 
121).  Analysis of transfection efficiency demonstrated that the transfection 
efficiency for pzeo-based plasmids was higher than that for pUAA-based plasmids 
(Figure 122, p < 0.001). 
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Figure 121.  Fluorescent microscope images of control cells transiently transfected with pzeoCL, pzeoGFPCL, pUAACL, or pUAAGFPCL.  Scale bar = 75 µm. 
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Figure 122.  Graph showing transfection efficiency of Rac1 control cells transfected with either 
pzeoCL, pzeoGFPCL, pUAACL or pUAAGFPCL, using Fugene.  Images were captured using 
fluorescent microscopy and number of GFP-positive cells counted.  Errors represent average of n=6 
transfections. 
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6.3.5.2 Rac1 control fibroblast cells are capable of amber suppression 
The ability of control cells to produce NAA-containing gene using transient 
transfection of plasmid pY23TAG, was investigated.  Quantitative analysis of 
fluorescent microscopy demonstrated that some Rac1 control cells transiently 
transfected with pY23TAG plasmid were GFP-positive when the medium was 
supplemented with either iodoF or azF (Figure 123).  This experiment demonstrated 
that the fibroblasts were capable of taking up the NAA and performing amber 
suppression. 
6.3.5.3 NAA can be dissolved by sonication or NaOH 
For previous experiments, the NAA had been dissolved in growth medium and 
sonicated to ensure the NAA was fully dissolved.  This was undertaken to limit the 
addition of substances to cell culture to NAA only.  The NAA did not dissolve easily 
in growth medium and therefore this limited the concentrations of NAA that could 
be used.  Previous work (Ye et al. 2008) had shown that NAA dissolved in NaOH 
could be used in amber suppression in mammalian culture.  Therefore, iodoF 
dissolved in NaOH were added at varying concentrations to control cells transiently 
transfected with pY23TAG and compared to NAA prepared by sonication.  It was 
demonstrated that using NaOH dissolved iodoF, a higher number of GFP-positive 
cells were obtained than for the same concentration using sonicated NAA (Figure 
124; p < 0.0001).  Adding 1 mM iodoF was optimal for both sonicated and NaOH 
dissolved iodoF (p < 0.0001).  GFP-positive cells were also obtained when NaOH 
dissolved azF was used, although the efficiency was lower than that when using 
iodoF.  This experiment demonstrated that NaOH dissolved NAA could be used in 
mammalian cell culture. 
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Figure 123.  Composite brightfield/ fluorescent images of Rac1 control cells transiently transfected with plasmid pY23TAG, plus/minus nonnatural amino acid.  Scale bar = 
75 µm. 
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Figure 124.  Graph comparing number of GFP-positive cells obtained when control cells were transiently transfected with plasmid pY23TAG and either sonicated or NaOH 
dissolved iodoF added to the media.  Error bars represent standard deviation of average from n=4 experiments. 
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6.4 Discussion 
6.4.1 Selectable one-plasmid for amber suppression 
Amber suppression technology has notoriously low efficiency in mammalian cells 
(Hino et al. 2005; Hino et al. 2011; Liu et al. 2007; Sakamoto et al. 2002; Shen et al. 
2011; Wang et al. 2007b; Ye et al. 2008).  This coupled with the low transfection 
efficiency of fibroblast cells acts in combination to drastically reduce the efficiency 
of production of NAA-protein, and therefore any phenotype observed.  To try to 
limit these effects, a selectable one plasmid construct was created, based on the 
pcDNA3.1/zeo plasmid.  In theory only cells successfully transfected with the 
plasmid and have successfully integrated the DNA into their genome, survive 
growth in medium containing Zeocin antibiotic, therefore it is only the efficiency of 
amber suppression that limits the success of the technology. 
6.4.1.1 Transient transfection 
It was demonstrated that the one-plasmid amber suppression system (pUAA-based 
plasmids) could be used transiently to express non-TAG target gene, both by GFP 
fluorescence and RNA analysis.  This demonstrated that one plasmid system, pUAA, 
was functional.  The transient expression, however, was less efficient than that 
from the pRacGFPCL and pzeoCL plasmids.  This was most probably due to the more 
complex nature of the plasmids, and the presence of E. coli genes, the expression of 
which are not well tolerated in mammalian culture.  It was also demonstrated that 
transfection efficiency varied among the cell lines tested; efficiency was lowest for 
the Rac1 KO cells, followed by the Rac1 control fibroblasts and the HEK293 cells 
showed highest efficiency.  The effect of transfection efficiency was important in 
the application of amber suppression technology and will be discussed in section 
6.4.2. 
6.4.1.2 Stable transfection 
The experiments in Chapter 5 demonstrated that stably transfected Rac1 KO cells 
expressing Rac1-GFPCL or eGFP only could be produced by selecting those cells that 
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were Zeocin resistant (at 100 µg / ml) and were positive for GFP (as ascertained by 
fluorescent microscopy).  This was encouraging and therefore provided the rational 
to attempt to create a stably transfected cell line expressing all the components 
required for amber suppression using the pUAA-based plasmids.  It was important 
to note that, because only some of the pzeoCL and pzeoGFPCL Zeocin resistant 
colonies actually expressed GFP, it was expected that only a proportion of the pUAA 
stable cell lines would express GFP.  However, none of the resistant colonies (using 
plasmids pUAACL, pUAAGFPCL) were shown to be GFP-positive, therefore were 
probably not expressing Rac1 and therefore were not used for further analysis. 
This inability to create stable cell colonies could have been due to toxicity of the 
encoded genes.  Although the cells tolerated short-term transient expression of the 
genes, long-term expression, as required during the production of stable cell lines, 
could have overloaded the cell with toxic protein and caused subsequent cell death 
or silencing of the genes.  It was later discovered that the cell line expressed the 
large T antigen (Personal communication, Klemens Rottner) therefore making the 
production of stable cell lines using plasmids encoding a SV40 promoter difficult 
(Sambrook et al. 1989)  Cells expressing the large T antigen are capable of 
replicating SV40-containing plasmids and after the insertion of the plasmid into the 
genome the replication of the plasmid still occurs (Sambrook et al. 1989).  This 
attempted replication may duplicate and insert parts of DNA sequence into the 
surrounding DNA sequence and therefore hinder the expression of target protein.  
It is possible that because the pzeo-based plasmids as used in Chapter 5 expressed 
only one gene of interest, this replication may not have perturbed expression of the 
gene.  However, the pUAA plasmids are large and complex and the attempted 
replication of this plasmid sequence may have had more of a consequence on the 
target gene expression or the genome integrity.  Replacing the SV40 sequence in 
the pUAA plasmids, with, for example the Ef1a promoter, may make the stable 
transfection of these plasmids possible (Gopalkrishnan et al. 1999).  It is also 
possible that some population of the Rac1 KO displayed some intrinsic Zeocin 
resistance and during selection this sub-population was selected and out-competed 
those cells that had stably integrated the target plasmid.  However, this was 
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unlikely because there were no resistant colonies isolated during the production of 
the kill curve. 
It is also possible that after integration of plasmid DNA into the host genome, the 
genes had been silenced by being incorporated into silenced parts of the genome or 
silenced post-integration due to the foreign nature of the target genes (Doerfler et 
al. 1997; Lichtenberg et al. 1988).  The successful isolation of one GFP-positive, 
resistant colony that subsequently lost GFP-expression during growth suggests that 
post-integration events had affected the expression of protein from the plasmid 
integration site.  The fact that not all resistant colonies expressed target gene 
would make things even more difficult for selection of the TAG-containing plasmids, 
as these cells would not be GFP-positive in the absence of NAA.  Attempts were 
made to select resistant colonies in the presence of NAA however; no colonies were 
GFP-positive.  The issues discussed above could be responsible for this finding. 
6.4.2 Amber suppression 
6.4.2.1 Cell lines successfully utilising amber suppression 
Amber suppression technology using previously designed plasmids (Liu et al. 2007; 
Ye et al. 2009) and the one-plasmid system created within this study was 
successfully applied to the HEK293 cell line.  Although the exact cell type of human 
embryonic kidney cell line is unknown (Graham et al. 1977), this HEK293 cell line 
has been widely used for a number of applications due to its robust nature, quick 
growth, easy maintenance, amenability to high transfection efficiency using a wide 
variety of methods; high protein production with faithful translation and 
processing, especially using constructs with CMV promoters (Thomas and Smart 
2005).  It is therefore an optimal cell type in which to perform amber suppression.  
This is evidenced by the fact that previous applications of amber suppression 
studies have utilised this cell line (Köhrer et al. 2001; Shen et al. 2011; Takimoto et 
al. 2009; Wang et al. 2007b; Ye et al. 2008; Ye et al. 2010). 
Other mammalian cell lines have been used for amber suppression and these 
include CHO cells (Hino et al. 2005; Liu et al. 2007; Sakamoto et al. 2002; Taki et al. 
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2002) and HeLa cells (Takimoto et al. 2009); used, once again, for their high 
transfection efficiencies and high fidelity recombinant protein expression (Jayapal 
et al. 2007).  It is important to demonstrate that different cell lines can be used for 
amber suppression, as the applications of this technology will inevitably expand and 
the use of specialised cell lines will become increasingly important.  When this work 
was initially undertaken, the cell lines routinely successfully utilised for amber 
suppression were limited to those cell lines mentioned above and one instance 
successful in neurons (Wang et al. 2007b).  
Wang et al (2007b), successfully performed amber suppression in neurons at an 
efficiency that could be detected by fluorescence microscopy.  The group 
subsequently studied NAA-containing integral membrane protein Kv1.4 that was 
expressed using HEK293 cells.  The group reported that amber suppression 
efficiencies in their study ranged from 13% to 41% relative to Tyr incorporation by 
the WT TyrRS.  It is worth noting that the efficiency reported was “relative to Tyr 
incorporation by wild-type TyrRS” and therefore takes into account the efficiency of 
amber suppression via the orthogonal tRNA and aaRS, therefore, a lower empirical 
efficiency can be proposed.  The efficiency of amber suppression in producing azF-
luciferase was reported by Ye et al (2009) to be 13 %.  During the research 
presented within this Thesis, efficiency of incorporation of Tyr was not ascertained 
and therefore efficiencies cannot be compared, however, this demonstrates that 
using specialised cell lines presents efficiency issues. 
Subsequent to the initiation of this Thesis investigation, Shen et al (2011) 
successfully performed amber suppression in neurons differentiated from the 
neural stem cell line, HCN-A94.  Amber suppression was utilised to incorporate a 
fluorescent NAA into the voltage-sensitive domain (VSD) of Ciona intestinalis 
voltage-sensitive phosphatase.  The NAA was then used to report the 
conformational changes in the VSD in response to membrane depolarisation.  The 
group stably transfected the cells with the machinery for amber suppression using 
lentiviral vectors.  Shen et al’s work demonstrated that amber suppression can be 
used in defined cell types, namely neuronal cells.  The efficiency of NAA 
incorporation was not reported however, the efficiency must have been high 
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enough to produce enough for protein for subsequent studies.  Therefore, the use 
of lentiviral vectors could be considered for application of amber suppression in the 
Rac1 KO fibroblasts because it may act to increase the ability to create stable cell 
lines and also improve amber suppression. 
The application of amber suppression to a variety of cell lines is important in 
expanding the applications of this technology, for example in studying cell line 
specific events.  The use of fibroblasts, as attempted within this Thesis, has been 
informative in developing this technology within more specialised cell lines.  
6.4.2.2 Amber suppression in fibroblasts 
Although it was demonstrated that amber suppression in Rac1 KO cells was 
successful, the efficiency was too low for further analysis.  It is possible that NAA 
incorporation had occurred in more cells but if expression of protein was too low to 
be determined via GFP fluorescence, the efficiency would most probably not be 
high enough to visualise cellular motility via scratch wound assay, which would 
require higher levels of functional protein.  However, during this study, amber 
suppression, using the pY23TAG plasmid, was demonstrated to be possible in 
HEK293 cells and Rac1 control fibroblasts.  These experiments were crucial to show 
that amber suppression was successful in fibroblasts.  Along with the observation 
that specialised cell lines, namely neurons, can be utilised for amber suppression 
(Shen et al. 2011), these considerations indicated that an issue specifically 
regarding the knock-out of Rac1 had perturbed the cells’ ability to perform amber 
suppression and demonstrated the complexities that can arise in using specialised 
cell lines for amber suppression.  Numerous possibilities for this will be considered 
below. 
6.4.2.2.1 Transfection efficiency 
It was demonstrated that the transfection efficiency was very low in Rac1 KO cells 
when compared to Rac1 control fibroblasts and HEK293 cells.  In addition, the 
pUAA-based plasmids showed lower transfection efficiencies compared to pzeo-
based or pRacGFPCL plasmids in all the cell lines transfected.  These considerations 
suggest that transfection efficiency using pY23TAG (a pUAA-based plasmid) was 
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very low in the Rac1 KO cells.  Therefore only a small population of the cells were in 
fact capable of amber suppression.  This combined with the low efficiency of amber 
suppression probably accounted for the very low numbers of GFP-positive cells 
during the experiments using NAA.  To address this issue, methods to improve 
transfection efficiency could be employed, for example, utilisation of other 
transfection methods  (for example, other proprietary transfection reagents, CaPO4, 
PEI, physical methods (For review see Luo and Saltzman 2000)); the use of stable 
cell lines (discussed above in section 6.4.1.2); and the use of a lentiviral-based 
system (as used by Shen et al (2011)).  To ascertain transfection efficiency the 
inclusion of another plasmid encoding a fluorescent protein (for example mCherry) 
during transfection would allow visualisation of transfection efficiency separate 
from the GFP used in elucidating amber suppression efficiency. 
6.4.2.2.2 Efficiency of amber suppression 
Due to the way in which the Rac1-GFP construct was designed and created, GFP 
fluorescence should have been indicative of whether NAA incorporation had 
occurred.  This is because read-through of the TAG should ideally only occur when 
NAA has been incorporated.  However, there is always a chance that a natural 
amino acid, most likely Tyrosine, could be incorporated and in this case green cells 
would be seen (Nehring et al. 2012).  GFP positive cells were visualised in the 
experiments when NAA was withheld from the medium, however, there were at 
statistically much lower levels when compared to when NAAs were included in the 
medium.  To ensure that full-length Rac1 was being expressed, a Western blot 
could have been performed using an antibody specific to full-length Rac1.  In 
addition, using an antibody for the N-terminal of Rac1, the ratio of full-length to 
truncated protein could be estimated.  To ensure NAA incorporation was occurring, 
target protein could be expressed, purified and analysed by mass spectroscopy 
(Sakamoto et al. 2002). 
In an attempt to improve formation of stable cell lines or expression of foreign 
DNA, sodium butyrate could have been utilised (Gorman et al. 1983; Kruh 1981).  It 
has been suggested that sodium butyrate enhances protein expression by 
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hyperacetyltion of histones and inhibition of histone deacetylases (HDACs), and 
therefore acts to increase the availability of the DNA for transcription. 
Specificity could be achieved by engineering a specific promoter that would drive 
the expression of mutant protein and/or orthogonal synthetase at the required 
time and in response to a specific signal.  This would limit any toxicity due to aaRS, 
mutant or truncated target protein and could help improve efficiency of amber 
suppression.  Control over expression of target genes has been utilised previously in 
amber suppression applications and is discussed further in section 6.4.2.2.6.  It 
could be beneficial if the Rac1 gene was controlled by the Rac1 endogenous 
promoter (rather than via CMV in these investigations), as a result the signalling 
cascade that culminates in upregulation of Rac1 could act to limit over-expression 
of Rac1 limiting production of truncated protein before NAA was present.  In 
addition, upregulation of Rac1 as a result of polarisation in response to scratch 
wounding and subsequent motility in to the wound could be brought about.  
Expression of orthogonal amber suppression machinery in the mammalian cell lines 
in the presence of NAA could also result in NAA being incorporated at TAG codons 
used at the translational termination position of endogenous genes.  Read-through 
of these TAGs could produce elongated proteins which could have altered function 
and signalling, which may affect the cell growth or viability (Köhrer et al. 2001; 
Sakamoto et al. 2002).  Control over the expression of the orthogonal machinery 
would aid to limit this effect by limiting amber suppression to a specified time 
frame. 
Similar investigations to those performed utilising the amber suppression Mj 
machinery (used in E. coli culture) as described in section 4.3.5.1, namely, the 
optimisation of amber suppression by creating orthogonal ribosomes or mutation 
of other factors involved in translation, could increase amber suppression efficiency 
in mammalian cells. 
6.4.2.2.3 NAA uptake and transport 
It is considered that NAAs are taken up by mammalian cells via the endogenous 
amino acid uptake machinery (Wang et al. 2007b).  The system L amino acid 
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transporter which specifically facilitates uptake of aromatic amino acids for 
example, Tyr, Phe, is the most likely candidate due to structural similarities 
between NAAs and amino acids recognised by this transporter (Giese et al. 2008; 
Malandro and Kilberg 1996).  However, uptake and metabolism of NAAs has not 
been rigorously investigated.  Further investigations into uptake of NAA and 
improvement of this will be beneficial to amber suppression technology and its 
applications. 
Giese et al (2008) demonstrated fluorinated tryptophan analogues are taken up by 
human breast cancer cells (MCF-7) through active transport using the system L 
amino acid transporter.  It was also demonstrated that NAA accumulated at a 70-
fold excess of intracellular over extracellular concentrations.  Nehring et al (2012) 
suggested that it is this accumulation of NAA at high intracellular concentrations 
that provides the means for the measurable efficiency of amber suppression 
observed.  Without this accumulation, the recognition of tyr, the original substrate 
for the orthogonal NAA-aaRSs, would occur more frequently (Nehring et al. 2012).  
However, the group also demonstrated that these NAAs effectively and irreversibly 
inhibited cell growth.  The toxicity arising from the indiscriminate substitution of 
the amino acid analogues into proteins, which disrupts their function.  Limited 
studies in to the uptake of p-benzoylphenylalanine (Bpa) by yeast have been 
performed.  It was demonstrated that at concentrations of <2 mM a methionine–
Bpa dipeptide was shown to increase the delivery of Bpa into yeast, while at 2 mM, 
both dipeptide and Bpa were equally effective (Huang et al. 2008). 
It has been demonstrated that uptake of NAAs that vastly deviate structurally from 
canonical amino acids in side chain could be improved by esterification of the 
carboxyl group (For example, DanAla, as performed by Takimoto et al. 2010).  
Takimoto’s argument was that the addition of an ester would increase the 
percentage of neutral moieties and increase lipophilicity and thereby increase 
translocation across the plasma membrane.  Once inside the cell, intracellular 
esterases would cleave the ester and regenerate the original NAA for incorporation.  
The efficiency of uptake was quantified using incorporation of NAA versus 
esterified-NAA in GFP in conjunction with flow cytometry; and HPLC (Takimoto et 
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al. 2010).  If uptake of NAA into Rac1 KO was limited due to the charged nature of 
the NAA, esterification or another modification may improve uptake and therefore 
efficiency of amber suppression. 
The work by Huang et al (2008) and Takimoto (2010) hint that uptake of NAA could 
be improved by modifying the NAA or the formation of a dipeptide.  Further 
investigations in to the mechanism of cellular uptake of NAA or augmentation of 
the NAA to improve uptake could improve amber suppression efficiency.  Future 
work could include analysis of uptake of NAA using technologies as developed by 
Takimoto (2010) or using a Northern blot-based assay as utilised by Ye et al (2008).  
This method allows separation and visualisation of two species of tRNA; those 
unbound and those bound to NAA. 
To overcome issues regarding NAA uptake via cognate amino acid transporters, a 
method using electroporation (Neumann et al. 1982) was attempted to try to 
increase uptake of NAA.  Although, typically, it is reported that electroporation can 
be used to introduce nucleic acid molecules, peptides and dyes in to mammalian 
cells, it was thought that the pores created during electroporation could facilitate 
uptake of NAA.  Electroporation had previously been used in NAA-incorporation 
technology to deliver aminoacylated-tRNAs into cells that were capable of 
expressing orthogonal aaRS and TAG-containing target genes (Monahan et al. 
2003).  Therefore, this provided the rational for attempting electroporation as a 
method to deliver NAA in to the cells.  However, the data provided in this Chapter 
demonstrated no improvement in amber suppression efficiency; however, further 
optimisation could be useful in ascertaining whether electroporation could be used 
to deliver particularly complex NAAs that might not be recognised by the 
endogenous amino acid uptake machinery. 
Liposomal transfection (Felgner et al. 1987) was also considered as a method to 
attempt to improve uptake of NAA.  Although, once again, typically reported for use 
with nucleic acids, it was hypothesised that if the NAA was present during liposome 
formation it would also be encapsulated and delivered to the cell.  The results 
indicated that liposomal transfection did not increase the production of NAA-
containing Rac1.  As further discussed below, Rac1 deficient cells may have limited 
337 
 
ability to traffic vesicles therefore it is possible that exogenous liposomes would be 
affected by this misregulation. 
Starvation of Rac1 KO of non-essential amino acids normally supplemented into the 
growth media was another method to try to increase uptake of NAA.  In this 
situation, the hypothesis was that at the point of re-supplementing the cells with 
natural amino acids or NAAs, uptake of amino acids would be upregulated because 
the cell required them for protein synthesis.  The similarities between natural and 
NAA would mean that the cell would take up both in equal quantity and this would 
increase the concentration of NAA within the cell for amber suppression.  However, 
this starvation did not appear to increase amber suppression. 
As amber suppression had been shown to be possible using the Rac1 control 
fibroblasts, it was considered that the knockout of Rac1 had implications beyond 
the limited ability of the cells to migrate.  The physical changes in the cells when 
Rac1 had been knocked out were evident by their different appearance and growth 
rate (as demonstrated in Chapter 5).  It could have been this difference in 
morphology that hinted at limitations in the cells ability to either uptake exogenous 
factors such as plasmid DNA (as observed in reduced transfection efficiency) or 
NAA, or in their ability to perform amber suppression. 
Rac1 has been demonstrated to be involved in trafficking to and from the plasma 
membrane (Benjamin et al. 2011; De Curtis 2001; Radhakrishna et al. 1999).  
Interruption of this trafficking by knockout of Rac1 could have the potential to 
affect the cells ability to take up plasmids and NAAs.  Although typically associated 
with endosomal or vesicular trafficking, the irregular signalling regarding the actin 
cytoskeleton and associated cargo movement due to the Rac1 KO could also have 
accounted for why uptake of NAA could have been a problem in the application of 
amber suppression.  
6.4.2.2.4 Gene context of the amber stop codon 
It has been reported previously that the gene context of the amber codon can 
affect the efficiency of amber suppression and therefore levels of protein produced 
(Antonczak 2012 Thesis; Antonczak et al. 2011; Bossi 1983; Normanly et al. 1986).  
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It is possible that the position of NAA incorporation within Rac1 was not optimal.  A 
directed evolution-type method to sample possible NAA incorporation sites could 
be used to optimise insertion position and protein expression efficiency (Daggett et 
al. 2009).  In fact, the application of directed evolutionary approach to sampling 
TAG insertion position has been reported to be successful (Baldwin et al. 2009).  
This method would screen unlikely and un-anticipated successful positions for 
insertion of NAA and by testing function of Rac1 protein; an ideal position could 
therefore be identified. 
In those cells where NAA incorporation was successful, it was possible that 
expressed protein would not be functional.  The mutation of the residue could have 
had a deleterious effect on Rac1 folding or function; or a gain of toxic function.  The 
removal of the Tyr could also have potential loss of function due to the abolition of 
the phosphorylation site.  This consideration would not pose a significant problem 
in Rac1-WT cells (HEK293 and Rac1 control fibroblasts) because functional Rac1 
would be present within the cells.  However, within the Rac1 KO cells, the presence 
of non-functional Rac1 could interfere with a variety of signalling cascades and 
result in severe alteration of phenotype.  This could have resulted in cell death 
before accumulation of NAA-containing RAC1 protein to visible and functional 
levels. 
Also worthy of consideration is that the build up of truncated protein where NAA 
incorporation had failed had a deleterious effect on the health or viability of the 
cell.  Therefore cells successfully transfected with the pY23TAG plasmid were less 
likely to survive and grow.  The insertion of the TAG mutation close to the N-
terminal of the protein was used in an attempt to limit the production of toxic 
truncated protein by producing very short truncates. 
In mammalian cells, another factor limiting the efficiency of NAA incorporation is 
the stability of the UAG-containing mRNA.  Nonsense mediated decay (NMD) 
orchestrates the degradation of mRNAs that contain premature stop codons and 
presents a significant problem when performing NAA incorporation via amber 
suppression.  Wang and Wang (2008) have addressed this issue in yeast, by 
developing a yeast strain lacking an essential component of the NMD mechanism, 
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UPF1.  Strains lacking UPF1 exhibited a two-fold increase in target gene expression 
when compared to wild type cells.  The development of a similar system within 
higher eukaryotes could help to improve the efficiency of NAA incorporation using 
amber suppression by increasing the mRNA levels. 
6.4.2.2.5 Expression of suppressor tRNA 
The number of BstRNA   
   
 copies used in the application of amber suppression 
varies from one copy (as used within this study and Wang et al. 2007b), three (Liu 
et al. 2007), four (Shen et al. 2011), nine (Hino et al. 2011; Sakamoto et al. 2002) 
and to a ten-fold excess of tRNA   
   
 containing plasmid (Ye et al. 2009).  It was 
considered that more than one copy of orthogonal tRNA was required for efficient 
amber suppression due to the efficiency of expression and function of a bacterial 
gene in mammalian cells.  However, during this study, plasmid pY23TAG contained 
one copy of BstRNA   
   
 and this was demonstrated to be sufficient to allow amber 
suppression in HEK293 cells and Rac1 control fibroblasts.  In fact the 
supplementation of extra plasmid containing BstRNA   
   
 in to the transfection did 
not appear to increase the efficiency of amber suppression.  However, this could 
not be considered a direct comparison as the BstRNA   
   
 copies were not in tandem 
as for the other applications but supplemented on a separate plasmid.  Unequal 
transfection efficiency of either of the plasmids or difference in levels of expression 
from different plasmid backbones could account for this difference.  To check the 
expression of tRNA   
   
 and whether the tRNA   
   
 was efficiently loaded with NAA, a 
Northern blot assay could be utilised (Ye et al. 2008). 
Mammalian cells stably expressing amber suppressing tRNA   
   
s have been created 
and shown not to perturb cell growth (Hudziak et al. 1982).  On the other hand, it 
has been suggested that constitutive expression of suppressor tRNA is detrimental 
to mammalian cells and that regulation of expression of the tRNA   
   
 could aid in 
the efficiency of amber suppression in mammalian cells by limiting the toxicity 
conferred by tRNA   
   
 (Köhrer et al. 2001). 
Both E. coli tRNA   
   
 (EctRNA   
   
) and Bacillus stearothermophilus tRNA   
   
 
(BstRNA   
   
) have been utilised for amber suppression in mammalian cells.  
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Although EctRNA   
   
 would be complementary to the EcTyrRS used within this 
study, the EctRNA   
   
  does not express well in mammalian cells due to the absence 
of an A-box which is required for efficient transcription by RNA polymerase III.  
Therefore the BstRNA   
   
 has previously (Kiga et al. 2002; Sakamoto et al. 2002), 
and within this study, been utilised in amber suppression in mammalian cells as it 
contains a natural A-box within its sequence (Bedouelle 1990; Sakamoto et al. 
2002).  However, various ways to increase the transcription of EctRNA   
   
 have 
been investigated.  Wang et al (Wang et al. 2007b), have demonstrated that the use 
of the H1 promoter at the 5’ end of the tRNA gene allows efficient expression of 
EctRNA   
   
 without the need of an intact A-box.  Therefore, it could be beneficial to 
use the EctRNA   
   
 in conjunction with EcTyrRS in this study, because the 
recognition of EctRNA   
   
 by EcTyrRS is cognate and may improve efficiency of 
aminoacylation and therefore efficiency of amber suppression.  By using either 
BstRNA   
   
 or EctRNA   
   
, efficiency of amber suppression could be improved by 
further engineering the tRNA   
   
 to improve expression, recognition by TyrRS or 
function during amber suppression. 
6.4.2.2.6 Expression of aaRS 
In order to ensure the expression of azRS from the pY23TAG plasmid was sufficient, 
supplementation of azRS was achieved by the transfection of extra azRS-containing 
plasmid (TPS192asRS_V1).  It was demonstrated that this supplementation did not 
improve the amber suppression efficiency in HEK293 cells, indicating that 
expression of azRS from pY23TAG was occurring at sufficient levels.  To perform a 
more detailed analysis of azRS expression, a Western blot could have been 
performed. 
NAA-specific synthetases are produced from a library of synthetase genes 
harbouring mutations at five defined positions that have been rationally selected.  
These positions were chosen based on the crystal structure of the homologous 
Bacillus stearothermophilus TyrRS and are within 6.5 Å of the para position of the 
aryl ring of the bound tyrosine (Chin et al. 2003a).  Takimoto et al (2009) recognised 
that the mutation of the anticodon of orthogonal tRNA   
   
 to CUA changes the 
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affinity of the tRNA towards its synthetase. The group therefore addressed this 
issue by attempting to improve the recognition of the EcTyrRS towards the tRNA   
   
 
by engineering the anticodon-binding region of the aaRS.  The work demonstrated 
that an Asp265Arg mutation in multiple NAA-specific aaRSs increased the activity 
toward tRNA   
   
, when compared to the original aaRS.  However, it has been 
considered previously that a rational design approach may not be ideal when 
engineering enzymes for altered functions.  Instead, the use of a directed 
evolutionary method may sample mutations not considered during rational design 
(Arnold and Volkov 1999; Dalby 2003).  Therefore, the Asp265Arg mutation along 
with further engineering of the aaRSs used in amber suppression may improve 
efficiency and fidelity of NAA recognition.   
Control over the expression of NAA-synthetases has been implemented using TetO 
regulation in conjunction with the T-REx-CHO cells (Invitrogen), which constitutively 
express the tetracycline repressor (Hino et al. 2005; Hino et al. 2011; Liu et al. 2007; 
Sakamoto et al. 2002).  The addition of tetracycline to the growth media induces 
expression of the NAA-aaRS, thereby allowing temporal control over the expression 
of the potentially toxic NAA-aaRS.  However, this method of control is limited, at 
this time, to the use of the T-REx-CHO cell line which contains the tetracycline 
repressor gene.  Introduction of this gene into other cell lines or expression from a 
plasmid could expand this application to more useful cell lines.  Control over 
expression of orthogonal machinery would limit the incorporation of NAA at TAGs 
at termination points of endogenous genes, which may increase health and viability 
of the cells and also improve, and add more control over, amber suppression. 
6.4.2.2.7 Promiscuity of azRS 
Six synthetase variants have been evolved that recognise azF (Chin et al. 2003a) 
(Table 17 ).  Of these six, Ye et al (2009), further analysed their ability to efficiently 
incorporate azF.  The group demonstrated that azRS_V1 was most effective at 
amber suppression and this azRS was therefore utilised in the work within this 
Chapter.  As shown in Chapter 3 and previous work (Antonczak 2012 Thesis), the Mj 
aaRSs evolved for certain NAAs for amber suppression in E. coli are promiscuous 
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towards the NAA that they can recognise and aminoacylate tRNA   
   
 with.  During 
the work presented within this Chapter, it was ascertained that the E. coli aaRS 
developed for incorporation of azF via amber suppression in mammalian cells also 
showed promiscuity towards the NAA it recognised and successfully aminoacylated.  
Namely, in the incorporation of iodoF in to target protein.  This finding was useful 
because iodoF is more stable compared to azF.  azF has been demonstrated to be 
thermo- and photo-reactive (Chapter 3 and references within); therefore storage of 
the diluted amino acid was unwise.  Using iodoF in place of azF has the benefits that 
stored iodoF and iodoF used throughout the culture period should remain 
chemically unchanged.  
In consideration of this promiscuity, the residues within various mutant aaRSs were 
compared (Table 17) (Brick et al. 1989; Chin et al. 2003a) .  As with mutant MjaaRSs, 
the residue at 37 is crucial in distinguishing cognate Tyr binding from NAA binding.  
In each of the iodoF and azF mutants the hydrogen bonding performed by Tyr37 
and Asp182 to cognate Tyr is abolished.  Instead a hydrophobic residue resides in 
place of Tyr37 and Ser (or Asn) in place of Asp182 (Table 17).  These residues 
therefore reduce recognition of Tyr and expand the binding cavity to allow 
accommodation of the bulkier side chains of the NAAs.  The other mutated residues 
are similar between aaRSs evolved for iodoF and azF.  Within the group of aaRSs for 
azF there is represented a residue that is also seen within the group of iodoF-
specific aaRSs (Table 17).  Therefore, these similarities may account for why iodoF is 
recognised by the azF-specific aaRS. 
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Table 17.  Important residues in mutant aaRSs for amber suppression in mammalian cells (Chin et 
al. 2003a). azF 1 was used in this study. 
 Residue 
NAA-specific aaRS 37 126 182 183 186 
WT Ec TyrRS  Tyr Asn Asp Phe Leu 
      
iodoRS 1 Val Asn Ser Tyr Leu 
iodoRS 2 Iso Asn Ser Met Leu 
iodoRS 3 Val Asn Ser Met Ala 
      
azF 1 Leu Asn Ser Met Ala 
azF 2 Val Asn Ser Ala Ala 
azF 3 Leu Asn Ser Ala Ala 
azF 4 Val Asn Ser Ala Val 
azF 5 Ile Asp Asn Phe Val 
azF 6 Thr Asn Ser Ala Leu 
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6.4.3 Controlling phenotype 
The aim of the work presented within this Chapter and Chapter 4 was to control the 
motile phenotype of a mammalian and bacterial cell respectively.  Although the 
application demonstrated limited success, the amber suppression technology has 
been explored previously to produce a cell readout system controllable by the 
presence of NAA.  In addition other methods to control phenotype have been 
utilised, some of these applications that relate to amber suppression or Rac1 
protein will be discussed below. 
Liu et al (2011), noted that bacteria control the expression of some of their genes 
through the use of 5′ transcriptional regulation units called cis-regulatory leader 
peptides.  The translation of this leader peptide determines whether the 
downstream genes are transcribed efficiently.  The group inserted a TAG mutation 
into the sequence of this leader peptide, so that when amber suppression 
machinery was introduced into the cell, it was capable of inserting NAA within the 
peptide.  The group produced switches that when NAA was supplemented; the 
leader peptide was produced, and orchestrated the production (ON) or the 
hindrance (OFF) of the downstream gene, which, in this case was a test protein, 
GFP. 
Huang et al (2008), have also investigated whether amber suppression can be 
utilised to control phenotype of a cell, in this case using Saccharomyces cerevisiae.  
The group investigated the production of NAA-containing (Bpa) Ste2p, a GPCR 
which arrests growth of cells in response to tridecapeptide pheromone α factor.  
The group explored whether NAA-containing Ste2p could bind ligand (α factor) and 
ultimately transduce the signal across the cell membrane, and in turn cause arrest 
of growth, as determined by formation of a clear halo (of no growth) around a disk 
impregnated with α factor when placed on top of an agar lawn of the yeast cells.  
The group demonstrated that in the presence of NAA, Ste2p was produced and the 
phenotype was observed (arrest of growth), whereas when NAA was absent the 
phenotype was reduced.  The group noted the importance of TAG read-through, as 
some functional receptor was produced when NAA was absent from the culture 
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which resulted in the specific phenotype being observed.  Also noted was the 
expression level and tolerance of NAA within insertion position affected whether 
functional receptors were produced and whether the phenotype was observed. 
Another application to attempt to control eukaryotic phenotype via amber 
suppression was described by Edwards et al (2009).  The group created a 
photocontrollable Cre-recombinase protein.  Cre protein catalyses the DNA strand 
exchange at loxP sites introduced in to flanking regions of a target gene allowing 
excision.  Cre mediates this process utilising nucleophilic tyrosine-324.  The group 
replaced tyrosine-324 with a photocaged o-nitrobenzyl tyrosine (ONBY) using 
amber suppression in E. coli cells.  Protein was introduced in to HEK293T cells and 
the photocaged group was unmasked by irradiation.  This resulted in subsequent 
function of the Cre protein, removal of target gene and loss of phenotype. 
A further report described the development of a genetically encoded 
photoactivatable derivative of Rac1 (Wang et al. 2010b; Wu et al. 2009).  The group 
created a Rac1-LOV (photoreactive light oxygen voltage domain from phototropin) 
construct, in which Rac1 is inactive (in the dark) due to steric blocking by the LOV 
domain.  Irradiation of the LOV domain induced a reversible conformational change 
which restored Rac1 function, resulting in Rac1-induced directed cell movement via 
lamellipodia formation.  This work demonstrated that cell migration could be 
controlled spatially and temporally, via the intracellular regulation of enzymatic 
activity of Rac1 using a reversible light-induced reaction. 
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6.5 Conclusion 
The aim of the work presented within this Chapter was to apply the amber 
suppression technology to control the mammalian cell readout system developed 
within Chapter 5.  To develop this technology, a one-plasmid system harbouring the 
machinery for amber suppression was designed, created and demonstrated to be 
functional.  However, amber suppression in the Rac1 KO cell line demonstrated low 
efficiency and despite optimisation of amber suppression using HEK293 cells and 
Rac1 control fibroblasts, a high enough efficiency to effect a change in phenotype 
could not be realised.  The results suggested that the specific nature of the Rac1 KO 
had rendered the cells refractory to amber suppression; therefore further work to 
circumvent these problems could still allow amber suppression control of cell 
motility. 
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7 CHAPTER 7:  GENERAL CONCLUSIONS 
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The site-specific incorporation of non-natural amino acids (NAAs) into proteins is a 
powerful tool used in modern chemical biology.  There have been a variety of 
methods explored to incorporate novel reactivities into protein.  The development 
of the amber suppression method provides a site-specific method that utilises the 
endogenous translation machinery along with exogenous orthogonal aminoacyl 
tRNA synthetase/tRNA pairs (aaRS/tRNA) to incorporate NAAs. 
This work presented within this thesis has evaluated the amber suppression 
method and the various applications it has been used for.  The use of orthogonal 
Tyr-derived machinery was the main focus as this machinery was used in the 
applications presented within this thesis.  Namely, the Methanococcus jannaschii 
TyrRS/tRNA for application in E. coli cells; and E. coli TyrRS/Bacillus 
stearothermophilus tRNA for application in mammalian cells.  Established 
applications of amber suppression include installation of post-translational 
modification mimics, modulation of protein function, protein structural 
determination, introduction of novel reactivity and probes.  The aims within this 
Thesis were to expand upon these current applications and to apply amber 
suppression technology to two novel applications.  Specifically, the study of a 
photoreactive moiety within a defined environment within a protein and the 
creation of a biological switch controlled by the presence or absence of NAA. 
The first novel application of amber suppression, presented within Chapter 3, 
successfully demonstrated generation of reactive intermediates derived from NAAs 
within the hydrophobic pocket of a protein interior.  Namely, the incorporation of 
the aryl azide-containing NAA, azF, into the hydrophobic pocket of T4 Lysozyme 
protein.  Photoreaction of the azide group was studied by EPR, which detected the 
production of triplet phenyl nitrene.  This work demonstrated the use of a novel, 
but also practical technique to generate and study highly reactive intermediates.  
The work presented within Chapter 3 has been accepted for publication by ACS 
Organic Letters. 
The second novel application, presented within Chapter 4, 5 and 6, was to develop 
a cellular readout system that could ultimately be controlled by the 
presence/absence of NAA.  Here, the amber suppression method itself was the 
349 
 
basis for the novel application rather than the chemical reactivity of the NAA.  The 
hypothesis was to exploit the nature of the method that two scenarios occur 
depending on the presence/absence of the non-natural amino acid.  The production 
of NAA-containing full-length protein would occur in the presence of NAA and 
would result in observation of phenotype, whereas when NAA was withheld, only 
truncated non-functional protein would be produced, and the phenotype would not 
be observed. 
Chapter 4 explored this duality of amber suppression in an attempt to control the 
motility of an E. coli cell by the modulation of flagellin (and therefore flagella) 
production.  It was hoped that in developing this readout system, a new method to 
screen NAA-specific aaRSs could be developed.  The selection of efficient aaRSs 
could be achieved by picking E. coli cells that display efficient swimming ability after 
the supplementation of NAA, namely, those from the outside of the swimming halo 
on a motility assay plate.  A cell readout system was successfully created using a 
FliC (flagellin gene) knockout strain and plasmid-encoded FliC (with or without TAG 
mutation).  However, when the amber suppression machinery was introduced in to 
the cell along with NAA, motility could not be restored to the non-motile strain.  
The complex nature of the flagellin subunit export or formation into functional 
flagella could have accounted for this; or possibly that the efficiency of NAA 
incorporation was too low to produce enough flagellin monomers to form 
functional flagella. 
Chapter 5 demonstrated the successful development of a cellular readout system 
for mammalian cells.  Once again, motility of the cell was chosen as a visual 
phenotype and the target gene was Rac1 GTPase, which is vital for the production 
of lamellipodia in fibroblasts and without it limited motility is observed.  In cells 
harbouring Rac1 knockout, this limited motility was observed and recovery of 
motility was observed after the re-introduction of Rac1 via plasmid. 
Chapter 6 sought to develop the readout system developed in Chapter 5 and apply 
amber suppression to control the readout.  A selectable one-plasmid system, 
harbouring the target gene and orthogonal machinery for amber suppression was 
designed and created.  However, after introduction into the Rac1 KO fibroblasts, 
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the motility could not be restored due to the low efficiency of target protein 
expression, despite optimisations.  Although, amber suppression was not successful 
in Rac1 KO fibroblasts, it was successful in Rac1 control fibroblasts and HEK293 
cells.  This demonstrated that the plasmid specially created for the purpose was 
functional.  Therefore, it was surmised that the specific nature of the Rac1 KO had 
significantly reduced transfection efficiency or rendered the cells refractory to 
amber suppression.  Further optimisation of amber suppression in E. coli and 
mammalian culture could improve the efficiency of expression of NAA-containing 
target gene and therefore improve the success of these applications.  In addition, 
the selection of less complex read-out systems could also be considered. 
In summary, the work presented within this Thesis has attempted to expand the 
applications of the amber suppression method and has therefore contributed to 
this expanding scientific field. 
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9.1 A1 Plasmids 
Table 18.  T4L specific plasmids (Chapter 3) 
Plasmid name 
Backbo
ne 
Resista
nce 
Promot
er 
Contr
ol 
Gene Mutations 
Termin
ator 
Ori 
Size 
(Kb) 
Use Provider 
pET101T4L153TAG pET101 Amp T7 lacI 
T4 
Lysozyme 
cys free, 153-->TAG T7 pBR322   
expression of T4L153p-iodo, 
used with , in BL21(DE3) 
Dr Eric 
Tippmann 
pAAT4L153TAG pAA CAM T5 lacO  
T4 
Lysozyme 
cys free, 153-->TAG; 
Missing ACG codon 
at T152, codon 
optimised 
T5 p15A 7.0 expression of T4L153, and 
cloning 
Dr Alicja 
Antonczak 
      lpp   M j tRNACUA  rrnC      
pT4L153TAG   CAM T5   
T4 
Lysozyme 
cys free, 153-->TAG; 
no histag 
to     
  
Dr Eric 
Tippmann 
      lpp   Mj tRNACUA   rrnC      
pBADT4LWT pBAD Amp araBAD araC 
T4 
Lysozyme 
cys free,  araBAD pBR322 7 expression of WT T4L 
Dr Ryan 
Mehl 
pBADT4L153TAG pBAD Amp araBAD araC 
T4 
Lysozyme 
cys free, 153-->TAG araBAD pBR322 7 expression of T4L153pazF 
Dr Ryan 
Mehl 
pDULEazF   Tet lpp   azRS   rrnB p15A 6.2 
expression of azRS for amber 
suppression 
Dr Jason 
Chin 
      lpp   tRNACUA   rrnC         
pAAazRS pAA CAM T5 lacO azRS   rrnC p15A 7.8 
express synthetase and tRNA, 
for expressions of T4L153paz 
Dr Matt 
Edmundson 
      lpp   
2 x M. j 
tRNACUA 
  rrnC       
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pBKpIodo pBK Kan glnS'  - Mj iodoRS  glnS'   
expression of iodoRS for amber 
suppression 
Ryu and 
Schultz 2006 
pSUPiodoRS pSUP CAM glnS'   
Mj 
iodoFaaRS 
  glnS' p15A   
expression of T4L153p-iodo, 
used with , in BL21(DE3) 
Dr Eric 
Tippmann 
      proK   
2 x (3 x 
tRNACUA) 
  proK       
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Table 19.  FliC specific plasmids (Chapter 4) 
 
                      
pAAFliC pAA CAM T5 lacO FliC - rrnC p15A 8.0 express synthetase and tRNA and 
WT FliC, introducing into FliC 
knockout strains 
Josephine 
Morris 
      lpp   2 x M. j tRNACUA   rrnC       
pQEFliC pQE60 Amp T5 lacO FliC 
Q76R, D121V, 
T400A 
to ColE1 5 
introducing into FliC knockout 
strains 
Josephine 
Morris 
pFD313 pBR322 Amp 
FliC 
natural 
- FliC 
missing 
codons 245 - 
301 
FliC 
natu
ral 
BR322   
introducing into FliC knockout 
strains, basis for cloning pFDFliC 
Berry Group 
pFDFliC pBR322 Amp 
FliC 
natural 
- FliC 
Y246R, A247S, 
A301K, V302L,  
FliC 
natu
ral 
BR322   
introducing into FliC knockout 
strains 
Josephine 
Morris 
pFDFliC239TAG pBR322 Amp 
FliC 
natural 
- FliC239TAG 
239TAG, 
Y246R, A247S, 
A301K, V302L,  
FliC 
natu
ral 
BR322   
introducing into FliC knockout 
strains, for amber suppression 
Josephine 
Morris 
pFDFliC318TAG pBR322 Amp 
FliC 
natural 
- FliC318TAG 
318TAG, 
Y246R, A247S, 
A301K, V302L,  
FliC 
natu
ral 
BR322   
introducing into FliC knockout 
strains, for amber suppression 
Josephine 
Morris 
pFDFliC54TAG pBR322 Amp 
FliC 
natural 
- FliC318TAG 
54TAG, 
Y246R, A247S, 
A301K, V302L,  
FliC 
natu
ral 
BR322   
introducing into FliC knockout 
strains, for amber suppression 
Josephine 
Morris 
pFDFliC4TAG pBR322 Amp 
FliC 
natural 
- FliC4TAG 
4TAG, Y246R, 
A247S, A301K, 
V302L,  
FliC 
natu
ral 
BR322   
introducing into FliC knockout 
strains, for amber suppression 
Josephine 
Morris 
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Table 20.  Mammalian Plasmid list (Chapter 5, 6) 
Name  Backbone 
Bacterial 
resistanc
e 
Pro
mot
er 
Regul
ation 
Gene of 
importance 
Mutation
/notes 
Termina
tor 
Ori 
Size 
(Kb) 
Use 
Created/ 
supplied by 
TPS136_pSVB-Yam pSVBpUC Amp     BstRNACUA     pUC9 7.7   
Prof. Thomas 
Sakmar 
TPS194_Fluc.Y70am pCMVTnT Amp CMV   
Firefly 
luciferase 
Y70TA
G 
SV40 
late pA 
  5 5' beta-globin leader sequence 
Prof. Thomas 
Sakmar 
TPS192_RS-V1 pcDNA3.1 Amp CMV   azRS   BGHpA pBR322 6.7 
azRS cloned in to pUAA derived 
plasmids 
Prof. Thomas 
Sakmar 
pSWANGFP37TAG   Amp CMV TetO 
GFP37TAG-c-
Myc,6his 
    pUC   
expression of GFP37azF in HEK cells 
under control of amber suppression 
technology 
  
Dr Wenshe Liu 
          
3 x 
BstRNACUA 
          
                        
peGFP   Kan/Neo CMV - eGFP - SV40pA pUC 4.7 
plasmid used to make racGFP 
construct and as control during 
transfections 
Josephine 
Morris 
pGFPRac   Kan/Neo CMV - 
GFP-rac 
fusion 
- SV40pA pUC 5.3 
plasmid used to make racGFP 
construct and used to restore 
motility to RacKO fibroblasts 
Klemens 
Rottner 
pRacGFPCL   Kan/Neo CMV - 
rac-GFPCL 
fusion 
CLLL 
sequence 
moved to 
C-term of 
GFP 
SV40pA pUC 5.3 
restore motility to RacKO fibroblasts, 
preliminary to non-natural amino 
acid technology implementation 
Josephine 
Morris 
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pRacGFPRK   Kan/Neo CMV - 
rac-GFPRK 
fusion 
polybasic 
and CLLL 
sequence 
C-term of 
GFP 
SV40pA pUC 5.3 
restore motility to RacKO fibroblasts, 
preliminary to non-natural amino 
acid technology implementation 
Josephine 
Morris 
                        
pBluescript-IRES   Amp     IRES 
IRES 
inserted 
between 
BamHI 
and EcoRI 
sites 
  ColE1 3.6 cloning using IRES 
Dr Xiao-Qing 
Wei 
                        
pBluescript-IRES-
racGFPCL 
  Amp -   
IRES-
racGFPCL 
    ColE1 5 
cloning azRS-IRES-racGFPCL 
construct 
Josephine 
Morris 
pBluescript-IRES-
racGFPRK 
  Amp -   
IRES-
racGFPRK 
    ColE1 5 
cloning azRS-IRES-racGFPRK 
construct 
  
pBluescript-azRS-
IRES-racGFPCL 
  Amp -   
azRS-IRES-
racGFPCL 
    ColE1 6.3 
cloning azRS-IRES-racGFPCL 
construct into pcDNA3/zeo 
Josephine 
Morris 
pBluescript-azRS-
IRES-racGFPRK 
  Amp -   
azRS-IRES-
racGFPRK 
    ColE1 6.3 
cloning azRS-IRES-racGFPRK 
construct into pcDNA3/zeo 
Josephine 
Morris 
                        
pcDNA3.1/zeo RS 
pcDNA3.1
/zeo 
Amp 
SV40
p 
  Zeocin - SV40pA pUC 6.3 
Used in cloning Zeocin selectable 
plasmid  
  
      CMV   EcTyrRS 
added 
AgeI 
BGHpA       
pzeoCL 
pcDNA3.1
/zeo 
Amp 
SV40
p 
  Zeocin 
 
SV40pA pUC 6.4 
Selectable rac-encoding plasmid, 
used to create stably transfected 
racKO cells, investigate racGFPCL in 
stable txns 
Josephine 
Morris 
      CMV   racGFPCL 
cloned 
into NotI 
& AgeI 
site of 
BGHpA     
392 
 
pzeo 
pzeoGFPCL 
pcDNA3.1
/zeo 
Amp 
SV40
p 
  Zeocin   SV40pA pUC 5.8 
Selectable GFPCL encoding plasmid, 
used to create stably transfected 
racKO cells, control for investigation 
into racGFPCL in stable txns 
Josephine 
Morris 
 
    CMV   GFPCL 
cloned 
into NotI 
& AgeI 
site of 
pzeo 
BGHpA     
pzeoRK 
pcDNA3.1
/zeo 
Amp 
SV40
p 
  Zeocin 
cloned 
into XbaI 
& ApaI 
site of 
pzeo 
SV40pA pUC 6.4 Selectable plasmid, expressing 
racGFPRK, not used to due toxicity 
Josephine 
Morris 
      CMV   racGFPRK   BGHpA     
pUAARK 
pcDNA3.1
/zeo 
Amp 
SV40
p 
  Zeocin - SV40pA pUC 8.4 
not used in mammalian culture, due 
to intolerance of racGFPRK construct 
Josephine 
Morris 
      CMV   
azRS-IRES-
racGFPRK 
  BGHpA     
pUAACL4 
pcDNA3.1
/zeo 
Amp 
SV40
p 
  Zeocin - SV40pA pUC 8.4 
Selectable plasmid used to create 
stably transfected racKO cells, 
investigate function of azRS-IRES-
RacGFPCL construct 
Josephine 
Morris 
      CMV   
azRS-IRES-
racGFPCL 
  BGHpA     
pUAA-rac 
pcDNA3.1
/zeo 
Amp 
SV40
p 
  Zeocin - SV40pA pUC 8.3 Selectable plasmid used to create 
stably transfected racKO cells, 
control for pUAACL 
Josephine 
Morris 
      CMV   
azRS-IRES-
GFPCL 
  BGHpA     
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pUAAGFP 
pcDNA3.1
/zeo 
Amp 
hum
an 
Tyr 
lead
er 
sequ
ence 
  BstRNACUA 
CUA 
anticodon 
    7.9 
control for pUAAY23TAG, no rac 
Josephine 
Morris 
 
    
SV40
p 
  Zeocin - SV40pA pUC   
      CMV   
azRS-IRES-
GFPCL 
  BGHpA     
pUAAGFP37TAG 
pcDNA3.1
/zeo 
Amp 
hum
an 
Tyr 
lead
er 
sequ
ence 
  BstRNACUA 
CUA 
anticodon 
    7.9 
37TAG mutant GFP, in one plasmid 
system.  Test whether azRS, BstRNA 
constructs work 
Josephine 
Morris 
 
    
SV40
p 
  Zeocin - SV40pA pUC   
      CMV   
azRS-IRES-
GFP37TAGCL 
GFP 
37TAG 
BGHpA     
pUAAY23TAG 
pcDNA3.1
/zeo 
Amp 
hum
an 
Tyr 
lead
er 
sequ
ence 
  BstRNACUA 
CUA 
anticodon 
    8.4 
Y23TAG  mutant of final plasmid, for 
important switch experiments 
Josephine 
Morris 
      
SV40
p 
  Zeocin - SV40pA pUC   
      CMV   azRS-IRES- rac BGHpA     
394 
 
racGFPCL Y23TAG 
      
SV40
p 
  Zeocin   SV40pA pUC   
      CMV   
azRS-IRES-
racGFPCL 
rac I4TAG BGHpA     
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9.2 A2 Primers 
Name Sequence (5' --> 3') 
Nucleotide 
length that 
anneals 
Tm 
(Finnzym
es; °C) 
GC % Annealing site Use 
Miscellaneous   
   
    
T7 promoter TAATACGACTCACTATAGGG 20 52 40 T7 promoter 
sequencing plasmids, e.g. pET, pBluescript-IRES 
T7 terminator GCTAGTTATTGCTCAGCGG 19 61 53 T7 terminator 
    
   
    
JYRS-for atggacgaatttgaaatgataaagag 26 64 31 anneals to aaRS gene, FP 
sequencing synthetase genes 
JYRS-rev ttataatctctttctaattggctc 24 57 29 anneals to aaRS gene, RP 
    
   
    
pBADrev  seq 58 tctgatttaatctgtatcaggc 58 
  
    
    
   
    
T4Lysozyme   
   
    
pAAT4L153TAG + 
ACG FP 
5' - /5Phos/GAA ACG CGT 
GAT TAC CAC GTA GAA AAC 
CG - 3'  
29 75 48 
around codon 153 
to try to re-introduce the missing ACG 
(Threonine) at codon 152, using Phusion site-
mutagenesis kit (PCR) 
pAAT4L153TAG  RP 
5' - /5Phos/GCG CGG TTC 
GGG GTC TGG T - 3' 
19 76 74 
    
   
    
JLMt4l003-F 
GAAACGCGTGATTACCACGT
AGAAAACCGCAC 
32 78 50 
around codon 153 
to try to re-introduce the missing ACG 
(Threonine) at codon 152, using Quikchange 
site-mutagenesis kit (PCR) JLMt4l004-R 
GTGCGGTTTTCTACGTGGTAA
TCACGCGTTTC 
32 78 50 
    
   
    
JLMt4l005-F CTGGGATGCGTATAAAAACC 26 75 54 around codon 153 to try to re-introduce the missing ACG 
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TGGGCG (Threonine) at codon 152, using Phusion site-
mutagenesis kit (PCR) 
JLMt4l006-R 
GTGCCGGTTTTCTACGTGGTA
ATCACG 
27 74 52 
    
   
    
T4L153TAG opt for 
CATATGAACATCTTCGAAATG
CTGCG 
26 71 42 Anneal pAAT4l153TAG plasmid at 
optimised T4L sequence beginning 
and histag at 3' end of gene 
colony PCR and sequencing 
T4L153TAG opt rev 
GCGGCCGCTTATTAATGATG
ATGATG 
26 73 46 
    
   
    
JLMt4l007-F 
ATGaatatatttgaaatgttacgtata
gatg 
31 61 23 primers designed to flank T4L gene 
within the pT4L153TAG plasmid 
(no histag),  
for colony PCR of expression culture cells 
JLMt4l008-R ttatagatttttatacgcgtccc 23 60 35 
    
   
    
JLMpAA001 
CAATTGTGAGCGGATAACAA
T 
21 62 38 
anneals  37bp upstream of  XmaI 
RE site of pAA plasmid 
sequence inserts in pAA 
JLMpAA002 
ATGGAGTTCTGAGGTCATTA
CTG 
23 61 44 
anneals 36bp downstream of NotI 
site of pAA RP 
    
   
    
JLMt4l009 
atatatggatccATGAATATATTT
GAAATGTTACGTATAGAT 
28 59 
 
6extra bases-BamH1site-gene FP to clone t4l into pLM1 
JLMt4l010 
atatataagcttTCAATGGTGAT
GGTGATGA  
62 
 
6exctra-HimdIIIsite-end of gene 
(histag) 
RP to clone into pLM1 
    
   
    
JLMt4l011 
ACCATGAATATATTTGAAATG
TTACGTATAG 
57 28 21 
5'-NcoI recognition site, ATG and 
start of t4l gene (in pT4L) FP 
for cloning into pBAD 
JLMt4l012 
TTATTAATGATGATGATGATG
ATGTAGATTTTTATACGCGTC
CC 
59 
  
3'-end of t4l gene (in pT4L), histag 
sequence, TAA stop codon, RP 
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JLMt4l013 TAGATTTTTATACGCGTCCC 59 20 40 
same as jlmt4l012 but no histag or 
stop 
  
JLMt4l014 
taccatggATGAATATATTTGAA
ATGTTACGTATAG 
57 
  
5' 2bp, NcoI site, t4l gene 3'   
JLMt4l015 
atgtttaaacTTATTAATGATGA
TGATGATGATGTAGATTTTTA
TACGCGTCCC 
59 
  
5' 2bp, PmeI site, histag, end of t4l 
3' 
  
    
   
    
T4L153 TAG-ttt 
AGTCATTACAACGTttAGAAC
TGGCACTT 
27 66 41 
anneals around codon 153, fp, 
5'phos 
mutate TAG153 back to WT Tyr 
T4L153 TAG-ttt RP 
CACCTAGATTTTTATACGCGT
CCC 
24 65 46 anneals around codon 153, rp 
    
   
    
FliC   
   
    
FliC FP CACC 
5'-
CACCATGGCACAAGTCATTAA
TAC-3' 
24 64 42 ATG--> of FliC 
to clone FliC gene (flagellin) from E.coli's 
genomic DNA using PCR, various DNA 
polymerases used (Phire most successful) 
FliC RP 
5'-
ACCCTGCAGCAGAGACAGAA
C -3' 
21 66 57 end of FliC   
    
   
    
JLMFliC003 
CTTACTGGAATTACCCTTTCT
ACGG 
25 64 44 anneals , forward primer 
sequencing 
JLMFliC004 GGTCATCATCACCATCACCAT 21 65 48 
anneals 623-599nts of FliC gene, 
forward primer 
JLMFliC005 AAGCAGCCACTGATACTGGC 20 65 55 
anneals 624-643nts of FliC gene, 
forward primer 
JLMFliC006 
ATGGTGATGGTGATGATGAC
C 
21 65 48 
anneals histag at end of FliC, 
reverse primer 
JLMFliC007 
CCGTAGAAAGGGTAATTCCA
GTAAG 
25 65 44 
anneals 623-599nts of FliC gene, 
reverse primer 
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JLMFliC008 
aaaaaaCCCGGGATGGCACAA
GTCATTAATACCAACAG 
26 66 38 
anneals first part of FliC gene, + 
XmaI REsite upstream, 
 for cloning FliC gene (+TAG already) into pAA, 
FP 
JLMFliC009 
aaaaaaCCCGGGATGGCACAA
GTCATTAATtagAACAGCC 
28 68 39 
anneals first part of FliC gene, + 
XmaI REsite upstream + TAG at 
codon 7(Tyr),  
for cloning FliC gene into pAA  (colony30), FP 
JLMFliC010 
tatatatGCGGCCGCttaACCCT
GCAGCAGAGACAGAAC 
21 66 57 
anneals last part of FliC, +TAA stop 
codon 
 to remove V5epitope and histag + NotI REsite, 
RP 
    
   
    
JLMFliC011 
GAGCTCGCCCTTATTAACCCT
GC 
23 70 57 
anneals last nts of FliC +TAAT to 
remove V5 epiope and histag using 
Phusion polymerase RP to remove V5 epiope and histag using Phusion 
polymerase RP   (GAGCTCGCCCTAACCCTGC) 
 
69 
 
  
JLMFliC012 
AATTCGAAGCTTGAAGGTAA
GCCTATC 
27 67 
 
anneals next to JLMFlic011, for use 
with Phusion 
    
   
    
    
   
    
JLMFliC013 
TTAACCCTGCAGCAGAGACA
G 
21 65 52 
RP to clone FliC gene from ASKA 
plasmid, with TAA stop at end, 
 clone into pET101 
    
   
    
JLMFliC014 
atatatccatggATGGCACAAGT
CATTAATACCAAC 
24 63 38 
FP; 6 extra bases + NcoI site + FliC 
gene 
to clone FliC into pQE60  
JLMFliC015 
atatatagatctTTAACCCTGCAG
CAGAGACA 
20 64 50 
RP ; 6 extra bases + BglII site + end 
of gene 
    
   
    
Alicja's pQE60 seq 
for 
gagcggataacaatttcacac 21 61 
 
MCS of pQE60 sequencing insertions into pAA 
Alicja's pQE60 seq 
rev 
aggagtccaagctcagctaat 21 61 
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JLMpQEFliC001 
AAATCACCGGTGtagATAACG
ATGGGA 
24 71 46 
FliC middle 
mutagenic: for use with Phusion.  GTG-->TAG 
mutation in middle 
JLMpQEFliC002 
TCGCATAGTAATCATTACCAT
TATCAGTATAAACAC 
36 67 31 RP for ^ 
p=with 5' 
phosphates 
  
   
    
    
   
    
JLMFliC016 
TTAACCCTGCAGCAGAGACA
G 
21 65 52 like FliC RP, but + TAA   
    
   
    
pFD313 bla 01 gttaccaatgcttaatcagtgag 23 60 40 
anneals to bla gene 
for sequencing pFD313 (in KAF95) & pSWANs 
pFD313 bla 02 ctcactgattaagcattggtaac 
   
for sequencing pFD313 (in KAF95) reverse 
complement of 01 
pFD313 1 for ttctcatgtt tgacagctta 20 57 35 as above, from 1 forward 
for sequencing pFD313 
pFD313 tet rev atccgttagcgaggtgc 17 62 59 reverse, end of tetr in pBR322 
    
   
    
pFD313 FliC 
insertion FP 
TACGCAGTAACAGTTGCTAAT
GATGGTACAGTGACAATGGC
GACTGGAGCAACGGCAAATG
CAACTGTAACTGATGCAAATA
CTACTAAAGCTACAACTATCA
CTTCAGGCGGTACACCTGTTC
AGATTGATAATACTGCAGGT
TCCGCAACTGCCAACCTTGGT
GCTGTTAGCTTAGTAAAACTG
CAGGATTCCAAG 
27 67 41 27 matched, FliC 
 5' insertion sequence part of FliC missing from 
pFD313 FP 
pFD313 FliC 
insertion RP 
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pFD313 tat-TAG FP 
ACGATGGGAAGTAgAGATCT
CCCGGGA 
26 74 54 
middle of FliC 
primer for Phusion mutagenesis, to introduce 
TAT (tyr) to TAG mutation at codon 244 of FliC 
within pFD313 plasmid, mutagenic FP 
pFD313 tat-TAG RP 
TATCACCACCGGTGATTTTCG
CATAGTA 
28 72 43 
primer for Phusion mutagenesis, to introduce 
TAT (tyr) to TAG mutation at codon 244 of FliC 
within pFD313 plasmid, RP 
    
   
    
pFD313 tat-TAG FP2 
ATGGGAAGTAgAGATCTCCC
GG 
21 65 52 
middle of FliC 
  
pFD313 tat-TAG 
RP2 
CGTTATCACCACCGGTGATTT 21 66 48   
    
   
    
pFD313 tat-TAG FP3 
GATACCGATACATAgGCGCTT
AAAGATAC 
29 64 39 
middle of FliC 
  
pFD313 tat-TAG 
RP3 
ATTACCCTTGGAATCCTGCAG
T 
22 65 46   
    
   
    
pFD313 - FliC FP 
tatataTAGATCTGTAACAGTT
GCTAATGA 
26 58 31 
extra bases, BglII RE site bit of FliC 
missing from pFD313 
cloning missing FliC sequence back into pFD313 
pFD313 - FliC RP 
atatataagcttACCAAGGTTGG
CAGTTG 
17 60 53 
extra bases, Hind lII RE site bit of 
FliC missing from pFD313 
    
   
    
pFD313 FliC seq FP ATTGAGCCGACGGGTG 16 64 62   sequence and screen FliC in pFD313 
pFD313 FliC seq RP TAAGCGCAGCGCATCA 16 65 56   sequence and screen FliC in pFD313 
    
   
    
pFD313frag16 TAG 
FP 
AATCACCGGTtagGATAACGA
TGG 
21 66 48 
around codon 239 of FliC mutate codon to TAG for amber suppression 
pFD313frag16 TAG 
RP 
TTCGCATAGTAATCATTACCA
TTATCAGTAT 
31 65 29 
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FliCPhe54TAG FP 
GCGATTGCTAACCGTtagACC
TCTAACATTA 
29 69 41 
mutagenic primers to mutate Phe 
ttc to TAG, 1st Phe or tyr from 
codon 1 mutate codon to TAG for amber suppression 
FliCPhe54TAG RP CTGACCCGCTGCGTCAT 17 67 65 
 primers to mutate Phe ttc to TAG, 
1st Phe or tyr from codon 1 RP 
eGFP   
   
    
eGFP FP atggtgagcaagggcga 17 66 59 ATG--> GFP gene 
for enhanced GFP in pEGFP-C2 and pSWANGFP 
eGFP RP ttacttgtacagctcgtccatgc 23 65 48 end of GFP gene <--TAA 
eGFP 003 ctgctggagttcgtgacc 18 63 61 
anneals just upstream of end of 
eGFP FP 
to sequence pEGFP-C2 plasmid after eGFP gene 
(Rac1) 
eGFP 004 gtccagctcgaccaggat 18 64 61 
anneals just downstream of 
beginning of eGFP RP 
to sequence peGFP plasmid before eGFP gene 
primer name sequence (5' --> 3') 
nucleotide 
length that 
anneals 
Tm 
(Finnzym
es; °C) 
GC % Annealing site use 
Rac1   
   
    
XhoImRac1 FP 
atatatctcgagATGCAGGCCAT
CAAGTGTGT 
20 66 50 
anneals to beginning of mrac1, 
XhoI site 5' forward primer, 6 spare 
bps 5' 
for cloning mRac1 into TPS194 
mRac1NotI RP 
atatatgcggccgcTTACAACAGG
CATTTTCTCTTCC 
23 63 39 
anneals to end of mrac1, NotI site 
5' forward primer, 6 spare bps 5' 
for cloning mRac1 into TPS194 
mRac1NotI RP2 
atatatgcggccgcTTACAACAGC
AGGCATTTTCTCTTC 
25 67 40 
anneals to end of mrac1, NotI site 
5' forward primer, 6 spare bps 5' 
for cloning mRac1 into TPS194, missing Leu 
    
   
    
mRac1 Y23TAG FP ctcatcagttaGacgaccaatgcatt 25 67 40 anneals around Y23 of rac1 
mutagenic primers mRac1 Tyr23-->TAG for use 
with Phusion, 5' phos 
mRac1 Y23TAG RP caggcaggttttaccaacagctc 23 68 52 anneals around Y23 of rac1 
reverse primer for mRac1 Tyr23-->TAG for use 
with Phusion, 5' phos 
    
   
    
CMV Forward CGCAAATGGGCGGTAG 16 64 62 
Human CMV immediate early 
promoter 
sequence DNA in mammalian plasmids, and 
after cloning  
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pCMVTnT seq FP AGGTGTCCACTCCCAGTTC 19 62 58 
anneals just upstream of XhoI site 
in TPS194 (pCMVTnT) of MCS  for sequencing cloning of mRAC1 into 
pCMVTnT 
pCMVTnT seq RP 
GCAATAGCATCACAAATTTCA
C 
22 61 36 
anneals just downstream of NotI 
site in TPS194 (pCMVTnT) of MCS 
    
   
    
    
   
    
Not1eGFP FP 
atatatGCGGCCGCatggtgagca
agggc 
15 59 60 
extra bases, not1 site, beginning of 
rac1 gene 
clone eGFP into pCMVTNTRac1 c-terminal to 
rac1 FP 
eGFPNot1 RP 
atatatGCGGCCGCttacttgtaca
gctcgtccat 
21 59 43 
extra bases, not1 site, end of rac1 
gene 
clone eGFP into pCMVTNTRac1 c-terminal to 
rac1 RP 
    
   
    
rac1eGFP FP CCTGCTGTTGggcatggtgagca 20 68 55 
end of rac1 gene, start of GFP 
 mutate TAA to GGC (Gly), start of eGFP 
rac1eGFP RP 
CATTTTCTCTTCCTCTTCTTGA
CAGGA 
27 68 41 
RP for mutant FP primer to make Rac1-eGFP 
fusion protein 
  stupid - forgotten NotI site 
   
    
    
   
    
Rac1GFP 001 caacagcaggcattttctcttcct 24 69 46 end of rac1 delete taaggc at end of rac1 eGFP cloning,  
Rac1GFP 002 CGCatggtgagcaagggc 18 71 67 end of rac1 delete taaggc at end of rac1 eGFP cloning,  
Rac1GFP 003 tctgtccccctcctgtcaa 19 66 58 
 anneals upstream of beginning of 
rac1 gene, in pCMVTnT, FP 
use with eGFP RP to screen pCMVTNTRac1 
eGFP cloning, screen for directionality, 
    
   
    
racGFP 005 
atatatACCGGTatgcaggccatca
agtg 
17 62 53 
6 extra bases, AgeI site, beginning 
of rac1 gene FP 
for cloning Rac1 into peGFP 5' to eGFP gene 
racGFP 004 
atatatACCGGTcaacagcaggcat
tttctc 
19 62 47 
6 extra bases, AgeI site, end of rac1 
gene -TAA.  RP 
racGFP 006 
atatatACCGGTttttctcttcctctt
cttgacag 
23 61 39 
6 extra bases, AgeI site, end of rac1 
gene -CLLL (CAAX) TAG RP 
racGFP 007 
atatatACCGGTgacaggaggggg
acaga 
17 62 65 
6 extra bases, AgeI site, end of rac1 
gene -KKRKRKCLLL (polybasic + 
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CAAX) TAG RP 
    
   
    
racGFP 012 
GGCGGGTCCGGCGGCTCGat
ggtgagcaagggcga 
17 66 59 anneals to seq between rac & GFP 
add GGSGGS linker sequence between rac1 and 
GFP in racGFP anneals to beginning of eGFP 
racGFP 013 gacaggagggggacagaga 19 65 63 anneals to seq between rac & GFP RP for racGFP012, racGFP3.1 (-KKRKRKCLLL) 
racGFP 014 ttttctcttcctcttcttgacagg 24 65 42 anneals to seq between rac & GFP RP for racGFP012, racGFP PCR2 (2.5) (-CLLL) 
    
   
    
racGFP 015 
ttacaacagcaggcacttgtacagctc
gtccatgc 
20 64 55 
anneals to end of eGFP, plus  CLLL 
(from rac1) 
mutagenic, RP 
racGFP 016 TCCGGCCGGACTCAGA 14 65 71 anneals just downstream of GFP,  for use with racGFP015 and 017, FP 
racGFP 017 
ttacaacagcaggcattttctcttcctc
ttcttcttgtacagctcgtccatgc 
20 64 55 
anneals to end of eGFP, plus 
polybasic, CLLL (from rac1) 
 mutagenic, RP 
    
   
    
pSWANRS seq CGTGAAGATCAGGGGATT 18 61 50 
anneals mid-EcRS gene to 
sequence  
for sequencing cloning into pBluescript for 
insertion of IRES 
    
   
    
racGFP IRES001 
atatatCTCGAGatgcaggccatca
agtg 
17 62 53 6bp, XhoI (CTCGAG), start of rac1 
 for cloning rac1-GFP into pBlue-IRES racGFP IRES002 
ttaattGGTACCttacaacagcagg
cacttgtac 
22 62 45 
6bp, KpnI site (GGTACC), end of 
GFP, CLL seq 
racGFP IRES003 
ttaattGGTACCttacaacagcagg
cattttctc 
22 63 41 
6bp, KpnI site (GGTACC), end of 
GFP, RKCL seq 
    
   
    
EcTyrRS FP 
ATGGCAAGCAGTAACTTGAT
T 
20 59 40 anneals to ATG+ of e coli tyr-RS, 
 for sequencing and PCR on cDNA from mRNA 
EcTyrRS RP TTACTTGTCGTCATCGTCTTT 21 59 38 
anneals to end of EcTyrRS in pUAA 
for Rt-PCR screen for azRS in pUAA 
tx't cells 
EcTyrRS RP2 CTTTCCAGCAAATCAGACAGT 21 61 43 
anneals to end of EcTyrRS in pUAA 
for Rt-PCR screen for azRS in pUAA 
tx't cells 
404 
 
    
   
    
rac FP atgcaggccatcaagtg 17 62 53 anneals to ATG+ of mRac1 gene 
for use in PCR after RT-PCR of RNA extraction 
from transfected racKO cells, use with rac FP rac RP CTGTCCCCCTCCTGTC 16 60 69 
anneals to end of rac gene 
upstream of polybasic and CLLL,  
    
   
    
racGFP 018 
atatattctagaATGCAGGCCAT
CAAGTGCGT 
17 62 53 6 bp, XbaI site, start of rac gene,  
for cloning into pSWANRS (pcDNA3.1hygro) racGFP 019 
ttaattgggcccttacaacagcaggca
cttgta 
21 62 43 6 bp, ApaI site, end of GFPCL gene,  
racGFP 020 
ttaattGGGCCCttacaacagcagg
cattttctc 
22 64 41 
6 bp, ApaI site, end of GFPRKCL 
gene,  
    
   
    
T3 promoter aattaaccctcactaaaggg 20 57 40   sequence cloning in pBluescript-IRES 
    
   
    
IRES 19FP CCCCTAACGTTACTGGC 17 59 59 anneals 19-35 of IRES  for sequencing 
    
   
    
racGFP IRES004 
atatatGAATTCatgcaggccatca
agtg 
17 62 53 
6bp, EcoRI site (GAATTC), start of 
rac1  
 for cloning rac1-GFP into pBlue-IRES racGFP IRES005 
ttaattCTCGAGttacaacagcagg
cacttgtac 
22 62 45 
6bp, XhoI site (CTCGAG), end of 
GFP, CLL seq 
racGFP IRES006 
ttaattCTCGAGttacaacagcagg
cattttctc 
22 63 41 
6bp, XhoI site (CTCGAG), end of 
GFP, RKCL seq 
    
   
    
AzRS IRES001 
aattaagcggccgcATGGCAAGC
AGTAACTTGA 
19 59 42 
6bp, NotI site (GCGGCCGC), start 
of AzRS 
for cloning AzRS into pblueIRES-racGFP and into 
pSWAN 
AzRS IRES002 
atatattctagaTTACTTGTCGTC
ATCGTCTT 
20 58 40 
6bp, XbaI site (TCTAGA), end of 
AzRS 
for cloning AzRS into pblueIRES-racGFP 
    
   
    
racGFP IRES007 
atatatACCGGTttacaacagcagg
cacttgtac 
22 62 45 
6bp, AgeI site (ACCGGT), end of 
racGFPCL 
for cloning AzRS-IRES-racGFPCL into pSWANRS, 
for use with AzRS IRES001 
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racGFP IRES008 
atatatACCGGTttacaacagcagg
cattttctc 
22 63 41 
6bp, AgeI site (ACCGGT), end of 
racGFPRKCL 
for cloning AzRS-IRES-racGFPRKCL into 
pSWANRS 
    
   
    
CMV RP CTACCGCCCATTTGCG 16 64 62 same as FP, but RP 
to sequence BstRNA upstream of CMV 
promoter 
    
   
    
pUAA001 ATGGTGAGCAAGGGCGA 17 66 59 5'-P, anneals to eGFP ATG--> for removing rac from pUAAs 
pUAA002 GGCCACAACCATGGAATTC 19 66 53 5'-P, anneals to end of IRES 
 for removing rac from pUAAs (wrong way I 
think) 
pUAA002-2 GAATTCCATGGTTGTGGCC 19 66 53 5'-P, anneals to end of IRES for removing rac from pUAAs 
    
   
    
pUAA005 
ACCATGGAAGTCATGCAGGC
C 
20 70 55 
anneals to seq around ATG of 
racGFP in pUAACL4 
to improve kozak consensus, FP, 5'-P 
pUAA006 
TGTGGCCATATTATCATCGTG
TTTTTC 
27 69 37 to improve kozak consensus, RP  5'-P 
pUAA007 
ACCATGGAAacCATGCAGGC
C 
20 70 55  to improve kozak consensus, FP, 5'-P (2) 
    
   
    
pUAA008 
AGTGGCGGCacCATGGCAAG
CAGT 
22 78 64 
anneals to seq around ATG of azRS 
in pUAACL4,  
to improve kozak consensus, FP 
pUAA009 
GTGCTGGATATCTGCAGAAT
TCCACC 
26 71 46  to improve kozak consensus, RP 
    
   
    
pUAA010 TTGCGGCATTTTGCCTTC 18 68 50 
anneals to pUAACL (PcDNAz3zeo) 
after where CMVRP sequences 
upto,  
sequence pUAA plasmids 
    
   
    
pUAAA3TAGFP 
GAATTCATGCAGtagATCAAG
TGCGTG 
24 70 46 anneals to end of IRES-rac in 
pUAACL4 
to mutate A3-->TAG 
pUAAA3TAGRP CATGGTTGTGGCCATATTATC 25 70 44 reverse primer for ^ 
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ATCG 
    
   
    
pUAAI4TAGFP ATGCAGGCCtagAAGTGCGTG 18 69 61 
anneals to end of IRES-rac in 
pUAACL4 
to mutate I4-->TAG 
pUAAI4TAGRP 
GAATTCCATGGTTGTGGCCAT
ATTA 
25 68 40 reverse primer for ^ 
    
   
    
zeoFP ATGGCCAAGTTGACCAGTG 19 64 53 
anneals to ATG--> of zeocin gene 
(pcDNA and pUAA) 
PCR of cDNA from RNA extraction, and 
sequencing 
zeoRP TCAGTCCTGCTCCTCGG 17 64 65 
anneals to end of Zeocin gene 
(pcDNA and pUAA) 
PCR of cDNA from RNA extraction, and 
sequencing 
    
   
    
pUAA011 
CACAACCAgGGAAacCATGCA
GGCC 
21 70 
 
anneals to kozak consensus and 
start of rac 
mutate consensus of rac (pUAACL4) , and 
remove previous ATG, need -P (PNK) 
pUAA012 
GCCATATTATCATCGTGTTTT
TCAAAGG 
28 68 36 
anneals to kozak consensus and 
start of rac 
RP for ^ need -P (PNK) 
    
   
    
pUAA013 
CACAACCATGGAAacCATGCA
GGC 
22 72 55 
anneals to kozak consensus and 
start of rac 
mutate consensus of rac (pUAACL4) , and 
remove previous ATG, use with 012 need -P 
(PNK) 
    
   
    
pUAA014 
AACCATGGAAacCATGCAGG
CCA 
21 72 52 
anneals to kozak consensus and 
start of rac 
mutate consensus of rac (pUAACL4) , and 
remove previous ATG, use with 015 need -P 
(PNK) 
pUAA015 
GTGGCCATATTATCATCGTGT
TTTTC 
26 67 39 
anneals to kozak consensus and 
start of rac 
RP for ^ need -P (PNK) 
β-actin forward 
CCACACTGTGCCCATCTACGA
GGGGT 26 76.8 62 
564 – 589 RT-PCR of β-actin 
β-actin reverse 
AGGGCAGTGATCTCCTTCTGC
ATCCT 
26 73.6 54 1043 - 1018 RT-PCR of β-actin 
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9.3 A3 Sequences of NAA-specific synthetases for E. coli 
culture 
The engineered aaRSs were provided by Schultz group (Wang et al. 2001) or A. 
Antonczak (Antonczak 2012 Thesis). The possible sites for mutagenesis were Y32, 
L65, H70, E107, F108, Q109, D158, I159, L162, A167 and D286.  The sequences of RS 
genes used in the study are compared to that of WT MjTyrRS and are indicated in 
Figure 124. 
 
Figure 125.  Comparison of protein sequences of MjTyrRS synthetases engineered for specific 
NAAs 
408 
 
9.4 A4 Mass spectrometry spectra 
 
Figure 126 Mass spectrum of WT T4L.  MS was obtained using ESI. 
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Figure 127.  Mass spectrum of T4L153azF.  MS was obtained using ESI. 
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Figure 128.  Mass spectrum of T4L153iodoF.  MS was obtained using ESI. 
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9.5 A5 Isolation of KAF95  
KAF95 was produced from mutagenesis screens with ethyl methanesulfonate 
(EMS), which typically results in guanine alkylation, forming O-6-methylguanine.  
During DNA replication, DNA polymerases frequently place thymine, instead of 
cytosine, opposite O-6-methylguanine, which, in following subsequent rounds of 
replication, turns the original G:C pair into an A:T pair. 
The E. coli strain KAF95 was supplied containing the ampicillin resistant plasmid, 
pFD313.  To lose this plasmid, the KAF95 culture was grown sequentially in the 
absence of antibiotics.  Two rounds of 8 – 14 hour liquid culture incubations were 
performed, a sample from the liquid culture was then spread onto an agar plate.  
The following day, 10 colonies were picked, resuspended in 300 µl LB and 1 µl 
samples pipetted onto 5 x agar plates each containing an antibiotic; carbenicillin, 
tetracycline, kanamycin, chloramphenicol or no antibiotic.  This was repeated until 
a colony was isolated that was susceptible to the four antibiotics.
412 
 
9.6 A6 Restoration of motility to KAF95 utilising plasmid 
pFD313 
 
Figure 129.  Restoration of motility of KAF95 using plasmid pFD313 
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9.7 A7 Translated protein sequences of FliC-containing 
constructs 
 
Figure 130.  Comparison of protein sequence of WT Flagellin and that encoded by plasmid pET101FliC.  
Plasmid DNA was sequenced, the sequence was translated to protein using ExPASy online tool and 
compared using ClustalW2 tool.  Difference from WT FliC are highlighted. 
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9.8 A8 PCR amplification of β-actin gene from cDNA 
synthesised from extracted RNA 
 
 
Figure 131.  Agarose gel (2%) of PCR to amplify β-actin gene from cDNA synthesised from RNA 
extracted from control cells (lane 1), racKO cells (lane 2), and racKO cells transfected with peGFP 
(lane 3), pGFPRac1 (lane 4), pRacGFPCL (lane 5), pRacGFPRK (lane 6), previously isolated cDNA 
(lane 7) a d DEPC water (lane 8). 
600bp 
500bp 
100bp      1            2             3           4           5            6         7          8 
415 
 
9.9 A9 Creation of plasmid pCMVTnTRac1 
Plasmid TPS194_FluCYam had previously been created using the commercially 
available plasmid pCMVTnT™ (Promega) and had been kindly donated by Dr 
Thomas Sakmar, Rockefeller University (Ye et al. 2009).  It encoded a luciferase 
gene under the control of constitutive CMV promoter, with a 5´ β-globin leader 
sequence and termination by the late SV40 polyadenylation signal.  
The luciferase gene was removed from TPS194 by digesting the plasmid with XhoI 
and NotI-HF (NEBuffer 4 + BSA, 37 °C).  DNA corresponding to linearised pCMVTnT 
minus the luciferase gene was excised from a preparative agarose gel and the DNA 
purified.  Rac1 was amplified from plasmid pGFPRac1 using primers that added an 
XhoI and NotI site to the 5’ and 3’ end of the PCR product, respectively.  The PCR 
product and complementarily digested PCR products were ligated and transformed 
into Top10 E. coli and plated onto agar containing carbenicillin.  Colony PCR was 
used to screen colonies for insertion of the Rac1 gene.  Positive colonies were 
confirmed by DNA sequencing.  This created plasmid pCMVTnTRac1. 
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9.10   A10 Sample X-ray diffraction pattern of T4L WT 
 
Figure 132. Sample x-ray diffraction of T4L WT.  Pattern was collected at Diamond light source, 
Didcot, by Dr P. Rizkallah. 
